[
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"Protein\": 5},\n    {\"GM-CSF\": 5},\n    {\"cDNAs\": 5},\n    {\"IgH\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"Stat proteins\": 5},\n    {\"immunohistochemistry\": 5},\n    {\"gene\": 5},\n    {\"cell type\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GM-kappa B\": 5},\n    {\"GC-box\": 5},\n    {\"GC-motif\": 5},\n    {\"GM-kappa B motif\": 5},\n    {\"p50\": 5},\n    {\"p65\": 5},\n    {\"HIV-1 LTR\": 5},\n    {\"NFAT-1\": 5},\n    {\"NF kappa B\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"SIVmac\": 5}\n]",
        "response3": "[{\"HMG boxes\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'HMG boxes': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a DNA entity (cDNAs) and its corresponding label.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence provides multiple examples of protein entities (EKLF, CBP, p300, P/CAF) and their corresponding labels.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides a clear example of a protein entity (G-CSF) and its corresponding label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3' enhancer) and its corresponding label.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides a clear example of a protein entity (CD95 ligand) and its corresponding label.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides a clear example of a DNA entity (DNA) and its corresponding label.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides a clear example of a cell line entity (SCM-1) and its corresponding label.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides a clear example of a cell type entity (cell adhesion molecules) and its corresponding label.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides a clear example of a protein entity (E2A) and its corresponding label.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides a clear example of a protein entity (BRCA1) and its corresponding label.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides multiple examples of protein entities (CREB, AR-CRE) and their corresponding labels.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence provides a clear example of a cell line entity (SIVsmmPBj14) and its corresponding label.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence provides a clear example of a protein entity (protein) and its corresponding label.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any entities related to the given entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any entities related to the given entity labels.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any entities related to the given entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals, and growth factors.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'DNA' and provides clear context for its presence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'RNA' and provides clear context for its presence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple mentions of protein-related entities and provides context for their presence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions the entity 'protein' and provides clear context for its presence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple mentions of protein-related entities and provides context for their presence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the entities 'RNA' and 'cell_line' and provides clear context for their presence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions the entity 'DNA' and provides clear context for its presence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions the entity 'protein' and provides clear context for its presence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple mentions of protein-related entities and provides context for their presence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions the entity 'protein' and provides clear context for its presence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions the entities 'protein' and provides clear context for their presence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the entities 'protein' and provides clear context for their presence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly mentions the entity 'cell_type' and provides clear context for its presence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains multiple mentions of protein-related entities and provides context for their presence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains multiple mentions of protein-related entities and provides context for their presence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not mention any specific entities related to the given label set.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not mention any specific entities related to the given label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not mention any specific entities related to the given label set.\"}\n]",
        "response3": "[{\"PDGF(B)\": \"RNA\"}]",
        "prediction": "{'PDGF(B)': 'RNA'}"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"57- to 53-kD proteins\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"CCRF-CEM\": \"cell_line\"}, {\"JY\": \"cell_line\"}, {\"Namalwa\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"lymphocyte cytosolic protein\": \"protein\"}, {\"lymphocyte DNA\": \"DNA\"}]",
        "prediction": "{'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 3},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein'}"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IM-9\": \"cell_line\"}, {\"estradiol\": \"protein\"}]",
        "prediction": "{'IM-9': 'cell_line', 'estradiol': 'protein'}"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 4},\n{\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"C/EBP\": \"protein\"}, {\"HIV-1 LTR\": \"DNA\"}]",
        "prediction": "{'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 3},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}, {\"GAL4 DNA binding domain\": \"DNA\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"IgH\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 4},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"IL-4\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"interleukin 10\": 5, \"IL-10R\": 5, \"STAT3\": 5, \"IL-6\": 5},\n    {\"IL-13\": 5, \"IL-4\": 5, \"B cell\": 5, \"monocyte\": 5},\n    {\"GATA-1\": 5},\n    {\"Sp1\": 5, \"Ets\": 5},\n    {\"Sp1\": 5, \"CD14\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"Egr-1\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"EGR-1\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"EBV\": 5, \"CD2\": 5},\n    {\"T cell\": 4, \"IL-2\": 5, \"IL-2 receptor\": 5, \"CD28\": 5},\n    {\"TIMP-1\": 5, \"DNA\": 5},\n    {\"IL-2\": 5, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"GATA-1\": 5},\n    {\"Syk\": 5, \"Zap\": 5, \"T cell\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"AP-1\": 5},\n    {\"FasL\": 5, \"IL-2\": 5, \"IFN-gamma\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 4},\n    {\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 4},\n    {\"Bak\": 5, \"Bad\": 5, \"Bcl-2\": 5, \"PDBu\": 4, \"DMSO\": 4},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"apoptosis\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"p53\": \"protein\"}, {\"apoptosis\": \"cell_type\"}, {\"thymocytes\": \"cell_type\"}, {\"p53\": \"protein\"}, {\"mitogen-activated mature T lymphocytes\": \"cell_type\"}]",
        "prediction": "{'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'mitogen-activated mature T lymphocytes': 'cell_type'}"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"1,25(OH)2D3\": \"protein\"}, {\"tuberculosis\": \"cell_type\"}, {\"unseparated lavage cells\": \"cell_type\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_type'}"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-5 mRNA\": 5, \"TCR\": 4, \"IL-2R\": 5, \"dexamethasone\": 5},\n    {\"phosphocreatine\": 5},\n    {\"HML\": 5, \"dexamethasone\": 5, \"cortisol\": 5, \"lysozyme\": 5},\n    {\"NF-E2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"MNDA\": 5, \"myeloid cell lines\": 5},\n    {\"P selectin\": 5},\n    {\"interleukin-2\": 5, \"alpha chain\": 5, \"CD25\": 5, \"IL-2 receptor\": 5},\n    {\"CTLA4Ig\": 5, \"NFAT\": 4, \"AP-1\": 4},\n    {\"Erbstatin\": 5, \"genistein\": 5, \"Egr-1\": 5},\n    {\"CD4+\": 5, \"CD8+\": 5, \"TPCK\": 5, \"anti-CD28\": 5, \"PMA\": 5},\n    {\"MR\": 5, \"aldosterone\": 5, \"progesterone\": 5},\n    {\"Ras\": 5, \"RasN17\": 5, \"IL-2\": 5, \"CIS\": 5, \"OSM\": 5, \"STAT5\": 5},\n    {\"Type I\": 4, \"Type II\": 4},\n    {},\n    {},\n    {}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5},\n    {\"UAS1\": 4, \"B cell\": 5},\n    {\"SIVsmmPBj14\": 5},\n    {\"hepatitis B virus\": 5, \"HBxAg\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GATA-1\": 5},\n    {\"AP-1\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n    {\"Egr-1\": 5},\n    {\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5},\n    {\"HIV-1 LTR\": 5, \"NFAT-1\": 5, \"NF kappa B\": 5},\n    {\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5},\n    {\"NF-E1\": 5, \"YY-1\": 5},\n    {\"Common pathway\": 1},\n    {\"Tumors\": 1},\n    {\"Distinct genes\": 1}\n]",
        "response3": "[{\"HIV-1\": \"DNA\"}, {\"HIV-2\": \"DNA\"}]",
        "prediction": "{'HIV-1': 'DNA', 'HIV-2': 'DNA'}"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 1},\n    {\"Example 14\": 1},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HeLa cells\": \"cell_line\"}, {\"T-cells\": \"cell_line\"}, {\"DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"52 kD\": \"protein\"}, {\"45 kilodaltons (kD)\": \"protein\"}, {\"82\": \"protein\"}, {\"67\": \"protein\"}, {\"43-47 kD\": \"protein\"}]",
        "prediction": "{'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein', '52 kD': 'protein', '45 kilodaltons (kD)': 'protein', '82': 'protein', '67': 'protein', '43-47 kD': 'protein'}"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"UAS1\": 5, \"B cell\": 4},\n{\"ZEBRA\": 5},\n{\"IL-4\": 4},\n{\"IL-2\": 5},\n{\"T cell\": 4, \"interleukin 2\": 4},\n{\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n{\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"Jun\": 5, \"ATF-2\": 5},\n{\"Sp1\": 5, \"CD14\": 5},\n{\"p50p50\": 5},\n{\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n{\"EKLF\": 5},\n{\"EBNA2\": 5, \"TP1\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CCAAT box\": 5, \"EKLF binding site\": 5},\n{\"None\": 1},\n{\"None\": 1},\n{\"None\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"protooncogenes\": \"protein\"}, {\"cytoskeletal\": \"protein\"}, {\"extracellular matrix genes\": \"protein\"}, {\"immediate early response genes\": \"protein\"}, {\"growth factor\": \"protein\"}, {\"cell proliferation\": \"cell_type\"}]",
        "prediction": "{'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'immediate early response genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1 ) and p27(KIP1)\": 5},\n    {\"The sentence contains specific protein names that are directly mentioned, making it highly helpful in extracting named entities.\": 5},\n    {\"calcineurin\": 5},\n    {\"The sentence directly mentions 'calcineurin' as a protein, making it highly helpful in extracting named entities.\": 5},\n    {\"Th1 and Th2\": 5},\n    {\"The sentence mentions specific cell types 'Th1' and 'Th2', making it highly helpful in extracting named entities.\": 5},\n    {\"IL-2\": 5},\n    {\"The sentence directly mentions 'IL-2' as a protein, making it highly helpful in extracting named entities.\": 5},\n    {\"IL-12 and STAT4\": 5},\n    {\"The sentence contains specific protein names 'IL-12' and 'STAT4', making it highly helpful in extracting named entities.\": 5},\n    {\"SLAP-130, SLP-76, T cell\": 5},\n    {\"The sentence mentions specific protein names 'SLAP-130' and 'SLP-76', along with the cell type 'T cell', making it highly helpful in extracting named entities.\": 5},\n    {\"tyrosine\": 5},\n    {\"The sentence directly mentions 'tyrosine' as a protein, making it highly helpful in extracting named entities.\": 5},\n    {\"IL-2, IFN-gamma, jak kinases, STAT1(alpha)\": 5},\n    {\"The sentence contains specific protein names 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)', making it highly helpful in extracting named entities.\": 5},\n    {\"IL-2, Aiolos, Ras\": 5},\n    {\"The sentence mentions specific protein names 'IL-2', 'Aiolos', and 'Ras', making it highly helpful in extracting named entities.\": 5},\n    {\"ERK, STAT3\": 5},\n    {\"The sentence contains specific protein names 'ERK' and 'STAT3', making it highly helpful in extracting named entities.\": 5},\n    {\"CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"The sentence mentions specific protein names 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', interleukin-2', and 'granulocyte-macrophage colony-stimulating factor', making it highly helpful in extracting named entities.\": 5},\n    {\"NF-kappaB, Sp1, p50\": 5},\n    {\"The sentence contains specific protein names 'NF-kappaB', 'Sp1', and 'p50', making it highly helpful in extracting named entities.\": 5},\n    {\"interleukin 10, IL-10R, STAT3, IL-6\": 5},\n    {\"The sentence contains specific protein names 'interleukin 10', 'IL-10R', 'STAT3', and 'IL-6', making it highly helpful in extracting named entities.\": 5},\n    {\"The sentence does not contain any relevant named entities.\": 1},\n    {\"The sentence does not contain any relevant named entities.\": 1},\n    {\"The sentence does not contain any relevant named entities.\": 1}\n]",
        "response3": "[{\"p94\": \"protein\"}, {\"p95\": \"protein\"}, {\"Stat1\": \"protein\"}]",
        "prediction": "{'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL-4\": 3},\n    {\"NF-E2\": 4},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"interferon regulatory factor\": 4},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"A-myb\": 5},\n    {\"Protein\": 3},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"p21(WAF1/CIP1)\": 4, \"p27(KIP1)\": 4},\n    {\"Drosophila Toll\": 4, \"human Toll\": 4},\n    {\"PAFR\": 4, \"PAF\": 4, \"NF-kappa B\": 4, \"protein kinase C\": 4},\n    {\"NF-kappa B\": 4, \"AP-1\": 4},\n    {\"EBNA-2\": 5, \"PU.1\": 5},\n    {\"NF-ATc\": 4, \"T lymphocytes\": 3, \"embryonic cardiac cells\": 3},\n    {\"immunoglobulin kappa 3' enhancer\": 1},\n    {\"Egr-1\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"IBR\": \"protein\"}, {\"NRF-1/alpha-Pal\": \"protein\"}, {\"P3A2\": \"protein\"}, {\"erected wing gene product (EWG)\": \"protein\"}]",
        "prediction": "{'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Example id\": 5, \"Reason id\": \"The sentence contains multiple protein entities and their corresponding labels, which can help in understanding the context and extracting named entities.\"},\n{\"Example id\": 4, \"Reason id\": \"The sentence contains cell type and protein entities, which can aid in identifying and extracting named entities.\"},\n{\"Example id\": 3, \"Reason id\": \"The sentence contains cell line entities and their labels, which can assist in recognizing and extracting named entities.\"},\n{\"Example id\": 4, \"Reason id\": \"The sentence includes cell type and protein entities, which can be helpful in extracting named entities.\"},\n{\"Example id\": 5, \"Reason id\": \"The sentence contains multiple protein entities and their corresponding labels, aiding in understanding the context and extracting named entities.\"},\n{\"Example id\": 5, \"Reason id\": \"The sentence includes a protein entity and a DNA entity, which can help in identifying and extracting named entities.\"},\n{\"Example id\": 3, \"Reason id\": \"The sentence contains a cell type entity and its label, which can assist in recognizing and extracting named entities.\"},\n{\"Example id\": 4, \"Reason id\": \"The sentence includes cell line and protein entities, which can be helpful in extracting named entities.\"},\n{\"Example id\": 4, \"Reason id\": \"The sentence contains cell type and DNA entities, which can aid in identifying and extracting named entities.\"},\n{\"Example id\": 3, \"Reason id\": \"The sentence includes a cell line entity and its label, which can assist in recognizing and extracting named entities.\"},\n{\"Example id\": 4, \"Reason id\": \"The sentence contains a protein entity, which can help in identifying and extracting named entities.\"},\n{\"Example id\": 5, \"Reason id\": \"The sentence includes DNA, protein, and DNA entities with their corresponding labels, aiding in understanding the context and extracting named entities.\"},\n{\"Example id\": 5, \"Reason id\": \"The sentence contains multiple protein entities and their corresponding labels, which can help in understanding the context and extracting named entities.\"},\n{\"Example id\": 4, \"Reason id\": \"The sentence includes protein, protein, and cell type entities, which can be helpful in extracting named entities.\"},\n{\"Example id\": 1, \"Reason id\": \"The sentence does not contain any relevant entities that can aid in extracting named entities.\"},\n{\"Example id\": 1, \"Reason id\": \"The sentence does not contain any relevant entities that can aid in extracting named entities.\"},\n{\"Example id\": 1, \"Reason id\": \"The sentence does not contain any relevant entities that can aid in extracting named entities.\"}\n]",
        "response3": "[{\"T-cell types\": \"cell_type\"}, {\"LTR\": \"DNA\"}]",
        "prediction": "{'T-cell types': 'cell_type', 'LTR': 'DNA'}"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"DCs\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a mutated human retinoic acid receptor alpha, which is a protein entity type mentioned in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions IL-7R and gamma(c) as proteins, which are entity types present in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions lymphoid neoplasms, which is a cell_type entity type present in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions retinoic acid receptor alpha, which is a protein entity type present in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions nonhuman primates, which is a cell_type entity type present in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions lymphocytes, benzene, and benzoquinone, which are cell_type and chemical compound entity types present in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides information about RXR, a protein entity type mentioned in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions G-CSF, which is a protein entity type present in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions IL4, IL13, gamma c chain, STAT6, STAT3, STAT5, and B cells, which are protein and cell_type entity types present in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions CCAAT box and EKLF binding site, which are DNA and protein entity types present in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions AP-1, which is a DNA entity type present in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions CD14, which is a protein entity type present in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides information about VDR, RXR, GRIP-1, DRIP205, and DRIP, which are protein entity types mentioned in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions interleukin-2, alpha chain, CD25, and IL-2 receptor, which are protein entity types present in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions TR55, TNF-alpha, and HIV, which are protein and cell_type entity types present in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides information about VDR, beta-globin, and a reporter gene, which are protein entity types mentioned in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entity types mentioned in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entity types mentioned in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entity types mentioned in the target sentence.\"}\n]",
        "response3": "[{\"VDR\": \"protein\"}]",
        "prediction": "{'VDR': 'protein'}"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the entity 'NF-kappa B' being associated with the entity type 'DNA', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides examples of entities 'NF-kappa B' and 'I kappa B alpha' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides examples of entities 'AP-1', 'PMA', 'monocytes', and 'macrophages' being associated with the entity types 'protein' and 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of entities 'granulocytes' and 'T cells' being associated with the entity type 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides an example of the entity 'NF-kappa B' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of entities 'NF-kappaB', 'Tax', and 'ATL' being associated with the entity types 'protein' and 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides examples of entities 'alpha-tocopherol', 'monocyte', and 'endothelial cells' being associated with the entity types 'protein' and 'cell_type', which is helpful for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides an example of the entity 'NF-kappa B' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides an example of the entity 'P selectin' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of entities 'NF-kappa B' and 'ARDS' being associated with the entity types 'protein' and 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides an example of the entity 'NF-kappa B' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of entities 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' being associated with the entity types 'protein' and 'cell_line', which is helpful for extracting named entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides an example of the entity 'E2A' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of entities 'NF-kappa B' and 'AP-1' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities related to the provided entity labels, hence it is not helpful for extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the provided entity labels, hence it is not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the provided entity labels, hence it is not helpful for extracting named entities.\"}\n]",
        "response3": "[{\"NFAT\": \"protein\"}, {\"CsA\": \"protein\"}, {\"endothelial cells\": \"cell_type\"}]",
        "prediction": "{'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5},\n    {\"Sentence 16\": 1},\n    {\"Sentence 17\": 1},\n    {\"Sentence 18\": 1}\n]",
        "response3": "[\n    {\"I kappa B alpha\": \"protein\"}\n]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"GATA-1\": 5},\n    {\"TAL1\": 4, \"T-ALL\": 4},\n    {\"granulocytes\": 4, \"T cells\": 4},\n    {\"cAMP-dependent protein kinase\": 5, \"Rap1\": 5},\n    {\"GATA-1\": 5},\n    {\"E2A\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4},\n    {\"TCL1\": 5},\n    {\"CREB\": 5, \"AR-CRE\": 5},\n    {\"RXR\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"Ter 119\": 5, \"beta-globin\": 5, \"glycoprotein IIb\": 5, \"platelet factor 4\": 5},\n    {\"2-deoxyguanosine\": 5, \"lymphoid progenitor cells\": 5, \"thymus stromal cells\": 4, \"B cell\": 5, \"tg epsilon26\": 5, \"fetal liver cells\": 5, \"T cell\": 4},\n    {\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 4},\n    {},\n    {}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"C1\": \"protein\"}, {\"C2\": \"protein\"}, {\"HIV enhancer\": \"DNA\"}, {\"Jurkat cells\": \"cell_line\"}]",
        "prediction": "{'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat cells': 'cell_line'}"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"TCF-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"embryonic cardiac cells\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"IL-2\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"NF-kappaB\": 5},\n    {\"rheumatoid arthritis\": 5},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"SIVmac\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"SIVmac\": 5},\n    {\"CTLA4Ig\": 5},\n    {\"NFAT\": 5},\n    {\"AP-1\": 5}\n]",
        "response3": "[{\"Ig heavy chain enhancer\": \"DNA\"}, {\"NF-muE3\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"non-B cells\": \"cell_type\"}]",
        "prediction": "{'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"EC1 antibody\": \"protein\"}, {\"p56\": \"protein\"}]",
        "prediction": "{'EC1 antibody': 'protein', 'p56': 'protein'}"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (RXR) and its corresponding entity label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains clear examples of cell types (granulocytes and T cells) and their corresponding entity labels.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a cell type (lymphoid neoplasms) and its corresponding entity label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear example of a protein (CD14) and its corresponding entity label.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains clear examples of proteins (phosphocreatine) and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of a cell line (HML) and proteins (dexamethasone, cortisol, lysozyme) with their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) with their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of proteins (cAMP-dependent protein kinase, Rap1) and their corresponding entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) with their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of proteins (PU.1, CSF-1 receptor, Mono A, Mono B) and their corresponding entity labels.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions DNA and NF-kappa B, which could be relevant entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of proteins (NF-kappa B, fibrinogen) and their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of a protein (MNDA) and cell types (monocytes, macrophages, leukemia/B lymphoma cell lines) with their corresponding entity labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of cell lines (PMA-stimulated U1 cells) and their corresponding entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entities for the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entities for the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any relevant entities for the given entity labels.\"}\n]",
        "response3": "[{\"androgen receptors\": \"protein\"}, {\"mononuclear leukocytes\": \"cell_type\"}, {\"follicular\": \"cell_type\"}, {\"luteal\": \"cell_type\"}, {\"menstrual cycle\": \"cell_type\"}, {\"flutamide\": \"protein\"}]",
        "prediction": "{'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 3},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HMG-I\": \"protein\"}, {\"GATA motifs\": \"DNA\"}, {\"HPFH syndrome\": \"cell_type\"}]",
        "prediction": "{'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"4\": \"The sentence contains 'STAT' and 'T cells' which are relevant protein and cell type entities.\"},\n    {\"4\": \"The sentence contains 'NF-ATc' and 'T lymphocytes' which are relevant protein and cell type entities.\"},\n    {\"5\": \"The sentence contains multiple relevant protein entities such as 'IL-2', 'IFN-gamma', 'jak kinases', 'STAT1(alpha)'.\"},\n    {\"5\": \"The sentence contains 'SIVmacMER', 'SIVmac239', and 'CEMx174' which are relevant cell line entities.\"},\n    {\"4\": \"The sentence contains 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' which are relevant protein and cell type entities.\"},\n    {\"3\": \"The sentence contains 'Th2-type lymphocytes' which is a relevant cell type entity.\"},\n    {\"5\": \"The sentence contains multiple relevant protein entities such as 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', 'phorbol myristate acetate'.\"},\n    {\"4\": \"The sentence contains 'PBMC' and 'adenovirus DNA' which are relevant cell type and DNA entities.\"},\n    {\"4\": \"The sentence contains 'TCL1' which is a relevant protein entity.\"},\n    {\"5\": \"The sentence contains multiple relevant protein entities such as 'HIV-1', 'IFN', 'PKR', 'IkappaBalpha'.\"},\n    {\"5\": \"The sentence contains relevant entities like 'B and T cell activation', 'Ramos', 'Jurkat', 'cDNA microarray technology'.\"},\n    {\"4\": \"The sentence contains 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' which are relevant protein and cell type entities.\"},\n    {\"4\": \"The sentence contains 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B' which are relevant DNA and protein entities.\"},\n    {\"4\": \"The sentence contains 'TCL1' and 'MTCP1/c6.1B' which are relevant protein entities.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"Id2\": \"protein\"}, {\"Id3\": \"protein\"}, {\"T-cell lines\": \"cell_line\"}, {\"HTLV-I\": \"cell_type\"}, {\"ATL-1k\": \"cell_line\"}, {\"MT-2\": \"cell_line\"}, {\"S-LB1\": \"cell_line\"}, {\"Mo\": \"cell_type\"}]",
        "prediction": "{'Id2': 'protein', 'Id3': 'protein', 'T-cell lines': 'cell_line', 'HTLV-I': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'Mo': 'cell_type'}"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"platelet-activating factor\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"arachidonic acid\": \"protein\"}, {\"5-hydroxyeicosatetraenoic acid\": \"protein\"}]",
        "prediction": "{'platelet-activating factor': 'protein', 'B cells': 'cell_type', 'arachidonic acid': 'protein', '5-hydroxyeicosatetraenoic acid': 'protein'}"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 5},\n{\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"GP Ib alpha\": \"protein\"}]",
        "prediction": "{'GP Ib alpha': 'protein'}"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific protein names and a cell type, which are relevant to the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names and a cell type, which directly match the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains specific protein names and cell types, which are relevant to the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name that directly matches the entity type in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence contains a DNA binding activity, which is relevant but not directly matching the entity types in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains specific protein names, which are relevant to the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names and a cell line, which directly match the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names that directly match the entity types in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any relevant entity types matching the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entity types matching the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entity types matching the target sentence.\"}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"myeloid PU.1 binding site\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of IL-2 being associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions RelA and NF-kappa B as members of the Rel homology family and NF-kappa B complex, respectively, which are associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly refers to the E2A gene at the protein level, providing a clear example of E2A being associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions IL-2, c-Jun, and c-Fos proteins in the context of nuclear factors and binding to the IL-2 promoter, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence clearly states that EBV is associated with B-cell activation, providing a clear example of EBV and B-cell being associated with the entity types 'cell_type' and 'cell_line', aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a direct example of UAS1 being B cell specific and associated with the entity type 'cell_line', aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions IL-2, IFN-gamma, jak kinases, and STAT1(alpha) in the context of T cell stimulation and activation, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence clearly mentions CCAAT box and EKLF binding site in the context of gene expression, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a clear example of a kB-like proto-enhancer element from the interleukin 2 promoter being associated with the entity types 'cell_type' and 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly refers to p50p50 and its binding efficiency, providing a clear example of p50p50 being associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions CD4+ cell counts and anti-EBV antibody titres in the context of replicative gene expression, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence clearly states the recruitment of EKLF to 5'HS3 and 5'HS2, providing a clear example of EKLF being associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions EBV and CD2 in the context of thymocyte proliferation, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a clear example of EBNA2 and TP1 being associated with the entity types 'protein' and 'cell_line', aiding in the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence directly refers to RXR and its mutants in the context of erythroid cell outgrowth, providing a clear example of RXR being associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, aiding in the extraction of named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell-specific element': 'cell_type'}]",
        "prediction": "{'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell-specific element': 'cell_type'}"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct link between the entity 'Th2-type lymphocytes' and the entity type 'cell_type' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example directly identifies the entity 'CD14' as a protein in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example clearly states that 'GATA-1' is a protein in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example specifies 'IL-4' as a protein in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example links 'TAL1' to 'protein' and 'T-ALL' to 'cell_type' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example indicates that 'NF-ATc' is a protein and 'T lymphocytes' is a cell type in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example identifies 'TCF-1' as a protein in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example specifies 'E2A' as a protein in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example links 'NF-E2' to 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example clearly states that 'nonhuman primates' are a cell type in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a direct link between 'NF-ATc' as a protein, 'T lymphocytes' as a cell type, and 'embryonic cardiac cells' as a cell type in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example specifies 'TRAF6' as a protein, 'RANKL' as a protein, and 'NF-kappaB' as a protein in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example identifies 'retinoic acid receptor alpha' as a protein in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example links 'RXR' to 'protein' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example specifies 'ZEB' as a protein, 'c-Myb' as a protein, 'Ets' as a protein, and 'hematopoietic cells' as a cell type in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example indicates 'B and T cell activation' as a cell type, 'Ramos' as a cell line, 'Jurkat' as a cell line, and 'cDNA microarray technology' as DNA in the sentence.\"}\n]",
        "response3": "[{\"TR\": \"protein\"}]",
        "prediction": "{'TR': 'protein'}"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n{\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5}\n]",
        "response3": "[{\"UV irradiation\": \"None\"}, {\"TRE -DNA fragment\": \"DNA\"}]",
        "prediction": "{'UV irradiation': 'None', 'TRE -DNA fragment': 'DNA'}"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (RXR) and its corresponding entity label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (Egr-1) with their corresponding entity labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) with their corresponding entity labels, which directly aid in extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain .\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 5},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific examples of entities and their corresponding labels, which directly relate to the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains relevant entities and their labels that are related to the entity types in the target sentence, although not as directly as Example 1.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence includes an entity and its label that is somewhat related to the entity types in the target sentence, but the connection is not as strong as in Examples 1 and 2.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides an entity and its label that is relevant to the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly addresses entities and their labels that are closely related to the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes entities and their labels that are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains an entity and its label that is related to the entity types in the target sentence, although not as directly as some other examples.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence includes an entity and its label that is somewhat related to the entity types in the target sentence, but the connection is not as strong as in other examples.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly addresses entities and their labels that are closely related to the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides specific examples of entities and their corresponding labels, which directly relate to the entity types in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains relevant entities and their labels that are related to the entity types in the target sentence, although not as directly as some other examples.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly addresses entities and their labels that are closely related to the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides specific examples of entities and their corresponding labels, which directly relate to the entity types in the target sentence.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The sentence includes an entity and its label that is somewhat related to the entity types in the target sentence, but the connection is not as strong as in other examples.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence contains an entity and its label that is related to the entity types in the target sentence, although not as directly as some other examples.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities or labels that are relevant to the entity types in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities or labels that are relevant to the entity types in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities or labels that are relevant to the entity types in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"PBMC\": 5, \"adenovirus\": 5, \"reasons\": \"PBMC and adenovirus are directly mentioned in the sentence and are clear entities.\"},\n    {\"WT1\": 5, \"reasons\": \"WT1 is directly mentioned in the sentence and is a clear entity.\"},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5, \"reasons\": \"CD70, B cell, plasma cells, IL-4, and CD40 are directly mentioned in the sentence and are clear entities.\"},\n    {\"TCL1\": 5, \"reasons\": \"TCL1 is directly mentioned in the sentence and is a clear entity.\"},\n    {\"myeloperoxidase\": 5, \"lysozyme\": 5, \"PU.1\": 5, \"reasons\": \"Myeloperoxidase, lysozyme, and PU.1 are directly mentioned in the sentence and are clear entities.\"},\n    {\"Ras\": 5, \"reasons\": \"Ras is directly mentioned in the sentence and is a clear entity.\"},\n    {\"T-PLL\": 5, \"reasons\": \"T-PLL is directly mentioned in the sentence and is a clear entity.\"},\n    {\"T lymphocytes\": 5, \"HLA-molecules\": 5, \"reasons\": \"T lymphocytes and HLA-molecules are directly mentioned in the sentence and are clear entities.\"},\n    {\"MNDA\": 5, \"Philadelphia chromosome-positive chronic myeloid leukemia\": 5, \"reasons\": \"MNDA and Philadelphia chromosome-positive chronic myeloid leukemia are directly mentioned in the sentence and are clear entities.\"},\n    {\"granulocytes\": 5, \"T cells\": 5, \"reasons\": \"Granulocytes and T cells are directly mentioned in the sentence and are clear entities.\"},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5, \"reasons\": \"TCRzeta and p56(lck) are directly mentioned in the sentence and are clear entities.\"},\n    {\"PBMC\": 5, \"adenovirus DNA\": 5, \"reasons\": \"PBMC and adenovirus DNA are directly mentioned in the sentence and are clear entities.\"},\n    {\"PML/RARalpha\": 5, \"reasons\": \"PML/RARalpha is directly mentioned in the sentence and is a clear entity.\"},\n    {\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5, \"reasons\": \"SIVmacMER, SIVmac239, and CEMx174 are directly mentioned in the sentence and are clear entities.\"},\n    {\"lymphoid neoplasms\": 5, \"reasons\": \"Lymphoid neoplasms is directly mentioned in the sentence and is a clear entity.\"},\n    {\"SIVsmmPBj14\": 5, \"reasons\": \"SIVsmmPBj14 is directly mentioned in the sentence and is a clear entity.\"},\n    {\"reasons\": \"No entities mentioned in the sentence.\"},\n    {\"reasons\": \"No entities mentioned in the sentence.\"},\n    {\"reasons\": \"No entities mentioned in the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 3},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 4},\n    {\"Example 14\": 3},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-myc\": \"protein\"}, {\"T lymphoblastic tumor cell line\": \"cell_line\"}]",
        "prediction": "{'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"T cell blasts treated with PMA are now responsive to IFN-gamma .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\": 5}\n]",
        "response3": "[{\"OTF-1\": \"protein\"}, {\"pre-B cells\": \"cell_type\"}, {\"HeLa cells\": \"cell_line\"}, {\"immunoglobulin gene\": \"protein\"}]",
        "prediction": "{'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n{\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n{\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 4},\n{\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n{\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 4},\n{\"T cell blasts treated with PMA are now responsive to IFN-gamma.\": 4},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example directly mentions the entity type 'DNA' which is present in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example provides a clear link between the entity 'CD95 ligand' and the entity type 'protein', aiding in the extraction of named entities.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The example mentions the entities 'EBNA-2' and 'PU.1' which are both proteins present in the target sentence, providing direct assistance in entity extraction.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The example directly refers to 'cDNAs' as 'DNA', matching an entity type in the target sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The example contains multiple protein entities ('IL-2', 'c-Jun', 'c-Fos') that are present in the target sentence, aiding in entity extraction.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The example mentions 'NF-kappa B' as a protein, which is present in the target sentence, providing direct assistance in entity extraction.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The example provides direct links between the entities 'c-kit', 'IL-4R alpha chain' and their corresponding entity types in the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The example mentions all the entities present in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The example directly mentions the protein entities 'EKLF', 'CBP', 'p300', and 'P/CAF' which are present in the target sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The example directly refers to the protein entities 'IL-4', 'LPS', and 'AP-1' which are present in the target sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The example provides direct links between the entities 'granulocytes', 'T cells' and their corresponding entity types in the target sentence.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The example directly mentions the entity 'SCM-1' as a 'cell_line', matching an entity type in the target sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The example mentions the entities 'CD40' and 'NF-kappa B' which are both proteins present in the target sentence, providing direct assistance in entity extraction.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The example directly refers to the protein entities 'p21(WAF1/CIP1)' and 'p27(KIP1)' which are present in the target sentence.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The example directly mentions the protein entity 'E2A' which is present in the target sentence.\"}\n]",
        "response3": "[{'octamer-binding proteins': 'protein'}, {'latter cells': 'cell_type'}]",
        "prediction": "{'octamer-binding proteins': 'protein', 'latter cells': 'cell_type'}"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"IL-2\": \"DNA\"}, {\"VDR\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"immunoglobulin heavy\": \"protein\"}, {\"kappa light chain\": \"protein\"}]",
        "prediction": "{'immunoglobulin heavy': 'protein', 'kappa light chain': 'protein'}"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"T cell\": 5, \"kB-like proto-enhancer element\": 4, \"interleukin 2\": 4},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CREB\": 4, \"AR-CRE\": 4},\n{\"SIVsmmPBj14\": 5},\n{\"EBNA2\": 4, \"TP1\": 4},\n{\"BRCA1\": 5},\n{\"p50p50\": 4},\n{\"GM-CSF\": 4},\n{\"retinoic acid receptor alpha\": 4},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"Protein\": 4},\n{\"Th2-type lymphocytes\": 5},\n{\"IgH\": 5},\n{\"VDR\": 4, \"RXR\": 4, \"GRIP-1\": 4, \"DRIP205\": 4, \"DRIP\": 4},\n{\"GM-kappa B\": 4, \"GC-box\": 4, \"GC-motif\": 4, \"GM-kappa B motif\": 4},\n{\"NF-kappaB\": 4, \"Sp1\": 4, \"SIVmac\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 3},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU-SF complex\": \"protein\"}, {\"PU.1\": \"protein\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a specific protein entity (NF-E2) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The examples provide protein entities (alpha-tocopherol), cell type entities (monocyte, endothelial cells) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The examples provide protein entities (NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The examples provide protein entities (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides RNA entity (IL-5 mRNA), protein entity (dexamethasone), cell type entities (TCR, IL-2R) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a specific protein entity (retinoic acid receptor alpha) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The examples provide protein entity (WT1), cell line entity (myeloid cell lines) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a specific protein entity (E2A) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The examples provide protein entities (NF-kappa B, I kappa B beta) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The examples provide cell type entity (lymphocytes), chemical compound entities (benzene, benzoquinone) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides a specific protein entity (NF-kappa B) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide cell line entity (Ter 119), protein entities (beta-globin, glycoprotein IIb, platelet factor 4) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The examples provide protein entities (Erbstatin, genistein), RNA entity (Egr-1) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The examples provide cell type entity (B cell), protein entity (Ig, Transforming growth factor-beta) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The examples provide DNA entity (EBV), protein entities (EBNA2, estrogen receptor) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The examples provide cell line entities (PMA, U1 cells) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities from the given entity label set.\"}\n]",
        "response3": "[{\"EBS\": \"protein\"}]",
        "prediction": "{'EBS': 'protein'}"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"c-myc RNA\": \"RNA\"}, {\"RWLeu-4 cells\": \"cell_line\"}, {\"VD3\": \"protein\"}]",
        "prediction": "{'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms\": 4},\n    {\"T lymphocytes\": 3},\n    {\"IL-4\": 3},\n    {\"Protein\": 2},\n    {\"WT1\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"GATA-1\": 4},\n    {\"Syk\": 4},\n    {\"Zap\": 4},\n    {\"T cell\": 3},\n    {\"RXR\": 4},\n    {\"E2A\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCF-1\": 4},\n    {\"immunohistochemistry\": 2},\n    {\"gene\": 1},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"Th1\": 3},\n    {\"Th2\": 3},\n    {\"Egr-1\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 3},\n    {\"plasma cells\": 3},\n    {\"IL-4\": 4},\n    {\"CD40\": 4}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"OTF-1\": \"protein\"}]",
        "prediction": "{'OTF-2': 'protein', 'OTF-1': 'protein'}"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 1},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"MATERIALS AND METHODS: Human monocytes were stimulated with PMA (50 ng/ml) alone or LPS (100 ng/ml) with and without a nonspecific serine/threonine protein kinase inhibitor staurosporine (Stauro), a specific pan-PKC inhibitor bisindolylmaleimide (Bis), or an inhibitor of PTK genistein (Gen).\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"DNA-binding phosphoproteins induced after T cell activation: effects of cyclosporin A.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "response1": "['cell_line', 'virus']",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 1},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"B-lymphoblastoid cell lines\": \"cell_line\"}, {\"multiple sclerosis patients\": \"cell_type\"}, {\"a healthy control\": \"cell_type\"}, {\"putative new human retrovirus\": \"virus\"}, {\"Epstein-Barr virus\": \"virus\"}]",
        "prediction": "{'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'a healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'virus'}"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"lymphoid-specific enhancer element\": \"DNA\"}, {\"immunoglobulin heavy-chain gene\": \"protein\"}]",
        "prediction": "{'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'protein'}"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"human papillomavirus-\": \"DNA\"}, {\"adenovirus-\": \"DNA\"}, {\"natural killer cells\": \"cell_type\"}]",
        "prediction": "{'human papillomavirus-': 'DNA', 'adenovirus-': 'DNA', 'natural killer cells': 'cell_type'}"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"Platelet thromboxane receptors\": \"protein\"}]",
        "prediction": "{'Platelet thromboxane receptors': 'protein'}"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "response1": "['cell_line', 'cell_line']",
        "response2": "[\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n{\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 3},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 4},\n{\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 3},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 4},\n{\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 4},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n{\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n{\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Human herpesvirus 6\": \"cell_type\"}, {\"EBV\": \"cell_line\"}, {\"B cell lines\": \"cell_line\"}, {\"EBV\": \"cell_type\"}]",
        "prediction": "{'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_type', 'B cell lines': 'cell_line'}"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"BLR2 mRNA\": \"RNA\"}, {\"mitogen\": \"protein\"}, {\"anti-CD3\": \"protein\"}, {\"peripheral blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding how different proteins and cell lines are mentioned in the text.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence includes multiple examples of named entities with their corresponding entity labels, helping to identify proteins and cell lines mentioned in the text.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains various examples of named entities with their corresponding entity labels, assisting in recognizing proteins and cell lines mentioned in the text.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding how different proteins are mentioned in the text.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence includes clear examples of named entities with their corresponding entity labels, helping to identify proteins mentioned in the text.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a clear example of a named entity with its corresponding entity label, assisting in recognizing DNA mentioned in the text.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding how NF-kappa B is mentioned in the text.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes clear examples of named entities with their corresponding entity labels, helping to identify proteins mentioned in the text.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains a clear example of a named entity with its corresponding entity label, assisting in recognizing proteins mentioned in the text.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding how NF-E2 is mentioned in the text.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence includes clear examples of named entities with their corresponding entity labels, helping to identify proteins mentioned in the text.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains clear examples of named entities with their corresponding entity labels, assisting in recognizing proteins mentioned in the text.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding how proteins and signaling pathways are mentioned in the text.\"},\n    {\"Example 14\": 1},\n    {\"Reason 14\": \"The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities.\"}\n]",
        "response3": "[{\"AP-1\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'DNA', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"RXR\": 5, \"cDNAs\": 4, \"E2A\": 5},\n{\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n{\"myeloperoxidase\": 5, \"lysozyme\": 5, \"PU.1\": 5},\n{\"IL-4\": 5, \"LPS\": 5, \"AP-1\": 5},\n{\"IL-4\": 5},\n{\"GATA-1\": 5},\n{\"Th1\": 4, \"Th2\": 4},\n{\"EBNA-2\": 5, \"PU.1\": 5},\n{\"NF-kappa B\": 5, \"AP-1\": 5},\n{\"NF-ATc\": 5, \"T lymphocytes\": 5, \"embryonic cardiac cells\": 5},\n{\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Distinct genes\": 1}\n]",
        "response3": "[{\"N-Oct-factors\": \"protein\"}, {\"Oct-1\": \"protein\"}, {\"Oct-2A\": \"protein\"}]",
        "prediction": "{'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"STAT5\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"JAK3\": \"protein\"}]",
        "prediction": "{'STAT5': 'protein', 'IL-2': 'protein', 'T cells': 'cell_type', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NP-1\": \"protein\"}, {\"NP-5\": \"protein\"}, {\"HNP-1\": \"protein\"}]",
        "prediction": "{'NP-1': 'protein', 'NP-5': 'protein', 'HNP-1': 'protein'}"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains a specific DNA element related to gene expression.\"},\n    {\"3\": \"The sentence contains 'T cell' and 'interleukin 2' which are related to cell_type and protein entities, but the context is not as specific as other examples.\"},\n    {\"3\": \"The sentence contains 'Th2-type lymphocytes' which is related to the cell_type entity, but the context is not as specific as other examples.\"},\n    {\"5\": \"The sentence provides detailed information about proteins involved in gene regulation.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence provides a variety of proteins and cytokines involved in gene expression and immune response.\"},\n    {\"5\": \"The sentence discusses specific isoforms of NF-ATc protein in T lymphocytes.\"},\n    {\"5\": \"The sentence provides information about the receptor for interleukin 10 and its signaling pathways.\"},\n    {\"5\": \"The sentence mentions specific proteins related to receptors and cytokines.\"},\n    {\"5\": \"The sentence discusses the composite element responsible for conferring IL-2 responsiveness.\"},\n    {\"5\": \"The sentence focuses on signaling by IL-2 and related cytokines, providing key protein names.\"},\n    {\"5\": \"The sentence highlights the role of Sp1 in tissue-specific promoter activity and CD14 expression.\"},\n    {\"5\": \"The sentence connects IL-2 receptor alpha subunit, p21ras, and B cell activation.\"},\n    {\"5\": \"The sentence emphasizes the role of Sp1 and Ets-related transcription factors in gene expression.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"IL-3\": \"protein\"}]",
        "prediction": "{'IL-3': 'protein'}"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_line']",
        "response2": "[\n{\"TIMP-1\": 4, \"DNA\": 3},\n{\"NF-kB\": 4, \"AP-1\": 4, \"OCT-1\": 4, \"NF-IL-2B\": 4},\n{\"RelA\": 4, \"NF-kappa B\": 4},\n{\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 3},\n{\"IkappaBbeta\": 4, \"NF-kappaB\": 4},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5, \"DNA\": 3},\n{\"IL-2\": 4, \"NF-kappa B\": 4, \"AP-1\": 4},\n{\"NF-kappa B\": 5, \"I kappa B alpha\": 4},\n{\"NF-kappa B\": 5, \"I kappa B alpha\": 4},\n{\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n{\"HIV-1\": 5, \"IFN\": 4, \"PKR\": 4, \"IkappaBalpha\": 4},\n{\"CD40\": 4, \"Rel/nuclear factor kappaB\": 4, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n{\"TR55\": 4, \"TNF-alpha\": 4, \"HIV\": 4},\n{\"NF-kappaB\": 5, \"Sp1\": 4, \"SIVmac\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"HIV type 1\": \"cell_type\"}, {\"HIV-1\": \"cell_type\"}, {\"viral RNA\": \"RNA\"}, {\"U937 cells\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'viral RNA': 'RNA', 'U937 cells': 'cell_line'}"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"NF-ATc isoforms\": 5},\n    {\"GATA-1\": 5},\n    {\"T cell\": 4},\n    {\"Sp1\": 5},\n    {\"A-myb\": 5},\n    {\"IgH\": 5},\n    {\"NF-ATc\": 5},\n    {\"TAL1\": 5},\n    {\"Sp1\": 5},\n    {\"IL-2\": 5},\n    {\"p50p50\": 5},\n    {\"UAS1\": 4},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL-2\": 5},\n    {\"BAT box\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"SIVmac\": 5}\n]",
        "response3": "[{\"Thy-1 gene\": \"protein\"}]",
        "prediction": "{'Thy-1 gene': 'protein'}"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n{\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"TCF-1\": \"protein\"}, {\"lymphoid malignancies\": \"cell_type\"}]",
        "prediction": "{'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and specific entity with its corresponding label, aiding in understanding how named entities are identified in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example includes multiple entities with their corresponding labels, demonstrating the diversity of named entities present in the sentence and how they are categorized.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example highlights a specific entity with its label, contributing to the understanding of how named entities related to proteins are identified in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example presents a specific entity with its label, showcasing how protein-related named entities are identified in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a specific entity with its label, aiding in understanding how cell type entities are identified in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example includes a specific entity with its label, demonstrating how DNA-related named entities are identified in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains multiple entities with their corresponding labels, showcasing the variety of protein-related named entities present in the sentence and how they are categorized.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example presents a specific entity with its label, aiding in understanding how protein-related named entities are identified in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example includes a specific entity with its label, demonstrating how cell line entities are identified in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a specific entity with its label, aiding in understanding how cell line entities are identified in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example includes multiple entities with their corresponding labels, showcasing the diversity of protein-related named entities present in the sentence and how they are categorized.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example presents a specific entity with its label, aiding in understanding how protein-related named entities are identified in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a specific entity with its label, aiding in understanding how protein-related named entities are identified in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example includes a specific entity with its label, demonstrating how protein-related named entities are identified in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example contains multiple entities with their corresponding labels, showcasing the variety of named entities present in the sentence and how they are categorized.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not include any named entities relevant to the entity types in the target sentence, providing no aid in understanding how named entities are identified.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any named entities relevant to the entity types in the target sentence, offering no assistance in understanding how named entities are identified.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example lacks named entities related to the entity types in the target sentence, providing no guidance on how named entities are identified.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the protein 'TCL1' and its association with the entity label 'protein'.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear and direct mention of the protein 'WT1' and its association with the entity label 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear and direct mention of the protein 'RXR' and its association with the entity label 'protein'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear and direct mention of the cell type 'lymphoid neoplasms' and its association with the entity label 'cell_type'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear and direct mention of the protein 'NF-kappa B' and its association with the entity label 'protein'.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear and direct mentions of the proteins 'TCRzeta' and 'p56(lck)' and their associations with the entity label 'protein'.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear and direct mention of the DNA 'AP-1' and its association with the entity label 'DNA'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear and direct mentions of the proteins 'EBNA-2' and 'PU.1' and their associations with the entity label 'protein'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear and direct mentions of the proteins 'IL-2 receptor alpha subunit', 'p21ras', and the cell type 'B cell' and their associations with the respective entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear and direct mentions of the proteins 'SLAP-130', 'SLP-76', and the cell type 'T cell' and their associations with the respective entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear and direct mentions of the protein 'NF-kappaB' and the cell type 'rheumatoid arthritis' and their associations with the respective entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear and direct mentions of the proteins 'myeloperoxidase', 'lysozyme', 'PU.1' and their associations with the entity label 'protein'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear and direct mention of the protein 'retinoic acid receptor alpha' and its association with the entity label 'protein'.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear and direct mentions of the proteins 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and the cell type 'B cells' and their associations with the respective entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear and direct mentions of the cell type 'T lymphocytes' and the protein 'HLA-molecules' and their associations with the respective entity labels.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities or entity labels mentioned.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities or entity labels mentioned.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities or entity labels mentioned.\"}\n]",
        "response3": "[{\"HLA class II antigens\": \"protein\"}, {\"ribonucleoproteins Ro(SSA)\": \"protein\"}, {\"La(SSB)\": \"protein\"}]",
        "prediction": "{'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 3},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities and their corresponding entity labels, which can aid in understanding the types of entities mentioned in the target sentence.\"},\n    {\"Example 2\": 2},\n    {\"Reason 2\": \"The sentence mentions a specific protein entity, which can help in identifying protein entities in the target sentence, but the context is not directly related to the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, directly related to the target sentence, which can greatly aid in extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of named entities and their corresponding entity labels, directly related to the target sentence, which can greatly aid in extracting named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides examples of protein entities and their corresponding entity labels, directly related to the target sentence, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides examples of protein entities and their corresponding entity labels, directly related to the target sentence, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides an example of a DNA entity and its corresponding entity label, directly related to the target sentence, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides examples of protein entities and their corresponding entity labels, directly related to the target sentence, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides multiple examples of cell line entities and their corresponding entity labels, directly related to the target sentence, which can greatly aid in extracting named entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides an example of a cell type entity and its corresponding entity label, directly related to the target sentence, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence provides an example of a cell type entity and its corresponding entity label, directly related to the target sentence, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides multiple examples of protein entities and their corresponding entity labels, directly related to the target sentence, which can greatly aid in extracting named entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides examples of RNA and protein entities with their corresponding entity labels, which can aid in understanding the types of entities mentioned.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The sentence mentions cell line entities, which can help in identifying cell line entities in the target sentence, but the context is not directly related to the target sentence.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The sentence does not provide examples of named entities or their corresponding entity labels that are directly related to the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not provide examples of named entities or their corresponding entity labels that are directly related to the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not provide examples of named entities or their corresponding entity labels that are directly related to the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"NFAT\": \"protein\"}]",
        "prediction": "{'calcineurin': 'protein', 'NFAT': 'protein'}"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"SIVsmmPBj14\": 5},\n    {\"SIVmacMER\": 5},\n    {\"SIVmac239\": 5},\n    {\"CEMx174\": 5},\n    {\"GM-CSF\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"protein\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"TCF-1\": 5},\n    {\"MIP-1 alpha\": 5},\n    {\"GOS19\": 5},\n    {\"LD78\": 5},\n    {\"AT464\": 5},\n    {\"CD14\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"T cell\": 5},\n    {\"Egr-1\": 5},\n    {\"E2A\": 5},\n    {\"CD95 ligand\": 5}\n]",
        "response3": "[{\"ets-1\": \"protein\"}, {\"cDNA\": \"DNA\"}, {\"mouse thymus\": \"cell_type\"}, {\"Moloney murine sarcoma virus (MSV)\": \"cell_line\"}, {\"long terminal repeat (LTR)\": \"DNA\"}]",
        "prediction": "{'ets-1': 'protein', 'cDNA': 'DNA', 'mouse thymus': 'cell_type', 'Moloney murine sarcoma virus (MSV)': 'cell_line', 'long terminal repeat (LTR)': 'DNA'}"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ER\": \"protein\"}, {\"NK activity\": \"cell_type\"}, {\"tumor ER concentration\": \"cell_type\"}, {\"ER -status\": \"cell_type\"}]",
        "prediction": "{'ER': 'protein', 'NK activity': 'cell_type', 'tumor ER concentration': 'cell_type', 'ER -status': 'cell_type'}"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the protein 'calcineurin' and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides clear examples of the proteins 'IkappaBalpha' and 'NF-kappaB' and their corresponding entity labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides clear examples of the proteins 'IkappaBbeta' and 'NF-kappaB' and their corresponding entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of the proteins 'NF-kappa B' and 'AP-1' and their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of the proteins 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of the proteins 'CD40' and 'NF-kappa B' and their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of the proteins 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' and their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of the proteins 'NF-kappaB', 'Tax', and 'ATL' and their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of the proteins 'NF-kappa B' and 'I kappa B beta' and their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of the proteins 'RelA' and 'NF-kappa B' and their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of the proteins 'Syk', 'Zap', and 'T cell' and their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of the proteins 'SP1', 'caspases', and 'B-cell' and their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities related to the given entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the given entity labels.\"}\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"CsA\": \"protein\"}, {\"PKC\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cell\": \"cell_type\"}]",
        "prediction": "{'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell': 'cell_type'}"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HTLV-I\": \"protein\"}]",
        "prediction": "{'HTLV-I': 'protein'}"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"CCAAT box\": 5, \"EKLF binding site\": 5},\n{\"ZEBRA\": 5},\n{\"T cell\": 4, \"interleukin 2\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"RXR\": 5},\n{\"p50p50\": 5},\n{\"RelA\": 5, \"NF-kappaB1\": 5},\n{\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"Egr-1\": 5},\n{\"IL-2\": 5},\n{\"CD4+\": 4, \"EBV\": 5},\n{\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n{\"AP-1\": 5},\n{\"EBNA2\": 5, \"TP1\": 5},\n{\"NF-kappa B\": 5, \"AP-1\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Genes\": 1}\n]",
        "response3": "[{\"R\": \"protein\"}]",
        "prediction": "{'R': 'protein'}"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\": 5},\n    {\"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear mention of the entity 'Runt domain' which is associated with the entity label 'protein'.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence directly mentions the entity 'TCF-1' which is associated with the entity label 'protein'.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence explicitly refers to 'tyrosine' which is commonly associated with the entity label 'protein'.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions 'nonhuman primates' which is associated with the entity label 'cell_type'.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions 'IL-7R' and 'gamma(c)' which are both associated with the entity label 'protein'.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions 'SIVsmmPBj14' which is associated with the entity label 'cell_line'.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions 'Jun' and 'ATF-2' which are both associated with the entity label 'protein'.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions 'GATA-1' which is associated with the entity label 'protein'.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'NF-kappaB' and 'rheumatoid arthritis' which are associated with the entity labels 'protein' and 'cell_type' respectively.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' which are all associated with the entity label 'protein'.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions 'RXR' which is associated with the entity label 'protein'.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions 'Protein' which is commonly associated with the entity label 'protein'.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions 'UAS3', 'UAS2', and 'YY1' which are associated with the entity labels 'DNA' and 'protein'.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions 'IL-2', 'Aiolos', and 'Ras' which are all associated with the entity label 'protein'.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'IL-4' which is associated with the entity label 'protein'.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions 'SCM-1' which is associated with the entity label 'cell_line'.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entities or terms that can be associated with the provided entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entities or terms that can be associated with the provided entity labels.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any specific entities or terms that can be associated with the provided entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n    {\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein'}"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (BRCA1) and its corresponding label, which directly aids in understanding how to extract named entities from the target sentence.\"}\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"TCR alpha/beta\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"T-prolymphocytic (T-PLL)\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of cell_type (T cell) and protein entities (IL-2, IL-2 receptor, CD28) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of RNA (IL-5 mRNA), cell_type (TCR), protein entities (IL-2R, dexamethasone) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides an example of a protein entity (IL-2) and its corresponding label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of protein entities (NF-ATc, T lymphocytes) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and cell_type (B cell) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (Syk, Zap) and cell_type (T cell) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of protein entities (IL-2, Aiolos, Ras) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of protein entities (IkappaBalpha, NF-kappaB) and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities that match the entity types in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities that match the entity types in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entities that match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"immunophilin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate\": \"These examples contain specific protein names that are directly related to the entity labels in the target sentence, making them highly relevant for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"NF-kappa B activation\": 5},\n{\"Gel-shift analysis\": 1},\n{\"phorbol esters\": 1},\n{\"mouse E2A gene\": 1},\n{\"granulocyte-macrophage lineage\": 5},\n{\"chimeric receptor\": 1},\n{\"PML/RARalpha\": 5},\n{\"RXR\": 5},\n{\"TRAF6\": 5},\n{\"NF-ATc\": 5},\n{\"CD40 cytoplasmic domain\": 1},\n{\"GATA-1\": 5},\n{\"TCF-1\": 5},\n{\"persistent activation of NF-kappa B\": 5},\n{\"IL-2 responsiveness\": 1},\n{\"ZEB and transcriptional activation by c-Myb /Ets\": 5}\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"hematopoietic cell lineage\": \"cell_type\"}]",
        "prediction": "{'NF-M': 'protein', 'hematopoietic cell lineage': 'cell_type'}"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a direct mapping between the entity 'IL-4' and the entity label 'protein' in the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[\n    {\"NF-IL6\": \"protein\"},\n    {\"IL-4\": \"protein\"},\n    {\"T cells\": \"cell_type\"}\n]",
        "prediction": "{'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HLA-DR alpha (DRA)\": \"protein\"}, {\"octamer\": \"protein\"}, {\"immunoglobulin variable region\": \"protein\"}, {\"B cell-specific\": \"cell_type\"}]",
        "prediction": "{'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Jak3\": \"protein\"}, {\"gamma c\": \"protein\"}, {\"XSCID\": \"cell_type\"}]",
        "prediction": "{'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"Ro-VDR\": \"cell_line\"}]",
        "prediction": "{'Ro-VDR': 'cell_line'}"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"1,25-dihydroxyvitamin D3\": \"protein\"}, {\"VDR\": \"protein\"}]",
        "prediction": "{'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"NF-kappa B\": 5, \"DNA\": 1, \"protein\": 5, \"cell_type\": 1, \"cell_line\": 1},\n    {\"NF-kappa B\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"DNA\": 5},\n    {\"IkappaBbeta\": 5, \"NF-kappaB\": 5, \"protein\": 5},\n    {\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 3, \"cell_type\": 3},\n    {\"RelA\": 5, \"NF-kappa B\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5, \"protein\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5, \"protein\": 5},\n    {\"AP-1\": 5, \"DNA\": 5},\n    {\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5, \"cell_type\": 5, \"protein\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 5, \"protein\": 5, \"cell_type\": 5},\n    {\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 5, \"protein\": 5, \"cell_type\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5, \"protein\": 5, \"cell_line\": 5},\n    {\"HIV-1 LTR\": 5, \"NFAT-1\": 5, \"NF kappa B\": 5, \"DNA\": 5, \"protein\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"IgH\": 5},\n    {\"BRCA1\": 4},\n    {\"EBNA2\": 4, \"TP1\": 3},\n    {\"GM-CSF\": 4},\n    {\"Protein\": 5},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"p50p50\": 4},\n    {\"EKLF\": 4},\n    {\"TCF-1\": 4},\n    {\"ZEBRA\": 4},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"Egr-1\": 4},\n    {\"T cell\": 5, \"interleukin 2\": 4},\n    {\"Th2-type lymphocytes\": 5},\n    {\"CD95 ligand\": 4},\n    {\"GM-kappa B\": 5, \"GC-box\": 5, \"GC-motif\": 5, \"GM-kappa B motif\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides clear examples of named entities with corresponding entity labels, aiding in understanding the types of entities present in the sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence contains multiple examples of named entities with corresponding entity labels, which can help in identifying similar entities in the target sentence.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence offers a variety of named entities with corresponding entity labels, facilitating the recognition of similar entities in the target sentence.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence presents named entities with corresponding entity labels, assisting in recognizing similar entities in the target sentence.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence includes a named entity with a corresponding entity label, aiding in understanding the types of entities present in the sentence.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence provides examples of named entities with corresponding entity labels, which can help in identifying similar entities in the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence offers a named entity with a corresponding entity label, aiding in understanding the types of entities present in the sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains multiple examples of named entities with corresponding entity labels, facilitating the recognition of similar entities in the target sentence.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence presents named entities with corresponding entity labels, assisting in recognizing similar entities in the target sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides a named entity with a corresponding entity label, aiding in understanding the types of entities present in the sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence includes multiple examples of named entities with corresponding entity labels, which can help in identifying similar entities in the target sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence offers named entities with corresponding entity labels, facilitating the recognition of similar entities in the target sentence.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence presents named entities with corresponding entity labels, aiding in recognizing similar entities in the target sentence.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence provides examples of named entities with corresponding entity labels, which can help in identifying similar entities in the target sentence.\"},\n{\"Example 15\": 1},\n{\"Reason 15\": \"The sentence does not contain any named entities with corresponding entity labels, making it less helpful in aiding the extraction of entities from the target sentence.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any named entities with corresponding entity labels, making it less helpful in aiding the extraction of entities from the target sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any named entities with corresponding entity labels, making it less helpful in aiding the extraction of entities from the target sentence.\"}\n]",
        "response3": "[{\"Bmax\": \"protein\"}, {\"DEX\": \"protein\"}]",
        "prediction": "{'Bmax': 'protein', 'DEX': 'protein'}"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "response1": "['cell_line', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the protein and its encoding gene, providing a clear link between the two entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence explicitly states the protein (Egr-1) and its function as a transcription factor, making it highly relevant for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions the protein (TCF-1) and its interaction with mice, providing valuable information for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence discusses the protein (E2A) and its detection at the protein level, aiding in the identification of the entity.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions the cell type (Th2-type lymphocytes) and its association with cytokine expression, facilitating entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence refers to the DNA entity (IgH) and its role in gene transcription, providing crucial information for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence explicitly mentions the DNA entity (cDNAs) and their cloning and sequencing, aiding in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence discusses multiple proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their interactions, providing valuable information for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions the protein (NF-ATc) and its synthesis in T lymphocytes, aiding in entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence refers to proteins (IL-2, c-Jun, c-Fos) and their presence in nuclear factors, facilitating entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence discusses proteins (CD70, IL-4, CD40) and their effects on cell differentiation, providing valuable information for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the protein (NF-ATc) and its expression in different cell types, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence refers to the protein (GM-CSF) and its conservation in human and murine genes, providing crucial information for entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence discusses proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their expression levels, aiding in entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions proteins (c-kit, IL-4R alpha chain) and their roles in receptor generation, providing valuable information for entity extraction.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"immunoglobulin heavy-chain mRNA\": \"RNA\"}, {\"immunoglobulin gene\": \"DNA\"}]",
        "prediction": "{'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA'}"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 1},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 1},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"PRL\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"Stat proteins\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a transcription factor (AP-1) binding to DNA, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions two proteins (Jun and ATF-2) and their interactions, which are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions Th2-type lymphocytes, which are a specific cell type, relevant to the entity types in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions a protein (Protein) involved in transcription, which is relevant to the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (Egr-1) which is a zinc finger transcription factor, directly related to the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions proteins (IL-2, c-Jun, c-Fos) and their interactions, which are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a protein (GM-CSF) which is relevant to the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a protein (GATA-1) which is a lineage-specific transcription factor, directly related to the entity types in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions a protein (TCF-1) involved in transactivation, which is relevant to the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions Stat proteins which form homo- or heterodimers and induce transcription, directly related to the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of acetylated transcription factors (EKLF) and their interactions with other proteins, directly related to the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions proteins (SCL, GATA-1) and their expression in specific cell lineages, directly relevant to the entity types in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions a protein (G-CSF) and its effects mediated by binding to receptors, which is relevant to the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205) and their interactions, directly related to the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions proteins (ZEB, c-Myb, Ets) involved in gene expression regulation and a specific cell type (hematopoietic cells), directly related to the entity types in the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions proteins (tal-1, GATA-binding proteins) and their expression during hematopoiesis, which is relevant to the entity types in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities relevant to the entity types in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities relevant to the entity types in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entities relevant to the entity types in the target sentence.\"}\n]",
        "response3": "[{'GGAAAA': 'DNA'}]",
        "prediction": "{'GGAAAA': 'DNA'}"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"E3 enhancer motif\": \"DNA\"}]",
        "prediction": "{'E3 enhancer motif': 'DNA'}"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a protein (GATA-1) associated with a specific cell type (erythroid cells), aiding in the extraction of named entities.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence clearly mentions a protein (Egr-1) associated with a specific cell type (macrophage), aiding in the extraction of named entities.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) associated with a specific cell type (erythroid), aiding in the extraction of named entities.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence clearly mentions a protein (retinoic acid receptor alpha) associated with a specific cell type (myeloid cells), aiding in the extraction of named entities.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides a clear example of a protein (CD14) associated with a specific cell type (monocytic), aiding in the extraction of named entities.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence clearly mentions specific cell types (Th1 and Th2) associated with distinct cytokine expression patterns, aiding in the extraction of named entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides a clear example of a protein (E2A) associated with a specific cell type (B cell lines), aiding in the extraction of named entities.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides a clear example of a protein (WT1) associated with a specific cell type (peripheral lymphocytes), aiding in the extraction of named entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides clear examples of proteins (CD14 and CD23) associated with protein expression, aiding in the extraction of named entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides clear examples of proteins (myeloperoxidase, lysozyme, PU.1) associated with specific cell types (granulomonocytes), aiding in the extraction of named entities.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides a clear example of a protein (WT1) associated with a specific cell type (myeloid cell lines), aiding in the extraction of named entities.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides a clear example of a protein (MNDA) associated with a specific cell type (Philadelphia chromosome-positive chronic myeloid leukemia), aiding in the extraction of named entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides clear examples of cell types (granulocytes and T cells) associated with methylation deviation, aiding in the extraction of named entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides a clear example of a protein (GATA-1) associated with a specific cell type (erythroid cells), aiding in the extraction of named entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence provides clear examples of proteins (Sp1 and Ets) associated with maintaining CTL-specific expression of the mouse perforin gene, aiding in the extraction of named entities.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any named entities related to the entity types in the target sentence, hence not helpful for extraction.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any named entities related to the entity types in the target sentence, hence not helpful for extraction.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any named entities related to the entity types in the target sentence, hence not helpful for extraction.\"}\n]",
        "response3": "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]",
        "prediction": "{'eosinophil': 'cell_type', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5},\n    {\"AP-1\": 5},\n    {\"IFN-gamma\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n    {\"Sp1\": 5, \"Ets\": 5},\n    {\"IL-7R\": 5, \"gamma(c)\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"IL-2\": 5},\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n    {\"IkappaBbeta\": 5, \"NF-kappaB\": 5},\n    {\"NF-kappaB\": 5, \"rheumatoid arthritis\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GATA-1\": 5},\n    {\"CD40\": 5, \"IFN-gamma\": 5, \"tumor necrosis factor-alpha\": 5, \"interleukin (IL)-1beta\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"Interferon-gamma\": \"protein\"}]",
        "prediction": "{'Interferon-gamma': 'protein'}"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (E2A) being mentioned in relation to a specific gene expression study, making it highly relevant for identifying protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions immunohistochemistry with antibodies against proteins, gene expression, and cell type within a tumor specimen, providing relevant context for protein, DNA, and cell type entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly discusses genes encoding eosinophil granule proteins and a specific transcription factor (GATA-1), making it highly relevant for identifying protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions eosinophils, indicating a clear reference to a cell type entity.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides detailed information about various proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells), making it highly relevant for identifying protein and cell type entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions specific proteins (myeloperoxidase, lysozyme, PU.1) associated with granulomonocytes, providing clear examples for identifying protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly discusses the expression of proteins (CD14, CD23) induced by PMA, making it highly relevant for identifying protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions specific proteins (IFN A, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) related to gene expression, making it highly relevant for identifying protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence explicitly mentions granulocytes and T cells, providing clear references to cell type entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides detailed information about proteins (IL-2, c-Jun, c-Fos) and their binding to specific sites, making it highly relevant for identifying protein entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a specific transcription factor (NF-E2) associated with a cellular differentiation program, providing a clear example for identifying protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly discusses the expression of proteins (interleukin-2, CD25) and their association with a receptor (IL-2R), making it highly relevant for identifying protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions a specific cell line (Ter 119) and the expression of proteins (beta-globin, glycoprotein IIb, platelet factor 4) in relation to erythroid cells, providing clear examples for identifying cell line and protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions specific compounds (Erbstatin, genistein) and a transcription factor (Egr-1) in relation to mRNA expression and protein phosphorylation, providing relevant context for protein and RNA entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence discusses the regulatory mechanism of a gene (gp91phox) in eosinophils and the use of a specific cell line (HL-60-C15) in a transfection study, making it highly relevant for identifying DNA and cell line entities.\"}\n]",
        "response3": "[{\"estrogen\": \"protein\"}, {\"progesterone\": \"protein\"}, {\"eosinophil cationic protein\": \"protein\"}, {\"eosinophils\": \"cell_type\"}]",
        "prediction": "{'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as a protein.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B alpha' and provides information that helps identify them as proteins.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions the entity 'NF-ATc' and provides information that helps identify it as a protein. It also mentions 'T lymphocytes' as a cell type.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions the entities 'NF-kappaB', 'Tax', and 'ATL' and provides information that helps identify 'NF-kappaB' as a protein and 'Tax' and 'ATL' as cell types.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as a protein.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B alpha' and provides information that helps identify them as proteins.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions the entity 'NF-ATc' and provides information that helps identify it as a protein. It also mentions 'T lymphocytes' and 'embryonic cardiac cells' as cell types.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions the entity 'GATA-1' and provides information that helps identify it as a protein.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as a protein.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B beta' and provides information that helps identify them as proteins.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' and provides information that helps identify them as proteins.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the entities 'Sp1' and 'Ets' and provides information that helps identify them as proteins.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'Th1' and 'Th2' as cell types.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence directly mentions the entities 'IL-2', 'NF-kappa B', and 'AP-1' and provides information that helps identify them as proteins.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as DNA.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entities related to the given entity labels.\"}\n]",
        "response3": "[{'NF-AT': 'protein'}, {'NF-kappa B': 'protein'}, {'T helper cell subsets': 'cell_type'}]",
        "prediction": "{'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Sentence\": \"The examples provide clear and direct mappings between the entities mentioned in the sentences and their corresponding entity labels, making it easy to understand and apply the labels to the target sentence.\"}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"NF-KB\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'NF-KB': 'protein'}"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"Recently, it has been shown that RelB knockout mice have no dendritic cells (DC).\": 4},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HU\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'HU': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n{\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 4},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n{\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n{\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n{\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n{\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5}\n]",
        "response3": "[{\"EBV type 2 EBNA-2\": \"protein\"}, {\"LMP1\": \"protein\"}, {\"EBV type 1 EBNA-2\": \"protein\"}]",
        "prediction": "{'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'cell_type', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"MNDA\": 5, \"monocytes\": 3, \"macrophages\": 3, \"leukemia/B lymphoma cell lines\": 4},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"B and T cell activation\": 4, \"Ramos\": 4, \"Jurkat\": 4, \"cDNA microarray technology\": 3},\n    {\"HIV-1\": 4, \"IFN\": 4, \"PKR\": 4, \"IkappaBalpha\": 4},\n    {\"interleukin-2\": 4, \"alpha chain\": 4, \"CD25\": 4, \"IL-2 receptor\": 4},\n    {\"TR55\": 4, \"TNF-alpha\": 4, \"HIV\": 4},\n    {\"Fibroblast growth factor-1\": 4, \"FGF-1\": 4, \"IL-2\": 4, \"NF-kappaB\": 4, \"FGF receptor\": 4, \"Jurkat T cells\": 4},\n    {\"MNDA\": 4, \"monocytes\": 4, \"macrophages\": 4, \"leukemia/B lymphoma cell lines\": 4},\n    {\"LITAF\": 4, \"TNF-alpha\": 4},\n    {\"nuclear factor-kappa B\": 4, \"NF-kappa B\": 4},\n    {\"NF-kappa B\": 4, \"fibrinogen\": 4},\n    {\"HIV\": 4, \"NF-kappa B\": 4, \"p105\": 4, \"p50\": 4, \"MAD3\": 4},\n    {\"alpha 4 beta 1\": 4, \"TCR/CD3\": 4, \"DNA\": 4},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"polymerase chain reaction\": \"DNA\"}, {\"monocytic U937 cells\": \"cell_type\"}, {\"HIV\": \"cell_type\"}, {\"U9-IIIB\": \"cell_line\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV': 'cell_type', 'U9-IIIB': 'cell_line'}"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 3},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}, {\"sea urchin\": \"cell_line\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"Cu2+\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'TNF-alpha': 'protein', 'Cu2+': 'protein'}"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 3},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n{\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n{\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell type (Th2-type lymphocytes) mentioned in relation to cytokines.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific proteins (NF-kappaB, Tax) and cell types (ATL) that are relevant for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein entities (IL-13, IL-4R, JAK2, IL-13R) and their signaling pathways in relation to colon cancer cells.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides examples of protein (immunohistochemistry) and DNA (gene) entities relevant for named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence clearly mentions a cell type (lymphoid neoplasms) which is important for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) in the context of lymphocyte activation.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of a protein (TAL1) and a cell type (T-ALL) relevant for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a protein entity (WT1) and a cell line (myeloid cell lines) which are important for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein entities (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) relevant for named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions a protein entity (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) which are important for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) relevant for named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions protein entities (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) which are important for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (IL-2, c-Jun, c-Fos) relevant for named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions protein entities (CD70, IL-4, CD40) and cell types (B cells, plasma cells) which are important for entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a DNA entity (AP-1) relevant for named entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of cell types (B and T cell activation) and cell lines (Ramos, Jurkat) which are important for entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": \"5\"},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'IgH' and the entity label 'DNA' in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": \"5\"},\n    {\"Reason 2\": \"The example directly links the entity 'Eosinophils' to the entity label 'cell_type' in the target sentence, facilitating the identification of named entities.\"},\n    {\"Example 3\": \"5\"},\n    {\"Reason 3\": \"The example offers explicit connections between entities such as 'IL-13', 'IL-4', 'B cell', and 'monocyte' with their corresponding entity labels in the target sentence, enhancing the extraction of named entities.\"},\n    {\"Example 4\": \"5\"},\n    {\"Reason 4\": \"The example establishes relationships between entities like 'EBV' and 'CD2' with their respective entity labels in the target sentence, aiding in the identification of named entities.\"},\n    {\"Example 5\": \"5\"},\n    {\"Reason 5\": \"The example provides direct mappings between entities 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' with their corresponding entity labels in the target sentence, facilitating the extraction of named entities.\"},\n    {\"Example 6\": \"5\"},\n    {\"Reason 6\": \"The example connects entities 'Th1' and 'Th2' with the entity label 'cell_type' in the target sentence, assisting in the identification of named entities.\"},\n    {\"Example 7\": \"5\"},\n    {\"Reason 7\": \"The example directly relates the entity 'Th2-type lymphocytes' to the entity label 'cell_type' in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": \"5\"},\n    {\"Reason 8\": \"The example establishes connections between entities like 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' with their respective entity labels in the target sentence, enhancing the identification of named entities.\"},\n    {\"Example 9\": \"5\"},\n    {\"Reason 9\": \"The example provides clear mappings between entities 'NF-ATc' and 'T lymphocytes' with their corresponding entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 10\": \"5\"},\n    {\"Reason 10\": \"The example establishes relationships between entities like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' with their respective entity labels in the target sentence, facilitating the identification of named entities.\"},\n    {\"Example 11\": \"5\"},\n    {\"Reason 11\": \"The example directly links entities 'T lymphocytes' and 'HLA-molecules' to their corresponding entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": \"5\"},\n    {\"Reason 12\": \"The example provides a clear mapping between the entity 'E2A' and the entity label 'protein' in the target sentence, enhancing the identification of named entities.\"},\n    {\"Example 13\": \"5\"},\n    {\"Reason 13\": \"The example establishes connections between entities like 'lymphocytes', 'benzene', and 'benzoquinone' with their respective entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 14\": \"5\"},\n    {\"Reason 14\": \"The example directly relates entities 'EBV' and 'B-cell' to their corresponding entity labels in the target sentence, facilitating the identification of named entities.\"},\n    {\"Example 15\": \"5\"},\n    {\"Reason 15\": \"The example provides explicit mappings between entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' with their respective entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 16\": \"5\"},\n    {\"Reason 16\": \"The example establishes relationships between entities like 'ICAM-1', 'CD71', 'LMP1', and 'IkappaB' with their corresponding entity labels in the target sentence, enhancing the identification of named entities.\"},\n    {\"Example 17\": \"1\"},\n    {\"Reason 17\": \"The example does not contain any entities that match the entity types present in the target sentence, hence providing no aid in the extraction of named entities.\"},\n    {\"Example 18\": \"1\"},\n    {\"Reason 18\": \"The example does not contain any entities that match the entity types present in the target sentence, hence providing no aid in the extraction of named entities.\"},\n    {\"Example 19\": \"1\"},\n    {\"Reason 19\": \"The example does not contain any entities that match the entity types present in the target sentence, hence providing no aid in the extraction of named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n{\"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NK cell\": \"cell_type\"}, {\"NFAT\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "response1": "['cell_type', 'protein', 'protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a transgenic mouse expressing a specific protein, PML/RARalpha, which aids in identifying the entity label 'protein'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific entities such as IL-5 mRNA, TCR, IL-2R, and dexamethasone, which are helpful in identifying the entity labels 'RNA', 'cell_type', and 'protein'.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides information about nuclear factors, IL-2, c-Jun, and c-Fos proteins, aiding in identifying the entity labels 'protein'.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions RelA and NF-kappaB1 proteins and their nuclear localization, which helps in identifying the entity labels 'protein'.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides information about FasL, IL-2, and IFN-gamma proteins, aiding in identifying the entity labels 'protein'.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence mentions AP-1 DNA binding activity, which is helpful in identifying the entity label 'DNA'.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions P selectin protein, which aids in identifying the entity label 'protein'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of IL-2, IFN-gamma, jak kinases, and STAT1(alpha) proteins, aiding in identifying the entity labels 'protein'.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions RelA and NF-kappa B proteins, which helps in identifying the entity labels 'protein'.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of MTHC cell line, TNF-alpha, IFN-gamma proteins, and DC cell type, aiding in identifying the entity labels 'cell_line', 'protein', and 'cell_type'.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta proteins, which are helpful in identifying the entity labels 'protein'.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of SP1 protein, caspases protein, and B-cell cell type, aiding in identifying the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate proteins, which are helpful in identifying the entity labels 'protein'.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions IkappaBbeta and NF-kappaB proteins, aiding in identifying the entity labels 'protein'.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides examples of IL-2, NF-kappa B, and AP-1 proteins, aiding in identifying the entity labels 'protein'.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions NF-kappaB, Tax, and ATL proteins, which are helpful in identifying the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'CML cells': 'cell_type'}, {'IFN-alpha': 'protein'}, {'CML cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]",
        "prediction": "{'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis\": 3},\n    {\"Our results\": 2},\n    {\"A conserved motif\": 1},\n    {\"Molecular cloning\": 4},\n    {\"Selected transfected clones\": 5},\n    {\"IL4 and IL13 receptors\": 5},\n    {\"TCRzeta and p56(lck)\": 4},\n    {\"To approach this\": 1},\n    {\"One cDNA clone\": 4},\n    {\"The cytoplasmic domain\": 5},\n    {\"To test this latter possibility\": 4},\n    {\"Flow cytometric and morphological analyses\": 5},\n    {\"This suggests that CHEMR1\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit\": 5},\n    {\"We find that TCL1\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation\": 5},\n    {\"We propose the common pathway\": 1},\n    {\"All of the tumors exhibited typical morphology\": 1},\n    {\"At least four distinct genes\": 1}\n]",
        "response3": "[{\"Burkitt's lymphoma receptor 1 (BLR1)\": \"protein\"}, {\"BLR2\": \"protein\"}]",
        "prediction": "{\"Burkitt's lymphoma receptor 1 (BLR1)\": 'protein', 'BLR2': 'protein'}"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'DNA' in the context of cloning and sequencing.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entities 'Tax' and 'TFIIA' in the context of interaction, providing clear references to proteins.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' in the context of binding to nuclear factors, clearly indicating protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly refers to 'tyrosine' in the context of protein-protein interaction, indicating a protein entity.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'A-myb' in the context of a transcription factor, providing a clear reference to a protein entity.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'IL-4' in the context of gene expression regulation and identified proteins, indicating a protein entity.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'retinoic acid receptor alpha' in the context of binding assays and proteolytic assay, indicating a protein entity.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' in the context of enhancer activity, indicating a DNA entity.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'EKLF' in the context of recruitment to enhancer elements, indicating a protein entity.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'IL-2', 'Aiolos', and 'Ras' in the context of immunofluorescence and phosphorylation, indicating protein entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'IL-7R' and 'gamma(c)' in the context of receptor function, indicating protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'CCAAT box' and 'EKLF binding site' in the context of gene expression, indicating DNA and protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'Th2-type lymphocytes' in the context of cytokine promoters, indicating a cell type entity.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' in the context of molecular cloning and protein interactions, indicating protein and cell type entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'p50p50' in the context of binding efficiency, indicating a protein entity.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'IL-2' in the context of element responsiveness, indicating a protein entity.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the provided entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the provided entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the provided entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) being expressed in a specific context, aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions the protein E2A and its level of expression, providing a direct example of a protein entity in a specific context.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly references the protein NF-E2 and its role in a cellular differentiation program, aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions the proteins EBNA2 and TP1 in the context of their interaction, providing clear examples of protein entities and a cell line entity in a specific context.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of the protein alpha-tocopherol, cell types monocyte and endothelial cells, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence clearly mentions the DNA entity AP-1 and its binding activity, aiding in the extraction of DNA entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of proteins (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and a cell line entity (Ter 119), aiding in the extraction of protein and cell line entities from the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions the proteins Erbstatin, genistein, and Egr-1 mRNA, providing clear examples of protein and RNA entities in a specific context.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins (EBNA2, estrogen receptor, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA), aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the DNA entities nuclear factor-kappa B and NF-kappa B, aiding in the extraction of DNA entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of the DNA entity PCNA and the protein entity E2F1, aiding in the extraction of DNA and protein entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions proteins (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1) and the protein erythropoietin, aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of the protein MR and the hormones aldosterone and progesterone, aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions the proteins FEV1, FVC, PEF, and prednisolone, aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of proteins (E2F, E2F-4, DP-1, p130) and the cell type AML, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities mentioned, making it not helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities mentioned, making it not helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities mentioned, making it not helpful in aiding the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{'estrogen': 'protein'}, {'tamoxifen': 'protein'}, {'type II EBS': 'protein'}]",
        "prediction": "{'estrogen': 'protein', 'tamoxifen': 'protein', 'type II EBS': 'protein'}"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "response1": "['cell_type', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 3},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 3},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCR alpha\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}, {\"T-cell-specific\": \"cell_type\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides specific protein names that are likely to be present in the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"CaM kinase II\": \"protein\"}]",
        "prediction": "{'CaM kinase II': 'protein'}"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"Oct-2A\": 5},\n    {\"HMG I/Y\": 5},\n    {\"HLA-DRA\": 5},\n    {\"B cells\": 4},\n    {\"T cell\": 4},\n    {\"interleukin 2\": 5},\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5},\n    {\"Egr-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 4},\n    {\"NF-ATc\": 5},\n    {\"A-myb\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"Jun\": 5},\n    {\"ATF-2\": 5},\n    {\"NF-E2\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 4},\n    {\"embryonic cardiac cells\": 4}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ubiquitin -proteasome system\": \"protein\"}, {\"ubiquitin\": \"protein\"}, {\"E2-F1\": \"protein\"}, {\"p53\": \"protein\"}, {\"ubiquitin -carrier protein\": \"protein\"}, {\"p105 precursor\": \"protein\"}, {\"ubiquitin -protein ligase\": \"protein\"}]",
        "prediction": "{'ubiquitin -proteasome system': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'p105 precursor': 'protein', 'ubiquitin -protein ligase': 'protein'}"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes\": 5},\n    {\"TCL1 is expressed in the majority of AIDS IBLP tumors examined\": 3},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"During infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation\": 4},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals\": 3},\n    {\"IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells\": 5},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well\": 1}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}, {\"thymic epithelial cells\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_type', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example provides a clear and specific entity label (DNA) that directly corresponds to the named entity 'immunoglobulin kappa 3' enhancer' in the sentence.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The examples provide specific entity labels (protein) that directly correspond to the named entities 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' in the sentence.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The examples provide specific entity labels (protein) that directly correspond to the named entities 'IL-2', 'c-Jun', and 'c-Fos' in the sentence.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The examples provide specific entity labels (protein) that directly correspond to the named entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' in the sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The examples provide specific entity labels (protein, cell_type) that directly correspond to the named entities 'PU.1', 'M-CSF receptor', and 'macrophage' in the sentence.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The examples provide specific entity labels (protein) that directly correspond to the named entities 'Sp1' and 'CD14' in the sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The example provides a specific entity label (cell_line) that directly corresponds to the named entity 'SIVsmmPBj14' in the sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The examples provide specific entity labels (cell_type, protein) that directly correspond to the named entities 'T cell' and 'interleukin 2' in the sentence.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The example provides a specific entity label (protein) that directly corresponds to the named entity 'p50p50' in the sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The examples provide specific entity labels (protein) that directly correspond to the named entities 'IkappaBbeta' and 'NF-kappaB' in the sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The examples provide specific entity labels (cell_type, protein) that directly correspond to the named entities 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' in the sentence.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The examples provide specific entity labels (protein, cell_line) that directly correspond to the named entities 'NF-kappaB', 'Sp1', and 'SIVmac' in the sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The examples provide specific entity labels (DNA, cell_line) that directly correspond to the named entities 'cDNA', 'Jurkat', and 'DRE 1' in the sentence.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The examples provide specific entity labels (DNA, protein) that directly correspond to the named entities 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B' in the sentence.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The examples provide specific entity labels (protein, cell_type) that directly correspond to the named entities 'TR55', 'TNF-alpha', and 'HIV' in the sentence.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The examples provide specific entity labels (protein) that directly correspond to the named entities 'ATF1', 'CREB', and 'H4' in the sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The example does not contain any named entities that match the provided entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The example does not contain any named entities that match the provided entity labels.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The example does not contain any named entities that match the provided entity labels.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}, {\"Jurkat T cells\": \"cell_type\"}, {\"GAL4\": \"protein\"}, {\"GAL4-substituted HIV-1 enhancer\": \"DNA\"}]",
        "prediction": "{'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Palombella\": \"protein\"}, {\"Rando\": \"protein\"}, {\"Goldberg\": \"protein\"}, {\"Maniatis\": \"protein\"}, {\"ubiquitin\": \"protein\"}]",
        "prediction": "{'Palombella': 'protein', 'Rando': 'protein', 'Goldberg': 'protein', 'Maniatis': 'protein', 'ubiquitin': 'protein'}"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple instances of protein entities related to interleukin-2, interleukin-2 receptor, IFN A, and IFNA, which are crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains protein entities IL-4, LPS, and AP-1, which are important for named entity extraction.\"},\n    {\"5\": \"The sentence includes protein entities NF-kappaB, Sp1, and p50, which are relevant for named entity extraction.\"},\n    {\"5\": \"The sentence contains protein entities NF-kB, AP-1, OCT-1, and NF-IL-2B, which are significant for named entity extraction.\"},\n    {\"3\": \"The sentence includes the protein entity TIMP-1 and the DNA entity, which are somewhat helpful for named entity extraction.\"},\n    {\"5\": \"The sentence contains protein entities RelA and NF-kappaB1, which are important for named entity extraction.\"},\n    {\"5\": \"The sentence includes protein entities EBNA-2 and PU.1, which are crucial for named entity extraction.\"},\n    {\"4\": \"The sentence contains a mix of cell_type and protein entities, which are somewhat helpful for named entity extraction.\"},\n    {\"5\": \"The sentence includes the protein entity RXR, which is significant for named entity extraction.\"},\n    {\"5\": \"The sentence contains protein entities EBNA2 and TP1, which are important for named entity extraction.\"},\n    {\"5\": \"The sentence includes RNA entity MNDA and cell_line entity myeloid cell lines, which are crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains protein entities p21(WAF1/CIP1) and p27(KIP1), which are important for named entity extraction.\"},\n    {\"5\": \"The sentence includes protein entities CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta, which are crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains cell_type entity CD4+ and protein entity EBV, which are important for named entity extraction.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{'EBNA-LP': 'protein'}, {'LMP1': 'protein'}, {'EBNA-2': 'protein'}]",
        "prediction": "{'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NFATp\": \"protein\"}, {\"NFATp\": \"protein\"}, {\"thymus\": \"cell_type\"}, {\"spleen\": \"cell_type\"}]",
        "prediction": "{'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-E2\": \"protein\"}, {\"megakaryocytes\": \"cell_type\"}]",
        "prediction": "{'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kappa B\": 5},\n    {\"CD28\": 4, \"CD80\": 4, \"CD86\": 4, \"CBL\": 4, \"VAV\": 4, \"NFAT\": 4, \"interleukin-2\": 4, \"granulocyte-macrophage colony-stimulating factor\": 4},\n    {\"cell adhesion molecules\": 4},\n    {\"P selectin\": 4},\n    {\"G-CSF\": 4},\n    {\"Stat3\": 4, \"Stat5\": 4, \"c-Mpl\": 4},\n    {\"cAMP-dependent protein kinase\": 4, \"Rap1\": 4},\n    {\"myeloperoxidase\": 4, \"lysozyme\": 4, \"PU.1\": 4},\n    {\"Tat-binding protein 7\": 4},\n    {\"IL4\": 4, \"IL13\": 4, \"gamma c chain\": 4, \"STAT6\": 4, \"STAT3\": 4, \"STAT5\": 4, \"B cells\": 4},\n    {\"NF-kappa B\": 4},\n    {\"p21ras\": 4},\n    {\"SLAP-130\": 4, \"SLP-76\": 4, \"T cell\": 4},\n    {\"Syk\": 4, \"Zap\": 4, \"T cell\": 4},\n    {\"GM-CSF\": 4},\n    {\"alpha-tocopherol\": 4, \"monocyte\": 4, \"endothelial cells\": 4},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"Platelet glycoprotein (GP) Ib-IX-V\": \"protein\"}]",
        "prediction": "{'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"IL-2 mRNA\": \"RNA\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"IL-5 mRNA\": 4},\n    {\"TCR\": 3},\n    {\"IL-2R\": 4},\n    {\"dexamethasone\": 4}\n]\n[\n    {\"NF-kappa B\": 4},\n    {\"I kappa B beta\": 4}\n]\n[\n    {\"T lymphocytes\": 5}\n]\n[\n    {\"ZAP-70\": 4}\n]\n[\n    {\"G-CSF\": 4}\n]\n[\n    {\"Egr-1\": 4}\n]\n[\n    {\"Th2-type lymphocytes\": 5}\n]\n[\n    {\"calcineurin\": 4}\n]\n[\n    {\"IL-2\": 4},\n    {\"NF-kappa B\": 4},\n    {\"AP-1\": 4}\n]\n[\n    {\"lymphocytes\": 5},\n    {\"benzene\": 1},\n    {\"benzoquinone\": 1}\n]\n[\n    {\"phosphocreatine\": 4}\n]\n[\n    {\"NF-E2\": 4}\n]\n[\n    {\"NF-kappa B\": 4}\n]\n[\n    {\"NF-kappa B\": 4}\n]\n[\n    {\"Syk\": 4},\n    {\"Zap\": 4},\n    {\"T cell\": 3}\n]\n[\n    {\"HML\": 4},\n    {\"dexamethasone\": 4},\n    {\"cortisol\": 4},\n    {\"lysozyme\": 4}\n]\n[]  \n[]  \n[]  \n]",
        "response3": "[{\"CEM C7 cells\": \"cell_line\"}, {\"T-cell line\": \"cell_type\"}]",
        "prediction": "{'CEM C7 cells': 'cell_line', 'T-cell line': 'cell_type'}"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear association between the entity 'E2A' and the entity type 'protein', aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear association between the entity 'GATA-1' and the entity type 'protein', aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear association between the entity 'lymphoid neoplasms' and the entity type 'cell_type', aiding in the extraction of cell type entities from the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a clear association between the entity 'phosphocreatine' and the entity type 'protein', which is helpful in extracting protein entities from the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear association between the entity 'NF-E2' and the entity type 'protein', aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of protein, DNA, and cell type entities from the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear association between the entity 'retinoic acid receptor alpha' and the entity type 'protein', aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear association between the entity 'CD14' and the entity type 'protein', aiding in the extraction of protein entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of cell line and protein entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of cell line, cell type, and DNA entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of protein, protein, and RNA entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides associations between multiple entities and their corresponding entity types, aiding in the extraction of DNA and protein entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the protein 'p50p50' and its binding activity, making it highly relevant for entity extraction.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the protein 'GATA-1' and its role in gene expression, providing a clear context for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly refers to 'Th2-type lymphocytes' as a cell type, making it a highly relevant example for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'SCM-1' genes, indicating a specific cell line, which is crucial for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein entities like 'Stat3', 'Stat5', and 'c-Mpl' with their roles in signal transduction, making it very helpful for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions 'E2A' as a protein and its expression level, providing a clear context for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'T cell' as a cell type and 'interleukin 2' as a protein, making it highly relevant for entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a clear mention of 'retinoic acid receptor alpha' as a protein, aiding in entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'GM-CSF' as a protein, providing a specific example for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'SIVsmmPBj14' as a cell line, which is crucial for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein entities like 'SLAP-130', 'SLP-76', and mentions 'T cell' as a cell type, making it very helpful for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions 'GATA-1' as a protein, providing a clear context for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'RXR' as a protein and its mutants, aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'cDNAs' as DNA, providing a specific example for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Ter 119' as a cell line, 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4' as proteins, making it highly relevant for entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'B and T cell activation' as a cell type, 'Ramos' and 'Jurkat' as cell lines, and 'cDNA microarray technology' as DNA, making it very helpful for entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the given entity labels, hence not helpful for entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the given entity labels, hence not helpful for entity extraction.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the given entity labels, hence not helpful for entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"EB1\": \"protein\"}]",
        "prediction": "{'EB1': 'protein'}"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-2, Aiolos, Ras) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (p21(WAF1/CIP1), p27(KIP1)) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains the protein 'tyrosine' which is relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-2, c-Jun, c-Fos) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains the protein 'ZAP-70' which is relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-4, LPS, AP-1) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (immunohistochemistry, gene) and cell type (cell type) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (NF-kappa B, I kappa B alpha) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (p50, p65) and entities related to DNA-protein complexes which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains entities related to HIV-1 infection (HIV-1, IFN, PKR, IkappaBalpha) which are relevant to the entity labels.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"gamma interferon\": \"protein\"}, {\"phosphotyrosine\": \"protein\"}]",
        "prediction": "{'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.\": 5},\n{\"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.\": 5},\n{\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Sp1\": 5, \"CD14\": 4},\n{\"IL-4\": 4},\n{\"Egr-1\": 5},\n{\"SCM-1\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"CD95 ligand\": 4},\n{\"UAS1\": 4, \"B cell\": 4},\n{\"Sp1\": 5, \"Ets\": 5},\n{\"GATA-1\": 5},\n{\"PML/RARalpha\": 5},\n{\"GATA-1\": 5},\n{\"NF-E2\": 5},\n{\"E2A\": 5},\n{\"IL-2\": 5},\n{\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"Protein\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Genes\": 1}\n]",
        "response3": "[{\"osteoblast\": \"cell_type\"}, {\"osteocalcin\": \"protein\"}]",
        "prediction": "{'osteoblast': 'cell_type', 'osteocalcin': 'protein'}"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 1},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 5},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 5},\n    {\"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.\": 5},\n    {\"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides a clear and direct mapping of the entity 'phosphocreatine' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides clear and direct mappings of the entities 'IL-2', 'NF-kappa B', and 'AP-1' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping of the entity 'T lymphocytes' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping of the entity 'lymphoid neoplasms' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides clear and direct mappings of the entities 'alpha-tocopherol', 'monocyte', and 'endothelial cells' to the entity labels 'protein', 'cell_type', and 'cell_type' respectively in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides clear and direct mappings of the entities 'IL-5 mRNA', 'TCR', 'IL-2R', and 'dexamethasone' to the entity labels 'RNA', 'cell_type', 'protein', and 'protein' respectively in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping of the entity 'NF-E2' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping of the entity 'NF-kappa B' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping of the entity 'P selectin' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear and direct mapping of the entity 'AP-1' to the entity label 'DNA' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear and direct mapping of the entity 'Eosinophils' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping of the entity 'NF-kappa B' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping of the entity 'G-CSF' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear and direct mappings of the entities 'cAMP-dependent protein kinase' and 'Rap1' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear and direct mappings of the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' to the entity labels 'protein', 'protein', 'protein', and 'cell_type' respectively in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 4},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"PEBP2 alpha/AML-1-related factor\": \"protein\"}, {\"osteocalcin\": \"protein\"}, {\"osteoblast-specific\": \"cell_type\"}]",
        "prediction": "{'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Markus Neurath\": \"protein\"}, {\"Eckhard Stuber\": \"protein\"}, {\"Warren Strober\": \"protein\"}, {\"BSAP\": \"protein\"}, {\"B-cell-specific genes\": \"protein\"}]",
        "prediction": "{'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"4\": \"The sentence contains 'NF-kappaB' which is a protein entity.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"3\": \"The sentence contains 'IL-4', 'LPS', and 'AP-1' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is a protein entity.\"},\n    {\"3\": \"The sentence contains 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is a protein entity.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'IL-2', 'NF-kappa B', and 'AP-1' which are protein entities.\"},\n    {\"3\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are protein entities.\"},\n    {\"3\": \"The sentence contains 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'B cell', 'Ig', and 'Transforming growth factor-beta' which are protein entities.\"},\n    {\"3\": \"The sentence contains 'CTLA4Ig', 'NFAT', and 'AP-1' which are protein entities.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{'PBMC': 'cell_type'}, {'NF kappa B': 'protein'}]",
        "prediction": "{'PBMC': 'cell_type', 'NF kappa B': 'protein'}"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"GATA-1\": 5, \"protein\": \"The sentence explicitly mentions the mRNA expression of GATA-1 binding transcription factor, making it highly relevant for named entity extraction.\"},\n{\"NF-E2\": 5, \"protein\": \"The sentence explicitly mentions the inhibition of binding of NF-E2, a cell-specific transcription factor, making it highly relevant for named entity extraction.\"},\n{\"Th2-type lymphocytes\": 5, \"cell_type\": \"The sentence explicitly mentions human Th2-type lymphocytes, indicating a specific cell type, making it highly relevant for named entity extraction.\"},\n{\"Egr-1\": 5, \"protein\": \"The sentence explicitly mentions Egr-1, a zinc finger transcription factor, making it highly relevant for named entity extraction.\"},\n{\"erythropoietin\": 5, \"protein\": \"The sentence explicitly mentions erythropoietin, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"CCAAT box\": 5, \"DNA\": \"The sentence explicitly mentions the altered CCAAT box, indicating a specific DNA element, making it highly relevant for named entity extraction.\"},\n{\"EKLF binding site\": 5, \"protein\": \"The sentence explicitly mentions the lack of an EKLF binding site, indicating a specific protein interaction, making it highly relevant for named entity extraction.\"},\n{\"AP-1\": 5, \"DNA\": \"The sentence explicitly mentions the impaired transcription factor AP-1 DNA binding activity, making it highly relevant for named entity extraction.\"},\n{\"IL-4\": 5, \"protein\": \"The sentence explicitly mentions IL-4 gene expression, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"retinoic acid receptor alpha\": 5, \"protein\": \"The sentence explicitly mentions retinoic acid receptor alpha, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"RXR\": 5, \"protein\": \"The sentence explicitly mentions RXR, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"WT1\": 5, \"protein\": \"The sentence explicitly mentions WT1, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"myeloid cell lines\": 5, \"cell_line\": \"The sentence explicitly mentions myeloid cell lines, indicating a specific cell line, making it highly relevant for named entity extraction.\"},\n{\"IL-2 receptor alpha subunit\": 5, \"protein\": \"The sentence explicitly mentions IL-2 receptor alpha subunit, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"p21ras\": 5, \"protein\": \"The sentence explicitly mentions p21ras, indicating a specific protein, making it highly relevant for named entity extraction.\"},\n{\"B cell\": 5, \"cell_type\": \"The sentence explicitly mentions B cell activation, indicating a specific cell type, making it highly relevant for named entity extraction.\"},\n{\"IgH\": 5, \"DNA\": \"The sentence explicitly mentions IgH genes, indicating a specific DNA element, making it highly relevant for named entity extraction.\"},\n{\"SCL\": 5, \"protein\": \"The sentence explicitly mentions SCL, a protein expressed in specific cell populations, making it highly relevant for named entity extraction.\"},\n{\"GATA-1\": 5, \"protein\": \"The sentence explicitly mentions GATA-1, a lineage-specific transcription factor, making it highly relevant for named entity extraction.\"},\n{\"immunoglobulin kappa 3' enhancer\": 5, \"DNA\": \"The sentence explicitly mentions the developmental control of immunoglobulin kappa 3' enhancer, indicating a specific DNA element, making it highly relevant for named entity extraction.\"}\n]",
        "response3": "[{\"globin gene\": \"protein\"}]",
        "prediction": "{'globin gene': 'protein'}"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.\": 5},\n    {\"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of proteins being phosphorylated, which is a key indicator for protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions specific proteins and their involvement in signaling pathways, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides specific protein names and their functions, helping in identifying protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions specific proteins and their roles in transcriptional activation, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides specific protein names and their involvement in signal transduction events, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions specific proteins and their roles in cellular distribution and phosphorylation, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence contains multiple examples of proteins involved in binding activities, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions specific proteins and their involvement in the activation of transcription factors, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides specific protein names and their roles in gene expression regulation, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions specific proteins and their roles in T-cell activation, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides specific protein names and their involvement in protein kinase activity, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions specific proteins and their presence in gel-shift analysis, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides specific protein names and their involvement in NF-kappa B activation, aiding in the identification of protein entities.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence does not contain any relevant entities for the given label set.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence does not contain any relevant entities for the given label set.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence does not contain any relevant entities for the given label set.\"}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"c-Jun\": \"protein\"}, {\"I kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"beta-galactosidase gene\": \"protein\"}, {\"adenovirus E2 promoter\": \"DNA\"}]",
        "prediction": "{'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"C/EBP beta\": \"protein\"}, {\"eosinophilic\": \"cell_type\"}, {\"hematopoietic progenitor cell line\": \"cell_line\"}]",
        "prediction": "{'NF-M': 'protein', 'C/EBP beta': 'protein', 'eosinophilic': 'cell_type', 'hematopoietic progenitor cell line': 'cell_line'}"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"EBV\": 5, \"B-cell\": 5},\n{\"retinoic acid receptor alpha\": 5},\n{\"Protein\": 5},\n{\"MIP-1 alpha\": 5, \"GOS19\": 5, \"LD78\": 5, \"AT464\": 5},\n{\"EBNA-2\": 5, \"PU.1\": 5},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"Egr-1\": 5},\n{\"E2A\": 5},\n{\"GM-CSF\": 5},\n{\"protein\": 5},\n{\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"EBNA2\": 5, \"TP1\": 4},\n{\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n{\"interleukin 10\": 5, \"IL-10R\": 5, \"STAT3\": 5, \"IL-6\": 5},\n{\"GATA-1\": 5},\n{\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Distinct genes\": 1}\n]",
        "response3": "[{\"G-protein coupled chemokine receptors\": \"protein\"}, {\"EBI1\": \"protein\"}]",
        "prediction": "{'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 1},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"eosinophils\": \"cell_type\"}]",
        "prediction": "{'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Example 2\": 5},\n{\"Example 3\": 5},\n{\"Example 4\": 5},\n{\"Example 5\": 5},\n{\"Example 6\": 5},\n{\"Example 7\": 5},\n{\"Example 8\": 5},\n{\"Example 9\": 5},\n{\"Example 10\": 5},\n{\"Example 11\": 5},\n{\"Example 12\": 4},\n{\"Example 13\": 5},\n{\"Example 14\": 5},\n{\"Example 15\": 4},\n{\"Example 16\": 1},\n{\"Example 17\": 1},\n{\"Example 18\": 1}\n]",
        "response3": "[{\"HMG-1\": \"protein\"}]",
        "prediction": "{'HMG-1': 'protein'}"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains a specific protein name (NF-E2) which is directly mentioned.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) which are directly mentioned.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains a specific protein name (IL-2) which is directly mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) which are directly mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains a specific protein name (Egr-1) which is directly mentioned.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name (IL-4) which is directly mentioned.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific cell type (T cell) and a protein name (interleukin 2) which are directly mentioned.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names (IL-2, c-Jun, c-Fos) which are directly mentioned.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains a specific cell type (Th2-type lymphocytes) which is directly mentioned.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains a specific DNA name (IgH) which is directly mentioned.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains a specific DNA name (kappa E3') which is directly mentioned.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (c-kit, IL-4R alpha chain) which are directly mentioned.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains a specific protein name (NF-kappa B) which is directly mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly mentioned.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) which are directly mentioned.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names (p50, p65) and mentions DNA and protein which are directly related to the entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the given entity labels.\"}\n]",
        "response3": "[{\"IgH\": \"DNA\"}, {\"NF-microB\": \"protein\"}]",
        "prediction": "{'IgH': 'DNA', 'NF-microB': 'protein'}"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"1\": \"The example does not contain any entities present in the target sentence.\"},\n    {\"1\": \"The example does not contain any entities present in the target sentence.\"},\n    {\"4\": \"The example contains the entity 'RXR' which is a protein, similar to the protein entity 'R' in the target sentence.\"},\n    {\"5\": \"The example contains multiple protein entities such as 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)', which are similar to the protein entity 'R' in the target sentence.\"},\n    {\"5\": \"The example contains multiple protein entities such as 'NF-kappaB', 'Sp1', and 'p50', which are similar to the protein entity 'R' in the target sentence.\"},\n    {\"5\": \"The example contains the protein entity 'EBNA2' and the cell line entity 'TP1', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"4\": \"The example contains the cell type entity 'T cell' and the protein entity 'interleukin 2', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"4\": \"The example contains the protein entity 'IL-2', which is similar to the protein entity 'R' in the target sentence.\"},\n    {\"1\": \"The example does not contain any entities present in the target sentence.\"},\n    {\"5\": \"The example contains multiple protein entities such as 'NF-kB', 'AP-1', 'OCT-1', and 'NF-IL-2B', which are similar to the protein entity 'R' in the target sentence.\"},\n    {\"5\": \"The example contains the cell line entity 'EBV' and the protein entity 'CD2', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"4\": \"The example contains the cell type entity 'CD4+' and the protein entity 'EBV', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"5\": \"The example contains the protein entities 'EBNA-2' and 'PU.1', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"5\": \"The example contains the cell line entity 'UAS1' and the cell type entity 'B cell', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"5\": \"The example contains the cell type entities 'EBV' and 'B-cell', which are similar to the entities 'R' and 'Z' in the target sentence.\"},\n    {\"4\": \"The example contains the protein entity 'GATA-1', which is similar to the protein entity 'R' in the target sentence.\"},\n    {\"1\": \"The example does not contain any entities present in the target sentence.\"},\n    {\"1\": \"The example does not contain any entities present in the target sentence.\"},\n    {\"1\": \"The example does not contain any entities present in the target sentence.\"}\n]",
        "response3": "[{'EBV': 'cell_line'}, {'R': 'protein'}, {'Z': 'protein'}]",
        "prediction": "{'EBV': 'cell_line', 'R': 'protein', 'Z': 'protein'}"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n{\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"ets-1\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'ets-1': 'protein'}"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 3},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 1},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"Platelet-activating factor\": \"protein\"}, {\"phospholipid\": \"protein\"}, {\"calcium\": \"protein\"}, {\"arachidonic acid\": \"protein\"}, {\"eicosanoid\": \"protein\"}, {\"oncogene\": \"protein\"}, {\"human B cell line\": \"cell_line\"}]",
        "prediction": "{'Platelet-activating factor': 'protein', 'phospholipid': 'protein', 'calcium': 'protein', 'arachidonic acid': 'protein', 'eicosanoid': 'protein', 'oncogene': 'protein', 'human B cell line': 'cell_line'}"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras\": 5}\n]",
        "response3": "[{\"T cells\": \"cell_type\"}]",
        "prediction": "{'T cells': 'cell_type'}"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains a specific protein entity that matches one of the entity labels in the target sentence.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example contains a protein entity that matches one of the entity labels in the target sentence, but the relevance is slightly lower compared to more specific examples.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains a protein entity that matches one of the entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example contains a protein entity that matches one of the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example contains a protein entity that matches one of the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides specific terms that directly match the entity labels in the target sentence.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The example contains terms related to signaling pathways, but they do not match the entity labels in the target sentence.\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The example contains terms related to tumors and clinical course, but they do not match the entity labels in the target sentence.\"},\n    {\"Example 16\": 3},\n    {\"Reason 16\": \"The example contains terms related to gene encoding and isoforms, but they do not match the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"salicylates\": \"protein\"}, {\"atherosclerosis\": \"cell_type\"}, {\"rheumatoid arthritis\": \"cell_type\"}, {\"monocyte\": \"cell_type\"}]",
        "prediction": "{'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[\n    {\"AP-1\": \"protein\"},\n    {\"NF-kappa B\": \"protein\"},\n    {\"T cells\": \"cell_type\"}\n]",
        "prediction": "{'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"PMA\": \"protein\"}, {\"PHA\": \"protein\"}]",
        "prediction": "{'PMA': 'protein', 'PHA': 'protein'}"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains multiple examples of protein entities (NF-ATc, NF-ATc isoforms) and cell type entities (T lymphocytes, embryonic cardiac cells).\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes various examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) and their corresponding labels.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains an example of a DNA entity (NF-kappa B) and its corresponding label.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains examples of protein entities (RelA, NF-kappa B) and their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes examples of protein entities (FasL, IL-2, IFN-gamma) and their corresponding labels.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides examples of protein entities (NF-ATc, NF-ATc isoforms) and cell type entities (T lymphocytes).\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of protein entities (CD40, NF-kappa B) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence includes examples of protein entities (NF-kappaB, Tax) and cell type entities (ATL) and their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains examples of protein entities (IL-10-stimulated STAT protein, STAT3) and cell type entities (T cells) and their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence includes examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the given entity labels.\"}\n]",
        "response3": "[{\"NFATc\": \"protein\"}, {\"NFATc mRNA\": \"RNA\"}, {\"NK cells\": \"cell_type\"}, {\"CD16 ligands\": \"protein\"}]",
        "prediction": "{'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n{\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CD30\": \"protein\"}]",
        "prediction": "{'CD30': 'protein'}"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-jun\": \"protein\"}, {\"HL-60 cells\": \"cell_line\"}, {\"TPA\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein', 'HL-60 cells': 'cell_line', 'TPA': 'protein'}"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4},\n    {\"MNDA\": 4},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"PMA\": 3},\n    {\"CD14\": 4},\n    {\"CD23\": 4},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 4},\n    {\"c-Fos\": 4},\n    {\"PML/RARalpha\": 5},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"NF-kappaB\": 4},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"TCRzeta\": 4},\n    {\"p56(lck)\": 4},\n    {\"p21(WAF1/CIP1)\": 4},\n    {\"p27(KIP1)\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"Ter 119\": 4},\n    {\"beta-globin\": 4},\n    {\"glycoprotein IIb\": 4},\n    {\"platelet factor 4\": 4},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"NF-kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"B and T cell activation\": 3},\n    {\"Ramos\": 4},\n    {\"Jurkat\": 4},\n    {\"cDNA microarray technology\": 5},\n    {\"HeLa cells\": 4},\n    {\"Daudi\": 4},\n    {\"B cell-encoded genes\": 4},\n    {\"B cell-specific\": 4},\n    {\"PU.1\": 4},\n    {\"CSF-1 receptor\": 4},\n    {\"Mono A\": 4},\n    {\"Mono B\": 4}\n]",
        "response3": "[{\"pbmc\": \"cell_type\"}, {\"bone marrow cells\": \"cell_type\"}, {\"c-fos\": \"protein\"}, {\"c-myc\": \"protein\"}, {\"p53\": \"protein\"}, {\"bcr/abl mRNA\": \"RNA\"}]",
        "prediction": "{'pbmc': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"GCR\": \"protein\"}, {\"GCS\": \"protein\"}, {\"bronchial asthma\": \"cell_type\"}, {\"cortisol\": \"protein\"}]",
        "prediction": "{'GCR': 'protein', 'GCS': 'protein', 'bronchial asthma': 'cell_type', 'cortisol': 'protein'}"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Id2 mRNA\": \"RNA\"}, {\"Id3 mRNA\": \"RNA\"}]",
        "prediction": "{'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well\": 1}\n]",
        "response3": "[{\"CD69 gene\": \"protein\"}, {\"TATA element\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['cell_line', 'protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"RNA\": \"RNA\"}, {\"cell_line\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'RNA': 'RNA', 'cell_line': 'cell_line'}"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell type (nonhuman primates) being mentioned in relation to signal transduction events.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions cell adhesion molecules, indicating a clear example of a cell type.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions G-CSF, a protein, in relation to its effects, providing a clear example of a protein entity.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple examples of entities including proteins (CD70, IL-4, CD40), cell types (B cell, plasma cells), and RNA (IL-5 mRNA) in the context of cell signaling and differentiation.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein entity (E2A) being examined at the protein level.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions NF-E2 as a cell-specific transcription factor, providing a clear example of a protein entity.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions various entities including RNA (IL-5 mRNA), cell types (TCR), proteins (IL-2R, dexamethasone), in the context of gene expression and stimulation.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides examples of cell types (granulocytes, T cells) in relation to methylation.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions IL-4 gene expression and recently identified proteins, indicating a clear example of a protein entity.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions various proteins (nuclear factors, c-Jun, c-Fos) in the context of gel-shift analysis.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions phosphocreatine in relation to lymphocytes during physical exercise, providing a clear example of a protein entity.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions HML as a cell line, along with proteins (dexamethasone, cortisol, lysozyme) in the context of glucocorticoid responsiveness.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions IFN-gamma as a T helper 1-type cytokine, providing a clear example of a protein entity.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions NF-kappa B activation in relation to xenogeneic serum, providing a clear example of a protein entity.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions VDR interacting proteins (RXR, GRIP-1, DRIP205) in the context of sensitivity to analog effects, providing clear examples of protein entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions CD40 stimulation, Rel/nuclear factor kappaB, and NF-kappaB factors in primary murine B lymphocytes, providing clear examples of protein entities and a cell type.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific examples of named entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific examples of named entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific examples of named entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[\n    {\"NF-kappa B\": \"protein\"},\n    {\"p50 NF-kappa B1\": \"protein\"},\n    {\"p65 RelA\": \"protein\"}\n]",
        "prediction": "{'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "response1": "None.",
        "response2": "[\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 3},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n{\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n{\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\": 4},\n{\"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs .\": 3},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both proteins mentioned in the label set.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the label set.\"},\n    {\"5\": \"The sentence contains 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' which are all entities from the label set.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all proteins mentioned in the label set.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both proteins mentioned in the label set.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the label set.\"},\n    {\"5\": \"The sentence contains 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' which are all entities from the label set.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both proteins mentioned in the label set.\"},\n    {\"5\": \"The sentence contains 'NF-kappaB', 'Tax', and 'ATL' which are entities from the label set.\"},\n    {\"5\": \"The sentence contains 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are all entities from the label set.\"},\n    {\"5\": \"The sentence contains 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' which are entities from the label set.\"},\n    {\"5\": \"The sentence contains 'YY1', 'Oct1', 'IL-5', and 'T cells' which are entities from the label set.\"},\n    {\"5\": \"The sentence contains 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor' which are all entities from the label set.\"},\n    {\"5\": \"The sentence contains 'CTLA4Ig', 'NFAT', and 'AP-1' which are entities from the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"IL4\": \"protein\"}, {\"Jurkat cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"tumor necrosis factor alpha\": \"protein\"}, {\"RelA\": \"protein\"}]",
        "prediction": "{'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'CD40' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IL-2', 'c-Jun', and 'c-Fos' which are proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'E2A' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappaB', 'Tax', and 'ATL' which are relevant to the cell_type and protein entities mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a DNA mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}, {\"mouse 70Z/3 cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"phorbol myristate acetate\": \"protein\"}, {\"lipopolysaccharide\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 5},\n    {\"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "response1": "['cell_line', 'gene']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (GM-CSF) and its corresponding label, which is helpful for understanding how protein entities are mentioned in the text.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of DNA entities (UAS3, UAS2) and a protein entity (YY1) with their corresponding labels, aiding in the extraction of these entities from the text.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions a protein entity (Protein) and its label, providing a straightforward example for identifying protein entities in the text.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes protein entities (IL-2, c-Jun, c-Fos) and their labels, assisting in recognizing protein entities and their roles in the text.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions protein entity (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) with their labels, aiding in identifying different types of entities in the text.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of a protein entity (EKLF) and its label, helping in understanding the role of protein entities in the text.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a protein entity (A-myb) and its label, assisting in identifying protein entities in the text.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains protein entities (Tax, TFIIA) and their labels, aiding in recognizing protein entities and their interactions in the text.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions a DNA entity (cDNAs) and its label, providing a clear example for identifying DNA entities in the text.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence includes a protein entity (GATA-1) and its label, assisting in recognizing protein entities and their roles in the text.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (EKLF, CBP, p300, P/CAF) and their labels, aiding in understanding the role of protein entities and their interactions in the text.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions a cell line entity (SCM-1) and its label, helping in identifying cell line entities in the text.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains a protein entity (NF-E2) and its label, assisting in recognizing protein entities and their roles in the text.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (p21(WAF1/CIP1), p27(KIP1)) and their labels, aiding in understanding the role of protein entities in the text.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions protein entity (NF-ATc) and cell type entity (T lymphocytes) with their labels, aiding in identifying different types of entities in the text.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence includes a protein entity (E2A) and its label, assisting in recognizing protein entities and their roles in the text.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any examples of the entity types present in the target sentence, making it less helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not mention any of the entity types present in the target sentence, providing no assistance in extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not include any examples of the entity types present in the target sentence, offering no help in extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1}\n]",
        "response3": "[{\"KBF1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'KBF1': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CVZ\": \"protein\"}, {\"IM-9\": \"cell_line\"}, {\"RU 38486\": \"protein\"}, {\"human GR\": \"protein\"}]",
        "prediction": "{'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"IFN-gamma-activated sequence (GAS)\": \"DNA\"}]",
        "prediction": "{'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"E1A\": \"protein\"}, {\"IFN\": \"protein\"}, {\"adenovirus-transformed cells\": \"cell_line\"}, {\"NK cells\": \"cell_type\"}]",
        "prediction": "{'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 4},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n{\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n{\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n{\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n{\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells, respectively.\": 5},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CD8+\": \"cell_type\"}, {\"progesterone receptor\": \"protein\"}, {\"CD4+\": \"cell_type\"}, {\"lymphocytes\": \"cell_type\"}]",
        "prediction": "{'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Cyclosporin A\": \"protein\"}, {\"CsA\": \"protein\"}, {\"lymphokine genes\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"interleukin-2\": \"protein\"}]",
        "prediction": "{'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 3},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 4},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n{\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 5},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4}\n]",
        "response3": "[{\"SCL\": \"DNA\"}]",
        "prediction": "{'SCL': 'DNA'}"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"kappa B complex\": \"protein\"}, {\"NFAT-1 complex\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"interleukin-2 enhancer\": \"protein\"}]",
        "prediction": "{'kappa B complex': 'protein', 'NFAT-1 complex': 'protein', 'DNA': 'DNA', 'interleukin-2 enhancer': 'protein'}"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"anti-CD3 Abs\": \"protein\"}]",
        "prediction": "{'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"bronchoalveolar lavage\": \"cell_line\"}, {\"blood mononuclear cells\": \"cell_type\"}, {\"sarcoidosis\": \"cell_type\"}, {\"tuberculosis\": \"cell_type\"}]",
        "prediction": "{'bronchoalveolar lavage': 'cell_line', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}, {\"lymphoblasts\": \"cell_type\"}, {\"steroid hormone receptor\": \"protein\"}]",
        "prediction": "{'DNA': 'DNA', 'lymphoblasts': 'cell_type', 'steroid hormone receptor': 'protein'}"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"SP1\": 5, \"caspases\": 4, \"B-cell\": 5},\n    {\"Sp1\": 4, \"Ets\": 4},\n    {\"GATA-1\": 4},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"SCM-1\": 5},\n    {\"IL-4\": 4},\n    {\"CD70\": 4, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 4, \"CD40\": 4},\n    {\"T cell\": 5, \"interleukin 2\": 4},\n    {\"PML/RARalpha\": 4},\n    {\"GATA-1\": 4},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5, \"embryonic cardiac cells\": 5},\n    {\"A-myb\": 4},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"IkappaBbeta\": 4, \"NF-kappaB\": 4},\n    {\"Common pathway\": 1},\n    {\"Tumors\": 1},\n    {\"Distinct genes\": 1}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}]",
        "prediction": "{'B-cell': 'cell_type'}"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains specific cell type and protein names that are relevant to the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example contains a specific protein name that is relevant to the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example contains specific RNA, cell type, and protein names that are relevant to the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example contains specific cell type and protein names that are relevant to the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains a specific protein name that is relevant to the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example contains specific protein and cell type names that are relevant to the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example contains specific protein names that are relevant to the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example contains specific protein and cell type names that are relevant to the target sentence.\"},\n    {\"Example 16\": 3},\n    {\"Reason 16\": \"The example does not contain any relevant entity names to the target sentence.\"},\n    {\"Example 17\": 3},\n    {\"Reason 17\": \"The example does not contain any relevant entity names to the target sentence.\"},\n    {\"Example 18\": 3},\n    {\"Reason 18\": \"The example does not contain any relevant entity names to the target sentence.\"}\n]",
        "response3": "[{\"IL-6\": \"protein\"}]",
        "prediction": "{'IL-6': 'protein'}"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"HIV LTR\": \"DNA\"}, {\"T cells\": \"cell_type\"}, {\"monocytic cells\": \"cell_type\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "response1": "['cell_line', 'protein', 'DNA']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities and their corresponding labels.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"4\": \"The sentence contains multiple protein entities and their corresponding labels.\"},\n    {\"3\": \"The sentence contains protein entities but does not cover all entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple protein entities and their corresponding labels.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"5\": \"The sentence contains multiple protein entities and their corresponding labels.\"},\n    {\"4\": \"The sentence contains 'NF-kappaB' and 'Tax' which are labeled as 'protein' and 'cell_type' respectively in the entity label set.\"},\n    {\"4\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are labeled as 'protein' in the entity label set.\"},\n    {\"5\": \"The sentence contains multiple protein entities and their corresponding labels.\"},\n    {\"5\": \"The sentence contains multiple protein entities and their corresponding labels.\"},\n    {\"5\": \"The sentence contains multiple protein entities and their corresponding labels.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"L540 cells\": \"cell_line\"}, {\"CD30\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'L540 cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n{\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n{\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 1},\n    {\"Example 13\": 1},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HDL\": \"protein\"}, {\"LDL\": \"protein\"}]",
        "prediction": "{'HDL': 'protein', 'LDL': 'protein'}"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"complementary DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"c-jun\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"25 kD\": \"protein\"}, {\"55 kD\": \"protein\"}]",
        "prediction": "{'25 kD': 'protein', '55 kD': 'protein'}"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell line (SCM-1) in the context of examining regulatory mechanisms of genes.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (p50p50) in the context of binding efficiency and mutation effects.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence discusses the role of a specific protein (PML/RARalpha) in myelopoiesis.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins (EKLF, CBP, p300, P/CAF) and their interactions in the context of transcription factor acetylation.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a specific protein (GATA-1) as a positive regulator of lineage-specific transcription factor in erythroid cells.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence discusses the transactivation role of a specific protein (TCF-1) in non-T cells.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a specific protein (ZEBRA) in the context of transactivation.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence discusses a specific protein (A-myb) and its restricted expression pattern.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions proteins involved in transcription, suggesting a similar role for the G0S24 product.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a specific protein (CD95 ligand) in the context of a luciferase reporter construct.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins (Tax, TFIIA) and their interaction in the yeast two-hybrid system.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions a specific protein (Egr-1) as a zinc finger transcription factor expressed upon macrophage differentiation.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions proteins (IL-2, c-Jun, c-Fos) in the context of nuclear factors binding to the IL-2 promoter.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence discusses the role of a specific protein (GATA-1) in erythroid development and gene regulation.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a specific protein (E2A) and its expression at the protein level using polyclonal antisera.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins (Sp1, Ets) and their critical role in maintaining CTL-specific expression of the mouse perforin gene.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entity types from the given label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entity types from the given label set.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any relevant entity types from the given label set.\"}\n]",
        "response3": "[{\"MZF-1\": \"protein\"}, {\"MZF-1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example contains a specific entity 'immunoglobulin kappa 3' enhancer' which is labeled as 'DNA' in the target sentence, making it highly relevant and helpful for extracting named entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example contains entities 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' which are labeled as 'protein' and 'cell_line' respectively in the target sentence, providing relevant information for extracting named entities.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The example contains entities 'IL-7R' and 'gamma(c)' which are labeled as 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The example contains entities 'granulocytes' and 'T cells' which are labeled as 'cell_type' in the target sentence, making it highly relevant and helpful for extracting named entities.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The example contains the entity 'Protein' which is labeled as 'protein' in the target sentence, providing relevant information for extracting named entities.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The example contains the entity 'GM-CSF' which is labeled as 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The example contains the entity 'G-CSF' which is labeled as 'protein' in the target sentence, providing relevant information for extracting named entities.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The example contains the entity 'SIVsmmPBj14' which is labeled as 'cell_line' in the target sentence, making it highly relevant and helpful for extracting named entities.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The example contains entities 'IL-2', 'c-Jun', and 'c-Fos' which are labeled as 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The example contains entities 'CREB' and 'AR-CRE' which are labeled as 'protein' in the target sentence, providing relevant information for extracting named entities.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The example contains entities 'CHEMR1', 'C-C chemokine', and 'MIP-1alpha' which are labeled as 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The example contains the entity 'lymphoid neoplasms' which is labeled as 'cell_type' in the target sentence, making it highly relevant and helpful for extracting named entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The example contains the entity 'SCM-1' which is labeled as 'cell_line' in the target sentence, making it highly relevant and helpful for extracting named entities.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The example contains the entity 'SCL' which is labeled as 'RNA' in the target sentence, providing relevant information for extracting named entities.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The example contains the entity 'RXR' which is labeled as 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 16\": 4},\n{\"Reason 16\": \"The example contains entities 'VDR', 'RXR', 'GRIP-1', and 'DRIP205' which are labeled as 'protein' in the target sentence, providing relevant information for extracting named entities.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The example does not contain any entities relevant to the target sentence, hence not helpful in extracting named entities.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The example does not contain any entities relevant to the target sentence, hence not helpful in extracting named entities.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The example does not contain any entities relevant to the target sentence, hence not helpful in extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Factor VII/VIIa\": \"protein\"}, {\"tissue factor (TF) receptor\": \"protein\"}]",
        "prediction": "{'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": \"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappaB, Sp1, p50) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Control of NF-kappa B activity by the I kappa B beta inhibitor .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, I kappa B beta) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (RelA, NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence contains the entity label 'NF-kappa B' which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (CD40, NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (IkappaBalpha, NF-kappaB) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (IkappaBbeta, NF-kappaB) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappaB, Tax) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, ARDS) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (IL-4, LPS, AP-1) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant entity labels to the target sentence.\"},\n    {\"Sentence\": \"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant entity labels to the target sentence.\"},\n    {\"Sentence\": \"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant entity labels to the target sentence.\"}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"p50\": \"protein\"}, {\"p65\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T cell\": \"cell_type\"}, {\"HIV\": \"cell_type\"}]",
        "prediction": "{'T cell': 'cell_type', 'HIV': 'cell_type'}"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"immunoglobulin\": \"protein\"}, {\"class II major histocompatibility (MHC) genes\": \"protein\"}, {\"B-lymphoid-specific genes\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"GATA\": \"protein\"}, {\"Ets\": \"protein\"}]",
        "prediction": "{'GATA': 'protein', 'Ets': 'protein'}"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a specific entity (SCM-1) and its corresponding entity label (cell_line) directly from the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides specific entities (CREB, AR-CRE) and their corresponding entity labels (protein) directly from the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides specific entities (IL-2, c-Jun, c-Fos) and their corresponding entity labels (protein) directly from the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides specific entities (granulocytes, T cells) and their corresponding entity labels (cell_type) directly from the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides specific entities (IL-2 receptor alpha subunit, p21ras, B cell) and their corresponding entity labels (protein, protein, cell_type) directly from the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides specific entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding entity labels (protein, protein, protein, protein, protein, protein) directly from the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides specific entities (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels (protein, protein, protein, protein) directly from the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a specific entity (IL-4) and its corresponding entity label (protein) directly from the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides specific entities (T cell, IL-2, IL-2 receptor, CD28) and their corresponding entity labels (cell_type, protein, protein, protein) directly from the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific entities (AP-1, PMA, monocytes, macrophages) and their corresponding entity labels (protein, protein, cell_type, cell_type) directly from the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a specific entity (RXR) and its corresponding entity label (protein) directly from the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a specific entity (IL-2) and its corresponding entity label (protein) directly from the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides specific entities (IL4, IL13, gamma c chain, STAT6, STAT3, STAT5, B cells) and their corresponding entity labels (protein, protein, protein, protein, protein, protein, cell_type) directly from the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides specific entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding entity labels (protein, protein, protein, protein) directly from the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides specific entities (IL-4, LPS, AP-1) and their corresponding entity labels (protein, protein, protein) directly from the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides specific entities (T cell, interleukin 2) and their corresponding entity labels (cell_type, protein) directly from the sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the given entity labels.\"}\n]",
        "response3": "[{'PRL': 'protein'}, {'IL-2': 'protein'}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 3},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 3},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"VDR concentration\": \"protein\"}, {\"serum phosphate\": \"protein\"}]",
        "prediction": "{'VDR concentration': 'protein', 'serum phosphate': 'protein'}"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "response1": "['cell_line', 'DNA', 'protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 3},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 3},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"multiple myeloma cell lines\": \"cell_line\"}, {\"B cells\": \"cell_type\"}, {\"PU.1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"mRNA\": \"RNA\"}]",
        "prediction": "{'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label, which directly aids in understanding how to extract named entities from the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains two examples of proteins (c-kit and IL-4R alpha chain) with their corresponding entity labels, providing direct guidance on identifying named entities in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes multiple examples of proteins (Syk, Zap) and a cell type (T cell) with their corresponding entity labels, offering clear instances for extracting named entities from the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence presents examples of proteins (Stat3, Stat5, c-Mpl) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of proteins (CD40, NF-kappa B) with their corresponding entity labels, offering direct assistance in identifying named entities in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains examples of proteins (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence includes examples of a protein (NF-ATc) and a cell type (T lymphocytes) with their corresponding entity labels, providing clear instances for extracting named entities from the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence presents an example of a cell type (cell adhesion molecules) with its corresponding entity label, offering direct guidance on identifying named entities in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cells, plasma cells) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains examples of proteins (IL-7R, gamma(c)) with their corresponding entity labels, offering clear instances for identifying named entities in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence presents examples of proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their corresponding entity labels, providing direct assistance in extracting named entities from the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes examples of proteins (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) with their corresponding entity labels, offering clear instances for identifying named entities in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence presents examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) with their corresponding entity labels, providing direct guidance on extracting named entities from the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes an example of a protein (NF-kappa B) with its corresponding entity label, offering direct assistance in identifying named entities in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains examples of proteins (ICAM-1, CD71, LMP1, IkappaB) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the entity types in the target sentence, making it least helpful in understanding how to extract named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the entity types in the target sentence, making it least helpful in understanding how to extract named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the entity types in the target sentence, making it least helpful in understanding how to extract named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TCL1 mRNA\": \"RNA\"}, {\"TCL1\": \"protein\"}, {\"PBLs\": \"cell_type\"}, {\"AT\": \"cell_type\"}]",
        "prediction": "{'TCL1 mRNA': 'RNA', 'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NFAT-1\": \"protein\"}, {\"SV40 T-antigen\": \"protein\"}]",
        "prediction": "{'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains multiple examples of transcription factors (Sp1, NF-kappaB, PU.1, GATA-1, Jun, EKLF, A-myb, EBNA2, NF-ATc) and their interactions, which are directly relevant to the entity labels provided.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence provides examples of transcription factors (Sp1, Ets, AP-1, EBNA2, Ets) and their roles in specific cellular contexts, aiding in the extraction of protein entities.\"},\n{\"Sentence\": 3},\n{\"Reason\": \"The sentence mentions the mutation of a Sp1 binding site and its effect on tissue-specific promoter activity, which is relevant to the protein entity label provided.\"},\n{\"Sentence\": 2},\n{\"Reason\": \"The sentence discusses the suppression of a cellular differentiation program and the inhibition of binding of a cell-specific transcription factor (NF-E2), which is relevant to the protein entity label provided.\"},\n{\"Sentence\": 1},\n{\"Reason\": \"The sentence provides information about the cleavage of transcription factor SP1 by caspases during B-cell apoptosis, which is directly relevant to the protein entity label provided.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"Ets-1\": \"protein\"}, {\"TFE-3\": \"protein\"}, {\"Sp1\": \"protein\"}]",
        "prediction": "{'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"I kappa B beta\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"p56\": \"protein\"}, {\"hsp70\": \"protein\"}, {\"hsp90\": \"protein\"}, {\"untransformed steroid receptors\": \"protein\"}]",
        "prediction": "{'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 4},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains the entity 'GATA-1' which is a protein, directly matching one of the entity types in the target sentence.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence contains the entities 'Jun' and 'ATF-2' which are both proteins, directly matching entity types in the target sentence.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence contains the entity 'NF-ATc' which is a protein, matching one of the entity types in the target sentence. Additionally, 'T lymphocytes' is a cell type which is related to the context of the target sentence.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence contains the entities 'Sp1' and 'Ets' which are both proteins, directly matching entity types in the target sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains the entities 'CREB' and 'AR-CRE' which are both proteins, directly matching entity types in the target sentence.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence contains the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' which are all proteins, directly matching entity types in the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains the entities 'Sp1' and 'CD14' which are both proteins, directly matching entity types in the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains the entities 'Tax' and 'TFIIA' which are both proteins, directly matching entity types in the target sentence.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains the entity 'A-myb' which is a protein, directly matching one of the entity types in the target sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains the entity 'NF-ATc' which is a protein, matching one of the entity types in the target sentence. Additionally, 'T lymphocytes' and 'embryonic cardiac cells' are cell types related to the context of the target sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains the entities 'IL-2', 'c-Jun', and 'c-Fos' which are all proteins, directly matching entity types in the target sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence contains the entity 'AP-1' which is related to DNA, matching one of the entity types in the target sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence contains the entity 'TCF-1' which is a protein, directly matching one of the entity types in the target sentence.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' which are all proteins or cell types, directly matching entity types in the target sentence.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence contains the entities 'ZEB', 'c-Myb', and 'Ets' which are all proteins, directly matching entity types in the target sentence. Additionally, 'hematopoietic cells' is a cell type related to the context of the target sentence.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence contains the entities 'IL-2', 'NFAT', 'NFAT delta418', 'calcineurin', 'Tpl-2', and 'cyclosporin A' which are all proteins or DNA, directly matching entity types in the target sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any entities that match the entity types in the target sentence.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any entities that match the entity types in the target sentence.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any entities that match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCF-2 alpha\": \"protein\"}, {\"CREB\": \"protein\"}, {\"T alpha 1\": \"protein\"}, {\"TCR alpha enhancer\": \"DNA\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'CREB': 'protein', 'T alpha 1': 'protein', 'TCR alpha enhancer': 'DNA'}"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 5},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"RelA\": 5},\n    {\"NF-kappaB1\": 5},\n    {\"Tax\": 5},\n    {\"TFIIA\": 5},\n    {\"CD40\": 5},\n    {\"NF-kappa B\": 5},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"tyrosine\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"Sp1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"p50\": 5},\n    {\"TRAF6\": 5},\n    {\"RANKL\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 5},\n    {\"NF-E2\": 5},\n    {\"CD14\": 5},\n    {\"AP-1\": 5},\n    {\"VDR\": 5},\n    {\"RXR\": 5},\n    {\"GRIP-1\": 5},\n    {\"DRIP205\": 5},\n    {\"DRIP\": 5},\n    {\"p50\": 5},\n    {\"p65\": 5},\n    {\"DNA\": 5},\n    {\"cDNA\": 5},\n    {\"Jurkat\": 5},\n    {\"DRE 1\": 5}\n]",
        "response3": "[{\"TR alpha 1\": \"protein\"}, {\"NE\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a cell line (SIVsmmPBj14) and its corresponding entity label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (IkappaBbeta, NF-kappaB) and their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) with their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of a protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) with their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of DNA (hepatitis B virus) and a protein (HBxAg) with their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of a protein (TCL1) and its corresponding entity label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of a cell type (T cell) and a protein (interleukin 2) with their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of a cell type (Th2-type lymphocytes) with its corresponding entity label.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of proteins (NF-kappaB, Sp1) and a cell line (SIVmac) with their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of proteins (ATF1, CREB, H4) with their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of DNA (HIV-1 LTR) and proteins (NFAT-1, NF kappa B) with their corresponding entity labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of proteins (tal-1, GATA-binding proteins) and a cell type (hematopoiesis) with their corresponding entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the given entity labels.\"}\n]",
        "response3": "[{'TRE': 'DNA'}, {'Tax': 'protein'}]",
        "prediction": "{'TRE': 'DNA', 'Tax': 'protein'}"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a specific gene name (SCM-1) which is likely a cell line based on the naming convention.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a specific transcription factor name (NF-E2) which is likely a protein based on its function.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides specific cell line name (HML) and protein names (dexamethasone, cortisol, lysozyme) which are likely corresponding entities based on their functions.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a specific substance name (phosphocreatine) which is likely a protein based on its function, but the relevance to the sentence context is slightly less clear.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a specific medical condition (lymphoid neoplasms) which is likely a cell type based on the context.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a specific gene name (E2A) which is likely a protein based on its function.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides specific cell type names (granulocytes, T cells) which are likely corresponding entities based on their biological classification.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a specific transcription factor name (AP-1) which is likely DNA based on its function.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a specific transcription factor name (GATA-1) which is likely a protein based on its function.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific substance names (Erbstatin, genistein) and gene name (Egr-1) which are likely corresponding entities based on their functions.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides specific protein names (ATF1, CREB, H4) which are likely corresponding entities based on their functions.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides specific entity names (EBV, EBNA2, estrogen receptor) which are likely corresponding entities based on their functions.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides specific protein names (MR, aldosterone, progesterone) which are likely corresponding entities based on their functions.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides specific protein names (FEV1, FVC, PEF, prednisolone) which are likely corresponding entities based on their functions.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides specific protein names (IL-2r, c-fos, IL-2, lymphokine) which are likely corresponding entities based on their functions.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides specific cell type names (Type I, Type II) which are likely corresponding entities based on their classification, but the relevance to the sentence context is slightly less clear.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not provide any specific entity names relevant to the sentence context.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not provide any specific entity names relevant to the sentence context.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The example does not provide any specific entity names relevant to the sentence context.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"RT\": \"protein\"}, {\"LCLs\": \"cell_line\"}]",
        "prediction": "{'RT': 'protein', 'LCLs': 'cell_line'}"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"T3 receptor\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'T3 receptor': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains a named entity with a clear entity label that matches the entity type in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains a named entity with a clear entity label that matches the entity type in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 13\": 1},\n    {\"Reason 13\": \"The sentence does not contain any named entities with entity labels that match the entity types in the target sentence.\"},\n    {\"Example 14\": 1},\n    {\"Reason 14\": \"The sentence does not contain any named entities with entity labels that match the entity types in the target sentence.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The sentence does not contain any named entities with entity labels that match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"platelet-activating factor\": \"protein\"}, {\"c-fos\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'platelet-activating factor': 'protein', 'c-fos': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"X boxes\": \"protein\"}, {\"Y boxes\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"major histocompatibility complex (MHC) class II promoters\": \"DNA\"}]",
        "prediction": "{'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'protein' in relation to the named entity 'A-myb', making it highly helpful for entity extraction.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'protein' in relation to 'Protein', aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions the entities 'NF-kappa B' and 'AP-1' as transcription factors, making it very helpful for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear mentions of the entities 'DNA' (UAS3, UAS2, YY1) and 'protein' (YY1), aiding in entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'cell_line' (B cell lines) and 'cell_type' (B cell), making it highly helpful for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions 'DNA', which is crucial for entity extraction in the context of DNA binding activity.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'protein' (NF-ATc) and 'cell_type' (T lymphocytes, embryonic cardiac cells), aiding in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'protein' (PU.1, M-CSF receptor) and 'cell_type' (macrophage), making it very helpful for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'cell_type' (T cell) and 'protein' (interleukin 2), aiding in entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions multiple 'protein' entities (EKLF, CBP, p300, P/CAF), making it highly helpful for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'protein' entities (RelA, NF-kappaB1), aiding in entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'DNA' (immunoglobulin kappa 3' enhancer), making it very helpful for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'protein' (NF-kappa B), aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'protein' entities (NF-kappaB, Sp1, p50), making it highly helpful for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'protein' entities (Jun, ATF-2), aiding in entity extraction.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.\"}\n]",
        "response3": "[{'DNA': 'DNA'}, {'upstream stimulatory factor': 'protein'}]",
        "prediction": "{'DNA': 'DNA', 'upstream stimulatory factor': 'protein'}"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"5\": \"The sentence contains the named entity 'GATA-1' which is a protein, matching one of the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'Stat3', 'Stat5', and 'c-Mpl' which are all proteins, matching the entity labels.\"},\n    {\"5\": \"The sentence contains the named entity 'TCF-1' which is a protein, matching one of the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' which are all proteins, matching the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'Sp1' and 'CD14' which are both proteins, matching the entity labels.\"},\n    {\"5\": \"The sentence contains the named entity 'E2A' which is a protein, matching one of the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all proteins, matching the entity labels.\"},\n    {\"5\": \"The sentence contains the named entity 'CD95 ligand' which is a protein, matching one of the entity labels.\"},\n    {\"5\": \"The sentence contains the named entity 'SCM-1' which is a cell line, matching one of the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' which match the entity labels 'cell_type', 'cell_line', and 'DNA'.\"},\n    {\"5\": \"The sentence contains the named entities 'Ter 119', 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4' which are all proteins or cell lines, matching the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'ATF1', 'CREB', and 'H4' which are all proteins, matching the entity labels.\"},\n    {\"5\": \"The sentence contains the named entities 'BAT box', 'CD20', and 'B cells' which match the entity labels 'DNA', 'protein', and 'cell_type'.\"},\n    {\"5\": \"The sentence contains the named entities 'IL-2', 'NFAT', 'NFAT delta418', 'calcineurin', 'Tpl-2', and 'cyclosporin A' which are all proteins or DNA, matching the entity labels.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"}\n]",
        "response3": "[{\"thromboxane receptor gene\": \"protein\"}, {\"thromboxane receptor gene promoter\": \"protein\"}, {\"chloramphenicol acetyltransferase (CAT)\": \"protein\"}, {\"K562 cells\": \"cell_line\"}]",
        "prediction": "{'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n{\"Protein\": 4},\n{\"MNDA\": 4, \"myeloid cell lines\": 4},\n{\"Runt domain\": 4},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"WT1\": 4},\n{\"T cell\": 5, \"interleukin 2\": 4},\n{\"PBMC\": 5, \"adenovirus DNA\": 5},\n{\"FasL\": 4, \"IL-2\": 4, \"IFN-gamma\": 4},\n{\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n{\"TCL1\": 4},\n{\"ZEBRA\": 4},\n{\"CD70\": 4, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 4, \"CD40\": 4},\n{\"GM-CSF\": 4},\n{\"EBV\": 5, \"B-cell\": 5},\n{\"granulocytes\": 5, \"T cells\": 5}\n]",
        "response3": "[{\"CEM\": \"cell_line\"}, {\"RPMI 8402\": \"cell_line\"}]",
        "prediction": "{'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 5},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 5},\n    {\"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"chloramphenicol acetyltransferase\": \"protein\"}, {\"HIV long terminal repeat (LTR)\": \"DNA\"}, {\"beta interferon\": \"protein\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon': 'protein'}"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4},\n    {\"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HeLa\": \"cell_line\"}, {\"IFN beta\": \"protein\"}]",
        "prediction": "{'HeLa': 'cell_line', 'IFN beta': 'protein'}"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly aids in extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone\": 5},\n    {\"IL-2 receptor alpha subunit is a hallmark of lymphocyte activation\": 4},\n    {\"IL-4 inhibits LPS-induced expression of AP-1 protein\": 4},\n    {\"chimeric receptor containing the extracellular domain of c-kit and the cytoplasmic and transmembrane domains of the IL-4R alpha chain\": 4},\n    {\"suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene\": 3},\n    {\"selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model\": 3},\n    {\"IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells\": 5},\n    {\"other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined\": 3},\n    {\"constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function\": 5},\n    {\"NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway\": 4},\n    {\"human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription\": 5},\n    {\"T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2\": 5},\n    {\"balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells\": 4}\n]",
        "response3": "[{\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"IL-2R alpha\": \"protein\"}]",
        "prediction": "{'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"CD14\": \"1\"},\n    {},\n    {}\n]",
        "response3": "[{\"M-CSF\": \"protein\"}, {\"monocytes\": \"cell_type\"}]",
        "prediction": "{'M-CSF': 'protein', 'monocytes': 'cell_type'}"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"CD28 MoAb\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'IL-2': 'protein', 'CD28 MoAb': 'protein'}"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5},\n    {\"SLAP-130\": 5, \"SLP-76\": 5, \"T cell\": 5},\n    {\"Sp1\": 5, \"Ets\": 5},\n    {\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5},\n    {\"GATA-1\": 5},\n    {\"IL-13\": 5, \"IL-4\": 5, \"B cell\": 5, \"monocyte\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"gamma c chain\": 1, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"GATA-1\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"Pax-5\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"cdc-2\": \"protein\"}, {\"cyclin E\": \"protein\"}, {\"CD23\": \"protein\"}, {\"cyclin D2\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5}\n]",
        "response3": "[{\"B4-2\": \"protein\"}]",
        "prediction": "{'B4-2': 'protein'}"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (IL-7R, gamma(c)) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names (IL-13, IL-4R, JAK2, IL-13R) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names (c-kit, IL-4R alpha chain) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (interleukin 10, IL-10R, STAT3, IL-6) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, Aiolos, Ras) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name (IL-4) that is directly related to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names (IL-12, STAT4, IL-12 receptor) and cell types (NK cells, T cells) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names (IL-2, c-Jun, c-Fos) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names (IL4, IL13, gamma c, STAT6, STAT3, STAT5) and a cell type (B cells) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (NF-kappaB, Tax, ATL) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (IL-2, IL-2 receptor, CD28) and a cell type (T cell) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (Stat3, Stat5, c-Mpl) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names (interleukin 2) and a cell type (T cell) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entity names related to the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entity names related to the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entity names related to the target sentence.\"}\n]",
        "response3": "[{\"IL-2 receptor\": \"protein\"}, {\"JAK1\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}]",
        "prediction": "{'IL-2 receptor': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBalpha\": 5},\n    {\"NF-kappaB\": 5},\n    {\"GATA-1\": 5},\n    {\"IL-4\": 5},\n    {\"Th1\": 4, \"Th2\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"GATA-1\": 5},\n    {\"Sp1\": 5, \"Ets\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"immunohistochemistry\": 5, \"gene\": 1, \"cell type\": 4},\n    {\"NF-E2\": 5},\n    {\"IgH\": 1},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"NF-kappaB\": 5, \"Tax\": 1, \"ATL\": 4},\n    {\"B and T cell activation\": 4, \"Ramos\": 4, \"Jurkat\": 4, \"cDNA microarray technology\": 1}\n]",
        "response3": "[{\"T cells\": \"cell_type\"}]",
        "prediction": "{'T cells': 'cell_type'}"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CR1\": \"protein\"}, {\"CD35\": \"protein\"}, {\"CR3\": \"protein\"}, {\"CD11b/CD18\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"p50/p65\": \"protein\"}, {\"monocytes\": \"cell_type\"}, {\"HIV-infected monocytic cells\": \"cell_type\"}]",
        "prediction": "{'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity type 'DNA' in the context of cDNAs.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific mentions of entities such as 'SP1', 'caspases', and 'B-cell' which are relevant to the entity labels provided.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence directly mentions 'Th2-type lymphocytes' which corresponds to the entity label 'cell_type'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly discusses the 'E2A gene' at the protein level, aligning with the entity label 'protein'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' in the context of protein interactions, supporting the entity labels provided.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence talks about 'TCF-1 knock-out mice' yielding antiserum titers against 'TCF-1 protein', directly linking to the entity label 'protein'.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence discusses 'T lymphocytes' and 'HLA-molecules' in the context of antigen recognition, aligning with the entity labels provided.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'IkappaBbeta' and 'NF-kappaB' in relation to protein interactions and inactivation, supporting the entity labels provided.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence refers to 'GM-CSF genes' and the conservation of the 'PB1 sequence motif', which are relevant to the entity label 'protein'.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence discusses the 'immunoglobulin kappa 3' enhancer' in the context of developmental control, aligning with the entity label 'DNA'.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides information on the 'gst-EBNA-2 fusion protein' and its interaction with 'PU.1', supporting the entity labels provided.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the 'hepatitis B virus genome' and the 'HBxAg' protein, aligning with the entity labels provided.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence discusses 'SIVsmmPBj14' in the context of viral mutations and phenotype, directly linking to the entity label 'cell_line'.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'EBV' and 'B-cell activation' in relation to pathway usage, supporting the entity labels provided.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence talks about 'p50' and 'p65 proteins' in the context of DNA-protein complexes, aligning with the entity labels provided.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence discusses 'B and T cell activation', 'Ramos', 'Jurkat cells', and 'cDNA microarray technology', which are relevant to the entity labels provided.\"}\n]",
        "response3": "[{'B-cell': 'cell_type'}, {'hepatitis B virus X protein': 'protein'}]",
        "prediction": "{'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of protein names that are directly mentioned in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein name, Tat-binding protein 7, which is helpful for extracting named entities, but the context is slightly less specific compared to other examples.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple specific protein names and terms related to proteins, making it very helpful for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear and specific examples of protein names that are directly mentioned in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'Protein' in the context of genomic sequences and transcription, providing a clear indication of the entity type, making it highly helpful for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides specific protein names and mentions their presence in the context of gel-shift analysis, making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'p50p50' in the context of binding, which is helpful for extracting named entities, but the context is slightly less specific compared to other examples.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple specific protein names and terms related to proteins, making it very helpful for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a specific protein name, Egr-1, and mentions its role as a transcription factor, making it highly helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions specific protein names and their roles in apoptosis, providing clear examples for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides specific protein names and mentions their interaction with IL-4 and LPS, making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions specific protein names and their involvement in gene expression regulation, providing clear examples for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions specific protein names, p21(WAF1/CIP1) and p27(KIP1), and their increase in cells, making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a specific type of protein, tyrosine, and its importance in protein-protein interaction, making it highly helpful for extracting named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides specific protein names, Tax and TFIIA, and mentions their interaction, making it highly helpful for extracting named entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions specific protein names, EBNA-2 and PU.1, and their interaction, providing clear examples for extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific examples or terms related to the entity labels in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific examples or terms related to the entity labels in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific examples or terms related to the entity labels in the target sentence, making it not helpful for extracting named entities.\"}\n]",
        "response3": "[{\"PhoQ\": \"protein\"}]",
        "prediction": "{'PhoQ': 'protein'}"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 4},\n{\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 4},\n{\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 3},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 4},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 3},\n{\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 4},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 4},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n{\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n{\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n{\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"c-myc\": \"protein\"}]",
        "prediction": "{'c-myc': 'protein'}"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific gene or protein names that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains gene or protein names that are relevant to the entity labels in the target sentence, although not as directly mentioned as in Example 1.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes gene or protein names that are related to the entity labels in the target sentence, providing relevant information for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions gene or protein names that match the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides specific gene or protein names that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence mentions a specific gene related to the 'protein' entity label in the target sentence, providing some relevant information for extracting named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains gene or protein names that are relevant to the entity labels in the target sentence, although not as directly mentioned as in Example 1.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence includes gene or protein names that are related to the entity labels in the target sentence, providing relevant information for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions gene or protein names that match the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides specific gene or protein names that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains gene or protein names that are relevant to the entity labels in the target sentence, although not as directly mentioned as in Example 1.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions a specific gene related to the 'protein' entity label in the target sentence, providing some relevant information for extracting named entities.\"},\n    {\"Example 13\": 2},\n    {\"Reason 13\": \"The sentence mentions gene or protein names, but they are not directly related to the entity labels in the target sentence, hence providing limited help in extracting named entities.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The sentence mentions a specific gene related to the 'protein' entity label in the target sentence, providing some relevant information for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence contains gene or protein names that are relevant to the entity labels in the target sentence, although not as directly mentioned as in Example 1.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any gene or protein names related to the entity labels in the target sentence, hence providing no help in extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any gene or protein names related to the entity labels in the target sentence, hence providing no help in extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any gene or protein names related to the entity labels in the target sentence, hence providing no help in extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains a specific cell line name that matches one of the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific cell type and DNA names that match the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific cell line names that match the entity labels in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific gene/protein, cell type, cell line, DNA, or RNA names that match the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific gene/protein, cell type, cell line, DNA, or RNA names that match the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific gene/protein, cell type, cell line, DNA, or RNA names that match the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"gag/pol\": \"protein\"}, {\"env mRNA\": \"RNA\"}, {\"HTLV-infected cells\": \"cell_type\"}]",
        "prediction": "{'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"long terminal repeat\": \"DNA\"}, {\"transcriptional enhancer\": \"DNA\"}, {\"nuclear factor kappa B\": \"protein\"}]",
        "prediction": "{'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides specific examples of proteins and a transcription factor, which are directly related to the entity labels in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions PBMC, which is a cell type, and adenovirus, which is DNA, both of which are relevant to the entity labels in the target sentence.\"},\n{\"Example 3\": 3},\n{\"Reason 3\": \"The sentence mentions IFN-gamma, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 4\": 2},\n{\"Reason 4\": \"The sentence mentions lymphoid neoplasms, which is a cell type, relevant to the entity labels in the target sentence.\"},\n{\"Example 5\": 3},\n{\"Reason 5\": \"The sentence mentions STAT1, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 6\": 3},\n{\"Reason 6\": \"The sentence mentions Ras, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 7\": 3},\n{\"Reason 7\": \"The sentence mentions immunohistochemistry, gene, and cell type, all relevant to the entity labels in the target sentence.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions NF-kappa B, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 9\": 3},\n{\"Reason 9\": \"The sentence mentions SCM-1, which is a cell line, relevant to the entity labels in the target sentence.\"},\n{\"Example 10\": 3},\n{\"Reason 10\": \"The sentence mentions SIVsmmPBj14, which is a cell line, relevant to the entity labels in the target sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence mentions nonhuman primates, which is a cell type, relevant to the entity labels in the target sentence.\"},\n{\"Example 12\": 3},\n{\"Reason 12\": \"The sentence mentions T-PLL, which is a cell type, relevant to the entity labels in the target sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions E2A, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 14\": 2},\n{\"Reason 14\": \"The sentence mentions AP-1, which is DNA, relevant to the entity labels in the target sentence.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions B and T cell activation, Ramos, Jurkat, and cDNA microarray technology, all relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"NF-E2\": 5},\n    {\"EBV\": 4, \"B-cell\": 4},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GATA-1\": 5},\n    {\"Syk\": 5, \"Zap\": 5, \"T cell\": 4},\n    {\"Th1\": 5, \"Th2\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"IL-2\": 5},\n    {\"AP-1\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n    {\"SCL\": 5, \"GATA-1\": 5},\n    {\"IL-2\": 5, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"gamma c chain\": 4, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 4},\n    {\"STAT1\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 4},\n    {\"Sentence\": 4},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 4},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1}\n]",
        "response3": "[{\"NF-KB\": \"protein\"}]",
        "prediction": "{'NF-KB': 'protein'}"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"AP-1\": 4},\n    {\"WT1\": 4},\n    {\"myeloid cell lines\": 4},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"PU.1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"SCM-1\": 5},\n    {\"IL-13\": 5},\n    {\"IL-4R\": 5},\n    {\"JAK2\": 5},\n    {\"IL-13R\": 5},\n    {\"STAT1\": 5},\n    {\"SCL\": 4},\n    {\"GATA-1\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 4},\n    {\"ATL\": 4}\n]",
        "response3": "[{\"TCL1\": \"protein\"}]",
        "prediction": "{'TCL1': 'protein'}"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"Bcl-2\": \"protein\"}]",
        "prediction": "{'Bcl-2': 'protein'}"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"PRE-I\": \"DNA\"}, {\"Jurkat cells\": \"cell_line\"}]",
        "prediction": "{'PRE-I': 'DNA', 'Jurkat cells': 'cell_line'}"
    },
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"Protein\": 5},\n    {\"GM-CSF\": 5},\n    {\"cDNAs\": 5},\n    {\"IgH\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"Stat proteins\": 5},\n    {\"immunohistochemistry\": 5},\n    {\"gene\": 5},\n    {\"cell type\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GM-kappa B\": 5},\n    {\"GC-box\": 5},\n    {\"GC-motif\": 5},\n    {\"GM-kappa B motif\": 5},\n    {\"p50\": 5},\n    {\"p65\": 5},\n    {\"HIV-1 LTR\": 5},\n    {\"NFAT-1\": 5},\n    {\"NF kappa B\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"SIVmac\": 5}\n]",
        "response3": "[{\"HMG boxes\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'HMG boxes': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear mention of a protein (EKLF) and its interaction with other proteins, which can aid in identifying protein entities.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence directly mentions a protein (G-CSF) and its interaction with receptors, aiding in identifying protein entities.\"},\n{\"Example 3\": 1},\n{\"Reason 3\": \"The sentence does not contain any specific entity mentions relevant to the provided entity labels.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' which is a DNA entity, aiding in identifying DNA entities.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions 'CD95 ligand' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions 'DNA binding activity' which is relevant to DNA entities, aiding in identifying DNA entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions 'SCM-1' which is a cell line entity, aiding in identifying cell line entities.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions 'cell adhesion molecules' which is relevant to cell type entities, aiding in identifying cell type entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'E2A' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions 'NF-kappa B' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions 'BRCA1' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions 'TCF-1' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions 'retinoic acid receptor alpha' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions 'CREB' and 'AR-CRE' which are protein entities, aiding in identifying protein entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'SIVsmmPBj14' which is a cell line entity, aiding in identifying cell line entities.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions 'protein' which is a protein entity, aiding in identifying protein entities.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entity mentions relevant to the provided entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entity mentions relevant to the provided entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals, and growth factors.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'DNA' and provides context for its binding activity.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'RNA' and provides context for its synthesis.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions multiple entities such as 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' with clear relationships to protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'TIMP-1' and 'DNA' with clear context for their roles in cell survival and synthesis.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' with clear context for their presence and activity as proteins.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'MNDA' as RNA and 'myeloid cell lines' as cell lines with clear context for their levels and effects.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'NF-kappa B' with clear context for its DNA binding activity.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'CD14' with clear context for its regulation during monocytic differentiation.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'Bak', 'Bad', 'Bcl-2', 'PDBu', and 'DMSO' with clear context for their roles in apoptosis and treatment effects.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'P selectin' with clear context for its effect on cytokine production.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'CD14' and 'CD23' with clear context for their induction by PMA.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' with clear context for their mRNA and protein levels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'cell adhesion molecules' with clear context for their surface expression.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' with clear context for their roles in differentiation and signaling.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Protein kinase B', 'phosphatidylinositol 3-kinase', 'STAT5', 'erythropoietin', 'HCD57', 'EPO', 'HCD57-SREI', and 'c-Akt' with clear context for their activation and activity in cells.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the given entity labels.\"}\n]",
        "response3": "[{\"PDGF(B)\": \"RNA\"}]",
        "prediction": "{'PDGF(B)': 'RNA'}"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"57- to 53-kD proteins\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"CCRF-CEM\": \"cell_line\"}, {\"JY\": \"cell_line\"}, {\"Namalwa\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}]",
        "prediction": "{'T lymphocytes': 'cell_type'}"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"lymphocyte cytosolic protein\": \"protein\"}, {\"lymphocyte DNA\": \"DNA\"}]",
        "prediction": "{'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IM-9\": \"cell_line\"}, {\"estradiol\": \"protein\"}]",
        "prediction": "{'IM-9': 'cell_line', 'estradiol': 'protein'}"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"C/EBP\": \"protein\"}, {\"HIV-1 LTR\": \"DNA\"}]",
        "prediction": "{'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 3},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}, {\"GAL4 DNA binding domain\": \"DNA\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"IgH\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"IL-4\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"STAT3\": 5},\n    {\"IL-6\": 5},\n    {\"IL-13\": 5},\n    {\"IL-4\": 5},\n    {\"B cell\": 5},\n    {\"monocyte\": 5},\n    {\"GATA-1\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"Sp1\": 5},\n    {\"CD14\": 5},\n    {\"T cell\": 5},\n    {\"interleukin 2\": 5},\n    {\"Egr-1\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"EGR-1\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"EBV\": 5, \"CD2\": 5},\n    {\"T cell\": 4, \"IL-2\": 5, \"IL-2 receptor\": 5, \"CD28\": 5},\n    {\"TIMP-1\": 5, \"DNA\": 5},\n    {\"IL-2\": 5, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"GATA-1\": 5},\n    {\"Syk\": 5, \"Zap\": 5, \"T cell\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"AP-1\": 5},\n    {\"FasL\": 5, \"IL-2\": 5, \"IFN-gamma\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 4},\n    {\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 4},\n    {\"Bak\": 5, \"Bad\": 5, \"Bcl-2\": 5, \"PDBu\": 4, \"DMSO\": 4},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"apoptosis\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"1,25(OH)2D3\": \"protein\"}, {\"tuberculosis\": \"cell_type\"}, {\"unseparated lavage cells\": \"cell_type\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_type'}"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-5 mRNA\": 4, \"TCR\": 3, \"IL-2R\": 4, \"dexamethasone\": 4},\n    {\"phosphocreatine\": 4},\n    {\"HML\": 5, \"dexamethasone\": 4, \"cortisol\": 4, \"lysozyme\": 4},\n    {\"NF-E2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"MNDA\": 4, \"myeloid cell lines\": 5},\n    {\"P selectin\": 5},\n    {\"interleukin-2\": 4, \"alpha chain\": 4, \"CD25\": 4, \"IL-2 receptor\": 4},\n    {\"CTLA4Ig\": 4, \"NFAT\": 3, \"AP-1\": 3},\n    {\"Erbstatin\": 4, \"genistein\": 4, \"Egr-1\": 5},\n    {\"CD4+\": 4, \"CD8+\": 4, \"TPCK\": 4, \"anti-CD28\": 4, \"PMA\": 4},\n    {\"MR\": 4, \"aldosterone\": 4, \"progesterone\": 4},\n    {\"Ras\": 4, \"RasN17\": 4, \"IL-2\": 4, \"CIS\": 4, \"OSM\": 4, \"STAT5\": 4},\n    {\"Type I\": 3, \"Type II\": 3},\n    {},\n    {},\n    {}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5, \"Reason\": \"Both 'Th1' and 'Th2' are specific cell types mentioned in the sentence, providing clear examples of cell types.\"},\n    {\"UAS1\": 4, \"B cell\": 5, \"Reason\": \"'UAS1' is a specific cell line mentioned in the sentence, providing a clear example of a cell line. 'B cell' is also mentioned as a cell type.\"},\n    {\"SIVsmmPBj14\": 5, \"Reason\": \"'SIVsmmPBj14' is a specific cell line mentioned in the sentence, providing a clear example of a cell line.\"},\n    {\"hepatitis B virus\": 5, \"HBxAg\": 5, \"Reason\": \"'hepatitis B virus' is a specific DNA entity mentioned in the sentence, providing a clear example of DNA. 'HBxAg' is mentioned as a protein entity.\"},\n    {\"Th2-type lymphocytes\": 5, \"Reason\": \"'Th2-type lymphocytes' is a specific cell type mentioned in the sentence, providing a clear example of a cell type.\"},\n    {\"GATA-1\": 5, \"Reason\": \"'GATA-1' is a specific protein mentioned in the sentence, providing a clear example of a protein.\"},\n    {\"AP-1\": 5, \"Reason\": \"'AP-1' is a specific DNA entity mentioned in the sentence, providing a clear example of DNA.\"},\n    {\"T cell\": 5, \"interleukin 2\": 5, \"Reason\": \"'T cell' is a specific cell type mentioned in the sentence, providing a clear example of a cell type. 'interleukin 2' is mentioned as a protein entity.\"},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5, \"Reason\": \"'NF-ATc' is a specific protein mentioned in the sentence, providing a clear example of a protein. 'T lymphocytes' is mentioned as a cell type.\"},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5, \"Reason\": \"Multiple protein entities are mentioned in the sentence, providing clear examples of proteins.\"},\n    {\"Egr-1\": 5, \"Reason\": \"'Egr-1' is a specific protein mentioned in the sentence, providing a clear example of a protein.\"},\n    {\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5, \"Reason\": \"Multiple entities related to the sentence context are mentioned, providing clear examples of proteins and cell types.\"},\n    {\"HIV-1 LTR\": 5, \"NFAT-1\": 5, \"NF kappa B\": 5, \"Reason\": \"'HIV-1 LTR' is a specific DNA entity mentioned in the sentence, providing a clear example of DNA. 'NFAT-1' and 'NF kappa B' are mentioned as protein entities.\"},\n    {\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 5, \"Reason\": \"Multiple entities related to the sentence context are mentioned, providing clear examples of proteins and cell types.\"},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5, \"Reason\": \"'NF-kappaB' and 'Sp1' are specific protein entities mentioned in the sentence, providing clear examples of proteins. 'SIVmac' is mentioned as a cell line.\"},\n    {\"NF-E1\": 5, \"YY-1\": 5, \"Reason\": \"'NF-E1' and 'YY-1' are specific protein entities mentioned in the sentence, providing clear examples of proteins.\"},\n    {\"Reason\": \"No relevant entities related to the target sentence are mentioned in this sentence.\"},\n    {\"Reason\": \"No relevant entities related to the target sentence are mentioned in this sentence.\"},\n    {\"Reason\": \"No relevant entities related to the target sentence are mentioned in this sentence.\"}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 1},\n    {\"Example 14\": 1},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HeLa cells\": \"cell_line\"}, {\"T-cells\": \"cell_line\"}, {\"DNA\": \"DNA\"}, {\"52 kD\": \"protein\"}, {\"45 kilodaltons (kD)\": \"protein\"}, {\"52 kD\": \"protein\"}, {\"82\": \"protein\"}, {\"67\": \"protein\"}, {\"43-47 kD\": \"protein\"}]",
        "prediction": "{'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', '52 kD': 'protein', '45 kilodaltons (kD)': 'protein', '82': 'protein', '67': 'protein', '43-47 kD': 'protein'}"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"RNA\": \"RNA\"}, {\"c-myc\": \"protein\"}]",
        "prediction": "{'RNA': 'RNA', 'c-myc': 'protein'}"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"UAS1\": 5, \"B cell\": 4},\n{\"ZEBRA\": 5},\n{\"IL-4\": 4},\n{\"IL-2\": 5},\n{\"T cell\": 4, \"interleukin 2\": 4},\n{\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n{\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"Jun\": 5, \"ATF-2\": 5},\n{\"Sp1\": 5, \"CD14\": 5},\n{\"p50p50\": 5},\n{\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n{\"EKLF\": 5},\n{\"EBNA2\": 5, \"TP1\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CCAAT box\": 5, \"EKLF binding site\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n{\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n{\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5}\n]",
        "response3": "[{\"protooncogenes\": \"protein\"}, {\"cytoskeletal\": \"protein\"}, {\"extracellular matrix genes\": \"protein\"}, {\"growth factor\": \"protein\"}, {\"cell proliferation\": \"cell_type\"}]",
        "prediction": "{'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1 )\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"calcineurin\": 5},\n    {\"Th1\": 5},\n    {\"Th2\": 5},\n    {\"IL-2\": 5},\n    {\"STAT\": 5},\n    {\"STAT3\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"STAT6\": 5},\n    {\"STAT5\": 5},\n    {\"IL-12\": 5},\n    {\"STAT4\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"tyrosine\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"Aiolos\": 5},\n    {\"Ras\": 5},\n    {\"ERK\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"IL-6\": 5}\n]",
        "response3": "[{\"p94\": \"protein\"}, {\"p95\": \"protein\"}, {\"Stat1\": \"protein\"}]",
        "prediction": "{'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Example id\": 5, \"helpfulness score\": 5},\n{\"Reason id\": 5, \"reasons\": \"The sentence contains multiple instances of protein entities, which are relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 6, \"helpfulness score\": 4},\n{\"Reason id\": 6, \"reasons\": \"The sentence contains a specific protein entity (TIMP-1) and a DNA entity, which are relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 7, \"helpfulness score\": 4},\n{\"Reason id\": 7, \"reasons\": \"The sentence contains a specific cell type entity (Th2-type lymphocytes), which is relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 8, \"helpfulness score\": 4},\n{\"Reason id\": 8, \"reasons\": \"The sentence contains specific protein (CD2) and cell line (EBV) entities, which are relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 9, \"helpfulness score\": 4},\n{\"Reason id\": 9, \"reasons\": \"The sentence contains specific cell type (PBMC) and DNA entities, which are relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 10, \"helpfulness score\": 4},\n{\"Reason id\": 10, \"reasons\": \"The sentence contains a specific cell line entity (SIVsmmPBj14), which is relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 11, \"helpfulness score\": 5},\n{\"Reason id\": 11, \"reasons\": \"The sentence contains multiple instances of protein and DNA entities, which are relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 12, \"helpfulness score\": 4},\n{\"Reason id\": 12, \"reasons\": \"The sentence contains specific DNA, protein, and cell line entities, which are relevant for the entity labels in the target sentence.\"},\n{\"Example id\": 13, \"helpfulness score\": 4},\n{\"Reason id\": 13, \"reasons\": \"The sentence contains specific protein, protein, and cell type entities, which are relevant for the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"Virus stocks\": \"cell_line\"}, {\"human T-cell types\": \"cell_type\"}, {\"LTR\": \"DNA\"}]",
        "prediction": "{'Virus stocks': 'cell_line', 'human T-cell types': 'cell_type', 'LTR': 'DNA'}"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"DCs\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a mutated human retinoic acid receptor alpha, which is a protein entity type mentioned in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions IL-7R and gamma(c) as proteins, which are entity types present in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions lymphoid neoplasms, which is a cell_type entity type present in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions retinoic acid receptor alpha, which is a protein entity type present in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions nonhuman primates, which is a cell_type entity type present in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions lymphocytes, benzene, and benzoquinone, which are cell_type and chemical compound entity types present in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides information about RXR, which is a protein entity type mentioned in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions G-CSF, which is a protein entity type present in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions IL4, IL13, gamma c chain, STAT6, STAT3, STAT5, and B cells, which are protein and cell_type entity types present in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions CCAAT box and EKLF binding site, which are DNA and protein entity types present in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions AP-1, which is a DNA entity type present in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions CD14, which is a protein entity type present in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides information about VDR, RXR, GRIP-1, DRIP205, and DRIP, which are protein entity types mentioned in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions interleukin-2, alpha chain, CD25, and IL-2 receptor, which are protein entity types present in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions TR55, TNF-alpha, and HIV, which are protein and cell_type entity types present in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions VDR and beta-globin, which are protein entity types present in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not provide any specific examples of entity types mentioned in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not provide any specific examples of entity types mentioned in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not provide any specific examples of entity types mentioned in the target sentence.\"}\n]",
        "response3": "[{\"VDR\": \"protein\"}]",
        "prediction": "{'VDR': 'protein'}"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the entity 'NF-kappa B' being associated with the entity type 'DNA', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides examples of entities 'NF-kappa B' and 'I kappa B alpha' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides examples of entities 'AP-1', 'PMA', 'monocytes', and 'macrophages' being associated with the entity types 'protein' and 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of entities 'granulocytes' and 'T cells' being associated with the entity type 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides an example of the entity 'NF-kappa B' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of entities 'NF-kappaB', 'Tax', and 'ATL' being associated with the entity types 'protein' and 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides examples of entities 'alpha-tocopherol', 'monocyte', and 'endothelial cells' being associated with the entity types 'protein' and 'cell_type', which is helpful for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides an example of the entity 'NF-kappa B' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides an example of the entity 'P selectin' being associated with the entity type 'protein', which is helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of entities 'NF-kappa B' and 'ARDS' being associated with the entity types 'protein' and 'cell_type', making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides an example of the entity 'NF-kappa B' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of entities 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' being associated with the entity types 'protein' and 'cell_line', which is helpful for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides an example of the entity 'E2A' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of entities 'NF-kappa B' and 'AP-1' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' being associated with the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities related to the provided entity labels, so it is not helpful for extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the provided entity labels, so it is not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the provided entity labels, so it is not helpful for extracting named entities.\"}\n]",
        "response3": "[{\"NFAT\": \"protein\"}, {\"CsA\": \"protein\"}, {\"endothelial cells\": \"cell_type\"}]",
        "prediction": "{'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5},\n    {\"Sentence 16\": 1},\n    {\"Sentence 17\": 1},\n    {\"Sentence 18\": 1}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 4},\n    {\"embryonic cardiac cells\": 4},\n    {\"GATA-1\": 5},\n    {\"TAL1\": 5},\n    {\"T-ALL\": 4},\n    {\"granulocytes\": 4},\n    {\"T cells\": 4},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"GATA-1\": 5},\n    {\"E2A\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 4},\n    {\"TCL1\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 5},\n    {\"RXR\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"Ter 119\": 5},\n    {\"beta-globin\": 5},\n    {\"glycoprotein IIb\": 5},\n    {\"platelet factor 4\": 5},\n    {\"2-deoxyguanosine\": 5},\n    {\"lymphoid progenitor cells\": 5},\n    {\"thymus stromal cells\": 5},\n    {\"B cell\": 5},\n    {\"tg epsilon26\": 5},\n    {\"fetal liver cells\": 5},\n    {\"T cell\": 4},\n    {\"TR55\": 5},\n    {\"TNF-alpha\": 5},\n    {\"HIV\": 5}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"C1\": \"protein\"}, {\"C2\": \"protein\"}, {\"HIV\": \"cell_type\"}, {\"Jurkat\": \"cell_line\"}]",
        "prediction": "{'C1': 'protein', 'C2': 'protein', 'HIV': 'cell_type', 'Jurkat': 'cell_line'}"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"TCF-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 4, \"p21ras\": 4, \"B cell\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"NF-kappaB\": 5, \"rheumatoid arthritis\": 4},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5},\n    {\"CTLA4Ig\": 5, \"NFAT\": 5, \"AP-1\": 5}\n]",
        "response3": "[{\"Ig heavy chain enhancer\": \"DNA\"}, {\"NF-muE3\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"non-B cells\": \"cell_type\"}]",
        "prediction": "{'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"EC1 antibody\": \"protein\"}, {\"p56\": \"protein\"}]",
        "prediction": "{'EC1 antibody': 'protein', 'p56': 'protein'}"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'RXR' and the entity label 'protein' in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example directly identifies the entities 'granulocytes' and 'T cells' as 'cell_type' entities in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example points out the entity 'lymphoid neoplasms' as a 'cell_type' entity in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example correctly identifies 'CD14' as a 'protein' entity in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example correctly identifies 'phosphocreatine' as a 'protein' entity in the target sentence, but the relevance to named entity extraction is slightly lower due to the specificity of the term.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example correctly identifies 'HML' as a 'cell_line' entity, 'dexamethasone' and 'cortisol' as 'protein' entities, and 'lysozyme' as a 'protein' entity in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example accurately identifies 'NF-E2' as a 'protein' entity in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example correctly identifies 'E2A' as a 'protein' entity in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example identifies 'CD70' as a 'protein' entity, 'B cell' and 'plasma cells' as 'cell_type' entities, and 'IL-4' and 'CD40' as 'protein' entities in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example correctly identifies 'cAMP-dependent protein kinase' and 'Rap1' as 'protein' entities in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example identifies 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' as entities in the target sentence, aiding in named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example correctly identifies 'PU.1', 'CSF-1 receptor', 'Mono A', and 'Mono B' as 'protein' entities in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example correctly identifies 'nuclear factor-kappa B' and 'NF-kappa B' as 'DNA' entities in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example correctly identifies 'NF-kappa B' and 'fibrinogen' as 'protein' entities in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example correctly identifies 'MNDA' as a 'protein' entity, 'monocytes' and 'macrophages' as 'cell_type' entities, and 'leukemia/B lymphoma cell lines' as a 'cell_line' entity in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example correctly identifies 'PMA' and 'U1 cells' as 'cell_line' entities in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not provide any specific entities or labels that can aid in named entity extraction from the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not provide any specific entities or labels that can aid in named entity extraction from the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The example does not provide any specific entities or labels that can aid in named entity extraction from the target sentence.\"}\n]",
        "response3": "[{'androgen receptors': 'protein'}, {'mononuclear leukocytes': 'cell_type'}, {'follicular and luteal phases': 'cell_type'}, {'menstrual cycle': 'cell_type'}, {'flutamide': 'protein'}]",
        "prediction": "{'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular and luteal phases': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HMG-I\": \"protein\"}, {\"GATA motifs\": \"DNA\"}]",
        "prediction": "{'HMG-I': 'protein', 'GATA motifs': 'DNA'}"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence contains no named entities from the given entity label set.\"},\n    {\"1\": \"The sentence contains no named entities from the given entity label set.\"},\n    {\"4\": \"The sentence contains multiple named entities of type 'protein' and 'cell_type' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'protein' and 'cell_type' which are relevant to the entity label set.\"},\n    {\"5\": \"The sentence contains multiple named entities of type 'protein' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'cell_line' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'protein' and 'cell_type' which are relevant to the entity label set.\"},\n    {\"3\": \"The sentence contains a named entity of type 'cell_type' which is relevant to the entity label set.\"},\n    {\"5\": \"The sentence contains multiple named entities of type 'protein' and 'DNA' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'cell_type' and 'DNA' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains a named entity of type 'protein' which is relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'cell_type' and 'cell_line' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'protein' and 'cell_type' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'DNA' and 'protein' which are relevant to the entity label set.\"},\n    {\"4\": \"The sentence contains named entities of type 'protein' which are relevant to the entity label set.\"},\n    {\"1\": \"The sentence contains no named entities from the given entity label set.\"},\n    {\"1\": \"The sentence contains no named entities from the given entity label set.\"},\n    {\"1\": \"The sentence contains no named entities from the given entity label set.\"}\n]",
        "response3": "[{\"Id2\": \"protein\"}, {\"Id3\": \"protein\"}, {\"mRNA\": \"RNA\"}, {\"T-cell lines\": \"cell_line\"}, {\"human T-cell leukemia virus type I ( HTLV-I )\": \"cell_type\"}, {\"ATL-1k\": \"cell_line\"}, {\"MT-2\": \"cell_line\"}, {\"S-LB1\": \"cell_line\"}, {\"type II ( Mo )\": \"cell_line\"}]",
        "prediction": "{'Id2': 'protein', 'Id3': 'protein', 'mRNA': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I ( HTLV-I )': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II ( Mo )': 'cell_line'}"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"myeloid PU.1 binding site\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear mentions of specific proteins and their corresponding entity labels, aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains explicit references to proteins and protein complexes, facilitating the identification of named entities in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions a specific protein and its entity label, assisting in the extraction of named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes detailed information about proteins involved in the process, aiding in the identification of named entities in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides information about specific cell types and a virus, helping in the extraction of named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions specific elements and their entity labels, which can assist in extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains explicit references to proteins, cytokines, and transcription factors, aiding in the identification of named entities in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides details about DNA elements and a protein, assisting in the extraction of named entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions specific cell types and a protein, aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence explicitly mentions a specific protein and its entity label, helping in the extraction of named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides information about a cell type and a virus, aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions specific proteins and a cell line, assisting in the extraction of named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains explicit references to proteins, a transcription factor, and a promoter, aiding in the identification of named entities in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear mentions of specific proteins and a cell line, facilitating the extraction of named entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions specific proteins and a promoter, aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities or terms that match the entity labels in the target sentence, hence not helpful for named entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities or terms that match the entity labels in the target sentence, hence not helpful for named entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities or terms that match the entity labels in the target sentence, hence not helpful for named entity extraction.\"}\n]",
        "response3": "[{\"HeLa cells\": \"cell_line\"}, {\"EB1\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n{\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "response1": "['protein', 'DNA', 'cell_line']",
        "response2": "[\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n{\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n{\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5}\n]",
        "response3": "[{\"UV irradiation\": \"None\"}, {\"TRE -DNA fragment\": \"DNA\"}]",
        "prediction": "{'UV irradiation': 'None', 'TRE -DNA fragment': 'DNA'}"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain .\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 5},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific examples of entities and their corresponding labels, which directly relate to the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific examples of entities and their corresponding labels that match the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions an entity and its label that aligns with the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear example of an entity and its label that matches the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence includes entities and their labels that directly correspond to the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains examples of entities and their labels that align with the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a specific example of an entity and its label that matches the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions an entity and its label that aligns with the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes entities and their labels that directly correspond to the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains examples of entities and their labels that align with the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides a specific example of an entity and its label that matches the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions an entity and its label that aligns with the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence includes entities and their labels that directly correspond to the entity types in the target sentence.\"},\n    {\"Example 14\": 1},\n    {\"Reason 14\": \"The sentence does not contain any entities or labels that match the entity types in the target sentence.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The sentence does not provide any entities or labels that align with the entity types in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not mention any entities or labels that correspond to the entity types in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"PBMC\": 5, \"adenovirus\": 5},\n    {\"WT1\": 5},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5},\n    {\"TCL1\": 5},\n    {\"myeloperoxidase\": 5, \"lysozyme\": 5, \"PU.1\": 5},\n    {\"Ras\": 5},\n    {\"T-PLL\": 5},\n    {\"T lymphocytes\": 5, \"HLA-molecules\": 5},\n    {\"MNDA\": 5, \"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5, \"T cells\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"PBMC\": 5, \"adenovirus DNA\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"SIVsmmPBj14\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-myc\": \"protein\"}, {\"T lymphoblastic tumor cell line\": \"cell_line\"}]",
        "prediction": "{'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"T cell blasts treated with PMA are now responsive to IFN-gamma .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\": 5}\n]",
        "response3": "[{\"OTF-1\": \"protein\"}, {\"pre-B cells\": \"cell_type\"}, {\"HeLa cells\": \"cell_line\"}, {\"immunoglobulin gene\": \"protein\"}]",
        "prediction": "{'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n{\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n{\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 4},\n{\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n{\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 4},\n{\"T cell blasts treated with PMA are now responsive to IFN-gamma.\": 4},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 4},\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n{\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\": 5},\n{\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"octamer-binding proteins\": \"protein\"}]",
        "prediction": "{'octamer-binding proteins': 'protein'}"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"IL-2 promoter/reporter constructs\": \"DNA\"}, {\"VDR\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'IL-2': 'protein', 'Jurkat': 'cell_line', 'IL-2 promoter/reporter constructs': 'DNA', 'VDR': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of proteins and cell types mentioned in the target sentence, which directly align with the entity types in the target sentence. This makes it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"immunoglobulin heavy and kappa light chain gene enhancers\": \"DNA\"}]",
        "prediction": "{'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"T cell\": 5, \"kB-like proto-enhancer element\": 3, \"interleukin 2\": 3},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CREB\": 4, \"AR-CRE\": 4},\n{\"SIVsmmPBj14\": 5},\n{\"EBNA2\": 4, \"TP1\": 3},\n{\"BRCA1\": 5},\n{\"p50p50\": 5},\n{\"GM-CSF\": 3},\n{\"retinoic acid receptor alpha\": 4},\n{\"IL-2\": 3, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"Protein\": 3},\n{\"Th2-type lymphocytes\": 5},\n{\"IgH\": 5},\n{\"VDR\": 4, \"RXR\": 4, \"GRIP-1\": 4, \"DRIP205\": 4, \"DRIP\": 3},\n{\"GM-kappa B\": 5, \"GC-box\": 5, \"GC-motif\": 5, \"GM-kappa B motif\": 5},\n{\"NF-kappaB\": 4, \"Sp1\": 4, \"SIVmac\": 5}\n]",
        "response3": "[{\"RCGCRYGCGY\": \"DNA\"}, {\"IBR/F\": \"protein\"}, {\"TGCGCATGCGCA\": \"DNA\"}]",
        "prediction": "{'RCGCRYGCGY': 'DNA', 'IBR/F': 'protein', 'TGCGCATGCGCA': 'DNA'}"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 3},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU-SF complex\": \"protein\"}, {\"PU.1\": \"protein\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a specific protein entity (NF-E2) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The examples provide protein entities (alpha-tocopherol, endothelial cells) and a cell type entity (monocyte) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The examples provide protein entities (NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The examples provide protein entities (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The examples provide RNA, cell type, and protein entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a specific protein entity (retinoic acid receptor alpha) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The examples provide protein and cell line entities (WT1, myeloid cell lines) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The examples provide protein entities (E2A, NF-kappa B, I kappa B beta) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The examples provide cell type and chemical compound entities (lymphocytes, benzene, benzoquinone) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a specific protein entity (NF-kappa B) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide cell line and protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide protein and RNA entities (Erbstatin, genistein, Egr-1) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The examples provide cell type, protein, and RNA entities (B cell, Ig, Transforming growth factor-beta) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The examples provide DNA and protein entities (EBV, EBNA2, estrogen receptor) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The examples provide cell line entities (PMA, U1 cells) mentioned in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities from the given entity label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"IL-4\": 4},\n    {\"Protein\": 4},\n    {\"WT1\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"GATA-1\": 5},\n    {\"Syk\": 5},\n    {\"Zap\": 5},\n    {\"T cell\": 5},\n    {\"RXR\": 5},\n    {\"E2A\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"TCF-1\": 5},\n    {\"immunohistochemistry\": 3},\n    {\"gene\": 1},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"PU.1\": 5},\n    {\"Th1\": 5},\n    {\"Th2\": 5},\n    {\"Egr-1\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 4},\n    {\"CD40\": 4}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"OTF-1\": \"protein\"}]",
        "prediction": "{'OTF-2': 'protein', 'OTF-1': 'protein'}"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 1},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"MATERIALS AND METHODS: Human monocytes were stimulated with PMA (50 ng/ml) alone or LPS (100 ng/ml) with and without a nonspecific serine/threonine protein kinase inhibitor staurosporine (Stauro), a specific pan-PKC inhibitor bisindolylmaleimide (Bis), or an inhibitor of PTK genistein (Gen).\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"DNA-binding phosphoproteins induced after T cell activation: effects of cyclosporin A.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "response1": "['cell_line', 'virus']",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 1},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"B-lymphoblastoid cell lines\": \"cell_line\"}, {\"multiple sclerosis patients\": \"cell_type\"}, {\"a healthy control\": \"cell_type\"}, {\"putative new human retrovirus\": \"virus\"}, {\"Epstein-Barr virus\": \"virus\"}]",
        "prediction": "{'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'a healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'virus'}"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"lymphoid-specific enhancer element\": \"DNA\"}, {\"immunoglobulin heavy-chain gene\": \"DNA\"}]",
        "prediction": "{'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of DNA binding activity, directly linking the entity 'NF-kappa B' to the entity type 'DNA'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence clearly mentions the protein 'ZAP-70' and its responsiveness to treatment, indicating a strong association between the entity and the entity type.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions multiple entities such as 'NF-kappaB', 'Tax', and 'ATL' in the context of leukemic cells, providing clear associations with the respective entity types.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly links the overexpression of 'WT1' to myeloid cell lines, establishing a strong connection between the entities and their respective types.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a comprehensive list of entities such as 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' with clear indications of their entity types, making it highly helpful for extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly discusses the activation of 'NF-kappa B' in phagocytosing neutrophils, establishing a strong link between the entity and its entity type.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence clearly mentions the inactivation of 'IkappaBbeta' by the tax protein, linking both entities to the entity type 'protein'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly links the induction of 'TIMP-1' to cell survival and DNA synthesis, providing a clear association between the entity and its entity type.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'PBMC' and 'adenovirus DNA' in the context of adenoviral infection, establishing a strong connection between the entities and their respective types.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence discusses the induction of various entities such as 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' in myeloid cells, providing clear associations with the respective entity types.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly links the mutants of 'NF-kappaB' and 'Sp1' to SIVmac cell line, establishing a strong connection between the entities and their respective types.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions entities like 'pRB', 'U937', 'p53', 'apoptosis', 'calphostin C', 'ceramide', and 'serum withdrawal' with clear indications of their entity types, making it highly helpful for extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly links the generation of 'T lymphocytes' to immunizations with adenovirus vectors, providing a clear association between the entity and its entity type.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence discusses the activation of 'NF-kappa B' in human neutrophils in response to phagocytic stimuli, establishing a strong link between the entity and its entity type.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a comprehensive list of entities such as 'HIV', 'NF-kappa B', 'p105', 'p50', and 'MAD3' with clear indications of their entity types, making it highly helpful for extraction.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions purified CD4+ and CD8+ T cells and their responses to different stimuli, indicating a strong association between the entities and their respective types.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the entity labels provided.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the entity labels provided.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entities related to the entity labels provided.\"}\n]",
        "response3": "[{\"human papillomavirus- or adenovirus- transformed cells\": \"cell_type\"}, {\"natural killer cells\": \"cell_type\"}]",
        "prediction": "{'human papillomavirus- or adenovirus- transformed cells': 'cell_type', 'natural killer cells': 'cell_type'}"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of cell adhesion molecules, which directly relate to the 'cell_type' entity label in the entity label set.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence explicitly mentions 'retinoic acid receptor alpha', which is a specific protein, aligning with the 'protein' entity label in the entity label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple instances of proteins such as 'Stat3', 'Stat5', and 'c-Mpl', which are directly relevant to the 'protein' entity label in the entity label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'cAMP-dependent protein kinase' and 'Rap1', both of which are proteins, aligning with the 'protein' entity label in the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence explicitly refers to 'G-CSF', which is a protein, matching the 'protein' entity label in the entity label set.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides specific examples of proteins ('CD14' and 'CD23') mentioned in the context of mRNA and protein expression.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence includes 'alpha-tocopherol', 'monocyte', and 'endothelial cells', which correspond to the 'protein', 'cell_type', and 'cell_type' entity labels in the entity label set, respectively.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'AP-1', 'PMA', 'monocytes', and 'macrophages', all of which align with the 'protein' and 'cell_type' entity labels in the entity label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins ('Syk' and 'Zap') and mentions 'T cell', which corresponds to the 'protein' and 'cell_type' entity labels in the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence includes 'P selectin', which is a protein, aligning with the 'protein' entity label in the entity label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'GATA-1', which is a protein, directly related to the 'protein' entity label in the entity label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence refers to 'phosphocreatine', which is a protein, aligning with the 'protein' entity label in the entity label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence includes 'NF-kappa B', which is a protein, directly related to the 'protein' entity label in the entity label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins ('PAFR', 'PAF', 'NF-kappa B', 'protein kinase C') that align with the 'protein' entity label in the entity label set.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells', all of which correspond to the 'protein' and 'cell_type' entity labels in the entity label set.\"}\n]",
        "response3": "[{'Platelet thromboxane receptors': 'protein'}]",
        "prediction": "{'Platelet thromboxane receptors': 'protein'}"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.\": 5}\n]",
        "response3": "[{\"Human herpesvirus 6\": \"cell_type\"}, {\"EBV\": \"cell_line\"}, {\"B cell lines\": \"cell_line\"}, {\"EBV lytic cycle\": \"cell_type\"}]",
        "prediction": "{'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_line', 'B cell lines': 'cell_line', 'EBV lytic cycle': 'cell_type'}"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example contains specific protein and cell type names that are mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example contains specific protein and cell type names that are mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example contains specific protein and cell type names that are mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains specific cell type names that are mentioned in the target sentence, aiding in the extraction of cell type entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains specific cell line and protein names that are mentioned in the target sentence, aiding in the extraction of cell line and protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example contains specific protein names that are mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example contains specific protein and cell type names that are mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The example does not contain any specific entity names mentioned in the target sentence, hence not aiding in the extraction of named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not contain any specific entity names mentioned in the target sentence, hence not aiding in the extraction of named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any specific entity names mentioned in the target sentence, hence not aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"BLR2 mRNA\": \"RNA\"}, {\"mitogen\": \"protein\"}, {\"anti-CD3\": \"protein\"}, {\"peripheral blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains an example of a protein entity that is relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains an example of a protein entity that is relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains an example of a protein entity that is relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple examples of protein entities that are relevant to the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[{\"AP-1\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'DNA', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"RXR\": 5},\n    {\"cDNAs\": 5},\n    {\"E2A\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"PU.1\": 5},\n    {\"IL-4\": 5},\n    {\"LPS\": 5},\n    {\"AP-1\": 5},\n    {\"GATA-1\": 5},\n    {\"Th1\": 5},\n    {\"Th2\": 5},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"NF-kappa B\": 5},\n    {\"AP-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"embryonic cardiac cells\": 5},\n    {\"Sp1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"p50\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"STAT5\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"JAK3\": \"protein\"}]",
        "prediction": "{'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 3},\n    {\"Example 10\": 3},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"IL-3\": \"protein\"}]",
        "prediction": "{'IL-3': 'protein'}"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_line']",
        "response2": "[\n{\"TIMP-1\": 4, \"DNA\": 3},\n{\"NF-kB\": 4, \"AP-1\": 4, \"OCT-1\": 4, \"NF-IL-2B\": 4},\n{\"RelA\": 4, \"NF-kappa B\": 4},\n{\"NF-kappaB\": 5, \"Tax\": 4, \"ATL\": 4},\n{\"IkappaBbeta\": 4, \"NF-kappaB\": 4},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5, \"IL-2\": 4, \"AP-1\": 4},\n{\"NF-kappa B\": 5, \"I kappa B alpha\": 4},\n{\"NF-kappa B\": 5, \"I kappa B alpha\": 4},\n{\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n{\"HIV-1\": 5, \"IFN\": 4, \"PKR\": 4, \"IkappaBalpha\": 4},\n{\"CD40\": 4, \"Rel/nuclear factor kappaB\": 4, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n{\"TR55\": 4, \"TNF-alpha\": 4, \"HIV\": 4},\n{\"NF-kappaB\": 5, \"Sp1\": 4, \"SIVmac\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"HIV type 1\": \"cell_type\"}, {\"HIV-1\": \"cell_type\"}, {\"viral RNA\": \"RNA\"}, {\"U937 cells\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'viral RNA': 'RNA', 'U937 cells': 'cell_line'}"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Sentence\": \"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein (NF-ATc) and cell type (T lymphocytes) entities which are directly mentioned.\"},\n    {\"Sentence\": \"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions a specific protein entity (GATA-1) which is directly related to the entity labels.\"},\n    {\"Sentence\": \"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions specific cell type (T cell) and protein (interleukin 2) entities which are directly related to the entity labels.\"},\n    {\"Sentence\": \"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein entities (Sp1, CD14) and cell type (monocytic cells) which are directly mentioned.\"},\n    {\"Sentence\": \"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions a specific protein entity (A-myb) which is directly related to the entity labels.\"},\n    {\"Sentence\": \"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions a specific DNA entity (IgH) which is directly related to the entity labels.\"},\n    {\"Sentence\": \"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein entity (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) which are directly mentioned.\"},\n    {\"Sentence\": \"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions specific protein (TAL1) and cell type (T-ALL) entities which are directly related to the entity labels.\"},\n    {\"Sentence\": \"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein entities (Sp1, Ets, perforin) which are directly mentioned.\"},\n    {\"Sentence\": \"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein entities (IL-2, AP-1, c-Jun, c-Fos) which are directly mentioned.\"},\n    {\"Sentence\": \"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions a specific protein entity (p50p50) which is directly related to the entity labels.\"},\n    {\"Sentence\": \"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific cell line (UAS1) and cell type (B cell) entities which are directly mentioned.\"},\n    {\"Sentence\": \"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions a specific cell type entity (Th2-type lymphocytes) which is directly related to the entity labels.\"},\n    {\"Sentence\": \"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein entities (IL-2, NFAT, NFAT delta418, calcineurin, Tpl-2, cyclosporin A) which are directly mentioned.\"},\n    {\"Sentence\": \"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific DNA entity (BAT box), protein (CD20), and cell type (B cells) entities which are directly mentioned.\"},\n    {\"Sentence\": \"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein entities (NF-kappaB, Sp1) and cell line (SIVmac) which are directly mentioned.\"},\n    {\"Sentence\": \"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\", \"helpfulness score\": 1, \"reasons\": \"The sentence does not contain any specific entities related to the entity labels.\"},\n    {\"Sentence\": \"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\", \"helpfulness score\": 1, \"reasons\": \"The sentence does not contain any specific entities related to the entity labels.\"},\n    {\"Sentence\": \"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\", \"helpfulness score\": 1, \"reasons\": \"The sentence does not contain any specific entities related to the entity labels.\"}\n]",
        "response3": "[{\"Thy-1 gene\": \"protein\"}]",
        "prediction": "{'Thy-1 gene': 'protein'}"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 3},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"TCF-1\": \"protein\"}, {\"lymphoid malignancies\": \"cell_type\"}]",
        "prediction": "{'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example includes multiple entities with specific labels, demonstrating the diversity of named entities present in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example highlights a specific entity with its label, contributing to the understanding of named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear entity with its label, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example includes a specific entity with its label, helping in identifying named entities in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example presents a specific entity with its label, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example includes a specific entity with its label, contributing to the understanding of named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear entity with its label, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example includes a specific entity with its label, helping in identifying named entities in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example presents a specific entity with its label, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example includes multiple entities with specific labels, demonstrating the diversity of named entities present in the sentence.\"},\n    {\"Example 12\": 1},\n    {\"Reason 12\": \"The example does not provide any specific entity with its label, making it less helpful in understanding named entity extraction.\"},\n    {\"Example 13\": 1},\n    {\"Reason 13\": \"The example does not include any specific entity with its label, making it less helpful in identifying named entities in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear entity with its label, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example includes multiple entities with specific labels, demonstrating the diversity of named entities present in the sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not provide any specific entity with its label, making it less helpful in understanding named entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not include any specific entity with its label, making it less helpful in identifying named entities in the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the protein 'TCL1' and its association with the entity label 'protein'.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear and direct mention of the protein 'WT1' and its association with the entity label 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear and direct mention of the protein 'RXR' and its association with the entity label 'protein'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear and direct mention of the cell type 'lymphoid neoplasms' and its association with the entity label 'cell_type'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear and direct mention of the protein 'NF-kappa B' and its association with the entity label 'protein'.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear and direct mentions of the proteins 'TCRzeta' and 'p56(lck)' and their associations with the entity label 'protein'.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear and direct mention of the DNA 'AP-1' and its association with the entity label 'DNA'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear and direct mentions of the proteins 'RelA' and 'NF-kappa B' and their associations with the entity label 'protein'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear and direct mentions of the proteins 'EBNA-2' and 'PU.1' and their associations with the entity label 'protein'.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear and direct mentions of the proteins 'IL-2 receptor alpha subunit', 'p21ras', and the cell type 'B cell' and their associations with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear and direct mentions of the proteins 'SLAP-130', 'SLP-76', and the cell type 'T cell' and their associations with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear and direct mentions of the protein 'NF-kappaB' and the cell type 'rheumatoid arthritis' and their associations with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear and direct mentions of the proteins 'myeloperoxidase', 'lysozyme', and 'PU.1' and their associations with the entity label 'protein'.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a clear and direct mention of the protein 'retinoic acid receptor alpha' and its association with the entity label 'protein'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear and direct mentions of the proteins 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and the cell type 'B cells' and their associations with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear and direct mentions of the cell type 'T lymphocytes' and the protein 'HLA-molecules' and their associations with the entity labels 'cell_type' and 'protein'.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities or entity labels mentioned.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities or entity labels mentioned.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities or entity labels mentioned.\"}\n]",
        "response3": "[{\"HLA class II antigens\": \"protein\"}, {\"ribonucleoproteins Ro(SSA)\": \"protein\"}, {\"La(SSB)\": \"protein\"}]",
        "prediction": "{'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 1},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n{\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n{\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 3},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities and their corresponding entity labels, which can aid in understanding the types of entities mentioned in the target sentence.\"},\n    {\"Example 2\": 2},\n    {\"Reason 2\": \"The sentence mentions phosphocreatine, which is a protein, providing a relevant example of a named entity but not directly related to the entities in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple examples of named entities (AP-1, PMA, monocytes, macrophages) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of named entities (granulocytes, T cells) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains examples of named entities (NF-kappa B, AP-1) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of named entities (IL-4, LPS, AP-1) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions AP-1 as a DNA binding activity, providing an example of a named entity and its corresponding entity label, indirectly related to the entities in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains examples of named entities (CD14, CD23) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of named entities (SIVmacMER, SIVmac239, CEMx174) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains examples of named entities (MTHC, TNF-alpha, IFN-gamma, DC) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions T lymphocytes, providing an example of a named entity and its corresponding entity label, indirectly related to the entities in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of named entities (SP1, caspases, B-cell) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains examples of named entities (Tip, Tap, Jurkat-T cells) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of named entities (PMA, LPS, staurosporine, bisindolylmaleimide, genistein) and their corresponding entity labels, directly related to the entities in the target sentence, aiding in understanding the types of entities mentioned.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions interleukin-1beta and inhibitor-kappaB alpha, providing examples of named entities and their corresponding entity labels, indirectly related to the entities in the target sentence.\"},\n    {\"Example 16\": 3},\n    {\"Reason 16\": \"The sentence mentions PMA and U1 cells, providing examples of named entities and their corresponding entity labels, indirectly related to the entities in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not provide examples of named entities relevant to the entities in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not provide examples of named entities relevant to the entities in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not provide examples of named entities relevant to the entities in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"NFAT\": \"protein\"}]",
        "prediction": "{'calcineurin': 'protein', 'NFAT': 'protein'}"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ER\": \"protein\"}]",
        "prediction": "{'ER': 'protein'}"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"SIVsmmPBj14\": 5},\n    {\"SIVmacMER\": 4, \"SIVmac239\": 4, \"CEMx174\": 4},\n    {\"GM-CSF\": 4},\n    {\"PML/RARalpha\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"protein\": 5},\n    {\"Sp1\": 4, \"Ets\": 4},\n    {\"c-kit\": 4, \"IL-4R alpha chain\": 4},\n    {\"TCF-1\": 4},\n    {\"MIP-1 alpha\": 4, \"GOS19\": 4, \"LD78\": 4, \"AT464\": 4},\n    {\"Sp1\": 4, \"CD14\": 4},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"SLAP-130\": 5, \"SLP-76\": 4, \"T cell\": 4},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"CD95 ligand\": 4}\n]",
        "response3": "[{\"ets-1 cDNA clone\": \"DNA\"}, {\"mouse thymus cDNA expression library\": \"DNA\"}, {\"double-stranded oligonucleotide probe\": \"DNA\"}, {\"Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)\": \"DNA\"}]",
        "prediction": "{'ets-1 cDNA clone': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)': 'DNA'}"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ER\": \"protein\"}, {\"NK\": \"cell_type\"}]",
        "prediction": "{'ER': 'protein', 'NK': 'cell_type'}"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the protein 'calcineurin' and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides clear examples of the proteins 'IkappaBalpha' and 'NF-kappaB' and their corresponding entity labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides clear examples of the proteins 'IkappaBbeta' and 'NF-kappaB' and their corresponding entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of the proteins 'NF-kappa B' and 'AP-1' and their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of the proteins 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of the proteins 'CD40' and 'NF-kappa B' and their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of the proteins 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' and their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of the proteins 'NF-kappaB', 'Tax', and 'ATL' and their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of the proteins 'NF-kappa B' and 'I kappa B beta' and their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of the proteins 'RelA' and 'NF-kappa B' and their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of the proteins 'Syk', 'Zap', and 'T cell' and their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of the proteins 'SP1', 'caspases', and 'B-cell' and their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities related to the given entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the given entity labels.\"}\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"FK506\": \"None\"}, {\"CsA\": \"None\"}, {\"PKC\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'calcineurin': 'protein', 'FK506': 'None', 'CsA': 'None', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n{\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n{\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n{\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Protein kinase inhibitor H-7\": \"protein\"}, {\"unspliced mRNA\": \"RNA\"}, {\"human T-cell leukemia virus type I (HTLV-I)\": \"cell_type\"}]",
        "prediction": "{'Protein kinase inhibitor H-7': 'protein', 'unspliced mRNA': 'RNA', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type'}"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"CCAAT box\": 5, \"EKLF binding site\": 5},\n    {\"ZEBRA\": 5},\n    {\"T cell\": 4, \"interleukin 2\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"RXR\": 5},\n    {\"p50p50\": 5},\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"Egr-1\": 5},\n    {\"IL-2\": 5},\n    {\"CD4+\": 4, \"EBV\": 5},\n    {\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n    {\"AP-1\": 5},\n    {\"EBNA2\": 5, \"TP1\": 5},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"R\": \"protein\"}]",
        "prediction": "{'R': 'protein'}"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\": 5},\n    {\"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 5},\n{\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n{\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n{\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein'}"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (BRCA1) and its corresponding label, which directly relates to the entity types present in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a protein entity (TCF-1) which is relevant to the entity types in the target sentence, although the context is not as specific as in Example 1.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes multiple protein entities (SLAP-130, SLP-76) and a cell type entity (T cell), directly aligning with the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions protein entities (IkappaBbeta, NF-kappaB) that are relevant to the entity types in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides a cell type entity (Th2-type lymphocytes) which is in line with the entity types in the target sentence, although the context is not as specific.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) that directly relate to the entity types in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions protein entities (c-kit, IL-4R alpha chain) that are relevant to the entity types in the target sentence, although the context is not as specific.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes protein entities (IL-13, IL-4R, JAK2, IL-13R) that align with the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides protein entities (TCRzeta, p56(lck)) that are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a cell type entity (T cell) and a protein entity (interleukin 2) which are in line with the entity types in the target sentence, although the context is not as specific.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions a cell line entity (SCM-1) which is relevant to the entity types in the target sentence, but the context is not as closely related.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes a protein entity (TAL1) and a cell type entity (T-ALL) that directly align with the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a cell type entity (T-PLL) that is directly relevant to the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a protein entity (TCL1) that aligns with the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains protein entities (SCL, GATA-1) that are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities relevant to the entity types in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities relevant to the entity types in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities relevant to the entity types in the target sentence.\"}\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"TCR alpha/beta\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"T-prolymphocytic (T-PLL)\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'calcineurin' to the entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping of the entity 'NF-kappa B' to the entity type 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping of multiple entities to the entity type 'protein' in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping of multiple entities to the entity type 'protein' in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping of multiple entities to their respective entity types in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear and direct mapping of multiple entities to their respective entity types in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping of multiple entities to the entity type 'protein' in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping of the entity 'IL-2' to the entity type 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping of the entity 'NF-ATc' to the entity type 'protein' and 'T lymphocytes' to the entity type 'cell_type' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping of the entities 'IkappaBbeta' and 'NF-kappaB' to the entity type 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear and direct mapping of the entities 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' to their respective entity types in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear and direct mapping of the entities 'Syk', 'Zap', and 'T cell' to their respective entity types in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping of the entities 'IL-2', 'NF-kappa B', and 'AP-1' to their respective entity types in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping of the entities 'IL-2', 'Aiolos', and 'Ras' to their respective entity types in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping of the entities 'IkappaBalpha' and 'NF-kappaB' to their respective entity types in the sentence.\"}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"immunophilin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate\": \"The sentence contains specific mentions of proteins and stimuli, which are directly related to the entity labels provided. These examples are highly relevant for extracting named entities from the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"NF-kappa B activation\": 5},\n{\"Gel-shift analysis\": 1},\n{\"phorbol esters\": 1},\n{\"mouse E2A gene\": 1},\n{\"granulocyte-macrophage lineage\": 1},\n{\"chimeric receptor\": 1},\n{\"PML/RARalpha\": 5},\n{\"RXR\": 1},\n{\"TRAF6\": 5},\n{\"NF-ATc\": 5},\n{\"CD40 cytoplasmic domain\": 1},\n{\"GATA-1\": 5},\n{\"TCF-1\": 5},\n{\"NF-kappa B\": 5},\n{\"IL-2\": 5},\n{\"ZEB\": 1},\n{\"c-Myb /Ets\": 1},\n{\"common pathway\": 1},\n{\"tumors\": 1},\n{\"ovary\": 1},\n{\"distinct genes\": 1}\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"hematopoietic cell lineage\": \"cell_type\"}]",
        "prediction": "{'NF-M': 'protein', 'hematopoietic cell lineage': 'cell_type'}"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a direct mapping between the entity 'IL-4' and the entity type 'protein' in the sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"NF-IL6\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HLA-DR alpha (DRA)\": \"protein\"}, {\"octamer\": \"protein\"}, {\"immunoglobulin variable region\": \"protein\"}, {\"B cell-specific\": \"cell_type\"}]",
        "prediction": "{'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 5},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Jak3\": \"protein\"}, {\"gamma c\": \"protein\"}, {\"XSCID\": \"cell_type\"}]",
        "prediction": "{'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names like TIMP-1 and DNA, which are directly related to the entity labels provided.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions specific protein (MNDA) and cell line (Philadelphia chromosome-positive chronic myeloid leukemia) names, which are relevant to the entity labels provided.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence includes multiple protein names (IFN A, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) that match the entity labels provided.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence directly mentions a specific protein (CD14) relevant to the entity labels provided.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains a specific protein name (retinoic acid receptor alpha) that aligns with the entity labels provided.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions a specific protein (WT1) and a cell line (myeloid cell lines) relevant to the entity labels provided.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence includes a specific protein name (NF-E2) that matches the entity labels provided.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence directly mentions a specific protein (retinoic acid receptor alpha) relevant to the entity labels provided.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains a specific protein name (RXR) that aligns with the entity labels provided.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions a specific protein (ZAP-70) that is relevant to the entity labels provided.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence includes specific protein names (IL-5 mRNA, interleukin-2, IL-2R) and a drug (dexamethasone) that correspond to the entity labels provided.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains multiple protein names (VDR, RXR, GRIP-1, DRIP205) that match the entity labels provided.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions specific protein names (interleukin-2, alpha chain, CD25, IL-2 receptor) that align with the entity labels provided.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence includes specific protein names (Protein kinase B, phosphatidylinositol 3-kinase, STAT5, erythropoietin, EPO) and cell line names (HCD57, HCD57-SREI) that are relevant to the entity labels provided.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence directly mentions cell line names (hematopoietic cell line, 47.10, nontransgenic mice) that align with the entity labels provided.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence includes specific entities like 2-deoxyguanosine, lymphoid progenitor cells, thymus stromal cells, B cell, tg epsilon26, fetal liver cells, and T cell, which are directly related to the entity labels provided.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels provided.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels provided.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any specific entities related to the entity labels provided.\"}\n]",
        "response3": "[{\"Ro-VDR\": \"cell_line\"}, {\"control cell line\": \"cell_line\"}]",
        "prediction": "{'Ro-VDR': 'cell_line', 'control cell line': 'cell_line'}"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"1,25-dihydroxyvitamin D3\": \"protein\"}, {\"VDR\": \"protein\"}]",
        "prediction": "{'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"NF-kappa B\": 5, \"IkappaBbeta\": 4, \"protein\": 4, \"DNA\": 3, \"Tax\": 4, \"ATL\": 4, \"RelA\": 4, \"I kappa B alpha\": 4, \"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4, \"AP-1\": 3, \"HIV-1\": 4, \"IFN\": 4, \"PKR\": 4, \"IkappaBalpha\": 4, \"CD40\": 4, \"Rel/nuclear factor kappaB\": 4, \"B lymphocytes\": 4, \"TR55\": 4, \"TNF-alpha\": 4, \"SIVmac\": 4, \"HIV-1 LTR\": 4, \"NFAT-1\": 4},\n    {\"reasons\": \"The sentences contain specific entities related to the entity labels in the target sentence, making them highly relevant for named entity extraction. The examples provide direct mentions of the entities and their relationships, aiding in understanding the context and improving entity extraction accuracy.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"DNA\"}]",
        "prediction": "{'NF-kappa B': 'DNA'}"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"IgH\": 5},\n    {\"BRCA1\": 4},\n    {\"EBNA2\": 4, \"TP1\": 3},\n    {\"GM-CSF\": 4},\n    {\"Protein\": 5},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"p50p50\": 4},\n    {\"EKLF\": 4},\n    {\"TCF-1\": 4},\n    {\"ZEBRA\": 4},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"Egr-1\": 4},\n    {\"T cell\": 4, \"interleukin 2\": 4},\n    {\"Th2-type lymphocytes\": 5},\n    {\"CD95 ligand\": 4},\n    {\"GM-kappa B\": 5, \"GC-box\": 5, \"GC-motif\": 5, \"GM-kappa B motif\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides clear examples of named entities with corresponding entity labels, aiding in understanding and identifying similar entities in the target sentence.\"}\n]",
        "response3": "[{\"Bmax\": \"protein\"}, {\"DEX\": \"protein\"}]",
        "prediction": "{'Bmax': 'protein', 'DEX': 'protein'}"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "response1": "['cell_line', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the protein and its encoding gene, providing a clear link between the two entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence explicitly states the protein (Egr-1) and its function as a transcription factor, making it highly relevant for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions the protein (TCF-1) and its interaction with mice, providing valuable information for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence discusses the protein (E2A) and its detection at the protein level, aiding in the identification of the entity.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions the cell type (Th2-type lymphocytes) and its association with cytokine expression, facilitating entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence refers to the DNA entity (IgH) and its role in gene transcription, providing crucial information for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence discusses the DNA entity (cDNAs) and their cloning and sequencing, directly linking the entity to its function.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions multiple proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their interactions, aiding in entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions the protein (NF-ATc) and its synthesis in T lymphocytes, providing valuable information for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence discusses proteins (IL-2, c-Jun, c-Fos) and their presence in nuclear factors, aiding in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions proteins (CD70, IL-4, CD40) and their effects on cell differentiation, facilitating entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence refers to the protein (NF-ATc) and its expression in different cell types, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions the protein (GM-CSF) and its conservation in human and murine genes, providing valuable information for entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence discusses proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their expression, aiding in entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions proteins (c-kit, IL-4R alpha chain) and their involvement in receptor generation, facilitating entity extraction.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"pre-B-cell lines\": \"cell_line\"}, {\"OTF-2\": \"protein\"}, {\"immunoglobulin heavy-chain mRNA\": \"RNA\"}, {\"immunoglobulin gene\": \"DNA\"}]",
        "prediction": "{'pre-B-cell lines': 'cell_line', 'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA'}"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple instances of protein entities (IL4, IL13, STAT6, STAT3, STAT5) and a cell type entity (B cells), directly matching the entity labels.\"},\n    {\"4\": \"The sentence contains protein entities (AP-1, PMA) and cell type entities (monocytes, macrophages), which are relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell), partially matching the entity labels.\"},\n    {\"4\": \"The sentence contains protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains the protein entity 'IL-2', directly matching the entity label.\"},\n    {\"4\": \"The sentence contains protein entities (IL-2, c-Jun, c-Fos) relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains protein entities (CD70, IL-4, CD40) and cell type entities (B cell, plasma cells), which are relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains the protein entity 'NF-kappa B', partially matching the entity labels.\"},\n    {\"5\": \"The sentence contains protein entities (Stat3, Stat5, c-Mpl) directly matching the entity labels.\"},\n    {\"4\": \"The sentence contains protein entities (IL-2, Aiolos, Ras) relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains protein entities (IL-4, LPS, AP-1) relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains protein entities (IL-12, STAT4, IL-12 receptor) and cell type entities (NK cells, T cells), directly matching the entity labels.\"},\n    {\"4\": \"The sentence contains the protein entity 'E2A', relevant to the entity labels.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"PRL\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"Stat proteins\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a transcription factor (AP-1) binding to DNA, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions two proteins (Jun and ATF-2) and their interaction in transcription, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a specific cell type (Th2-type lymphocytes) expressed in humans, which is relevant to the cell_type entity type in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions a protein (Protein) involved in transcription, which is relevant to the protein entity type in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (Egr-1) that is a zinc finger transcription factor, directly related to the protein entity type in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions proteins (IL-2, c-Jun, c-Fos) involved in transcription and binding to DNA, directly related to the protein entity type in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a protein (GM-CSF) that is highly conserved in human and murine genes, which is relevant to the protein entity type in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a clear example of a protein (GATA-1) that is a lineage-specific transcription factor in erythroid cells, directly related to the protein entity type in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions a protein (TCF-1) involved in transactivation through its cognate motif, which is relevant to the protein entity type in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions Stat proteins forming dimers and inducing transcription, directly related to the protein entity type in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of acetylated transcription factors (EKLF) interacting with other proteins (CBP, p300, P/CAF), directly related to the protein entity type in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions proteins (SCL, GATA-1) expressed in specific cell lineages, directly related to the protein and cell_type entity types in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions a protein (G-CSF) binding to receptors, which is relevant to the protein entity type in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205) interacting with each other, directly related to the protein entity type in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of proteins (ZEB, c-Myb, Ets) involved in gene expression regulation in hematopoietic cells, directly related to the protein and cell_type entity types in the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions proteins (tal-1, GATA-binding proteins) during human hematopoiesis, which is relevant to the protein and cell_type entity types in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entity types mentioned in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entity types mentioned in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any relevant entity types mentioned in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with clear entity labels, such as 'EKLF', 'CBP', 'p300', and 'P/CAF', all identified as 'protein' entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of named entities 'Jun' and 'ATF-2' with clear entity labels, both identified as 'protein' entities.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence only contains one example of a named entity 'immunoglobulin kappa 3' enhancer' with a clear entity label, identified as 'DNA' entity.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence only contains one example of a named entity 'A-myb' with a clear entity label, identified as 'protein' entity.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides examples of named entities 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' with clear entity labels, identified as 'protein' and 'cell_type' entities.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with clear entity labels, such as 'Sp1' and 'Ets', both identified as 'protein' entities.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence only contains one example of a named entity 'Th2-type lymphocytes' with a clear entity label, identified as 'cell_type' entity.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a named entity 'p50p50' with a clear entity label, identified as 'protein' entity.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a named entity 'TCF-1' with a clear entity label, identified as 'protein' entity.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a named entity 'GATA-1' with a clear entity label, identified as 'protein' entity.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with clear entity labels, such as 'CREB' and 'AR-CRE', both identified as 'protein' entities.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides examples of named entities 'CCAAT box' and 'EKLF binding site' with clear entity labels, identified as 'DNA' and 'protein' entities.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a named entity 'Egr-1' with a clear entity label, identified as 'protein' entity.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with clear entity labels, such as 'IL-2', 'c-Jun', and 'c-Fos', all identified as 'protein' entities.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with clear entity labels, such as 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells', all identified as 'protein' and 'cell_type' entities.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with clear entity labels, such as 'p50', 'p65', 'DNA', and 'protein', all identified as 'protein' and 'DNA' entities.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence does not contain any named entities with clear entity labels.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence does not contain any named entities with clear entity labels.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence does not contain any named entities with clear entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n{\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n{\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"eosinophil\": \"cell_type\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'eosinophil': 'cell_type', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5},\n    {\"AP-1\": 5},\n    {\"IFN-gamma\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n    {\"Sp1\": 5, \"Ets\": 5},\n    {\"IL-7R\": 5, \"gamma(c)\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"IL-2\": 5},\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n    {\"IkappaBbeta\": 5, \"NF-kappaB\": 5},\n    {\"NF-kappaB\": 5, \"rheumatoid arthritis\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GATA-1\": 5},\n    {\"CD40\": 5, \"IFN-gamma\": 5, \"tumor necrosis factor-alpha\": 5, \"interleukin (IL)-1beta\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (E2A) being mentioned in relation to a specific gene expression study, making it highly relevant for identifying protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions immunohistochemistry with antibodies against proteins encoded by a gene, helping to identify protein entities. It also mentions gene and cell type, which are relevant for DNA and cell_type entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions genes encoding eosinophil granule proteins and a specific transcription factor (GATA-1), providing clear examples of protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions eosinophils, indicating the presence of a cell_type entity.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells), making it highly relevant for identifying protein and cell_type entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions specific lysosomal proteins (myeloperoxidase, lysozyme) and a transcription factor (PU.1), providing clear examples of protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions proteins (CD14, CD23) and their corresponding mRNA, making it highly relevant for identifying protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides examples of proteins (p21(WAF1/CIP1), p27(KIP1)) and their corresponding mRNA, making it highly relevant for identifying protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions granulocytes and T cells, indicating the presence of cell_type entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the protein IL-2 and transcription factors (c-Jun, c-Fos) in relation to the IL-2 promoter, providing clear examples of protein entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a specific transcription factor (NF-E2), providing a clear example of a protein entity.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of proteins (interleukin-2, CD25) and their corresponding receptors, making it highly relevant for identifying protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions a specific cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4), providing clear examples of cell_line and protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions specific compounds (Erbstatin, genistein) and a transcription factor (Egr-1), providing examples of protein and RNA entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions the gene gp91phox and a specific cell line (HL-60-C15), providing clear examples of DNA and cell_line entities.\"}\n]",
        "response3": "[{\"estrogen\": \"protein\"}, {\"progesterone\": \"protein\"}, {\"eosinophil cationic protein\": \"protein\"}, {\"eosinophils\": \"cell_type\"}]",
        "prediction": "{'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as a protein.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B alpha' and provides information that helps identify them as proteins.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions the entity 'NF-ATc' and provides information that helps identify it as a protein. It also mentions 'T lymphocytes' as a cell type.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions the entities 'NF-kappaB', 'Tax', and 'ATL' and provides information that helps identify them as proteins and cell types.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as a protein.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B alpha' and provides information that helps identify them as proteins.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions the entity 'NF-ATc' and provides information that helps identify it as a protein. It also mentions 'T lymphocytes' and 'embryonic cardiac cells' as cell types.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions the entity 'GATA-1' and provides information that helps identify it as a protein.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions the entity 'NF-kappa B' and provides information that helps identify it as a protein.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B beta' and provides information that helps identify them as proteins.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' and provides information that helps identify them as proteins.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the entities 'Sp1' and 'Ets' and provides information that helps identify them as proteins.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'Th1' and 'Th2' as cell types and provides information that helps identify them.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type and provides information that helps identify it.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence directly mentions the entities 'IL-2', 'NF-kappa B', and 'AP-1' and provides information that helps identify them as proteins.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities from the given label set.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities from the given label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities from the given label set.\"}\n]",
        "response3": "[{'NF-AT': 'protein'}, {'NF-kappa B': 'protein'}, {'T helper cell subsets': 'cell_type'}]",
        "prediction": "{'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Sentence\": \"The examples provide clear instances of the entity labels mentioned in the target sentence, such as 'NF-kappa B', 'I kappa B alpha', 'IkappaBbeta', 'NF-kappaB', 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', 'phorbol myristate acetate', 'SIVmacMER', 'SIVmac239', 'CEMx174', 'NF-kappaB', 'Tax', 'ATL', 'HIV-1', 'IFN', 'PKR', 'IkappaBalpha', 'B and T cell activation', 'Ramos', 'Jurkat', 'cDNA microarray technology', 'CD40', 'Rel/nuclear factor kappaB', 'B lymphocytes', 'TR55', 'TNF-alpha', 'HIV', 'HIV-1 LTR', 'NFAT-1', 'NF kappa B', 'Sp1', 'SIVmac', 'PU.1', 'CSF-1 receptor', 'Mono A', 'Mono B', 'fibrinogen'\"},\n    {\"Sentence\": 4},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 3},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"NF-KB\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'NF-KB': 'protein'}"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"Recently, it has been shown that RelB knockout mice have no dendritic cells (DC).\": 4},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'myeloid cell lines' which is a cell line entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"2\": \"The sentence contains 'RXR' which is a protein entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'Jun' and 'ATF-2' which are protein entity types, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'SCL' and 'GATA-1' which are protein entity types, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'Egr-1' which is a protein entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'NF-E2' which is a protein entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'CCAAT box' which is a DNA entity type and 'EKLF binding site' which is a protein entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'GATA-1' which is a protein entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"4\": \"The sentence contains multiple protein entity types such as 'Protein kinase B', 'phosphatidylinositol 3-kinase', 'STAT5', 'erythropoietin', 'c-Akt', and 'EPO', as well as cell line entity types 'HCD57' and 'HCD57-SREI'. It also mentions 'apoptosis' which is not in the target sentence but is related to cell types.\"},\n    {\"4\": \"The sentence contains 'Ter 119' which is a cell line entity type, as well as protein entity types 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4'. It also mentions 'megakaryocytic transcripts' which are related to cell types.\"},\n    {\"4\": \"The sentence contains protein entity types 'ZEB', 'c-Myb', and 'Ets', as well as the cell type 'hematopoietic cells' which are related to the target sentence.\"},\n    {\"4\": \"The sentence contains protein entity types 'tal-1' and 'GATA-binding proteins', as well as the cell type 'hematopoiesis' which are related to the target sentence.\"},\n    {\"3\": \"The sentence contains 'Erbstatin' and 'genistein' which are protein entity types, and 'Egr-1' which is an RNA entity type, but does not contain any other entity types present in the target sentence.\"},\n    {\"3\": \"The sentence contains 'ATF1', 'CREB', and 'H4' which are protein entity types, but does not contain any other entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[{'HU': 'protein'}, {'c-jun': 'protein'}]",
        "prediction": "{'HU': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"C/EBP\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}, {\"myelomonocytic cells\": \"cell_type\"}]",
        "prediction": "{'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n{\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 4},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n{\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n{\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n{\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n{\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"EBV type 2 EBNA-2\": \"protein\"}, {\"LMP1\": \"protein\"}, {\"EBV type 1 EBNA-2\": \"protein\"}]",
        "prediction": "{'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'cell_type', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"MNDA\": 5, \"monocytes\": 3, \"macrophages\": 3, \"leukemia/B lymphoma cell lines\": 4},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"B and T cell activation\": 4, \"Ramos\": 4, \"Jurkat\": 4, \"cDNA microarray technology\": 4},\n    {\"HIV-1\": 4, \"IFN\": 4, \"PKR\": 4, \"IkappaBalpha\": 4},\n    {\"interleukin-2\": 4, \"alpha chain\": 4, \"CD25\": 4, \"IL-2 receptor\": 4},\n    {\"TR55\": 4, \"TNF-alpha\": 4, \"HIV\": 4},\n    {\"Fibroblast growth factor-1\": 4, \"FGF-1\": 4, \"IL-2\": 4, \"NF-kappaB\": 4, \"FGF receptor\": 4, \"Jurkat T cells\": 4},\n    {\"MNDA\": 4, \"monocytes\": 4, \"macrophages\": 4, \"leukemia/B lymphoma cell lines\": 4},\n    {\"LITAF\": 4, \"TNF-alpha\": 4},\n    {\"nuclear factor-kappa B\": 4, \"NF-kappa B\": 4},\n    {\"NF-kappa B\": 4, \"fibrinogen\": 4},\n    {\"HIV\": 4, \"NF-kappa B\": 4, \"p105\": 4, \"p50\": 4, \"MAD3\": 4},\n    {\"alpha 4 beta 1\": 4, \"TCR/CD3\": 4, \"DNA\": 4},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"polymerase chain reaction\": \"DNA\"}, {\"monocytic U937 cells\": \"cell_type\"}, {\"HIV\": \"cell_type\"}, {\"U9-IIIB\": \"cell_line\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV': 'cell_type', 'U9-IIIB': 'cell_line'}"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}, {\"sea urchin\": \"cell_line\"}, {\"B cells\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"IL-2\": 4, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"NF-kappaB\": 4, \"Tax\": 3, \"ATL\": 3},\n    {\"IkappaBbeta\": 4, \"NF-kappaB\": 5},\n    {\"RelA\": 4, \"NF-kappa B\": 5},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"MTHC\": 5, \"TNF-alpha\": 4, \"IFN-gamma\": 4, \"DC\": 5},\n    {\"RelA\": 4, \"NF-kappaB1\": 4},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5},\n    {\"Bak\": 5, \"Bad\": 5, \"Bcl-2\": 5, \"PDBu\": 4, \"DMSO\": 4},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B beta\": 5},\n    {\"CD40\": 5, \"NF-kappa B\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"Cu2+\": \"cell_line\"}]",
        "prediction": "{'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 3},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example contains a specific cell type 'Th2-type lymphocytes' which matches the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains multiple entities that match the entity labels in the target sentence, such as 'NF-kappaB' (protein), 'Tax' (cell_type), and 'ATL' (cell_type).\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example contains multiple entities that match the entity labels in the target sentence, such as 'IL-13' (protein), 'IL-4R' (protein), 'JAK2' (protein), and 'IL-13R' (protein).\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains entities that match the entity labels in the target sentence, such as 'immunohistochemistry' (protein), 'gene' (DNA), and 'cell type' (cell_type).\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example contains an entity 'lymphoid neoplasms' that matches the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example contains entities that match the entity labels in the target sentence, such as 'IL-2 receptor alpha subunit' (protein), 'p21ras' (protein), and 'B cell' (cell_type).\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains entities that match the entity labels in the target sentence, such as 'TAL1' (protein) and 'T-ALL' (cell_type).\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example contains entities that match the entity labels in the target sentence, such as 'WT1' (protein) and 'myeloid cell lines' (cell_line).\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example contains entities that match the entity labels in the target sentence, such as 'IL4' (protein), 'IL13' (protein), 'STAT6' (protein), 'STAT3' (protein), 'STAT5' (protein), and 'B cells' (cell_type).\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains entities that match the entity labels in the target sentence, such as 'MNDA' (protein) and 'Philadelphia chromosome-positive chronic myeloid leukemia' (cell_line).\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains entities that match the entity labels in the target sentence, such as 'CD28' (protein), 'CD80' (protein), 'CD86' (protein), 'CBL' (protein), 'VAV' (protein), 'NFAT' (protein), 'interleukin-2' (protein), and 'granulocyte-macrophage colony-stimulating factor' (protein).\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains entities that match the entity labels in the target sentence, such as 'Oct-2A' (protein), 'HMG I/Y' (protein), 'HLA-DRA' (protein), and 'B cells' (cell_type).\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example contains entities that match the entity labels in the target sentence, such as 'IL-2' (protein), 'c-Jun' (protein), and 'c-Fos' (protein).\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example contains entities that match the entity labels in the target sentence, such as 'CD70' (protein), 'B cell' (cell_type), 'plasma cells' (cell_type), 'IL-4' (protein), and 'CD40' (protein).\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The example contains an entity 'AP-1' that matches the 'DNA' entity label in the target sentence, but the relevance to the overall sentence context is not as strong.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example contains entities that match the entity labels in the target sentence, such as 'B and T cell activation' (cell_type), 'Ramos' (cell_line), 'Jurkat' (cell_line), and 'cDNA microarray technology' (DNA).\"}\n]",
        "response3": "[{'lymphocyte': 'cell_type'}, {'breast cancers': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]",
        "prediction": "{'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'IgH' and the entity label 'DNA' in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example directly links the entity 'Eosinophils' to the entity label 'cell_type' in the target sentence, facilitating the identification of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example offers explicit connections between entities such as 'IL-13', 'IL-4', 'B cell', and 'monocyte' with their corresponding entity labels in the target sentence, enhancing the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example establishes relationships between entities like 'EBV' and 'CD2' with their respective entity labels in the target sentence, aiding in the identification of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides clear mappings between entities such as 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' with their corresponding entity labels in the target sentence, facilitating the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example directly connects entities 'Th1' and 'Th2' with the entity label 'cell_type' in the target sentence, assisting in the identification of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example explicitly links the entity 'Th2-type lymphocytes' to the entity label 'cell_type' in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example establishes relationships between entities like 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' with their respective entity labels in the target sentence, enhancing the identification of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides clear mappings between entities such as 'NF-ATc' and 'T lymphocytes' with their corresponding entity labels in the target sentence, facilitating the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example directly connects entities like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' with their respective entity labels in the target sentence, aiding in the identification of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example establishes relationships between entities such as 'T lymphocytes' and 'HLA-molecules' with their corresponding entity labels in the target sentence, enhancing the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear mapping between the entity 'E2A' and the entity label 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example directly links entities like 'lymphocytes', 'benzene', and 'benzoquinone' with their respective entity labels in the target sentence, facilitating the identification of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example establishes relationships between entities such as 'EBV' and 'B-cell' with their corresponding entity labels in the target sentence, enhancing the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear mappings between entities like 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' with their respective entity labels in the target sentence, aiding in the identification of named entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example directly connects entities such as 'ICAM-1', 'CD71', 'LMP1', and 'IkappaB' with their corresponding entity labels in the target sentence, facilitating the extraction of named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any entities that match the entity types present in the target sentence, hence providing no aid in extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not contain any entities that match the entity types present in the target sentence, hence providing no aid in extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The example does not contain any entities that match the entity types present in the target sentence, hence providing no aid in extracting named entities.\"}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 3},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 4},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 3},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n{\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n{\"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Bik\": \"protein\"}, {\"BH1\": \"protein\"}, {\"BH2\": \"protein\"}, {\"Bcl-2\": \"protein\"}, {\"BH3\": \"protein\"}, {\"Bax\": \"protein\"}, {\"Bak\": \"protein\"}]",
        "prediction": "{'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NK cell\": \"cell_type\"}, {\"NFAT\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"PML/RARalpha\": 5},\n    {\"IL-5 mRNA\": 4, \"TCR\": 4, \"IL-2R\": 4, \"dexamethasone\": 4},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"RelA\": 4, \"NF-kappaB1\": 4},\n    {\"FasL\": 4, \"IL-2\": 4, \"IFN-gamma\": 4},\n    {\"AP-1\": 5},\n    {\"P selectin\": 4},\n    {\"IL-2\": 4, \"IFN-gamma\": 4, \"jak kinases\": 4, \"STAT1(alpha)\": 4},\n    {\"RelA\": 4, \"NF-kappa B\": 4},\n    {\"MTHC\": 5, \"TNF-alpha\": 4, \"IFN-gamma\": 4, \"DC\": 5},\n    {\"CD40\": 4, \"IFN-gamma\": 4, \"tumor necrosis factor-alpha\": 4, \"interleukin (IL)-1beta\": 4},\n    {\"SP1\": 4, \"caspases\": 4, \"B-cell\": 4},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"IkappaBbeta\": 4, \"NF-kappaB\": 4},\n    {\"IL-2\": 4, \"NF-kappa B\": 4, \"AP-1\": 4},\n    {\"NF-kappaB\": 4, \"Tax\": 4, \"ATL\": 4},\n    {\"Common pathway\": 1},\n    {\"Tumors\": 1},\n    {\"Distinct genes\": 1}\n]",
        "response3": "[{\"CML\": \"cell_line\"}, {\"IFN-alpha\": \"protein\"}, {\"CML\": \"cell_line\"}, {\"cytoplasmic proteins\": \"protein\"}, {\"nuclear protein-DNA complexes\": \"DNA\"}]",
        "prediction": "{'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis\": 1},\n    {\"Our results\": 1},\n    {\"A conserved motif\": 1},\n    {\"Molecular cloning\": 4},\n    {\"Selected transfected clones\": 3},\n    {\"IL4 and IL13 receptors\": 5},\n    {\"TCRzeta and p56(lck)\": 4},\n    {\"To approach this\": 1},\n    {\"One cDNA clone\": 3},\n    {\"The cytoplasmic domain\": 5},\n    {\"To test this latter possibility\": 4},\n    {\"Flow cytometric and morphological analyses\": 5},\n    {\"This suggests that CHEMR1\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit\": 5},\n    {\"We find that TCL1\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation\": 4},\n    {\"We propose the common pathway\": 1},\n    {\"All of the tumors\": 1},\n    {\"At least four distinct genes\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'DNA' in the context of cloning and sequencing.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entities 'Tax' and 'TFIIA' in the context of interaction, providing clear and specific entity references.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' in the context of binding to nuclear factors, providing specific entity references.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions 'tyrosine' in the context of protein-protein interaction, providing a specific entity reference.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'A-myb' in the context of a transcription factor, providing a specific entity reference.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'IL-4' in the context of gene expression regulation, providing a specific entity reference.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'retinoic acid receptor alpha' in the context of binding assays, providing a specific entity reference.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' in the context of gene expression control, providing a specific entity reference.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'EKLF' in the context of recruitment to enhancer sites, providing a specific entity reference.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'IL-2', 'Aiolos', and 'Ras' in the context of cellular distribution and phosphorylation, providing specific entity references.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'IL-7R' and 'gamma(c)' in the context of receptor function, providing specific entity references.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'CCAAT box' and 'EKLF binding site' in the context of gene expression regulation, providing specific entity references.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'Th2-type lymphocytes' in the context of cytokine expression, providing a specific entity reference.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' in the context of molecular cloning and protein interactions, providing specific entity references.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'p50p50' in the context of binding efficiency, providing a specific entity reference.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'IL-2' in the context of promoter responsiveness, providing a specific entity reference.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entity references related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entity references related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entity references related to the given entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) and its corresponding entity label, which directly matches one of the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label, which directly matches one of the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly matches one of the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (EBNA2, TP1) and their corresponding entity labels, which directly match two of the entity types in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides examples of proteins (alpha-tocopherol, monocyte) and cell types (endothelial cells) which are relevant to the entity types in the target sentence, although not a direct match.\"},\n    {\"Example 6\": 1},\n    {\"Reason 6\": \"The sentence mentions a DNA binding activity but does not provide a clear example of a specific DNA entity, which is the entity type in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of cell lines (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (mRNA) which directly match the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) which directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of proteins (alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) which directly match the entity types in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence provides examples of DNA (DNA polymerase-associated processivity factor PCNA) and proteins (E2F1) which are relevant to the entity types in the target sentence, although not a direct match.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of proteins (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1, erythropoietin) which directly match the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of proteins (MR, aldosterone, progesterone) which directly match the entity types in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides examples of proteins (FEV1, FVC, PEF, prednisolone) which are relevant to the entity types in the target sentence, although not a direct match.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) which directly match the entity types in the target sentence.\"}\n]",
        "response3": "[{'estrogen': 'protein'}, {'tamoxifen': 'protein'}, {'type II EBS': 'protein'}]",
        "prediction": "{'estrogen': 'protein', 'tamoxifen': 'protein', 'type II EBS': 'protein'}"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'E2A' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides mappings for both 'MNDA' to 'protein' and 'Philadelphia chromosome-positive chronic myeloid leukemia' to 'cell_line', aiding in the extraction of named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example provides mappings for 'granulocytes' to 'cell_type' and 'T cells' to 'cell_type', aiding in the extraction of named entities. The context of methylation deviation also supports the identification of cell types.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear mapping between the entity 'IgH' and its corresponding label 'DNA', aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear mapping between the entity 'PML/RARalpha' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear mapping between the entity 'GM-CSF' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear mapping between the entity 'GATA-1' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear mapping between the entity 'SCM-1' and its corresponding label 'cell_line', aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides mappings for 'IFN A' and 'IFNA' to 'protein', 'interleukin-2' to 'protein', 'interleukin-2 receptor' to 'protein', 'phytohemagglutinin' to 'protein', and 'phorbol myristate acetate' to 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear mapping between the entity 'GATA-1' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides mappings for 'CCAAT box' to 'DNA' and 'EKLF binding site' to 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear mapping between the entity 'Egr-1' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear mapping between the entity 'RXR' and its corresponding label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides mappings for 'Sp1' to 'protein', 'Ets' to 'protein', and 'mouse perforin gene' to 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides mappings for 'c-kit' to 'protein' and 'IL-4R alpha chain' to 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides mappings for 'ZEB' to 'protein', 'c-Myb' to 'protein', 'Ets' to 'protein', and 'hematopoietic cells' to 'cell_type', aiding in the extraction of named entities. The context of gene expression in hematopoietic cells supports the identification of cell types.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any named entities relevant to the provided entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not contain any named entities relevant to the provided entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The example does not contain any named entities relevant to the provided entity labels.\"}\n]",
        "response3": "[{'mouse embryonic stem (ES) cells': 'cell_type'}, {'globin gene': 'DNA'}]",
        "prediction": "{'mouse embryonic stem (ES) cells': 'cell_type', 'globin gene': 'DNA'}"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"4\": \"The sentence contains 'IL-2' which is a protein entity.\"},\n    {\"4\": \"The sentence contains 'Jun' and 'ATF-2' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'Sp1' and 'CD14' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'GATA-1' which is a protein entity.\"},\n    {\"4\": \"The sentence contains 'T cell' and 'interleukin 2' which are cell_type and protein entities respectively.\"},\n    {\"4\": \"The sentence contains 'Sp1' and 'Ets' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'Tax' and 'TFIIA' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'EKLF', 'CBP', 'p300', and 'P/CAF' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'RelA' and 'NF-kappa B' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'Egr-1' which is a protein entity.\"},\n    {\"4\": \"The sentence contains 'TCF-1' which is a protein entity.\"},\n    {\"4\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are protein entities.\"},\n    {\"4\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are protein entities.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCR alpha\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}, {\"T-cell-specific\": \"cell_type\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"CaM kinase II\": \"protein\"}]",
        "prediction": "{'CaM kinase II': 'protein'}"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"Oct-2A\": 5},\n    {\"HMG I/Y\": 5},\n    {\"HLA-DRA\": 5},\n    {\"B cells\": 4},\n    {\"T cell\": 4},\n    {\"interleukin 2\": 5},\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5},\n    {\"Egr-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"NF-ATc\": 5},\n    {\"A-myb\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"Jun\": 5},\n    {\"ATF-2\": 5},\n    {\"NF-E2\": 5},\n    {\"GATA-1\": 5}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ubiquitin -proteasome system\": \"protein\"}, {\"ubiquitin\": \"protein\"}, {\"E2-F1\": \"protein\"}, {\"p53\": \"protein\"}, {\"ubiquitin -carrier protein\": \"protein\"}, {\"ubiquitin -protein ligase\": \"protein\"}, {\"p105 precursor\": \"protein\"}]",
        "prediction": "{'ubiquitin -proteasome system': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein', 'p105 precursor': 'protein'}"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 1},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}, {\"thymic epithelial cells\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "response1": "['protein', 'cell_line', 'cell_type']",
        "response2": "[\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n{\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n{\"Sp1\": 5, \"CD14\": 5},\n{\"SIVsmmPBj14\": 5},\n{\"T cell\": 5, \"interleukin 2\": 5},\n{\"p50p50\": 5},\n{\"IkappaBbeta\": 5, \"NF-kappaB\": 5},\n{\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5},\n{\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5},\n{\"cDNA\": 5, \"Jurkat\": 5, \"DRE 1\": 5},\n{\"HIV-1 LTR\": 5, \"NFAT-1\": 5, \"NF kappa B\": 5},\n{\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 5},\n{\"ATF1\": 5, \"CREB\": 5, \"H4\": 5},\n{\"None\": 1},\n{\"None\": 1},\n{\"None\": 1}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}, {\"Jurkat T cells\": \"cell_type\"}, {\"GAL4\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}]",
        "prediction": "{'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein'}"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 3},\n    {\"Reason 1\": \"The sentence contains multiple protein names and their corresponding entities, which can aid in identifying protein entities.\"},\n    {\"Example 2\": 2},\n    {\"Reason 2\": \"The sentence mentions a protein name, but the context is not as clear or specific as other examples.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides a clear list of protein names and their corresponding entities, aiding in the identification of protein entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains protein names and their corresponding entities, providing clear context for entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence includes protein names and their corresponding entities, aiding in the identification of protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides protein names and their corresponding entities, aiding in the identification of protein entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a protein name and DNA, which can aid in identifying protein and DNA entities.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence mentions protein names, aiding in the identification of protein entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides protein names and their corresponding entities, aiding in the identification of protein entities.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions protein names and a cell type, aiding in the identification of protein and cell type entities.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions a protein name, aiding in the identification of protein entities.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions protein and cell line names, aiding in the identification of protein and cell line entities.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The sentence mentions protein names, aiding in the identification of protein entities.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The sentence mentions protein names, aiding in the identification of protein entities.\"},\n    {\"Example 15\": 2},\n    {\"Reason 15\": \"The sentence does not contain specific entities related to the given label set.\"},\n    {\"Example 16\": 2},\n    {\"Reason 16\": \"The sentence does not contain specific entities related to the given label set.\"},\n    {\"Example 17\": 2},\n    {\"Reason 17\": \"The sentence does not contain specific entities related to the given label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein entity (erythropoietin) and its corresponding label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein entity (E2A) and its corresponding label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of protein entities (MNDA, Philadelphia chromosome-positive chronic myeloid leukemia) and their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein entity (phosphocreatine) and its corresponding label.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of protein entities (TCRzeta, p56(lck)) and their corresponding labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of protein entities (alpha-tocopherol, phosphocreatine) and cell type entities (monocyte, endothelial cells) with their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of protein entities (CD70, IL-4, CD40) and cell type entities (B cell, plasma cells) with their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes) with their corresponding labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of protein entities (beta-globin, glycoprotein IIb, platelet factor 4) and a cell line entity (Ter 119) with their corresponding labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of cell type entities (B and T cell activation) and cell line entities (Ramos, Jurkat) with their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of DNA entity (EBV) and protein entities (EBNA2, estrogen receptor) with their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of protein entities (Erbstatin, genistein, Egr-1) and an RNA entity (mRNA) with their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of cell line entities (PMA-stimulated U1 cells) with their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of protein entities (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1, erythropoietin) with their corresponding labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of cell type entities (HPCs) and protein entities (PML, Rb) with their corresponding labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the given entity labels.\"}\n]",
        "response3": "[{\"peripheral blood samples\": \"cell_type\"}, {\"young\": \"cell_type\"}, {\"postmenopausal females\": \"cell_type\"}, {\"estrogen replacement therapy\": \"protein\"}]",
        "prediction": "{'peripheral blood samples': 'cell_type', 'young': 'cell_type', 'postmenopausal females': 'cell_type', 'estrogen replacement therapy': 'protein'}"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NFATp\": \"protein\"}, {\"NFATp\": \"protein\"}, {\"thymus\": \"cell_type\"}, {\"spleen\": \"cell_type\"}]",
        "prediction": "{'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"RXR\": 5},\n    {\"SCL\": 5},\n    {\"GATA-1\": 5},\n    {\"Stat3\": 5},\n    {\"Stat5\": 5},\n    {\"c-Mpl\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"EKLF\": 5},\n    {\"CBP\": 5},\n    {\"p300\": 5},\n    {\"P/CAF\": 5},\n    {\"Egr-1\": 5},\n    {\"erythropoietin\": 5},\n    {\"NF-E2\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 5},\n    {\"ATL\": 5},\n    {\"E2A\": 5},\n    {\"ZEB\": 5},\n    {\"c-Myb\": 5},\n    {\"Ets\": 5},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"B lymphocytes\": 5}\n]",
        "response3": "[{\"NF-E2\": \"protein\"}]",
        "prediction": "{'NF-E2': 'protein'}"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kappa B\": 5},\n    {\"CD28\": 4, \"CD80\": 4, \"CD86\": 4, \"CBL\": 4, \"VAV\": 4, \"NFAT\": 4, \"interleukin-2\": 4, \"granulocyte-macrophage colony-stimulating factor\": 4},\n    {\"cell adhesion molecules\": 4},\n    {\"P selectin\": 4},\n    {\"G-CSF\": 4},\n    {\"Stat3\": 4, \"Stat5\": 4, \"c-Mpl\": 4},\n    {\"cAMP-dependent protein kinase\": 4, \"Rap1\": 4},\n    {\"myeloperoxidase\": 4, \"lysozyme\": 4, \"PU.1\": 4},\n    {\"Tat-binding protein 7\": 4},\n    {\"IL4\": 4, \"IL13\": 4, \"gamma c chain\": 4, \"STAT6\": 4, \"STAT3\": 4, \"STAT5\": 4, \"B cells\": 4},\n    {\"NF-kappa B\": 4},\n    {\"p21ras\": 4},\n    {\"SLAP-130\": 4, \"SLP-76\": 4, \"T cell\": 4},\n    {\"Syk\": 4, \"Zap\": 4, \"T cell\": 4},\n    {\"GM-CSF\": 4},\n    {\"alpha-tocopherol\": 4, \"monocyte\": 4, \"endothelial cells\": 4},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"Platelet glycoprotein (GP) Ib-IX-V\": \"protein\"}]",
        "prediction": "{'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"IL-2 mRNA\": \"RNA\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n{\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 5},\n{\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 4},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n{\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n{\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).\": 5},\n{\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Cortivazol\": \"protein\"}, {\"CVZ\": \"protein\"}, {\"CEM C7 cells\": \"cell_line\"}]",
        "prediction": "{'Cortivazol': 'protein', 'CVZ': 'protein', 'CEM C7 cells': 'cell_line'}"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'E2A' and the entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear mapping between the entity 'GATA-1' and the entity type 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear mapping between the entity 'lymphoid neoplasms' and the entity type 'cell_type' in the sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a clear mapping between the entity 'phosphocreatine' and the entity type 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The examples provide clear mappings between the entities 'SLAP-130', 'SLP-76', 'T cell' and the entity types 'protein', 'protein', 'cell_type' respectively in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear mapping between the entity 'NF-E2' and the entity type 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The examples provide clear mappings between the entities 'immunohistochemistry', 'gene', 'cell type' and the entity types 'protein', 'DNA', 'cell_type' respectively in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear mapping between the entity 'retinoic acid receptor alpha' and the entity type 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear mapping between the entity 'CD14' and the entity type 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The examples provide clear mappings between the entities 'HML', 'dexamethasone', 'cortisol', 'lysozyme' and the entity types 'cell_line', 'protein', 'protein', 'protein' respectively in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide clear mappings between the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', 'B lymphocytes' and the entity types 'protein', 'protein', 'protein', 'cell_type' respectively in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide clear mappings between the entities 'B and T cell activation', 'Ramos', 'Jurkat', 'cDNA microarray technology' and the entity types 'cell_type', 'cell_line', 'cell_line', 'DNA' respectively in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The examples provide clear mappings between the entities 'tal-1', 'GATA-binding proteins', 'hematopoiesis' and the entity types 'protein', 'protein', 'cell_type' respectively in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The examples provide clear mappings between the entities 'Erbstatin', 'genistein', 'Egr-1' and the entity types 'protein', 'protein', 'RNA' respectively in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The examples provide clear mappings between the entities 'EBV', 'EBNA2', 'estrogen receptor' and the entity types 'DNA', 'protein', 'protein' respectively in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear mappings between the entities 'MR', 'aldosterone', 'progesterone' and the entity types 'protein', 'protein', 'protein' respectively in the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the protein 'p50p50' and its binding activity, making it highly relevant for entity extraction.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the protein 'GATA-1' and its role in gene expression, providing valuable information for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly refers to 'Th2-type lymphocytes' as a cell type, aiding in the identification of cell type entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'SCM-1' genes, indicating a specific cell line entity, which is crucial for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein entities such as 'Stat3', 'Stat5', and 'c-Mpl' along with their roles in signal transduction, making it highly informative for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the protein 'E2A' and its expression level, providing valuable information for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'T cell' as a cell type and 'interleukin 2' as a protein, aiding in the identification of relevant entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides information about the protein 'retinoic acid receptor alpha' and its characterization, making it highly relevant for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'GM-CSF' as a protein, aiding in the identification of protein entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence explicitly refers to 'SIVsmmPBj14' as a cell line, providing crucial information for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein entities such as 'SLAP-130', 'SLP-76', and mentions 'T cell' as a cell type, aiding in the identification of relevant entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the protein 'GATA-1' and its role in erythroid cells, providing valuable information for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides information about the protein 'RXR' and its expression level, making it highly relevant for entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'cDNAs' as DNA entities, aiding in the identification of DNA entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Ter 119' as a cell line, 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4' as proteins, providing valuable information for entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'B and T cell activation' as a cell type, 'Ramos' and 'Jurkat' as cell lines, and 'cDNA microarray technology' as DNA, aiding in the identification of relevant entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the provided entity labels, hence not helpful for entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the provided entity labels, hence not helpful for entity extraction.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the provided entity labels, hence not helpful for entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"EB1\": \"protein\"}]",
        "prediction": "{'EB1': 'protein'}"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"gamma interferon\": \"protein\"}, {\"phosphotyrosine\": \"protein\"}]",
        "prediction": "{'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.\": 5},\n{\"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.\": 5},\n{\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Sp1\": 5, \"CD14\": 4},\n{\"IL-4\": 4},\n{\"Egr-1\": 5},\n{\"SCM-1\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"CD95 ligand\": 4},\n{\"UAS1\": 4, \"B cell\": 4},\n{\"Sp1\": 5, \"Ets\": 5},\n{\"GATA-1\": 5},\n{\"PML/RARalpha\": 5},\n{\"GATA-1\": 5},\n{\"NF-E2\": 5},\n{\"E2A\": 5},\n{\"IL-2\": 5},\n{\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"Protein\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Genes\": 1}\n]",
        "response3": "[{\"Sp1\": \"protein\"}, {\"CD14\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"SCM-1\": \"cell_line\"}, {\"IL-2\": \"protein\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}, {\"CD95 ligand\": \"protein\"}, {\"UAS1\": \"cell_line\"}, {\"B cell\": \"cell_type\"}, {\"Sp1\": \"protein\"}, {\"Ets\": \"protein\"}, {\"GATA-1\": \"protein\"}, {\"PML/RARalpha\": \"protein\"}, {\"GATA-1\": \"protein\"}, {\"NF-E2\": \"protein\"}, {\"E2A\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"EKLF\": \"protein\"}, {\"CBP\": \"protein\"}, {\"p300\": \"protein\"}, {\"P/CAF\": \"protein\"}, {\"Protein\": \"protein\"}]",
        "prediction": "{'Sp1': 'protein', 'CD14': 'protein', 'IL-4': 'protein', 'Egr-1': 'protein', 'SCM-1': 'cell_line', 'IL-2': 'protein', 'c-Jun': 'protein', 'c-Fos': 'protein', 'CD95 ligand': 'protein', 'UAS1': 'cell_line', 'B cell': 'cell_type', 'Ets': 'protein', 'GATA-1': 'protein', 'PML/RARalpha': 'protein', 'NF-E2': 'protein', 'E2A': 'protein', 'EKLF': 'protein', 'CBP': 'protein', 'p300': 'protein', 'P/CAF': 'protein', 'Protein': 'protein'}"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 1},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 5},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 5},\n    {\"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.\": 5},\n    {\"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PEBP2 alpha/AML-1-related factor\": \"protein\"}, {\"osteocalcin\": \"protein\"}, {\"osteoblast-specific\": \"cell_type\"}]",
        "prediction": "{'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Markus Neurath\": \"protein\"}, {\"Eckhard Stuber\": \"protein\"}, {\"Warren Strober\": \"protein\"}, {\"BSAP\": \"protein\"}, {\"B-cell-specific genes\": \"protein\"}]",
        "prediction": "{'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains 'NF-kappaB' (protein), 'Tax' (cell_type), and 'ATL' (cell_type), which are relevant entities for extraction.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains 'IL-4' (protein), 'LPS' (protein), and 'AP-1' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' (protein), which is a relevant entity for extraction.\"},\n    {\"5\": \"The sentence contains 'IL-2' (protein), 'IFN-gamma' (protein), 'jak kinases' (protein), and 'STAT1(alpha)' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' (protein), which is a relevant entity for extraction.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' (protein) and 'I kappa B beta' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'IL-2' (protein), 'NF-kappa B' (protein), and 'AP-1' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'IFN A' (protein), 'IFNA' (protein), 'interleukin-2' (protein), 'interleukin-2 receptor' (protein), 'phytohemagglutinin' (protein), and 'phorbol myristate acetate' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'HIV-1' (cell_type), 'IFN' (protein), 'PKR' (protein), and 'IkappaBalpha' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'interleukin-2' (protein), 'alpha chain' (protein), 'CD25' (protein), and 'IL-2 receptor' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'B cell' (cell_type), 'Ig' (protein), and 'Transforming growth factor-beta' (protein), which are relevant entities for extraction.\"},\n    {\"5\": \"The sentence contains 'CTLA4Ig' (protein), 'NFAT' (cell_type), and 'AP-1' (cell_type), which are relevant entities for extraction.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{'NF kappa B': 'protein'}]",
        "prediction": "{'NF kappa B': 'protein'}"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"GATA-1\": 5, \"protein\": \"The sentence explicitly mentions the mRNA expression of GATA-1 binding transcription factor, making it highly relevant for named entity extraction.\"},\n{\"NF-E2\": 5, \"protein\": \"The sentence explicitly mentions the inhibition of binding of NF-E2, a cell-specific transcription factor, making it highly relevant for named entity extraction.\"},\n{\"Th2-type lymphocytes\": 5, \"cell_type\": \"The sentence explicitly mentions human Th2-type lymphocytes, indicating a specific cell type, making it highly relevant for named entity extraction.\"},\n{\"Egr-1\": 5, \"protein\": \"The sentence explicitly mentions Egr-1, a zinc finger transcription factor, making it highly relevant for named entity extraction.\"},\n{\"erythropoietin\": 5, \"protein\": \"The sentence explicitly mentions erythropoietin, indicating a protein involved in red blood cell production, making it highly relevant for named entity extraction.\"},\n{\"CCAAT box\": 5, \"DNA\": \"The sentence explicitly mentions the altered CCAAT box, indicating a DNA element, making it highly relevant for named entity extraction.\"},\n{\"EKLF binding site\": 5, \"protein\": \"The sentence explicitly mentions the lack of an EKLF binding site, indicating a protein involved in gene expression, making it highly relevant for named entity extraction.\"},\n{\"AP-1\": 5, \"DNA\": \"The sentence explicitly mentions the impaired transcription factor AP-1 DNA binding activity, making it highly relevant for named entity extraction.\"},\n{\"IL-4\": 5, \"protein\": \"The sentence explicitly mentions IL-4 gene expression, indicating a protein involved in gene regulation, making it highly relevant for named entity extraction.\"},\n{\"retinoic acid receptor alpha\": 5, \"protein\": \"The sentence explicitly mentions retinoic acid receptor alpha, indicating a protein involved in cell differentiation, making it highly relevant for named entity extraction.\"},\n{\"RXR\": 5, \"protein\": \"The sentence explicitly mentions RXR, indicating a protein involved in erythroid cell outgrowth, making it highly relevant for named entity extraction.\"},\n{\"WT1\": 5, \"protein\": \"The sentence explicitly mentions WT1, indicating a protein involved in myeloid cell differentiation, making it highly relevant for named entity extraction.\"},\n{\"myeloid cell lines\": 5, \"cell_line\": \"The sentence explicitly mentions myeloid cell lines, indicating a specific cell line, making it highly relevant for named entity extraction.\"},\n{\"IL-2 receptor alpha subunit\": 5, \"protein\": \"The sentence explicitly mentions the IL-2 receptor alpha subunit, indicating a protein involved in lymphocyte activation, making it highly relevant for named entity extraction.\"},\n{\"p21ras\": 5, \"protein\": \"The sentence explicitly mentions p21ras, indicating a protein involved in B cell activation, making it highly relevant for named entity extraction.\"},\n{\"IgH\": 5, \"DNA\": \"The sentence explicitly mentions the germ-line IgH genes, indicating a DNA element, making it highly relevant for named entity extraction.\"},\n{\"GATA-1\": 5, \"protein\": \"The sentence explicitly mentions positive regulators of the lineage-specific transcription factor GATA-1, making it highly relevant for named entity extraction.\"},\n{\"immunoglobulin kappa 3' enhancer\": 5, \"DNA\": \"The sentence explicitly mentions the developmental control of immunoglobulin kappa 3' enhancer activity, indicating a DNA element, making it highly relevant for named entity extraction.\"},\n{\"SCL\": 5, \"protein\": \"The sentence explicitly mentions SCL, a protein expressed in specific cell populations, making it highly relevant for named entity extraction.\"},\n{\"GATA-1\": 1, \"protein\": \"The sentence does not provide specific information about GATA-1, making it less helpful for named entity extraction.\"},\n{\"common pathway\": 1, \"reason\": \"The sentence does not contain any specific entities related to the given entity labels, making it not helpful for named entity extraction.\"},\n{\"tumors\": 1, \"reason\": \"The sentence does not contain any specific entities related to the given entity labels, making it not helpful for named entity extraction.\"},\n{\"genes\": 1, \"reason\": \"The sentence does not contain any specific entities related to the given entity labels, making it not helpful for named entity extraction.\"}\n]",
        "response3": "[{\"globin gene\": \"DNA\"}]",
        "prediction": "{'globin gene': 'DNA'}"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"LCLs\": \"cell_line\"}, {\"RVLP\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.\": 5},\n    {\"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"cysteamine\": \"protein\"}, {\"lymphocyte\": \"cell_type\"}, {\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"NF-AT\": \"protein\"}, {\"Oct1\": \"protein\"}]",
        "prediction": "{'IL-2': 'protein', 'cysteamine': 'protein', 'lymphocyte': 'cell_type', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of activation-induced transcription.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of NF-kappa B activation.\"},\n    {\"5\": \"The sentence contains multiple 'protein' entities that are directly mentioned and play a significant role in the context of signal transduction events and transcriptional activation.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of cellular distribution and tyrosine phosphorylation.\"},\n    {\"5\": \"The sentence contains multiple 'protein' entities that are directly mentioned and play a significant role in the context of binding activity.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of inactivation and induction of NF-kappaB.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of protein-protein interaction.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of transcriptional activation.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of inhibition of transcription factors.\"},\n    {\"5\": \"The sentence contains multiple 'protein' entities that are directly mentioned and play a significant role in the context of gene expression regulation.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of T-cell activation and NF-kappaB release.\"},\n    {\"5\": \"The sentence contains multiple 'protein' entities that are directly mentioned and play a significant role in the context of protein kinase and substrate identification.\"},\n    {\"5\": \"The sentence contains multiple 'protein' entities that are directly mentioned and play a significant role in the context of gel-shift analysis and nuclear factors.\"},\n    {\"5\": \"The sentence contains 'protein' entities that are directly mentioned and play a significant role in the context of NF-kappaB activation.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"beta-galactosidase gene\": \"protein\"}, {\"adenovirus E2 promoter\": \"DNA\"}]",
        "prediction": "{'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"C/EBP beta\": \"protein\"}, {\"eosinophilic\": \"cell_type\"}, {\"hematopoietic progenitor cell line\": \"cell_line\"}]",
        "prediction": "{'NF-M': 'protein', 'C/EBP beta': 'protein', 'eosinophilic': 'cell_type', 'hematopoietic progenitor cell line': 'cell_line'}"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"EBV\": 5, \"B-cell\": 5},\n{\"retinoic acid receptor alpha\": 5},\n{\"Protein\": 5},\n{\"MIP-1 alpha\": 5, \"GOS19\": 5, \"LD78\": 5, \"AT464\": 5},\n{\"EBNA-2\": 5, \"PU.1\": 5},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"Egr-1\": 5},\n{\"E2A\": 5},\n{\"GM-CSF\": 5},\n{\"protein\": 5},\n{\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"EBNA2\": 5, \"TP1\": 4},\n{\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n{\"interleukin 10\": 5, \"IL-10R\": 5, \"STAT3\": 5, \"IL-6\": 5},\n{\"GATA-1\": 5},\n{\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n{\"common pathway\": 1},\n{\"tumors\": 1},\n{\"genes\": 1}\n]",
        "response3": "[{\"G-protein coupled chemokine receptors\": \"protein\"}, {\"EBI1\": \"protein\"}]",
        "prediction": "{'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 1},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 5},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.\": 5},\n    {\"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Sexual hormones\": \"protein\"}, {\"receptors\": \"protein\"}, {\"eosinophils\": \"cell_type\"}]",
        "prediction": "{'Sexual hormones': 'protein', 'receptors': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a cell line (SCM-1) being mentioned in relation to regulatory mechanisms of genes, making it highly relevant for extracting named entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence contains specific DNA-related terms (CCAAT box) and protein-related terms (EKLF binding site) that are helpful for identifying named entities, although the context is slightly complex.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions a specific protein (GM-CSF) in relation to gene sequences, aiding in the extraction of named entities.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence provides multiple examples of protein-related terms (IL-2, c-Jun, c-Fos) in the context of gel-shift analysis, making it highly relevant for named entity extraction.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence clearly mentions a cell type (Th2-type lymphocytes) in relation to cytokine promoters, which is crucial for identifying named entities.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions proteins and genomic sequences, providing relevant information for extracting named entities, although the context is slightly general.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains specific protein terms (IL-7R, gamma(c)) in the context of structure/function analyses, making it highly relevant for named entity extraction.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides clear examples of protein terms (c-kit, IL-4R alpha chain) in the context of a chimeric receptor system, aiding in named entity extraction.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions multiple protein terms (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) in relation to gene expression, making it highly relevant for named entity extraction.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions a specific protein (retinoic acid receptor alpha) in the context of binding assays, which is crucial for identifying named entities.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides examples of protein terms (CHEMR1, C-C chemokine, MIP-1alpha) in relation to receptor functions, making it highly relevant for named entity extraction.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions a specific protein (TCF-1) in the context of transactivation, which is crucial for identifying named entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence clearly mentions DNA binding activity, providing relevant information for extracting named entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides examples of protein terms (SLAP-130, SLP-76, T cell) in relation to molecular cloning, making it highly relevant for named entity extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions a specific protein (ZAP-70) in relation to cellular responses, aiding in named entity extraction.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any specific named entities related to the provided entity labels, making it not helpful for named entity extraction.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific named entities related to the provided entity labels, making it not helpful for named entity extraction.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific named entities related to the provided entity labels, making it not helpful for named entity extraction.\"}\n]",
        "response3": "[{\"HMG-1\": \"protein\"}]",
        "prediction": "{'HMG-1': 'protein'}"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"NF-E2\": 5},\n{\"Oct-2A\": 5},\n{\"HMG I/Y\": 5},\n{\"HLA-DRA\": 5},\n{\"B cells\": 4},\n{\"IL-2\": 5},\n{\"NF-ATc\": 5},\n{\"T lymphocytes\": 5},\n{\"embryonic cardiac cells\": 5},\n{\"Egr-1\": 5},\n{\"IL-4\": 5},\n{\"T cell\": 5},\n{\"interleukin 2\": 5},\n{\"IL-2\": 5},\n{\"c-Jun\": 5},\n{\"c-Fos\": 5},\n{\"Th2-type lymphocytes\": 5},\n{\"IgH\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"c-kit\": 5},\n{\"IL-4R alpha chain\": 5},\n{\"NF-kappa B\": 5},\n{\"IFN A\": 5},\n{\"IFNA\": 5},\n{\"interleukin-2\": 5},\n{\"interleukin-2 receptor\": 5},\n{\"phytohemagglutinin\": 5},\n{\"phorbol myristate acetate\": 5},\n{\"CD40\": 5},\n{\"Rel/nuclear factor kappaB\": 5},\n{\"NF-kappaB\": 5},\n{\"B lymphocytes\": 5},\n{\"p50\": 5},\n{\"p65\": 5},\n{\"DNA\": 1},\n{\"protein\": 1}\n]",
        "response3": "[{\"NF-microB\": \"protein\"}, {\"IgH\": \"DNA\"}]",
        "prediction": "{'NF-microB': 'protein', 'IgH': 'DNA'}"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 3},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 2},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 3},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 2},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 3},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 4},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 4},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 4},\n    {\"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"4\": \"The example mentions the protein RXR, which is relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple relevant entities such as IL-2, IFN-gamma, jak kinases, and STAT1(alpha).\"},\n    {\"5\": \"The example contains relevant entities NF-kappaB, Sp1, and p50.\"},\n    {\"5\": \"The example contains relevant entities EBNA2 and TP1.\"},\n    {\"3\": \"The example contains relevant entity interleukin 2.\"},\n    {\"4\": \"The example mentions the impaired transcription factor AP-1, which is relevant to the target sentence.\"},\n    {\"5\": \"The example contains relevant entities NF-kB, AP-1, OCT-1, and NF-IL-2B.\"},\n    {\"4\": \"The example mentions EBV and CD2, which are relevant to the target sentence.\"},\n    {\"4\": \"The example mentions CD4+ and EBV, which are relevant to the target sentence.\"},\n    {\"5\": \"The example contains relevant entities EBNA-2 and PU.1.\"},\n    {\"5\": \"The example contains relevant entities UAS1 and B cell.\"},\n    {\"5\": \"The example contains relevant entities EBV and B-cell.\"},\n    {\"5\": \"The example contains relevant entity GATA-1.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"}\n]",
        "response3": "[{'Epstein-Barr virus': 'cell_line'}, {'EBV': 'protein'}, {'R': 'protein'}, {'Z': 'protein'}]",
        "prediction": "{'Epstein-Barr virus': 'cell_line', 'EBV': 'protein', 'R': 'protein', 'Z': 'protein'}"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n{\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"ets-1\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'ets-1': 'protein'}"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 3},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 1},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"Platelet-activating factor\": \"protein\"}, {\"phospholipid\": \"protein\"}, {\"calcium\": \"protein\"}, {\"arachidonic acid\": \"protein\"}, {\"eicosanoid\": \"protein\"}, {\"oncogene\": \"protein\"}, {\"B cell line\": \"cell_line\"}]",
        "prediction": "{'Platelet-activating factor': 'protein', 'phospholipid': 'protein', 'calcium': 'protein', 'arachidonic acid': 'protein', 'eicosanoid': 'protein', 'oncogene': 'protein', 'B cell line': 'cell_line'}"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras\": 5}\n]",
        "response3": "[{\"T cells\": \"cell_type\"}]",
        "prediction": "{'T cells': 'cell_type'}"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear examples of proteins and cell types mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides a clear example of a protein mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides a clear example of a protein mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of proteins and cell types mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of proteins and cell types mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins and cell types mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of proteins and cell types mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides a clear example of DNA mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of proteins mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of proteins mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of proteins mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of DNA mentioned in the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"salicylates\": \"protein\"}, {\"atherosclerosis\": \"cell_type\"}, {\"rheumatoid arthritis\": \"cell_type\"}, {\"monocyte\": \"cell_type\"}]",
        "prediction": "{'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (NF-kappa B, AP-1) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a specific protein name (NF-E2) that is directly related to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name (MNDA) and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains a specific protein name (NF-kappa B) that is directly related to the entity labels in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains a specific protein name (P selectin) that is directly related to the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a specific protein name (NDP kinase) and specific cell types (KA, SCC, BCC) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names (CD14, CD23) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (IL-4, LPS, AP-1) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (PMA, IFN-gamma) and a specific cell type (T cell blasts) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entity names or types that are related to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entity names or types that are related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entity names or types that are related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"PMA\": \"protein\"}, {\"PHA\": \"protein\"}]",
        "prediction": "{'PMA': 'protein', 'PHA': 'protein'}"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "response1": "['RNA', 'cell_type', 'protein']",
        "response2": "[\n{\"NF-kappa B activation\": \"protein\", \"kappa B-responsive genes\": \"protein\"}: 5,\n{\"NF-ATc\": \"protein\", \"T lymphocytes\": \"cell_type\", \"embryonic cardiac cells\": \"cell_type\"}: 5,\n{\"IFN A\": \"protein\", \"IFNA\": \"protein\", \"interleukin-2\": \"protein\", \"interleukin-2 receptor\": \"protein\", \"phytohemagglutinin\": \"protein\", \"phorbol myristate acetate\": \"protein\"}: 5,\n{\"CD40 expression\": \"protein\", \"CD40\": \"protein\", \"IFN-gamma\": \"protein\", \"tumor necrosis factor-alpha\": \"protein\", \"interleukin (IL)-1beta\": \"protein\"}: 5,\n{\"NF-kappa B\": \"DNA\"}: 3,\n{\"NF-kappa B\": \"protein\", \"I kappa B alpha\": \"protein\"}: 5,\n{\"IL-2\": \"protein\", \"IFN-gamma\": \"protein\", \"jak kinases\": \"protein\", \"STAT1(alpha)\": \"protein\"}: 5,\n{\"RelA\": \"protein\", \"NF-kappa B\": \"protein\"}: 5,\n{\"FasL\": \"protein\", \"TCR\": \"protein\", \"IL-2\": \"protein\", \"IFN-gamma\": \"protein\"}: 5,\n{\"NF-ATc\": \"protein\", \"T lymphocytes\": \"cell_type\"}: 5,\n{\"NF-kappa B\": \"protein\", \"I kappa B alpha\": \"protein\"}: 5,\n{\"CD40\": \"protein\", \"NF-kappa B\": \"protein\"}: 5,\n{\"NF-kappaB\": \"protein\", \"Tax\": \"cell_type\", \"ATL\": \"cell_type\"}: 5,\n{\"STAT\": \"protein\", \"STAT3\": \"protein\", \"T cells\": \"cell_type\"}: 5,\n{\"IkappaBbeta\": \"protein\", \"NF-kappaB\": \"protein\"}: 5,\n{\"CD28\": \"protein\", \"CD80\": \"protein\", \"CD86\": \"protein\", \"CBL\": \"protein\", \"VAV\": \"protein\", \"NFAT\": \"protein\", \"interleukin-2\": \"protein\", \"granulocyte-macrophage colony-stimulating factor\": \"protein\"}: 5\n]",
        "response3": "[{\"NFATc\": \"protein\"}, {\"NFATc mRNA\": \"RNA\"}, {\"NK cells\": \"cell_type\"}, {\"CD16 ligands\": \"protein\"}]",
        "prediction": "{'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Th\": \"cell_type\"}, {\"CD30\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 1},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-jun\": \"protein\"}, {\"HL-60 cells\": \"cell_line\"}, {\"TPA\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein', 'HL-60 cells': 'cell_line', 'TPA': 'protein'}"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4},\n    {\"MNDA\": 4},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 4},\n    {\"PMA\": 3},\n    {\"CD14\": 4},\n    {\"CD23\": 4},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 4},\n    {\"c-Fos\": 4},\n    {\"PML/RARalpha\": 5},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"NF-kappaB\": 4},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"TCRzeta\": 4},\n    {\"p56(lck)\": 4},\n    {\"p21(WAF1/CIP1)\": 4},\n    {\"p27(KIP1)\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"Ter 119\": 4},\n    {\"beta-globin\": 4},\n    {\"glycoprotein IIb\": 4},\n    {\"platelet factor 4\": 4},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"NF-kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"B and T cell activation\": 4},\n    {\"Ramos\": 4},\n    {\"Jurkat\": 4},\n    {\"cDNA microarray technology\": 4},\n    {\"HeLa cells\": 4},\n    {\"Daudi\": 4},\n    {\"PU.1\": 4},\n    {\"CSF-1 receptor\": 4},\n    {\"Mono A\": 4},\n    {\"Mono B\": 4}\n]",
        "response3": "[{\"pbmc\": \"cell_type\"}, {\"bone marrow cells\": \"cell_type\"}, {\"c-fos\": \"protein\"}, {\"c-myc\": \"protein\"}, {\"p53\": \"protein\"}, {\"bcr/abl mRNA\": \"RNA\"}]",
        "prediction": "{'pbmc': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"GCR\": \"protein\"}, {\"GCS\": \"protein\"}, {\"BA\": \"cell_type\"}]",
        "prediction": "{'GCR': 'protein', 'GCS': 'protein', 'BA': 'cell_type'}"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Id2 mRNA\": \"RNA\"}, {\"Id3 mRNA\": \"RNA\"}]",
        "prediction": "{'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif\": 4},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well\": 1}\n]",
        "response3": "[{\"CD69 gene\": \"protein\"}, {\"TATA element\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"DNA viruses\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['cell_line', 'protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"RNA\": \"RNA\"}, {\"cell_line\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'RNA': 'RNA', 'cell_line': 'cell_line'}"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell type (nonhuman primates) being mentioned in relation to signal transduction events.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions cell adhesion molecules, indicating a clear example of a cell type.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions G-CSF as a protein, providing a clear example of a protein entity.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple examples of entities including proteins (CD70, IL-4, CD40), cell types (B cell, plasma cells), and RNA (IL-5 mRNA), making it highly helpful for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions E2A as a protein, providing a clear example for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions NF-E2 as a protein, aiding in the extraction of protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of RNA (IL-5 mRNA), cell types (TCR), and proteins (IL-2R, dexamethasone) which are crucial for entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions granulocytes and T cells as cell types, aiding in the extraction of these entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions IL-4 as a protein, providing a clear example for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains examples of proteins (IL-2, c-Jun, c-Fos) which are important for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions phosphocreatine as a protein, aiding in the extraction of protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of a cell line (HML) and proteins (dexamethasone, cortisol, lysozyme) which are crucial for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions IFN-gamma as a protein, aiding in the extraction of protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions NF-kappa B as a protein, aiding in the extraction of protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205, DRIP) which are important for entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) which are crucial for entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the given entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"p50 NF-kappa B1\": \"protein\"}, {\"p65 RelA\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "response1": "None.",
        "response2": "[\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 3},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n{\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n{\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\": 4},\n{\"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs .\": 3},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"IL4 promoter\": \"DNA\"}, {\"Jurkat cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"tumor necrosis factor alpha\": \"protein\"}, {\"RelA\": \"protein\"}]",
        "prediction": "{'IL4 promoter': 'DNA', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'CD40' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IL-2', 'c-Jun', and 'c-Fos' which are proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'E2A' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappaB', 'Tax', and 'ATL' which are relevant to the cell_type and protein entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a DNA mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"}\n]",
        "response3": "[{'I kappa B alpha': 'protein'}, {'mouse 70Z/3 cells': 'cell_line'}, {'NF-kappa B': 'protein'}, {'phorbol myristate acetate': 'protein'}, {'lipopolysaccharide': 'protein'}]",
        "prediction": "{'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 5},\n    {\"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "response1": "['cell_line', 'gene']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": \"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains multiple protein entities such as PAFR, PAF, NF-kappa B, and protein kinase C, which are directly mentioned in the text.\"},\n    {\"Sentence\": \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions NF-kappa B, which is a protein entity present in the target sentence.\"},\n    {\"Sentence\": \"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains protein entities such as Sp1, NF-kappaB, and p50, which are directly related to the entities in the target sentence.\"},\n    {\"Sentence\": \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions NF-kappa B, which is a protein entity present in the target sentence.\"},\n    {\"Sentence\": \"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence directly mentions NF-kappa B and I kappa B alpha, which are protein entities present in the target sentence.\"},\n    {\"Sentence\": \"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains protein entities such as RelA, NF-kappa B, and Rel homology family, which are directly related to the entities in the target sentence.\"},\n    {\"Sentence\": \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence mentions NF-kappaB, Tax, and ATL, which are protein and cell_type entities present in the target sentence.\"},\n    {\"Sentence\": \"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions NF-ATc and T lymphocytes, which are protein and cell_type entities present in the target sentence.\"},\n    {\"Sentence\": \"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions NF-kappa B, which is a protein entity present in the target sentence.\"},\n    {\"Sentence\": \"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions NF-ATc, T lymphocytes, and embryonic cardiac cells, which are protein and cell_type entities present in the target sentence.\"},\n    {\"Sentence\": \"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains protein entities such as NF-kB, AP-1, OCT-1, and NF-IL-2B, which are directly related to the entities in the target sentence.\"},\n    {\"Sentence\": \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\", \"Helpfulness score\": 3, \"Reason\": \"The sentence mentions NF-kappa B, which is a protein entity present in the target sentence.\"},\n    {\"Sentence\": \"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains protein entities such as IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are directly related to the entities in the target sentence.\"},\n    {\"Sentence\": \"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence mentions protein entities such as p21(WAF1/CIP1) and p27(KIP1), which are directly related to the entities in the target sentence.\"},\n    {\"Sentence\": \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence directly mentions NF-kappa B and I kappa B alpha, which are protein entities present in the target sentence.\"},\n    {\"Sentence\": \"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains protein entities such as NF-kappa B and AP-1, which are directly related to the entities in the target sentence.\"},\n    {\"Sentence\": \"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant protein or entity type mentioned in the target sentence.\"},\n    {\"Sentence\": \"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant protein or entity type mentioned in the target sentence.\"},\n    {\"Sentence\": \"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant protein or entity type mentioned in the target sentence.\"}\n]",
        "response3": "[{\"KBF1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'KBF1': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CVZ\": \"protein\"}, {\"IM-9\": \"cell_line\"}, {\"RU 38486\": \"protein\"}, {\"human GR\": \"protein\"}, {\"CVZ-resistant cells\": \"cell_line\"}]",
        "prediction": "{'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein', 'CVZ-resistant cells': 'cell_line'}"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Gel-shift analysis\": 1},\n    {\"constitutive presence\": 1},\n    {\"nuclear factors\": 1},\n    {\"resting PBL\": 1},\n    {\"proximal AP-1 site\": 1},\n    {\"IL-2 promoter\": 1},\n    {\"immunoreactive c-Jun\": 1},\n    {\"c-Fos protein\": 1},\n    {\"Extracellular signal-regulated protein kinase\": 1},\n    {\"ERK-dependent\": 1},\n    {\"ERK-independent pathways\": 1},\n    {\"STAT3\": 1},\n    {\"serine-727\": 1},\n    {\"human neutrophils\": 1},\n    {\"chemotactic factors\": 1},\n    {\"cytokines\": 1},\n    {\"gst- EBNA-2 fusion protein\": 1},\n    {\"PU.1\": 1},\n    {\"nuclear extracts\": 1},\n    {\"in vitro translated PU.1\": 1},\n    {\"EBNA-2 -PU.1 interaction\": 1},\n    {\"electrophoretic mobility shift assays\": 1},\n    {\"IL-4\": 1},\n    {\"LPS-induced expression\": 1},\n    {\"AP-1 protein\": 1},\n    {\"Protein\": 1},\n    {\"genomic sequences\": 1},\n    {\"G0S24 product\": 1},\n    {\"IFN A\": 1},\n    {\"IFNA\": 1},\n    {\"interleukin-2\": 1},\n    {\"interleukin-2 receptor\": 1},\n    {\"phytohemagglutinin\": 1},\n    {\"phorbol myristate acetate\": 1},\n    {\"Murine macrophage inflammatory protein 1 alpha\": 1},\n    {\"MIP-1 alpha\": 1},\n    {\"GOS19\": 1},\n    {\"LD78\": 1},\n    {\"AT464\": 1},\n    {\"cDNA clone\": 1},\n    {\"primary response gene\": 1},\n    {\"macrophage differentiation\": 1},\n    {\"Egr-1\": 1},\n    {\"promoters\": 1},\n    {\"cytokines\": 1},\n    {\"human Th2-type lymphocytes\": 1},\n    {\"IL4\": 1},\n    {\"IL13\": 1},\n    {\"gamma c chain\": 1},\n    {\"STAT6\": 1},\n    {\"STAT3\": 1},\n    {\"STAT5\": 1},\n    {\"normal human B cells\": 1},\n    {\"monocytes\": 1},\n    {\"IL-10 -stimulated STAT protein\": 1},\n    {\"M(r)\": 1},\n    {\"70 kDa\": 1},\n    {\"STAT3 Ab\": 1},\n    {\"T cells\": 1},\n    {\"mouse E2A gene\": 1},\n    {\"polyclonal antisera\": 1},\n    {\"distinct portions\": 1},\n    {\"E2A protein\": 1},\n    {\"Activated Stat proteins\": 1},\n    {\"homo- or heterodimers\": 1},\n    {\"translocate to the nucleus\": 1},\n    {\"responsive genes\": 1},\n    {\"human peripheral blood T cells\": 1},\n    {\"TCR\": 1},\n    {\"IFN-gamma\": 1},\n    {\"jak kinases\": 1},\n    {\"STAT1(alpha)\": 1},\n    {\"signal transducer\": 1},\n    {\"activator of transcription\": 1},\n    {\"genes\": 1},\n    {\"eosinophil granule proteins\": 1},\n    {\"mRNA expression\": 1},\n    {\"GATA-1 binding transcription factor\": 1},\n    {\"eosinophil differentiation\": 1},\n    {\"Northern blot analysis\": 1},\n    {\"p21(WAF1/CIP1 )\": 1},\n    {\"p27(KIP1)\": 1},\n    {\"mRNA\": 1},\n    {\"protein\": 1},\n    {\"common pathway\": 1},\n    {\"common requirements\": 1},\n    {\"properties\": 1},\n    {\"signaling pathway\": 1},\n    {\"tumors\": 1},\n    {\"typical morphology\": 1},\n    {\"ovary\": 1},\n    {\"stage I\": 1},\n    {\"benign clinical course\": 1},\n    {\"distinct genes\": 1},\n    {\"family members\": 1},\n    {\"isoforms\": 1}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"IFN-gamma-activated sequence (GAS)\": \"DNA\"}]",
        "prediction": "{'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"E1A\": \"protein\"}, {\"IFN\": \"protein\"}, {\"adenovirus-transformed cells\": \"cell_line\"}, {\"NK cells\": \"cell_type\"}]",
        "prediction": "{'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CD8+\": \"cell_type\"}, {\"progesterone receptor\": \"protein\"}, {\"CD4+\": \"cell_type\"}, {\"lymphocytes\": \"cell_type\"}]",
        "prediction": "{'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[\n    {\"Cyclosporin A\": \"protein\"},\n    {\"CsA\": \"protein\"},\n    {\"lymphokine genes\": \"protein\"},\n    {\"T-cell\": \"cell_type\"},\n    {\"interleukin-2\": \"protein\"}\n]",
        "prediction": "{'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 3},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n{\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor).\": 4},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n{\"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\": 5},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"SCL\": \"protein\"}]",
        "prediction": "{'SCL': 'protein'}"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"kappa B complex\": \"protein\"}, {\"NFAT-1 complex\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"interleukin-2 enhancer\": \"protein\"}]",
        "prediction": "{'kappa B complex': 'protein', 'NFAT-1 complex': 'protein', 'DNA': 'DNA', 'interleukin-2 enhancer': 'protein'}"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"anti-CD3 Abs\": \"protein\"}]",
        "prediction": "{'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"bronchoalveolar lavage\": \"cell_type\"}, {\"blood mononuclear cells\": \"cell_type\"}, {\"sarcoidosis\": \"cell_type\"}, {\"tuberculosis\": \"cell_type\"}]",
        "prediction": "{'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 5},\n    {\"Sp1\": 4, \"Ets\": 4},\n    {\"GATA-1\": 4},\n    {\"immunoglobulin kappa 3' enhancer\": 3},\n    {\"SCM-1\": 5},\n    {\"IL-4\": 4},\n    {\"CD70\": 4, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 4, \"CD40\": 4},\n    {\"T cell\": 5, \"interleukin 2\": 4},\n    {\"PML/RARalpha\": 4},\n    {\"GATA-1\": 4},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"NF-ATc\": 4, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"A-myb\": 4},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"IkappaBbeta\": 4, \"NF-kappaB\": 4},\n    {\"Common pathway\": 1},\n    {\"Tumors\": 1},\n    {\"Distinct genes\": 1}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}]",
        "prediction": "{'B-cell': 'cell_type'}"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example includes entities that match some of the entity labels in the target sentence, providing relevant information for named entity extraction.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example includes an entity that matches one of the entity labels in the target sentence, offering some assistance in named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides specific entities that match the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The example does not include any entities that match the entity labels in the target sentence, providing no assistance in named entity extraction.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not include any entities that match the entity labels in the target sentence, providing no assistance in named entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not include any entities that match the entity labels in the target sentence, providing no assistance in named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"HIV LTR\": \"DNA\"}, {\"T cells\": \"cell_type\"}, {\"monocytic cells\": \"cell_type\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "response1": "['cell_line', 'protein', 'DNA']",
        "response2": "[\n    {\"1\": \"The entity 'NF-kappa B' is mentioned in the sentence, but it is not explicitly labeled as 'DNA' or 'protein'. Therefore, this example is not very helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"2\": \"The entities 'RelA' and 'NF-kappa B' are mentioned in the sentence and correctly labeled as 'protein'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' are mentioned in the sentence and correctly labeled as 'protein'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"4\": \"The entity 'NF-kappa B' is mentioned in the sentence and correctly labeled as 'protein'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"4\": \"The entities 'CD40', 'IFN-gamma', 'tumor necrosis factor-alpha', and 'interleukin (IL)-1beta' are mentioned in the sentence and correctly labeled as 'protein'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"3\": \"The entities 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' are mentioned in the sentence, but 'IL-2 receptor alpha subunit' and 'p21ras' are not explicitly labeled as 'protein'. This example is somewhat helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'IL-2', 'NF-kappa B', and 'AP-1' are mentioned in the sentence and correctly labeled as 'protein'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"4\": \"The entity 'NF-kappa B' is mentioned in the sentence and correctly labeled as 'protein'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"4\": \"The entities 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' are mentioned in the sentence and correctly labeled as 'protein' or 'cell_type'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"4\": \"The entities 'NF-kappaB', 'Tax', and 'ATL' are mentioned in the sentence and correctly labeled as 'protein' or 'cell_type'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'IkappaBbeta' and 'NF-kappaB' are mentioned in the sentence and correctly labeled as 'protein'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' are mentioned in the sentence and correctly labeled as 'protein'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'CD40' and 'NF-kappa B' are mentioned in the sentence and correctly labeled as 'protein'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'p50', 'p65', 'DNA', and 'protein' are mentioned in the sentence and correctly labeled as 'protein' or 'DNA'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"5\": \"The entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' are mentioned in the sentence and correctly labeled as 'protein' or 'cell_type'. This example is highly helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"4\": \"The entities 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' are mentioned in the sentence and correctly labeled as 'cell_type' or 'protein'. This example is helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"1\": \"This sentence does not contain any entities that match the entity types in the target sentence. Therefore, this example is not helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"1\": \"This sentence does not contain any entities that match the entity types in the target sentence. Therefore, this example is not helpful in aiding the extraction of named entities from the target sentence.\"},\n    {\"1\": \"This sentence does not contain any entities that match the entity types in the target sentence. Therefore, this example is not helpful in aiding the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{\"L540 cells\": \"cell_line\"}, {\"Hodgkin's disease\": \"cell_type\"}, {\"T cell-like\": \"cell_type\"}, {\"CD30\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'L540 cells': 'cell_line', \"Hodgkin's disease\": 'cell_type', 'T cell-like': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n{\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 3},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label, which directly aids in understanding how to extract protein entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions a protein entity (retinoic acid receptor alpha) and its label, providing direct assistance in identifying protein entities in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein entities (myeloperoxidase, lysozyme, PU.1) with their corresponding labels, which greatly assist in recognizing protein entities in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes protein entities (IL-4, AP-1, LPS) and their labels, offering direct guidance on identifying protein entities in the target sentence.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence mentions a protein entity (alpha-tocopherol) and two cell type entities (monocyte, endothelial cells), which provide some assistance in recognizing protein and cell type entities in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides a protein entity (phosphocreatine) and its label, offering some help in understanding how to extract protein entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a DNA entity (AP-1) and its label, directly aiding in identifying DNA entities in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes a protein entity (P selectin) and its label, providing direct assistance in recognizing protein entities in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein entities (cAMP-dependent protein kinase, Rap1) with their labels, greatly assisting in identifying protein entities in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions protein entities (Stat3, Stat5, c-Mpl) and their labels, offering direct guidance on identifying protein entities in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence includes a protein entity (NF-kappa B) and its label, providing direct assistance in recognizing protein entities in the target sentence.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions a cell type entity (cell adhesion molecules), which provides some assistance in recognizing cell type entities in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple protein entities (interleukin-2, alpha chain, CD25, IL-2 receptor) with their labels, greatly assisting in identifying protein entities in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions multiple protein entities (Protein kinase B, phosphatidylinositol 3-kinase, STAT5, erythropoietin, c-Akt) and cell line entities (HCD57, HCD57-SREI) with their labels, offering direct guidance on identifying these entities in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes cell type entities (T lymphocytes, adenovirus vectors) and their labels, providing direct assistance in recognizing these entities in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions cell type entities (sickle red blood cells, leukocytes, vascular endothelium, blood vessel) and their labels, offering direct guidance on identifying these entities in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities that match the entity labels provided, hence not helpful in extracting named entities from the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities that match the entity labels provided, hence not helpful in extracting named entities from the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities that match the entity labels provided, hence not helpful in extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"HDL\": \"protein\"}, {\"LDL\": \"protein\"}]",
        "prediction": "{'HDL': 'protein', 'LDL': 'protein'}"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R )\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"complementary DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"25 kD\": \"protein\"}, {\"55 kD\": \"protein\"}, {\"alternative splicing\": \"RNA\"}]",
        "prediction": "{'25 kD': 'protein', '55 kD': 'protein', 'alternative splicing': 'RNA'}"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell line (SCM-1) in the context of examining regulatory mechanisms of genes.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (p50p50) in the context of binding efficiency and mutation effects.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence discusses the role of a specific protein (PML/RARalpha) in myelopoiesis.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins (EKLF, CBP, p300, P/CAF) and their interactions in the context of acetylated transcription factors.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a specific protein (GATA-1) as a positive regulator of lineage-specific transcription factor in erythroid cells.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence discusses the transactivation role of a specific protein (TCF-1) in non-T cells.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a specific protein (ZEBRA) in the context of transactivation.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence discusses a specific protein (A-myb) and its restricted pattern of expression.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions proteins involved in transcription, suggesting a similar role for the G0S24 product.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a specific protein (CD95 ligand) in the context of a luciferase reporter construct.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins (Tax, TFIIA) and their interaction in the yeast two-hybrid system.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions a specific protein (Egr-1) as a zinc finger transcription factor expressed upon macrophage differentiation.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) involved in binding to the IL-2 promoter.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions a specific protein (GATA-1) required for erythroid development and gene regulation.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence discusses the expression of a specific protein (E2A) at the protein level using polyclonal antisera.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins (Sp1, Ets) critical for maintaining CTL-specific expression of the mouse perforin gene.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entity types from the given label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entity types from the given label set.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any relevant entity types from the given label set.\"}\n]",
        "response3": "[{\"MZF-1\": \"protein\"}, {\"MZF-1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example provides a clear entity with a specific entity label that matches the entity types in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example provides entities with specific entity labels that match the entity types in the target sentence, but the relevance is slightly lower compared to Example 1.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The example provides entities with specific entity labels that match the entity types in the target sentence, but the relevance is slightly lower compared to Example 1.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The example provides clear entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The example provides a clear entity with a specific entity label that matches the entity types in the target sentence.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The example provides a clear entity with a specific entity label that matches the entity types in the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The example provides a clear entity with a specific entity label that matches the entity types in the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The example provides clear entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The example provides clear entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The example provides clear entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The example provides clear entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 12\": 1},\n{\"Reason 12\": \"The example does not provide any entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 13\": 1},\n{\"Reason 13\": \"The example does not provide any entities with specific entity labels that match the entity types in the target sentence.\"},\n{\"Example 14\": 1},\n{\"Reason 14\": \"The example does not provide any entities with specific entity labels that match the entity types in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Factor VII/VIIa\": \"protein\"}, {\"tissue factor (TF) receptor\": \"protein\"}]",
        "prediction": "{'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": \"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains specific protein names (NF-kappaB, Sp1, p50) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Control of NF-kappa B activity by the I kappa B beta inhibitor .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions NF-kappa B and I kappa B beta, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains the protein entity RelA and NF-kappa B, which are relevant to the target sentence.\"},\n    {\"Sentence\": \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\", \"helpfulness score\": 4, \"reasons\": \"The sentence mentions NF-kappa B, which is a relevant protein entity in the target sentence. The mention of DNA binding activity may also be helpful.\"},\n    {\"Sentence\": \"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) which are relevant to the target sentence.\"},\n    {\"Sentence\": \"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions CD40 and NF-kappa B, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains IkappaBalpha and NF-kappaB, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions IkappaBbeta and NF-kappaB, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains NF-kappaB, Tax, and ATL, which are relevant entities in the target sentence.\"},\n    {\"Sentence\": \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions NF-kappa B and I kappa B alpha, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains NF-kappa B and ARDS, which are relevant entities in the target sentence.\"},\n    {\"Sentence\": \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions NF-kappa B, which is a relevant protein entity in the target sentence.\"},\n    {\"Sentence\": \"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains NF-kappa B and I kappa B alpha, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions NF-kappa B, which is a relevant protein entity in the target sentence.\"},\n    {\"Sentence\": \"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\", \"helpfulness score\": 5, \"reasons\": \"The sentence contains IL-4, LPS, and AP-1, which are relevant protein entities in the target sentence.\"},\n    {\"Sentence\": \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\", \"helpfulness score\": 5, \"reasons\": \"The sentence mentions NF-kappa B, which is a relevant protein entity in the target sentence.\"}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"p50\": \"protein\"}, {\"p65\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T cell\": \"cell_type\"}, {\"HIV\": \"cell_type\"}]",
        "prediction": "{'T cell': 'cell_type', 'HIV': 'cell_type'}"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of named entities with their corresponding entity labels, which directly match the entity types present in the target sentence. This provides clear and relevant examples for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"immunoglobulin\": \"protein\"}, {\"class II major histocompatibility (MHC) genes\": \"protein\"}, {\"B-lymphoid-specific genes\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"GATA\": \"protein\"}, {\"Ets\": \"protein\"}]",
        "prediction": "{'GATA': 'protein', 'Ets': 'protein'}"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"VDR\": \"protein\"}, {\"serum phosphate\": \"protein\"}]",
        "prediction": "{'VDR': 'protein', 'serum phosphate': 'protein'}"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "response1": "['cell_line', 'DNA', 'protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 3},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 3},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"multiple myeloma cell lines\": \"cell_line\"}, {\"B cells\": \"cell_type\"}, {\"PU.1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"mRNA\": \"RNA\"}]",
        "prediction": "{'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label, which directly aids in understanding how to extract named entities from the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains two examples of proteins (c-kit and IL-4R alpha chain) and their corresponding entity labels, providing direct guidance on extracting named entities from the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes multiple examples of proteins (Syk and Zap) and a cell type (T cell), along with their corresponding entity labels, which are crucial for extracting named entities from the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (Stat3 and Stat5) and a protein (c-Mpl) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains examples of proteins (CD40 and NF-kappa B) with their corresponding entity labels, which are essential for understanding how to extract named entities from the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes examples of proteins (IL4 and IL13), proteins (STAT6, STAT3, and STAT5), and a cell type (B cells) with their corresponding entity labels, providing clear guidance on extracting named entities from the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of a protein (NF-ATc) and a cell type (T lymphocytes) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains an example of a cell type (cell adhesion molecules) with its corresponding entity label, which is crucial for understanding how to extract named entities from the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes examples of proteins (CD70, IL-4, and CD40), a cell type (B cells), and a cell type (plasma cells) with their corresponding entity labels, providing clear guidance on extracting named entities from the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of proteins (IL-7R and gamma(c)) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains examples of proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor) with their corresponding entity labels, which are crucial for understanding how to extract named entities from the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes examples of proteins (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) with their corresponding entity labels, providing clear guidance on extracting named entities from the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins (interleukin 10, IL-10R, STAT3, and IL-6) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) with their corresponding entity labels, providing clear guidance on extracting named entities from the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes an example of a protein (NF-kappa B) with its corresponding entity label, which is crucial for understanding how to extract named entities from the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins (ICAM-1, CD71, LMP1, IkappaB) with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the entity types in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the entity types in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the entity types in the target sentence, making it not helpful for extracting named entities.\"}\n]",
        "response3": "[{\"VLA-5 fibronectin receptor\": \"protein\"}, {\"CD4 cells\": \"cell_type\"}, {\"CD3 - TCR\": \"protein\"}, {\"fibronectin\": \"protein\"}]",
        "prediction": "{'VLA-5 fibronectin receptor': 'protein', 'CD4 cells': 'cell_type', 'CD3 - TCR': 'protein', 'fibronectin': 'protein'}"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 1},\n    {\"Example 10\": 1},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TCL1 mRNA\": \"RNA\"}, {\"TCL1\": \"protein\"}, {\"PBLs\": \"cell_type\"}, {\"AT\": \"cell_type\"}]",
        "prediction": "{'TCL1 mRNA': 'RNA', 'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NFAT-1\": \"protein\"}, {\"SV40 T-antigen\": \"protein\"}]",
        "prediction": "{'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains multiple examples of transcription factors (Sp1, NF-kappaB, AP-1, OCT-1, NF-IL-2B) which are relevant entities in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains a relevant example of a transcription factor (PU.1) and a cell type (macrophage) which are entities in the given label set.\"},\n{\"Sentence\": 3},\n{\"Reason\": \"The sentence contains a relevant example of a cell type (T cell) and a protein (interleukin 2) which are entities in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains a relevant example of a transcription factor (GATA-1) which is an entity in the given label set.\"},\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains examples of transcription factors (Jun, ATF-2) which are relevant entities in the given label set.\"},\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains multiple examples of transcription factors (NF-kB, AP-1, OCT-1, NF-IL-2B) which are relevant entities in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains a relevant example of a protein (Egr-1) which is an entity in the given label set.\"},\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains examples of transcription factors (EKLF, CBP, p300, P/CAF) which are relevant entities in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains a relevant example of a protein (A-myb) which is an entity in the given label set.\"},\n{\"Sentence\": 3},\n{\"Reason\": \"The sentence contains a relevant example of a DNA binding activity (AP-1) which is an entity in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains relevant examples of a protein (EBNA2) and a cell line (TP1) which are entities in the given label set.\"},\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains examples of transcription factors (Sp1, Ets) which are relevant entities in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains relevant examples of a protein (SP1), caspases, and a cell type (B-cell) which are entities in the given label set.\"},\n{\"Sentence\": 5},\n{\"Reason\": \"The sentence contains examples of a protein (Sp1) and a protein (CD14) which are relevant entities in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains a relevant example of a protein (NF-E2) which is an entity in the given label set.\"},\n{\"Sentence\": 4},\n{\"Reason\": \"The sentence contains relevant examples of a protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) which are entities in the given label set.\"},\n{\"Sentence\": 1},\n{\"Reason\": \"The sentence does not contain any entities from the given label set.\"},\n{\"Sentence\": 1},\n{\"Reason\": \"The sentence does not contain any entities from the given label set.\"},\n{\"Sentence\": 1},\n{\"Reason\": \"The sentence does not contain any entities from the given label set.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"Ets-1\": \"protein\"}, {\"TFE-3\": \"protein\"}, {\"Sp1\": \"protein\"}]",
        "prediction": "{'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[\n    {\"NF-kappa B\": \"protein\"},\n    {\"I kappa B alpha\": \"protein\"},\n    {\"I kappa B beta\": \"protein\"}\n]",
        "prediction": "{'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 1},\n    {\"Sentence 3\": 1},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5},\n    {\"Sentence 16\": 1},\n    {\"Sentence 17\": 1},\n    {\"Sentence 18\": 1}\n]",
        "response3": "[{\"p56\": \"protein\"}, {\"hsp70\": \"protein\"}, {\"hsp90\": \"protein\"}, {\"untransformed steroid receptors\": \"protein\"}]",
        "prediction": "{'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 4},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Antigen B27\": \"protein\"}, {\"glucocorticoid receptors\": \"protein\"}, {\"blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCF-2 alpha\": \"protein\"}, {\"T alpha 1\": \"protein\"}, {\"CREB\": \"protein\"}, {\"TCR alpha enhancer\": \"DNA\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"Reason\": \"Both 'RelA' and 'NF-kappaB1' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"Tax\": 4, \"TFIIA\": 4},\n    {\"Reason\": \"Both 'Tax' and 'TFIIA' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"CD40\": 4, \"NF-kappa B\": 4},\n    {\"Reason\": \"Both 'CD40' and 'NF-kappa B' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"Reason\": \"'retinoic acid receptor alpha' is a protein mentioned in the sentence, and providing this example can directly aid in identifying protein entities in the target sentence.\"},\n    {\"tyrosine\": 3},\n    {\"Reason\": \"'tyrosine' is a protein mentioned in the sentence, providing this example can somewhat aid in identifying protein entities in the target sentence.\"},\n    {\"IL-2\": 4, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"Reason\": \"'IL-2', 'c-Jun', and 'c-Fos' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"EBNA-2\": 5, \"PU.1\": 5},\n    {\"Reason\": \"'EBNA-2' and 'PU.1' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Reason\": \"'NF-kappaB', 'Sp1', and 'p50' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"TRAF6\": 5, \"RANKL\": 5, \"NF-kappaB\": 5},\n    {\"Reason\": \"'TRAF6', 'RANKL', and 'NF-kappaB' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"CREB\": 5, \"AR-CRE\": 5},\n    {\"Reason\": \"'CREB' and 'AR-CRE' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"NF-E2\": 5},\n    {\"Reason\": \"'NF-E2' is a protein mentioned in the sentence, and providing this example can directly aid in identifying protein entities in the target sentence.\"},\n    {\"Sp1\": 5, \"CD14\": 5},\n    {\"Reason\": \"'Sp1' and 'CD14' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"AP-1\": 3},\n    {\"Reason\": \"'AP-1' is mentioned as DNA in the sentence, providing this example can somewhat aid in identifying DNA entities in the target sentence.\"},\n    {\"VDR\": 5, \"RXR\": 5, \"GRIP-1\": 5, \"DRIP205\": 5, \"DRIP\": 3},\n    {\"Reason\": \"'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' are proteins mentioned in the sentence, and providing these examples can directly aid in identifying protein entities in the target sentence.\"},\n    {\"p50\": 5, \"p65\": 5, \"DNA\": 3, \"protein\": 3},\n    {\"Reason\": \"'p50' and 'p65' are proteins, and 'DNA' and 'protein' are mentioned in the sentence, providing these examples can directly aid in identifying protein entities and DNA entities in the target sentence.\"},\n    {\"cDNA\": 3, \"Jurkat\": 5, \"DRE 1\": 4},\n    {\"Reason\": \"'cDNA' is mentioned as DNA, 'Jurkat' is a cell line, and 'DRE 1' is a cell type in the sentence, providing these examples can somewhat aid in identifying DNA entities and cell line entities in the target sentence.\"},\n    {\"Reason\": \"The sentence does not contain any entities from the given label set.\"},\n    {\"Reason\": \"The sentence does not contain any entities from the given label set.\"},\n    {\"Reason\": \"The sentence does not contain any entities from the given label set.\"}\n]",
        "response3": "[{\"TR alpha 1\": \"protein\"}, {\"NE\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides a clear example of a cell line (SIVsmmPBj14) and its corresponding entity label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence provides clear examples of proteins (IkappaBbeta and NF-kappaB) and their corresponding entity labels.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides clear examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) and their corresponding entity labels.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides clear examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) with their corresponding entity labels.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides clear examples of a protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) with their corresponding entity labels.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides clear examples of DNA (hepatitis B virus) and a protein (HBxAg) with their corresponding entity labels.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides clear examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding entity labels.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides a clear example of a protein (TCL1) and its corresponding entity label.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides clear examples of a cell type (T cell) and a protein (interleukin 2) with their corresponding entity labels.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides clear examples of a protein (NF-kappaB, Sp1) and a cell line (SIVmac) with their corresponding entity labels.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides clear examples of proteins (ATF1, CREB, H4) with their corresponding entity labels.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides clear examples of DNA (HIV-1 LTR) and proteins (NFAT-1, NF kappa B) with their corresponding entity labels.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence provides clear examples of proteins (tal-1, GATA-binding proteins) and a cell type (hematopoiesis) with their corresponding entity labels.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any named entities related to the given entity labels.\"}\n]",
        "response3": "[{'HTLV-I': 'cell_type'}, {'TRE': 'DNA'}, {'Tax': 'protein'}]",
        "prediction": "{'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T-helper-cell\": \"cell_type\"}, {\"protein\": \"protein\"}, {\"cysteine-rich antigen segments\": \"protein\"}, {\"cathepsin B\": \"protein\"}, {\"cathepsin L\": \"protein\"}, {\"cathepsin D\": \"protein\"}]",
        "prediction": "{'T-helper-cell': 'cell_type', 'protein': 'protein', 'cysteine-rich antigen segments': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'SCM-1' and its entity label 'cell_line', making it highly helpful for extracting named entities.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence directly mentions the entity 'NF-E2' and its entity label 'protein', providing a clear reference for named entity extraction.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence contains multiple entities such as 'HML', 'dexamethasone', 'cortisol', and 'lysozyme' with their corresponding entity labels, making it very helpful for named entity extraction.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence directly mentions 'phosphocreatine' as a protein, aiding in the extraction of named entities.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence clearly mentions 'lymphoid neoplasms' as a 'cell_type', providing a direct reference for named entity extraction.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides a direct mention of 'E2A' as a 'protein', aiding in named entity extraction.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains clear references to 'granulocytes' and 'T cells' as 'cell_type', making it highly helpful for named entity extraction.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence directly mentions 'AP-1' as 'DNA', aiding in the extraction of named entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides a direct mention of 'GATA-1' as a 'protein', aiding in named entity extraction.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions 'Egr-1' as 'RNA' and 'Erbstatin' and 'genistein' as 'protein', making it highly helpful for named entity extraction.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence directly mentions 'ATF1', 'CREB', and 'H4' as 'protein', aiding in named entity extraction.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides clear references to 'EBV', 'EBNA2', and 'estrogen receptor' as 'DNA' and 'protein', aiding in named entity extraction.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence directly mentions 'MR', 'aldosterone', and 'progesterone' as 'protein', making it highly helpful for named entity extraction.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains multiple entities such as 'FEV1', 'FVC', 'PEF', and 'prednisolone' with their corresponding entity labels, making it very helpful for named entity extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence provides clear references to 'IL-2r', 'c-fos', 'IL-2', and 'lymphokine' as 'protein', aiding in named entity extraction.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions 'Type I' and 'Type II' as 'cell_type', providing direct references for named entity extraction.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entities or entity labels mentioned, making it not helpful for named entity extraction.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entities or entity labels mentioned, making it not helpful for named entity extraction.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any specific entities or entity labels mentioned, making it not helpful for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"T3 receptor\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'T3 receptor': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-fos\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'c-fos': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"X boxes\": \"protein\"}, {\"Y boxes\": \"protein\"}, {\"major histocompatibility complex (MHC) class II promoters\": \"DNA\"}]",
        "prediction": "{'X boxes': 'protein', 'Y boxes': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"A-myb\": 5},\n    {\"Protein\": 5},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"DNA\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5, \"embryonic cardiac cells\": 5},\n    {\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Jun\": 5, \"ATF-2\": 5},\n    {\"p50p50\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"5\": \"The sentence contains the named entity 'GATA-1' which is a protein, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'Stat3', 'Stat5', and 'c-Mpl' which are all proteins, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entity 'TCF-1' which is a protein, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' which are all proteins, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'Sp1' and 'CD14' which are both proteins, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entity 'E2A' which is a protein, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all proteins, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entity 'CD95 ligand' which is a protein, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entity 'SCM-1' which is a cell line, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' which are all relevant to the entity labels provided, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'Ter 119', 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4' which are all relevant to the entity labels provided, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'ATF1', 'CREB', and 'H4' which are all proteins, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'BAT box', 'CD20', and 'B cells' which are all relevant to the entity labels provided, and this information is crucial for named entity extraction.\"},\n    {\"5\": \"The sentence contains the named entities 'IL-2', 'NFAT', 'NFAT delta418', 'calcineurin', 'Tpl-2', and 'cyclosporin A' which are all relevant to the entity labels provided, and this information is crucial for named entity extraction.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n    {\"1\": \"The sentence does not contain any named entities from the given entity label set.\"}\n]",
        "response3": "[{\"thromboxane receptor gene\": \"protein\"}, {\"thromboxane receptor gene promoter\": \"protein\"}, {\"chloramphenicol acetyltransferase\": \"protein\"}, {\"K562 cells\": \"cell_line\"}]",
        "prediction": "{'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'K562 cells': 'cell_line'}"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n{\"Protein\": 4},\n{\"MNDA\": 4, \"myeloid cell lines\": 4},\n{\"Runt domain\": 4},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"WT1\": 4},\n{\"T cell\": 5, \"interleukin 2\": 4},\n{\"PBMC\": 5, \"adenovirus DNA\": 5},\n{\"FasL\": 4, \"IL-2\": 4, \"IFN-gamma\": 4},\n{\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n{\"TCL1\": 4},\n{\"ZEBRA\": 4},\n{\"CD70\": 4, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 4, \"CD40\": 4},\n{\"GM-CSF\": 4},\n{\"EBV\": 5, \"B-cell\": 5},\n{\"granulocytes\": 5, \"T cells\": 5}\n]",
        "response3": "[{\"CEM\": \"cell_line\"}, {\"RPMI 8402\": \"cell_line\"}]",
        "prediction": "{'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 5},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 5},\n    {\"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"chloramphenicol acetyltransferase\": \"protein\"}, {\"HIV long terminal repeat (LTR)\": \"DNA\"}, {\"beta interferon\": \"protein\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon': 'protein'}"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4},\n    {\"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HeLa\": \"cell_line\"}, {\"IFN beta\": \"protein\"}]",
        "prediction": "{'HeLa': 'cell_line', 'IFN beta': 'protein'}"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (NF-E2) that are directly mentioned, making it highly relevant for extracting named entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions a specific protein (P selectin) that is directly related to the context, aiding in the extraction of named entities.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides multiple instances of specific entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) directly relevant to the entity labels in the target sentence, making it very helpful for extraction.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions specific proteins (TIMP-1) and DNA, which are relevant to the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains specific cell types (T cell), proteins (IL-2, IL-2 receptor, CD28) directly related to the context, making it highly relevant for extracting named entities.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions a specific protein (G-CSF) that is directly related to the context, aiding in the extraction of named entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides multiple instances of specific entities (IL-2, NF-kappa B, AP-1) directly relevant to the entity labels in the target sentence, making it very helpful for extraction.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains specific proteins (IL-2, Aiolos, Ras) directly related to the context, making it highly relevant for extracting named entities.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence mentions a specific cell type (cell adhesion molecules) that is directly related to the context, aiding in the extraction of named entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains specific proteins (NF-kappa B) directly related to the context, making it highly relevant for extracting named entities.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides multiple instances of specific entities (interleukin-2, CD25, IL-2 receptor) directly relevant to the entity labels in the target sentence, making it very helpful for extraction.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions specific proteins (Erbstatin, genistein) and RNA (Egr-1) that are relevant to the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions specific entities (cDNA, Jurkat, DRE 1) that are relevant to the entity labels in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides multiple instances of specific entities (IL-2, NFAT, NFAT delta418, calcineurin, Tpl-2, cyclosporin A) directly relevant to the entity labels in the target sentence, making it very helpful for extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence contains specific proteins (NF-kappa B) and cell type (neutrophils) directly related to the context, making it highly relevant for extracting named entities.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone\": 5},\n    {\"IL-2 receptor alpha subunit is a hallmark of lymphocyte activation\": 4},\n    {\"IL-4 inhibits LPS-induced expression of AP-1 protein\": 4},\n    {\"chimeric receptor containing the extracellular domain of c-kit and the cytoplasmic and transmembrane domains of the IL-4R alpha chain\": 4},\n    {\"suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene\": 3},\n    {\"selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model\": 3},\n    {\"IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells\": 5},\n    {\"other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined\": 3},\n    {\"constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 4},\n    {\"structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function\": 5},\n    {\"NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway\": 4},\n    {\"human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription\": 5},\n    {\"T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2\": 5},\n    {\"balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells\": 4}\n]",
        "response3": "[{\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"IL-2R alpha\": \"protein\"}]",
        "prediction": "{'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"M-CSF\": \"protein\"}, {\"monocytes\": \"cell_type\"}]",
        "prediction": "{'M-CSF': 'protein', 'monocytes': 'cell_type'}"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"CD28 MoAb\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'IL-2': 'protein', 'CD28 MoAb': 'protein'}"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5, \"Reasons\": \"Both 'Th1' and 'Th2' are cell types mentioned in the sentence, and providing these examples can directly aid in identifying cell types in the target sentence.\"},\n    {\"SLAP-130\": 5, \"SLP-76\": 5, \"T cell\": 5, \"Reasons\": \"All three examples are proteins or related to cell types mentioned in the sentence, which can help in identifying similar entities in the target sentence.\"},\n    {\"Sp1\": 5, \"Ets\": 5, \"Reasons\": \"Both 'Sp1' and 'Ets' are proteins mentioned in the sentence, which can assist in recognizing protein entities in the target sentence.\"},\n    {\"UAS3\": 4, \"UAS2\": 4, \"YY1\": 5, \"Reasons\": \"'UAS3' and 'UAS2' are DNA entities, and 'YY1' is a protein mentioned in the sentence, which can aid in identifying similar entities in the target sentence.\"},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5, \"Reasons\": \"All examples are proteins or cell types mentioned in the sentence, which can be helpful in identifying entities in the target sentence.\"},\n    {\"GATA-1\": 5, \"Reasons\": \"'GATA-1' is a protein mentioned in the sentence, which can assist in recognizing protein entities in the target sentence.\"},\n    {\"IL-13\": 5, \"IL-4\": 5, \"B cell\": 5, \"monocyte\": 5, \"Reasons\": \"All examples are proteins or cell types mentioned in the sentence, which can help in identifying entities in the target sentence.\"},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5, \"Reasons\": \"'IL-2', 'c-Jun', and 'c-Fos' are proteins mentioned in the sentence, which can aid in recognizing protein entities in the target sentence.\"},\n    {\"Th2-type lymphocytes\": 5, \"Reasons\": \"'Th2-type lymphocytes' is a cell type mentioned in the sentence, which can assist in identifying cell types in the target sentence.\"},\n    {\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5, \"Reasons\": \"All examples are proteins or cell types mentioned in the sentence, which can be helpful in identifying entities in the target sentence.\"},\n    {\"lymphoid neoplasms\": 5, \"Reasons\": \"'lymphoid neoplasms' is a cell type mentioned in the sentence, which can assist in identifying cell types in the target sentence.\"},\n    {\"PML/RARalpha\": 5, \"Reasons\": \"'PML/RARalpha' is a protein mentioned in the sentence, which can aid in recognizing protein entities in the target sentence.\"},\n    {\"GM-CSF\": 5, \"Reasons\": \"'GM-CSF' is a protein mentioned in the sentence, which can assist in recognizing protein entities in the target sentence.\"},\n    {\"UAS1\": 4, \"B cell\": 5, \"Reasons\": \"'UAS1' is a cell line and 'B cell' is a cell type mentioned in the sentence, which can help in identifying similar entities in the target sentence.\"},\n    {\"T cell\": 5, \"interleukin 2\": 5, \"Reasons\": \"'T cell' is a cell type and 'interleukin 2' is a protein mentioned in the sentence, which can aid in recognizing entities in the target sentence.\"},\n    {\"GATA-1\": 5, \"Reasons\": \"'GATA-1' is a protein mentioned in the sentence, which can assist in recognizing protein entities in the target sentence.\"}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"Pax-5\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"cdc-2\": \"protein\"}, {\"cyclin E\": \"protein\"}, {\"CD23\": \"protein\"}, {\"cyclin D2\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"B4-2\": \"protein\"}]",
        "prediction": "{'B4-2': 'protein'}"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (IL-7R, gamma(c)) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names (IL-13, IL-4R, JAK2, IL-13R) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names (c-kit, IL-4R alpha chain) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (interleukin 10, IL-10R, STAT3, IL-6) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, Aiolos, Ras) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name (IL-4) that is directly related to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names (IL-12, STAT4, IL-12 receptor) and cell types (NK cells, T cells) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names (IL-2, c-Jun, c-Fos) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names (IL4, IL13, gamma c, STAT6, STAT3, STAT5) and a cell type (B cells) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (NF-kappaB, Tax, ATL) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (T cell, IL-2, IL-2 receptor, CD28) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (Stat3, Stat5, c-Mpl) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific cell type (T cell) and protein name (interleukin 2) that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entity names related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entity names related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entity names related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"IL-2 receptor\": \"protein\"}, {\"JAK1\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}]",
        "prediction": "{'IL-2 receptor': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CR1\": \"protein\"}, {\"CD35\": \"protein\"}, {\"CR3\": \"protein\"}, {\"CD11b/CD18\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"p50/p65\": \"protein\"}, {\"monocytes\": \"cell_type\"}, {\"HIV-infected monocytic cells\": \"cell_type\"}]",
        "prediction": "{'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of 'cDNAs' which is a specific type of entity (DNA) in the context of molecular biology.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific mentions of entities like 'SP1' (protein), 'caspases' (protein), and 'B-cell' (cell_type) which are relevant in the context of molecular biology.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence directly mentions 'Th2-type lymphocytes' which is a specific type of cell (cell_type) in the context of immunology.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear mentions of 'E2A' which is a protein, making it highly relevant for extracting named entities in the context of molecular biology.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'SLAP-130' (protein), 'SLP-76' (protein), and 'T cell' (cell_type) which are specific entities in the context of molecular biology and immunology.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a direct mention of 'TCF-1' which is a protein, making it highly relevant for extracting named entities in the context of molecular biology.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'T lymphocytes' (cell_type) and 'HLA-molecules' (protein) which are specific entities in the context of immunology and molecular biology.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear mentions of 'IkappaBbeta' (protein) and 'NF-kappaB' (protein) which are relevant entities in the context of molecular biology.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions 'GM-CSF' which is a protein, making it relevant for extracting named entities in the context of molecular biology.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' which is a specific entity (DNA) in the context of molecular biology.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'EBNA-2' (protein) and 'PU.1' (protein) which are specific entities in the context of molecular biology.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'hepatitis B virus' (DNA) and 'HBxAg' (protein) which are specific entities in the context of molecular biology.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'SIVsmmPBj14' which is a specific cell line entity, making it highly relevant for extracting named entities in the context of molecular biology.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'EBV' (cell_type) and 'B-cell' (cell_type) which are specific entities in the context of immunology.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'p50' (protein), 'p65' (protein), 'DNA' (DNA), and 'protein' (protein) which are specific entities in the context of molecular biology.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions 'B and T cell activation' (cell_type), 'Ramos' (cell_line), 'Jurkat' (cell_line), and 'cDNA microarray technology' (DNA) which are specific entities in the context of immunology and molecular biology.\"}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}, {\"hepatitis B virus X protein\": \"protein\"}]",
        "prediction": "{'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"PhoQ\": \"protein\"}]",
        "prediction": "{'PhoQ': 'protein'}"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"c-myc\": \"protein\"}]",
        "prediction": "{'c-myc': 'protein'}"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific gene or protein names that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains gene or protein names that are relevant to the entity labels in the target sentence, although not as directly as Example 1.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes gene or protein names that are related to the entity labels in the target sentence, providing relevant information for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions gene or protein names that match the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific gene or protein names that are directly relevant to the entity labels in the target sentence, making it very helpful for extracting named entities.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence mentions gene or protein names that are related to the entity labels in the target sentence, but the relevance is not as direct as other examples.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides gene or protein names that are relevant to the entity labels in the target sentence, although the connection is not as direct as in other examples.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions gene or protein names that match the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific gene or protein names that are directly relevant to the entity labels in the target sentence, making it very helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions a cell line name that matches one of the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence includes gene or protein names that are relevant to the entity labels in the target sentence, providing relevant information for extracting named entities.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions gene or protein names that are related to the entity labels in the target sentence, but the relevance is not as direct as other examples.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly mentions a protein name that matches one of the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence directly mentions a protein name that matches one of the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides gene or protein names that are relevant to the entity labels in the target sentence, although the connection is not as direct as in other examples.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific gene, protein, or entity names that are directly related to the entity labels in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific gene, protein, or entity names that are directly related to the entity labels in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific gene, protein, or entity names that are directly related to the entity labels in the target sentence, making it not helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"cDNA clone\": \"DNA\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}, {\"activator protein-1\": \"protein\"}]",
        "prediction": "{'cDNA clone': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific gene/protein names and a virus name that match the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains a specific cell line name that matches one of the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific gene/protein names and a DNA name that match the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains a specific gene/protein name and a transcription factor name that match the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific gene/protein names, a virus name, and a cell type name that match the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific gene/protein names and a DNA name that match the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains specific gene/protein names and a protein name that match the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific cell type names and a DNA name that match the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific gene/protein names and a protein name that match the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific cell line names and a DNA name that match the entity labels in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific gene/protein, cell type, cell line, RNA, or DNA names that match the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific gene/protein, cell type, cell line, RNA, or DNA names that match the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific gene/protein, cell type, cell line, RNA, or DNA names that match the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"gag/pol\": \"protein\"}, {\"env mRNA\": \"RNA\"}, {\"HTLV-infected cells\": \"cell_type\"}]",
        "prediction": "{'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"long terminal repeat\": \"DNA\"}, {\"transcriptional enhancer\": \"DNA\"}, {\"nuclear factor kappa B\": \"protein\"}]",
        "prediction": "{'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides specific examples of proteins and a transcription factor, which are directly related to the entity labels in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions PBMC, which is a cell type, and adenovirus, which is DNA, both of which are relevant to the entity labels in the target sentence.\"},\n{\"Example 3\": 3},\n{\"Reason 3\": \"The sentence mentions IFN-gamma, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 4\": 2},\n{\"Reason 4\": \"The sentence mentions lymphoid neoplasms, which is a cell type, relevant to the entity labels in the target sentence.\"},\n{\"Example 5\": 3},\n{\"Reason 5\": \"The sentence mentions STAT1, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 6\": 3},\n{\"Reason 6\": \"The sentence mentions Ras, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The sentence mentions immunohistochemistry, gene, and cell type, all relevant to the entity labels in the target sentence.\"},\n{\"Example 8\": 3},\n{\"Reason 8\": \"The sentence mentions NF-kappa B, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 9\": 3},\n{\"Reason 9\": \"The sentence mentions SCM-1, which is a cell line, relevant to the entity labels in the target sentence.\"},\n{\"Example 10\": 3},\n{\"Reason 10\": \"The sentence mentions SIVsmmPBj14, which is a cell line, relevant to the entity labels in the target sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence mentions nonhuman primates, which is a cell type, relevant to the entity labels in the target sentence.\"},\n{\"Example 12\": 3},\n{\"Reason 12\": \"The sentence mentions T-PLL, which is a cell type, relevant to the entity labels in the target sentence.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions E2A, which is a protein, relevant to the entity labels in the target sentence.\"},\n{\"Example 14\": 2},\n{\"Reason 14\": \"The sentence mentions AP-1, which is DNA, relevant to the entity labels in the target sentence.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions B and T cell activation, Ramos, Jurkat, and cDNA microarray technology, all relevant to the entity labels in the target sentence.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any entities related to the entity labels in the target sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any entities related to the entity labels in the target sentence.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"NF-E2\": 5},\n{\"EBV\": 4, \"B-cell\": 4},\n{\"CD70\": 4, \"IL-4\": 4, \"CD40\": 4, \"B cell\": 4, \"plasma cells\": 4},\n{\"Th2-type lymphocytes\": 5},\n{\"GATA-1\": 5},\n{\"Syk\": 4, \"Zap\": 4, \"T cell\": 4},\n{\"Th1\": 5, \"Th2\": 5},\n{\"T cell\": 4, \"interleukin 2\": 4},\n{\"IL-2\": 5},\n{\"AP-1\": 4},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n{\"SCL\": 4, \"GATA-1\": 4},\n{\"IL-2\": 4, \"NF-kappa B\": 4, \"AP-1\": 4},\n{\"IL4\": 4, \"IL13\": 4, \"STAT6\": 4, \"STAT3\": 4, \"STAT5\": 4, \"B cells\": 4},\n{\"STAT1\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Genes\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides specific entities and their corresponding labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides a specific entity and its corresponding label that matches one of the entity types in the target sentence, making it quite helpful for extracting named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a specific entity and its corresponding label that directly matches one of the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a specific entity and its corresponding label that directly matches one of the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a specific entity and its corresponding label that directly matches one of the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a specific entity and its corresponding label that directly matches one of the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a specific entity and its corresponding label that directly matches one of the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides specific entities and their corresponding labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides specific entities and their corresponding labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific entities and their corresponding labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a specific entity and its corresponding label that directly matches one of the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides specific entities and their corresponding labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides specific entities and their corresponding labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 1},\n    {\"Reason 14\": \"The example does not provide any specific entities or labels that match the entity types in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The example does not provide any specific entities or labels that match the entity types in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not provide any specific entities or labels that match the entity types in the target sentence, making it not helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of proteins and their interactions, which directly relate to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence directly mentions the activation of NF-kappa B, which is a protein entity label in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence discusses the activation of NF-kappa B through a Tax-independent mechanism in leukemic cells, which is relevant to the protein and cell_type entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence focuses on the activation of NF-kappa B, which is a protein entity label in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides information about the activation of NF-kappa B and its inhibitor I kappa B alpha, directly related to the protein entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions specific proteins like EKLF, CBP, p300, and P/CAF, which are relevant to the protein entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence discusses the signaling determinant required for NF-kappa B activation, directly related to the protein entity label in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides information about the autoregulatory pathway involving NF-kappa B and I kappa B alpha, which are protein entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions T cell and interleukin 2, which are relevant to the cell_type and protein entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence focuses on NF-kappa B activation, which is a protein entity label in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides information about the interaction between EBNA2 and the TP1 promoter, which are relevant to the protein and cell_line entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence discusses the regulation of gene expression by various proteins, including NF-kappa B, PAFR, and protein kinase C, directly related to the protein entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions RelA and NF-kappa B, which are protein entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides specific examples of proteins, c-Jun, and c-Fos, which are relevant to the protein entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence discusses the role of NF-kappaB in rheumatoid arthritis, which is a protein entity label in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions TRAF6, RANKL, and NF-kappaB, which are protein entity labels in the target sentence.\"}\n]",
        "response3": "[{\"NF-KB\": \"protein\"}]",
        "prediction": "{'NF-KB': 'protein'}"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"AP-1\": 4},\n    {\"WT1\": 4},\n    {\"myeloid cell lines\": 4},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"PU.1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"SCM-1\": 5},\n    {\"IL-13\": 5},\n    {\"IL-4R\": 5},\n    {\"JAK2\": 5},\n    {\"IL-13R\": 5},\n    {\"STAT1\": 5},\n    {\"SCL\": 4},\n    {\"GATA-1\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 4},\n    {\"ATL\": 4}\n]",
        "response3": "[{\"TCL1\": \"protein\"}]",
        "prediction": "{'TCL1': 'protein'}"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"Bcl-2\": \"protein\"}]",
        "prediction": "{'Bcl-2': 'protein'}"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains the entity 'E2A' which is a protein, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entity 'IL-2' which is a protein, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'EBNA-2' and 'PU.1' which are proteins, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'p21(WAF1/CIP1)' and 'p27(KIP1)' which are proteins, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' which are proteins, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entity 'NF-kappa B' which is DNA, similar to the 'DNA' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'Jun' and 'ATF-2' which are proteins, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'IkappaBbeta' and 'NF-kappaB' which are proteins, similar to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'p50', 'p65', 'DNA', and 'protein' which are similar to the 'DNA' and 'protein' entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'Tip', 'Tap', and 'Jurkat-T cells' which are proteins and a cell line, similar to the 'protein' and 'cell_line' entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B' which are DNA and proteins, similar to the 'DNA' and 'protein' entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'cDNA', 'Jurkat', and 'DRE 1' which are DNA, a cell line, and a cell type, similar to the 'DNA', 'cell_line', and 'cell_type' entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' which are proteins and a cell type, similar to the 'protein' and 'cell_type' entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains the entities 'NF-E1' and 'YY-1' which are proteins, similar to the 'protein' entity type in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[{\"PRE-I\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"Jurkat cells\": \"cell_line\"}]",
        "prediction": "{'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}"
    },
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"Protein\": 5},\n    {\"GM-CSF\": 5},\n    {\"cDNAs\": 5},\n    {\"IgH\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"Stat proteins\": 5},\n    {\"immunohistochemistry\": 5},\n    {\"gene\": 5},\n    {\"cell type\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GM-kappa B\": 5},\n    {\"GC-box\": 5},\n    {\"GC-motif\": 5},\n    {\"GM-kappa B motif\": 5},\n    {\"p50\": 5},\n    {\"p65\": 5},\n    {\"HIV-1 LTR\": 5},\n    {\"NFAT-1\": 5},\n    {\"NF kappa B\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"SIVmac\": 5}\n]",
        "response3": "[{\"HMG boxes\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'HMG boxes': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence directly mentions the cloning and sequencing of cDNAs, which are related to the entity type 'DNA'.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence provides specific protein names (EKLF, CBP, p300, P/CAF) which are directly related to the entity type 'protein'.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence mentions G-CSF, which is a protein and directly related to the entity type 'protein'.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer', which is related to the entity type 'DNA'.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions 'CD95 ligand', which is related to the entity type 'protein'.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence directly mentions 'DNA binding activity', which is related to the entity type 'DNA'.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions 'SCM-1 genes', which is related to the entity type 'cell_line'.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions 'cell adhesion molecules', which are related to the entity type 'cell_type'.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'E2A gene' and 'E2A protein', which are related to the entity type 'protein'.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions 'NF-kappa B', which is related to the entity type 'protein'.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions 'BRCA1', which is related to the entity type 'protein'.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions 'TCF-1', which is related to the entity type 'protein'.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions 'retinoic acid receptor alpha', which is related to the entity type 'protein'.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions 'CREB' and 'AR-CRE', which are related to the entity type 'protein'.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'SIVsmmPBj14', which is related to the entity type 'cell_line'.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions 'protein', which is related to the entity type 'protein'.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entities related to the given entity labels.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any specific entities related to the given entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals, and growth factors.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'DNA' and provides clear context for its presence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'RNA' and provides clear context for its presence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple mentions of protein-related entities and provides context for their presence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'protein' and 'DNA' entities with clear context for their presence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions multiple protein-related entities with clear context for their presence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'RNA' and 'cell_line' entities with clear context for their presence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'DNA' and 'NF-kappa B' entities with clear context for their presence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'CD14' as a protein entity with clear context for its presence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions multiple protein-related entities with clear context for their presence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'P selectin' as a protein entity with clear context for its presence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'CD14' and 'CD23' as protein entities with clear context for their presence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' as protein entities with clear context for their presence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'cell adhesion molecules' as a cell_type entity with clear context for its presence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions multiple protein-related entities and cell types with clear context for their presence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions multiple protein-related entities and cell lines with clear context for their presence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entity mentions relevant to the provided entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entity mentions relevant to the provided entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entity mentions relevant to the provided entity labels.\"}\n]",
        "response3": "[{\"PDGF(B)\": \"RNA\"}]",
        "prediction": "{'PDGF(B)': 'RNA'}"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"CD40\": 5},\n    {\"NF-kappa B\": 5},\n    {\"RXR\": 4},\n    {\"AF-1\": 3},\n    {\"AF-2\": 3},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"c-kit\": 4},\n    {\"SCF\": 3},\n    {\"IL-4R alpha chain\": 4},\n    {\"CD70\": 5},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 5},\n    {\"TCF-1\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"RelA\": 5},\n    {\"p21ras\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"Syk\": 5},\n    {\"Zap\": 5},\n    {\"Egr-1\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"57- to 53-kD proteins\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"CCRF-CEM\": \"cell_line\"}, {\"mature B cells\": \"cell_type\"}, {\"JY\": \"cell_line\"}, {\"Namalwa\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'mature B cells': 'cell_type', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"lymphocyte cytosolic protein\": \"protein\"}, {\"lymphocyte DNA\": \"DNA\"}]",
        "prediction": "{'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 3},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein'}"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IM-9\": \"cell_line\"}, {\"estradiol\": \"protein\"}]",
        "prediction": "{'IM-9': 'cell_line', 'estradiol': 'protein'}"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 4},\n{\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"C/EBP\": \"protein\"}, {\"HIV-1 LTR\": \"DNA\"}]",
        "prediction": "{'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 3},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}, {\"GAL4 DNA binding domain\": \"DNA\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"IgH\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL-2\": 5},\n    {\"IL-4\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"IL-13\": 5},\n    {\"GATA-1\": 5},\n    {\"Sp1\": 5},\n    {\"CD14\": 5},\n    {\"T cell\": 5},\n    {\"Egr-1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"p50\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"EGR-1\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"EBV\": 5, \"CD2\": 5},\n    {\"T cell\": 4, \"IL-2\": 5, \"IL-2 receptor\": 5, \"CD28\": 5},\n    {\"TIMP-1\": 5, \"DNA\": 5},\n    {\"IL-2\": 5, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"GATA-1\": 5},\n    {\"Syk\": 5, \"Zap\": 5, \"T cell\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"AP-1\": 5},\n    {\"FasL\": 5, \"IL-2\": 5, \"IFN-gamma\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 4},\n    {\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 4},\n    {\"Bak\": 5, \"Bad\": 5, \"Bcl-2\": 5, \"PDBu\": 4, \"DMSO\": 4},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"apoptosis\": 1},\n    {},\n    {},\n    {}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"1,25(OH)2D3\": \"protein\"}, {\"tuberculosis\": \"cell_type\"}, {\"unseparated lavage cells\": \"cell_type\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_type'}"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities with corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"serum androgens\": \"protein\"}, {\"GnRH-stimulated gonadotropins\": \"protein\"}, {\"cortisol\": \"protein\"}, {\"17 alpha-hydroxyprogesterone\": \"protein\"}, {\"ACTH\": \"protein\"}]",
        "prediction": "{'serum androgens': 'protein', 'GnRH-stimulated gonadotropins': 'protein', 'cortisol': 'protein', '17 alpha-hydroxyprogesterone': 'protein', 'ACTH': 'protein'}"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5, \"Reason\": \"Both 'Th1' and 'Th2' are specific cell types mentioned in the sentence, providing clear examples of cell types.\"},\n    {\"UAS1\": 4, \"B cell\": 5, \"Reason\": \"'UAS1' is a specific cell line mentioned in the sentence, providing a clear example of a cell line. 'B cell' is also mentioned as a cell type, aiding in entity extraction.\"},\n    {\"SIVsmmPBj14\": 5, \"Reason\": \"'SIVsmmPBj14' is a specific cell line mentioned in the sentence, providing a clear example of a cell line.\"},\n    {\"hepatitis B virus\": 5, \"HBxAg\": 5, \"Reason\": \"'hepatitis B virus' is a specific DNA entity mentioned in the sentence, providing a clear example of DNA. 'HBxAg' is mentioned as a protein, aiding in entity extraction.\"},\n    {\"Th2-type lymphocytes\": 5, \"Reason\": \"'Th2-type lymphocytes' is a specific cell type mentioned in the sentence, providing a clear example of a cell type.\"},\n    {\"GATA-1\": 5, \"Reason\": \"'GATA-1' is a specific protein mentioned in the sentence, providing a clear example of a protein.\"},\n    {\"AP-1\": 5, \"Reason\": \"'AP-1' is a specific DNA entity mentioned in the sentence, providing a clear example of DNA.\"},\n    {\"T cell\": 5, \"interleukin 2\": 5, \"Reason\": \"'T cell' is a specific cell type mentioned in the sentence, providing a clear example of a cell type. 'interleukin 2' is mentioned as a protein, aiding in entity extraction.\"},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5, \"Reason\": \"'NF-ATc' is a specific protein mentioned in the sentence, providing a clear example of a protein. 'T lymphocytes' is mentioned as a cell type, aiding in entity extraction.\"},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5, \"Reason\": \"'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' are all specific proteins mentioned in the sentence, providing clear examples of proteins.\"},\n    {\"Egr-1\": 5, \"Reason\": \"'Egr-1' is a specific protein mentioned in the sentence, providing a clear example of a protein.\"},\n    {\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5, \"Reason\": \"'HIV-1' is a specific cell type mentioned in the sentence, providing a clear example of a cell type. 'IFN', 'PKR', and 'IkappaBalpha' are mentioned as proteins, aiding in entity extraction.\"},\n    {\"HIV-1 LTR\": 5, \"NFAT-1\": 5, \"NF kappa B\": 5, \"Reason\": \"'HIV-1 LTR' is a specific DNA entity mentioned in the sentence, providing a clear example of DNA. 'NFAT-1' and 'NF kappa B' are mentioned as proteins, aiding in entity extraction.\"},\n    {\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 5, \"Reason\": \"'TR55' is a specific protein mentioned in the sentence, providing a clear example of a protein. 'TNF-alpha' is also mentioned as a protein, aiding in entity extraction. 'HIV' is mentioned as a cell type, aiding in entity extraction.\"},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5, \"Reason\": \"'NF-kappaB' and 'Sp1' are specific proteins mentioned in the sentence, providing clear examples of proteins. 'SIVmac' is mentioned as a cell line, aiding in entity extraction.\"},\n    {\"NF-E1\": 5, \"YY-1\": 5, \"Reason\": \"'NF-E1' and 'YY-1' are specific proteins mentioned in the sentence, providing clear examples of proteins.\"},\n    {\"Reason\": 1, \"Reason\": \"The sentence does not contain any specific entities related to the provided entity labels.\"},\n    {\"Reason\": 1, \"Reason\": \"The sentence does not contain any specific entities related to the provided entity labels.\"},\n    {\"Reason\": 1, \"Reason\": \"The sentence does not contain any specific entities related to the provided entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 1},\n    {\"Example 14\": 1},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HeLa cells\": \"cell_line\"}, {\"T-cells\": \"cell_line\"}, {\"DNA\": \"DNA\"}, {\"proteins\": \"protein\"}]",
        "prediction": "{'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'proteins': 'protein'}"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"UAS1\": 5, \"B cell\": 4},\n{\"ZEBRA\": 4},\n{\"IL-4\": 4},\n{\"IL-2\": 4},\n{\"T cell\": 4, \"interleukin 2\": 4},\n{\"NF-kB\": 4, \"AP-1\": 4, \"OCT-1\": 4, \"NF-IL-2B\": 4},\n{\"NF-kappaB\": 4, \"Sp1\": 4, \"p50\": 4},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"Jun\": 4, \"ATF-2\": 4},\n{\"Sp1\": 5, \"CD14\": 4},\n{\"p50p50\": 4},\n{\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 4},\n{\"EKLF\": 5},\n{\"EBNA2\": 4, \"TP1\": 4},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CCAAT box\": 5, \"EKLF binding site\": 5},\n{},\n{},\n{},\n{}]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n{\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n{\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1 ) and p27(KIP1)\": 5},\n    {\"Reasons\": \"Both 'p21(WAF1/CIP1)' and 'p27(KIP1)' are proteins mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"calcineurin\": 5},\n    {\"Reasons\": \"'calcineurin' is a protein mentioned in the sentence, and its name is specific enough to be easily identified as a protein entity.\"},\n    {\"Th1 and Th2\": 5},\n    {\"Reasons\": \"'Th1' and 'Th2' are cell types mentioned in the sentence, and their names are specific enough to be easily identified as cell type entities.\"},\n    {\"IL-2, c-Jun, c-Fos\": 5},\n    {\"Reasons\": \"'IL-2', 'c-Jun', and 'c-Fos' are proteins mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"IL-10, STAT, STAT3, T cells\": 5},\n    {\"Reasons\": \"'IL-10', 'STAT', 'STAT3', and 'T cells' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein and cell type entities.\"},\n    {\"IL4, IL13, gamma c chain, STAT6, STAT3, STAT5, B cells\": 5},\n    {\"Reasons\": \"'IL4', 'IL13', 'gamma c chain', 'STAT6', 'STAT3', 'STAT5', and 'B cells' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein and cell type entities.\"},\n    {\"IL-2\": 5},\n    {\"Reasons\": \"'IL-2' is a protein mentioned in the sentence, and its name is specific enough to be easily identified as a protein entity.\"},\n    {\"IL-12, STAT4, NK cells, T cells, IL-12 receptor\": 5},\n    {\"Reasons\": \"'IL-12', 'STAT4', 'NK cells', 'T cells', and 'IL-12 receptor' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein and cell type entities.\"},\n    {\"SLAP-130, SLP-76, T cell\": 5},\n    {\"Reasons\": \"'SLAP-130', 'SLP-76', and 'T cell' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein and cell type entities.\"},\n    {\"tyrosine\": 5},\n    {\"Reasons\": \"'tyrosine' is a protein mentioned in the sentence, and its name is specific enough to be easily identified as a protein entity.\"},\n    {\"IL-2, IFN-gamma, jak kinases, STAT1(alpha)\": 5},\n    {\"Reasons\": \"'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"IL-2, Aiolos, Ras\": 5},\n    {\"Reasons\": \"'IL-2', 'Aiolos', and 'Ras' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"ERK, STAT3\": 5},\n    {\"Reasons\": \"'ERK' and 'STAT3' are proteins mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"Reasons\": \"'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"NF-kappaB, Sp1, p50\": 5},\n    {\"Reasons\": \"'NF-kappaB', 'Sp1', and 'p50' are proteins mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"interleukin 10, IL-10R, STAT3, IL-6\": 5},\n    {\"Reasons\": \"'interleukin 10', 'IL-10R', 'STAT3', and 'IL-6' are entities mentioned in the sentence, and their names are specific enough to be easily identified as protein entities.\"},\n    {\"Example id\": \"helpfulness score\"},\n    {\"Reason id\": \"reasons\"}\n]",
        "response3": "[{\"p94\": \"protein\"}, {\"p95\": \"protein\"}, {\"Stat1\": \"protein\"}]",
        "prediction": "{'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL-4\": 3},\n    {\"NF-E2\": 3},\n    {\"IL-2\": 3, \"c-Jun\": 3, \"c-Fos\": 3},\n    {\"interferon regulatory factor\": 3},\n    {\"EKLF\": 4, \"CBP\": 4, \"p300\": 4, \"P/CAF\": 4},\n    {\"A-myb\": 4},\n    {\"Protein\": 2},\n    {\"IFN A\": 3, \"IFNA\": 3, \"interleukin-2\": 3, \"interleukin-2 receptor\": 3, \"phytohemagglutinin\": 3, \"phorbol myristate acetate\": 3},\n    {\"p21(WAF1/CIP1)\": 3, \"p27(KIP1)\": 3},\n    {\"Drosophila Toll\": 3, \"human Toll\": 3},\n    {\"PAFR\": 3, \"PAF\": 3, \"NF-kappa B\": 3, \"protein kinase C\": 3},\n    {\"NF-kappa B\": 3, \"AP-1\": 3},\n    {\"EBNA-2\": 4, \"PU.1\": 4},\n    {\"NF-ATc\": 3, \"T lymphocytes\": 3, \"embryonic cardiac cells\": 3},\n    {\"immunoglobulin kappa 3' enhancer\": 3},\n    {\"Egr-1\": 4},\n    {\"common pathway\": 1},\n    {\"tumors\": 1},\n    {\"distinct genes\": 1}\n]",
        "response3": "[{\"IBR\": \"protein\"}, {\"NRF-1/alpha-Pal\": \"protein\"}, {\"P3A2\": \"protein\"}, {\"erected wing gene product (EWG)\": \"protein\"}]",
        "prediction": "{'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a direct mention of 'DNA' and 'RNA' entities, aiding in the extraction of these named entities from the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence directly mentions 'IL-2', which is a protein entity, aiding in the extraction of this named entity from the target sentence.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence mentions specific cell lines such as 'SIVmacMER', 'SIVmac239', and 'CEMx174', providing direct examples of 'cell_line' entities present in the target sentence.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions 'CD4+' and 'EBV', aiding in the extraction of 'cell_type' and 'protein' entities from the target sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides direct examples of various proteins such as 'IFN A', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', aiding in the extraction of these named entities from the target sentence.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions 'TIMP-1' and 'DNA', aiding in the extraction of 'protein' and 'DNA' entities from the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions 'Th2-type lymphocytes', providing a direct example of a 'cell_type' entity present in the target sentence.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions 'EBV' and 'CD2', aiding in the extraction of 'cell_line' and 'protein' entities from the target sentence.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'PBMC' and 'adenovirus DNA', aiding in the extraction of 'cell_type' and 'DNA' entities from the target sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions 'SIVsmmPBj14', providing a direct example of a 'cell_line' entity present in the target sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence mentions 'CD95 ligand', aiding in the extraction of 'protein' entities from the target sentence.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B', providing direct examples of 'DNA' and 'protein' entities present in the target sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions 'EBV', 'EBNA2', and 'estrogen receptor', aiding in the extraction of 'DNA' and 'protein' entities from the target sentence.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence mentions 'TR55', 'TNF-alpha', and 'HIV', aiding in the extraction of 'protein' and 'cell_type' entities from the target sentence.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'NF-kappaB', 'Sp1', and 'SIVmac', providing direct examples of 'protein' and 'cell_line' entities present in the target sentence.\"},\n{\"Example 16\": 4},\n{\"Reason 16\": \"The sentence mentions 'T lymphocytes' and 'adenovirus vectors', aiding in the extraction of 'cell_type' and 'DNA' entities from the target sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not mention any specific entities that are present in the target sentence.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not mention any specific entities that are present in the target sentence.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not mention any specific entities that are present in the target sentence.\"}\n]",
        "response3": "[{\"T-cell types\": \"cell_type\"}, {\"LTR\": \"DNA\"}]",
        "prediction": "{'T-cell types': 'cell_type', 'LTR': 'DNA'}"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"DCs\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a mutated human retinoic acid receptor alpha, which is a protein entity type mentioned in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions IL-7R and gamma(c) as proteins, which are entity types present in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions lymphoid neoplasms, which is a cell_type entity type present in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions retinoic acid receptor alpha, which is a protein entity type present in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions nonhuman primates, which is a cell_type entity type present in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions lymphocytes, benzene, and benzoquinone, which are cell_type and chemical compound entity types present in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides information about RXR, which is a protein entity type mentioned in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions G-CSF, which is a protein entity type present in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions IL4, IL13, gamma c chain, STAT6, STAT3, STAT5, and B cells, which are protein and cell_type entity types present in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions CCAAT box and EKLF binding site, which are DNA and protein entity types present in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions AP-1, which is a DNA entity type present in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions CD14, which is a protein entity type present in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of VDR, RXR, GRIP-1, and DRIP205, which are protein entity types mentioned in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions interleukin-2, alpha chain, CD25, and IL-2 receptor, which are protein entity types present in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions TR55, TNF-alpha, and HIV, which are protein and cell_type entity types present in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions VDR and beta-globin, which are protein entity types present in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not provide any specific examples of entity types mentioned in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not provide any specific examples of entity types mentioned in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not provide any specific examples of entity types mentioned in the target sentence.\"}\n]",
        "response3": "[{\"VDR\": \"protein\"}]",
        "prediction": "{'VDR': 'protein'}"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of DNA binding activity, which is directly related to the entity label 'DNA' in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions NF-kappa B and I kappa B alpha, which are both related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions AP-1, PMA, monocytes, and macrophages, all of which are related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions granulocytes and T cells, which are related to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions NF-kappa B, which is related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions NF-kappaB, Tax, and ATL, all of which are related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions alpha-tocopherol, monocytes, and endothelial cells, all of which are related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions NF-kappa B, which is related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions P selectin, which is related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions NF-kappa B and ARDS, which are related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions NF-kappa B, which is related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions MNDA and Philadelphia chromosome-positive chronic myeloid leukemia, which are related to the entity labels 'protein' and 'cell_line' in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions E2A, which is related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions NF-kappa B and AP-1, which are directly related to the entity labels 'protein' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, all of which are directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities related to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"NFAT\": \"protein\"}, {\"CsA\": \"protein\"}, {\"endothelial cells\": \"cell_type\"}]",
        "prediction": "{'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and cell types, which are directly related to the entity labels in the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific transcription factor (GATA-1) which is relevant to the 'protein' entity label in the entity label set.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes the gene name TAL1 and the cell type T-ALL, both of which correspond to the 'protein' and 'cell_type' entity labels in the entity label set.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions specific cell types (granulocytes and T cells) which are relevant to the 'cell_type' entity label in the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (cAMP-dependent protein kinase and Rap1) which are directly related to the 'protein' entity label in the entity label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions the gene name GATA-1, which corresponds to the 'protein' entity label in the entity label set.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence includes the gene name E2A, which is relevant to the 'protein' entity label in the entity label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names (NF-ATc and TCL1) and cell types (T lymphocytes) which are directly related to the entity labels in the entity label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions the protein name TCL1, which is directly related to the 'protein' entity label in the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names (CREB and AR-CRE) which are directly related to the 'protein' entity label in the entity label set.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions the gene name RXR, which corresponds to the 'protein' entity label in the entity label set.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence includes the cell type Th2-type lymphocytes, which is relevant to the 'cell_type' entity label in the entity label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (TCRzeta and p56(lck)) which are directly related to the 'protein' entity label in the entity label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions specific cell lines (Ter 119) and protein names (beta-globin, glycoprotein IIb, platelet factor 4) which are directly related to the entity labels in the entity label set.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (TR55, TNF-alpha) and cell type (HIV) which are directly related to the entity labels in the entity label set.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific named entities that correspond to the entity labels in the entity label set.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific named entities that correspond to the entity labels in the entity label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific named entities that correspond to the entity labels in the entity label set.\"}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"C1\": \"protein\"}, {\"C2\": \"protein\"}, {\"HIV\": \"cell_type\"}, {\"Jurkat\": \"cell_line\"}]",
        "prediction": "{'C1': 'protein', 'C2': 'protein', 'HIV': 'cell_type', 'Jurkat': 'cell_line'}"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"TCF-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 4, \"p21ras\": 4, \"B cell\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"NF-kappaB\": 5, \"rheumatoid arthritis\": 4},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5},\n    {\"CTLA4Ig\": 5, \"NFAT\": 5, \"AP-1\": 5}\n]",
        "response3": "[{\"NF-muE3\": \"protein\"}, {\"Ig heavy chain enhancer\": \"DNA\"}, {\"B cells\": \"cell_type\"}]",
        "prediction": "{'NF-muE3': 'protein', 'Ig heavy chain enhancer': 'DNA', 'B cells': 'cell_type'}"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"EC1 antibody\": \"protein\"}, {\"p56\": \"protein\"}]",
        "prediction": "{'EC1 antibody': 'protein', 'p56': 'protein'}"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"c-jun\": \"protein\"}, {\"EGR2\": \"protein\"}, {\"PDGF(B)\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein', 'EGR2': 'protein', 'PDGF(B)': 'protein'}"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 3},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HMG-I\": \"protein\"}, {\"GATA motifs\": \"DNA\"}]",
        "prediction": "{'HMG-I': 'protein', 'GATA motifs': 'DNA'}"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Id2\": \"RNA\"}, {\"Id3\": \"RNA\"}, {\"T-cell lines\": \"cell_line\"}, {\"human T-cell leukemia virus type I (HTLV-I)\": \"cell_type\"}, {\"ATL-1k\": \"cell_line\"}, {\"MT-2\": \"cell_line\"}, {\"S-LB1\": \"cell_line\"}, {\"type II (Mo)\": \"cell_type\"}]",
        "prediction": "{'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 5},\n{\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"GP Ib alpha\": \"protein\"}]",
        "prediction": "{'GP Ib alpha': 'protein'}"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"myeloid PU.1 binding site\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (IL-2) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains clear examples of protein entities (RelA and NF-kappa B) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein entity (E2A) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains clear examples of protein entities (IL-2, c-Jun, and c-Fos) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of cell type entities (EBV and B-cell) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains clear examples of cell line and cell type entities (UAS1 and B cell) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of protein entities (IL-2, IFN-gamma, jak kinases, and STAT1(alpha)) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains clear examples of DNA and protein entities (CCAAT box and EKLF binding site) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of cell type and protein entities (T cell and interleukin 2) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains a clear example of a protein entity (p50p50) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of cell type and protein entities (CD4+ and EBV) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains a clear example of a protein entity (EKLF) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of cell line and protein entities (EBV and CD2) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains clear examples of protein and cell line entities (EBNA2 and TP1) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of a protein entity (RXR) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains clear examples of cell type, cell line, and DNA entities (B and T cell activation, Ramos, Jurkat, and cDNA microarray technology) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities.\"}\n]",
        "response3": "[{'R': 'protein'}, {'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell-specific': 'cell_type'}]",
        "prediction": "{'R': 'protein', 'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n{\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n{\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain .\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 5},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (IFN-gamma) and its corresponding label, which is helpful for understanding how proteins are mentioned in the context of pathogenesis.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of protein entities (NF-kappaB, Tax) and cell type entities (ATL) with their corresponding labels, aiding in the identification of these entities in similar contexts.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence presents a specific example of a DNA entity (AP-1) and its label, which is valuable for recognizing DNA-related entities in pathogenesis contexts.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes a protein entity (P selectin) and its label, providing a clear example of how proteins are mentioned in relation to cytokine production.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence offers instances of protein entity (NF-kappaB) and cell type entity (rheumatoid arthritis) with their labels, aiding in understanding the role of proteins and cell types in pathogenesis.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of protein entities (PKC isoforms) and cell type entities (human alveolar macrophages, blood monocytes) with their labels, assisting in recognizing these entities in pathogenesis contexts.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains a protein entity (NF-kappa B) and its label, offering insight into how proteins are involved in xenograft survival strategies.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions cell adhesion molecules as a cell type entity, providing a clear example of how cell types are referenced in the context of pathogenesis.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes protein entity (NF-kappa B) and cell type entity (ARDS) with their labels, aiding in understanding the involvement of proteins and cell types in pathogenesis.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence presents protein entities (IkappaBbeta, NF-kappaB) and their labels, helping in recognizing these proteins and their roles in pathogenesis.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence offers examples of protein entity (IL-12) and cell type entity (macrophages) with their labels, aiding in understanding the involvement of proteins and cell types in pathogenesis.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains protein entities (Stat3, Stat5, c-Mpl) and their labels, providing insight into the role of these proteins in megakaryopoiesis and platelet function.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions eosinophils as a cell type entity, offering a clear example of how cell types are involved in allergic inflammation.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence includes protein entity (alpha-tocopherol) and cell type entities (monocyte, endothelial cells) with their labels, aiding in recognizing these entities in atherosclerosis context.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence presents protein entities (SP1, caspases) and cell type entity (B-cell) with their labels, assisting in understanding the involvement of proteins and cell types in B-cell apoptosis.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains a protein entity (NF-kappa B) and its label, providing insight into how proteins are involved in the activation of human monocytic cells.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific examples of entities related to the target sentence, making it less helpful in understanding named entities in pathogenesis.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not mention any entities related to the target sentence, making it less helpful in understanding named entities in pathogenesis.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not provide any examples of entities related to the target sentence, making it less helpful in understanding named entities in pathogenesis.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"PBMC\": 5, \"adenovirus\": 5},\n    {\"WT1\": 5},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5},\n    {\"TCL1\": 5},\n    {\"myeloperoxidase\": 5, \"lysozyme\": 5, \"PU.1\": 5},\n    {\"Ras\": 5},\n    {\"T-PLL\": 5},\n    {\"T lymphocytes\": 5, \"HLA-molecules\": 5},\n    {\"MNDA\": 5, \"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5, \"T cells\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"PBMC\": 5, \"adenovirus DNA\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"SIVsmmPBj14\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-myc\": \"protein\"}, {\"T lymphoblastic tumor cell line\": \"cell_line\"}]",
        "prediction": "{'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"T cell blasts treated with PMA are now responsive to IFN-gamma .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"OTF-1\": \"protein\"}, {\"pre-B cells\": \"cell_type\"}, {\"HeLa cells\": \"cell_line\"}, {\"immunoglobulin gene\": \"protein\"}]",
        "prediction": "{'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"5\": \"The sentence contains 'T-ALL' which is a cell type entity from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"5\": \"The sentence contains 'MNDA' which is a protein entity and 'Philadelphia chromosome-positive chronic myeloid leukemia' which is a cell line entity from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"5\": \"The sentence contains 'T lymphocytes' which is a cell type entity from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"5\": \"The sentence contains 'WT1' which is a protein entity and 'myeloid cell lines' which is a cell line entity from the given entity label set.\"},\n{\"5\": \"The sentence contains 'Egr-1' which is an RNA entity from the given entity label set.\"},\n{\"5\": \"The sentence contains 'PMA' and 'IFN-gamma' which are protein entities, and 'T cell blasts' which is a cell type entity from the given entity label set.\"},\n{\"5\": \"The sentence contains 'EBV' which is a DNA entity, 'EBNA2' and 'estrogen receptor' which are protein entities from the given entity label set.\"},\n{\"5\": \"The sentence contains 'TCL1' and 'MTCP1/c6.1B' which are protein entities from the given entity label set.\"},\n{\"5\": \"The sentence contains 'CD4+' and 'CD8+' which are cell type entities, 'TPCK' and 'anti-CD28' which are protein entities, and 'PMA' which is a protein entity from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"1\": \"The sentence does not contain any named entities from the given entity label set.\"}\n]",
        "response3": "[{'Tamoxifen': 'protein'}, {'CLL': 'cell_type'}, {\"Hodgkin's disease\": 'cell_type'}]",
        "prediction": "{'Tamoxifen': 'protein', 'CLL': 'cell_type', \"Hodgkin's disease\": 'cell_type'}"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example directly mentions the entity type 'DNA' which is present in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides a clear link between the entity 'CD95 ligand' and the entity type 'protein' present in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example mentions the entities 'EBNA-2' and 'PU.1' which are both of type 'protein' present in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example directly mentions the entity type 'DNA' which is present in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides multiple instances of entities ('IL-2', 'c-Jun', 'c-Fos') of type 'protein' present in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example directly mentions the entity 'NF-kappa B' which is of type 'protein' present in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example links the entities 'c-kit' and 'IL-4R alpha chain' to the entity type 'protein' present in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear link between the entities 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' to the entity types 'protein' and 'cell_type' present in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example mentions the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' which are all of type 'protein' present in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a direct link between the entities 'IL-4', 'LPS', and 'AP-1' to the entity type 'protein' present in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example directly mentions the entity types 'granulocytes' and 'T cells' which are present in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example directly mentions the entity 'SCM-1' which is of type 'cell_line' present in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear link between the entities 'CD40' and 'NF-kappa B' to the entity type 'protein' present in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example mentions the entities 'p21(WAF1/CIP1)' and 'p27(KIP1)' which are both of type 'protein' present in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example directly mentions the entity 'E2A' which is of type 'protein' present in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not contain any entity types present in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any entity types present in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not contain any entity types present in the target sentence.\"}\n]",
        "response3": "[{'octamer-binding proteins': 'protein'}, {'latter cells': 'cell_type'}]",
        "prediction": "{'octamer-binding proteins': 'protein', 'latter cells': 'cell_type'}"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"IL-2\": \"DNA\"}, {\"VDR\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"immunoglobulin heavy and kappa light chain gene enhancers\": \"DNA\"}]",
        "prediction": "{'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"T cell\": 5, \"kB-like proto-enhancer element\": 3, \"interleukin 2\": 3},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CREB\": 4, \"AR-CRE\": 4},\n{\"SIVsmmPBj14\": 5},\n{\"EBNA2\": 4, \"TP1\": 3},\n{\"BRCA1\": 5},\n{\"p50p50\": 5},\n{\"GM-CSF\": 4},\n{\"retinoic acid receptor alpha\": 5},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"Protein\": 4},\n{\"Th2-type lymphocytes\": 5},\n{\"IgH\": 5},\n{\"VDR\": 4, \"RXR\": 4, \"GRIP-1\": 4, \"DRIP205\": 4, \"DRIP\": 3},\n{\"GM-kappa B\": 5, \"GC-box\": 5, \"GC-motif\": 5, \"GM-kappa B motif\": 5},\n{\"NF-kappaB\": 4, \"Sp1\": 4, \"SIVmac\": 5},\n{\"common pathway\": 1, \"signaling pathway\": 1},\n{\"tumors\": 1, \"ovary\": 1},\n{\"distinct genes\": 1, \"family members\": 1}\n]",
        "response3": "[{\"RCGCRYGCGY\": \"DNA\"}, {\"IBR/F\": \"protein\"}, {\"TGCGCATGCGCA\": \"DNA\"}]",
        "prediction": "{'RCGCRYGCGY': 'DNA', 'IBR/F': 'protein', 'TGCGCATGCGCA': 'DNA'}"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 3},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU-SF complex\": \"protein\"}, {\"PU.1\": \"protein\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"TNF alpha\": \"protein\"}, {\"cAMP\": \"protein\"}, {\"cAMP activators\": \"protein\"}]",
        "prediction": "{'TNF alpha': 'protein', 'cAMP': 'protein', 'cAMP activators': 'protein'}"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms\": 4},\n    {\"T lymphocytes\": 3},\n    {\"IL-4\": 3},\n    {\"Protein\": 2},\n    {\"WT1\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"GATA-1\": 4},\n    {\"Syk\": 4},\n    {\"Zap\": 4},\n    {\"T cell\": 3},\n    {\"RXR\": 4},\n    {\"E2A\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCF-1\": 4},\n    {\"immunohistochemistry\": 4},\n    {\"gene\": 1},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"Th1\": 3},\n    {\"Th2\": 3},\n    {\"Egr-1\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 3},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"OTF-1\": \"protein\"}]",
        "prediction": "{'OTF-2': 'protein', 'OTF-1': 'protein'}"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 1},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"MATERIALS AND METHODS: Human monocytes were stimulated with PMA (50 ng/ml) alone or LPS (100 ng/ml) with and without a nonspecific serine/threonine protein kinase inhibitor staurosporine (Stauro), a specific pan-PKC inhibitor bisindolylmaleimide (Bis), or an inhibitor of PTK genistein (Gen).\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"DNA-binding phosphoproteins induced after T cell activation: effects of cyclosporin A.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "response1": "['cell_line', 'virus']",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 1},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"B-lymphoblastoid cell lines\": \"cell_line\"}, {\"multiple sclerosis patients\": \"cell_type\"}, {\"a healthy control\": \"cell_type\"}, {\"putative new human retrovirus\": \"virus\"}, {\"Epstein-Barr virus\": \"virus\"}]",
        "prediction": "{'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'a healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'virus'}"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"lymphoid-specific enhancer element\": \"DNA\"}, {\"immunoglobulin heavy-chain gene\": \"DNA\"}]",
        "prediction": "{'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of DNA binding activity, directly linking the entity 'NF-kappa B' to the entity label 'DNA'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence clearly mentions the protein 'ZAP-70' and its responsiveness to treatment, making it a helpful example for predicting the entity label 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple instances of entities like 'NF-kappaB', 'Tax', and 'ATL' with clear context, aiding in predicting the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a direct link between the overexpressed protein 'WT1' and the entity label 'protein', as well as mentioning 'myeloid cell lines' for the entity label 'cell_line'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions various proteins like 'IFN A', 'interleukin-2', and 'interleukin-2 receptor' along with stimuli like 'phytohemagglutinin' and 'phorbol myristate acetate', making it a rich example for predicting protein entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly links 'NF-kappa B' to activation, aiding in predicting the entity label 'protein'.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of inactivation of 'IkappaBbeta' by the 'tax protein', linking both entities to the entity label 'protein'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'TIMP-1' and 'DNA synthesis', providing a direct example for predicting the entity labels 'protein' and 'DNA'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'PBMC' and 'adenovirus DNA', providing clear examples for predicting the entity labels 'cell_type' and 'DNA'.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha', providing multiple examples for predicting the entity labels 'cell_type' and 'protein'.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'NF-kappaB', 'Sp1', and 'SIVmac', providing examples for predicting the entity labels 'protein' and 'cell_line'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'pRB', 'U937', 'p53', 'apoptosis', 'calphostin C', 'ceramide', and 'serum withdrawal', providing multiple examples for predicting the entity labels 'protein' and 'cell_line'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'T lymphocytes' and 'adenovirus vectors', providing examples for predicting the entity labels 'cell_type' and 'DNA'.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'NF-kappa B' and 'neutrophils', providing examples for predicting the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'HIV', 'p105', 'p50', and 'MAD3', providing examples for predicting the entity labels 'protein'.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'CD4+', 'CD8+', 'TPCK', 'anti-CD28', and 'PMA', providing examples for predicting the entity labels 'cell_type' and 'protein'.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'human papillomavirus': 'cell_type'}, {'adenovirus': 'cell_type'}, {'natural killer cells': 'cell_type'}]",
        "prediction": "{'human papillomavirus': 'cell_type', 'adenovirus': 'cell_type', 'natural killer cells': 'cell_type'}"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of cell adhesion molecules, which directly relate to the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions 'retinoic acid receptor alpha', which is a specific protein entity, matching the 'protein' entity label in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple instances of proteins such as 'Stat3', 'Stat5', and 'c-Mpl', which align with the 'protein' entity label in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly discusses 'cAMP-dependent protein kinase' and 'Rap1' as proteins, which correspond to the 'protein' entity label in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'G-CSF' as a protein, matching the 'protein' entity label in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of proteins 'CD14' and 'CD23', aligning with the 'protein' entity label in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence includes 'alpha-tocopherol' as a protein, 'monocyte' and 'endothelial cells' as cell types, all of which correspond to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'AP-1', 'PMA' as proteins, 'monocytes', and 'macrophages' as cell types, all matching the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence discusses 'Syk' and 'Zap' as proteins, and 'T cell' as a cell type, aligning with the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'PKC isoforms' as proteins, 'human alveolar macrophages' and 'blood monocytes' as cell types, all corresponding to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence includes 'P selectin' as a protein, matching the 'protein' entity label in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides 'GATA-1' as a protein, aligning with the 'protein' entity label in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'phosphocreatine' as a protein, which corresponds to the 'protein' entity label in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence discusses 'NF-kappa B' as a protein, aligning with the 'protein' entity label in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' as proteins, all matching the 'protein' entity label in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5' as proteins, and 'B cells' as a cell type, aligning with the entity labels in the target sentence.\"}\n]",
        "response3": "[{'Platelet thromboxane receptors': 'protein'}]",
        "prediction": "{'Platelet thromboxane receptors': 'protein'}"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "response1": "['cell_line', 'cell_line']",
        "response2": "[\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n{\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 3},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 4},\n{\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 4},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n{\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Human herpesvirus 6\": \"cell_type\"}, {\"EBV\": \"cell_line\"}, {\"B cell lines\": \"cell_line\"}, {\"EBV\": \"cell_type\"}]",
        "prediction": "{'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_type', 'B cell lines': 'cell_line'}"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"BLR2 mRNA\": \"RNA\"}, {\"mitogen\": \"protein\"}, {\"anti-CD3\": \"protein\"}, {\"peripheral blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding how different proteins and cell lines are mentioned in the text.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence offers multiple examples of named entities with their respective labels, demonstrating the variety of proteins and cell lines mentioned in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a comprehensive list of named entities with their corresponding labels, showcasing the different proteins and cell lines mentioned in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence presents clear examples of named entities with their respective labels, illustrating the proteins mentioned in the sentence and their relevance.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence offers specific examples of named entities with their corresponding labels, aiding in understanding the proteins mentioned in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of a named entity with its label, demonstrating how a specific DNA entity is mentioned in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence presents a specific example of a named entity with its label, aiding in understanding the protein mentioned in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence offers specific examples of named entities with their corresponding labels, showcasing the proteins mentioned in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of named entities with their respective labels, aiding in understanding the proteins mentioned in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence presents a specific example of a named entity with its label, demonstrating how a protein entity is mentioned in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence offers specific examples of named entities with their corresponding labels, aiding in understanding the proteins mentioned in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of named entities with their respective labels, showcasing the proteins mentioned in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence offers specific examples of named entities with their corresponding labels, aiding in understanding the proteins mentioned in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence presents a specific example of a named entity with its label, demonstrating how a protein entity is mentioned in the sentence.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The sentence does not contain any named entities from the given entity label set, hence it is not helpful in extracting named entities from the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any named entities from the given entity label set, hence it is not helpful in extracting named entities from the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities from the given entity label set, hence it is not helpful in extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"AP-1\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'DNA', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"RXR\": 5, \"cDNAs\": 5, \"E2A\": 5},\n{\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n{\"myeloperoxidase\": 5, \"lysozyme\": 5, \"PU.1\": 5},\n{\"IL-4\": 5, \"LPS\": 5, \"AP-1\": 5},\n{\"IL-4\": 5},\n{\"GATA-1\": 5},\n{\"Th1\": 5, \"Th2\": 5},\n{\"EBNA-2\": 5, \"PU.1\": 5},\n{\"NF-kappa B\": 5, \"AP-1\": 5},\n{\"NF-ATc\": 5, \"T lymphocytes\": 5, \"embryonic cardiac cells\": 5},\n{\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Distinct genes\": 1}\n]",
        "response3": "[{\"N-Oct-factors\": \"protein\"}, {\"Oct-1\": \"protein\"}, {\"Oct-2A\": \"protein\"}]",
        "prediction": "{'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 1},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n{\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n{\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\": 5},\n{\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\": 5},\n{\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"STAT5\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"JAK3\": \"protein\"}]",
        "prediction": "{'STAT5': 'protein', 'IL-2': 'protein', 'T cells': 'cell_type', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"IL-3\": \"protein\"}]",
        "prediction": "{'IL-3': 'protein'}"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_line']",
        "response2": "[\n{\"TIMP-1\": 4, \"DNA\": 3},\n{\"NF-kB\": 4, \"AP-1\": 4, \"OCT-1\": 4, \"NF-IL-2B\": 4},\n{\"RelA\": 4, \"NF-kappa B\": 4},\n{\"NF-kappaB\": 5, \"Tax\": 4, \"ATL\": 4},\n{\"IkappaBbeta\": 4, \"NF-kappaB\": 4},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5},\n{\"NF-kappa B\": 5, \"IL-2\": 4, \"AP-1\": 4},\n{\"NF-kappa B\": 5, \"I kappa B alpha\": 4},\n{\"NF-kappa B\": 5, \"I kappa B alpha\": 4},\n{\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n{\"HIV-1\": 5, \"IFN\": 4, \"PKR\": 4, \"IkappaBalpha\": 4},\n{\"CD40\": 4, \"Rel/nuclear factor kappaB\": 4, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n{\"TR55\": 4, \"TNF-alpha\": 4, \"HIV\": 4},\n{\"NF-kappaB\": 5, \"Sp1\": 4, \"SIVmac\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"HIV type 1\": \"cell_type\"}, {\"HIV-1\": \"cell_type\"}, {\"viral RNA\": \"RNA\"}, {\"U937 cells\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'viral RNA': 'RNA', 'U937 cells': 'cell_line'}"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor\": 4},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 5},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n{\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways\": 5},\n{\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well\": 1}\n]",
        "response3": "[{\"Thy-1 gene\": \"protein\"}]",
        "prediction": "{'Thy-1 gene': 'protein'}"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 3},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"TCF-1\": \"protein\"}, {\"lymphoid malignancies\": \"cell_type\"}]",
        "prediction": "{'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and specific entity with its corresponding label, aiding in understanding how named entities are identified in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example includes multiple entities with their respective labels, demonstrating the diversity of named entities present in the sentence and how they are categorized.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example highlights a specific entity with its label, showcasing the relevance of the named entity in the sentence and how it is classified.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example presents a distinct entity with its label, contributing to the understanding of named entity extraction and classification in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a specific entity with its label, aiding in the identification and categorization of named entities in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example includes multiple entities with their corresponding labels, demonstrating the variety of named entities present in the sentence and how they are recognized.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example highlights a specific entity with its label, showcasing the relevance of the named entity in the sentence and how it is categorized.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example presents a distinct entity with its label, contributing to the understanding of named entity extraction and classification in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a specific entity with its label, aiding in the identification and categorization of named entities in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example highlights a specific entity with its label, showcasing the relevance of the named entity in the sentence and how it is categorized.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example includes multiple entities with their corresponding labels, demonstrating the variety of named entities present in the sentence and how they are recognized.\"},\n    {\"Example 12\": 1},\n    {\"Reason 12\": \"The example does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in understanding named entity extraction.\"},\n    {\"Example 13\": 1},\n    {\"Reason 13\": \"The example does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in understanding named entity extraction.\"},\n    {\"Example 14\": 1},\n    {\"Reason 14\": \"The example does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in understanding named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains a clear mention of the protein 'TCL1', which is a named entity that can be easily identified.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence contains a clear mention of the protein 'WT1', which is a named entity that can be easily identified.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence contains a clear mention of the protein 'RXR', which is a named entity that can be easily identified.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence contains a clear mention of the cell type 'lymphoid neoplasms', which is a named entity that can be easily identified.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains a clear mention of the protein 'NF-kappa B', which is a named entity that can be easily identified.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence contains clear mentions of the proteins 'TCRzeta' and 'p56(lck)', which are named entities that can be easily identified.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains a clear mention of the DNA entity 'AP-1', which is a named entity that can be easily identified.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains clear mentions of the proteins 'EBNA-2' and 'PU.1', which are named entities that can be easily identified.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains clear mentions of the proteins 'IL-2 receptor alpha subunit', 'p21ras', and the cell type 'B cell', which are named entities that can be easily identified.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains clear mentions of the proteins 'SLAP-130', 'SLP-76', and the cell type 'T cell', which are named entities that can be easily identified.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains clear mentions of the protein 'NF-kappaB' and the cell type 'rheumatoid arthritis', which are named entities that can be easily identified.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains clear mentions of the proteins 'myeloperoxidase', 'lysozyme', and 'PU.1', which are named entities that can be easily identified.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence contains a clear mention of the protein 'retinoic acid receptor alpha', which is a named entity that can be easily identified.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains clear mentions of the proteins 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and the cell type 'B cells', which are named entities that can be easily identified.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence contains clear mentions of the cell type 'T lymphocytes' and the protein 'HLA-molecules', which are named entities that can be easily identified.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any named entities from the given entity label set.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any named entities from the given entity label set.\"}\n]",
        "response3": "[{\"HLA class II antigens\": \"protein\"}, {\"Ro(SSA)\": \"protein\"}, {\"La(SSB)\": \"protein\"}]",
        "prediction": "{'HLA class II antigens': 'protein', 'Ro(SSA)': 'protein', 'La(SSB)': 'protein'}"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 3},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities and their corresponding entity labels, which can aid in understanding the types of entities present in the target sentence.\"},\n    {\"Example 2\": 2},\n    {\"Reason 2\": \"The sentence mentions phosphocreatine, which is a protein, providing a relevant example for entity extraction, but the context is not directly related to the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple examples of named entities (AP-1, PMA, monocytes, macrophages) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of named entities (granulocytes, T cells) and their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions NF-kappa B and AP-1 as protein entities, which are relevant to the target sentence, but the context is not directly related.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains examples of named entities (IL-4, LPS, AP-1) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions AP-1 as a DNA entity, which is relevant to the target sentence, but the context is not directly related.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides examples of named entities (CD14, CD23) and their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains examples of named entities (SIVmacMER, SIVmac239, CEMx174) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of named entities (MTHC, TNF-alpha, IFN-gamma, DC) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions T lymphocytes as a cell type entity, which is relevant to the target sentence, but the context is not directly related.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains examples of named entities (SP1, caspases, B-cell) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of named entities (Tip, Tap, Jurkat-T cells) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains examples of named entities (PMA, LPS, staurosporine, bisindolylmaleimide, genistein) with their corresponding entity labels, directly relevant to the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions interleukin-1beta as an RNA entity and inhibitor-kappaB alpha as a protein entity, which are relevant to the target sentence, but the context is not directly related.\"},\n    {\"Example 16\": 3},\n    {\"Reason 16\": \"The sentence mentions PMA and U1 cells as cell line entities, which are relevant to the target sentence, but the context is not directly related.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not provide any examples of named entities relevant to the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not provide any examples of named entities relevant to the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not provide any examples of named entities relevant to the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"NFAT\": \"protein\"}]",
        "prediction": "{'calcineurin': 'protein', 'NFAT': 'protein'}"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ER\": \"protein\"}, {\"ER\": \"protein\"}]",
        "prediction": "{'ER': 'protein'}"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"SIVsmmPBj14\": 5},\n    {\"SIVmacMER\": 5},\n    {\"SIVmac239\": 5},\n    {\"CEMx174\": 5},\n    {\"GM-CSF\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"protein\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"TCF-1\": 5},\n    {\"MIP-1 alpha\": 5},\n    {\"GOS19\": 5},\n    {\"LD78\": 5},\n    {\"AT464\": 5},\n    {\"CD14\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"T cell\": 5},\n    {\"Egr-1\": 5},\n    {\"E2A\": 5},\n    {\"CD95 ligand\": 5}\n]",
        "response3": "[{\"ets-1\": \"protein\"}, {\"cDNA\": \"DNA\"}, {\"mouse thymus cDNA expression library\": \"cell_line\"}, {\"Moloney murine sarcoma virus\": \"cell_line\"}, {\"MSV\": \"cell_line\"}, {\"LTR\": \"DNA\"}]",
        "prediction": "{'ets-1': 'protein', 'cDNA': 'DNA', 'mouse thymus cDNA expression library': 'cell_line', 'Moloney murine sarcoma virus': 'cell_line', 'MSV': 'cell_line', 'LTR': 'DNA'}"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ER\": \"protein\"}, {\"NK\": \"cell_type\"}]",
        "prediction": "{'ER': 'protein', 'NK': 'cell_type'}"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the protein 'calcineurin' and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides clear examples of the proteins 'IkappaBalpha' and 'NF-kappaB' and their corresponding entity labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides clear examples of the proteins 'IkappaBbeta' and 'NF-kappaB' and their corresponding entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of the proteins 'NF-kappa B' and 'AP-1' and their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of the proteins 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of the proteins 'CD40' and 'NF-kappa B' and their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of the proteins 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' and their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of the proteins 'NF-kappaB', 'Tax', and 'ATL' and their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of the proteins 'NF-kappa B' and 'I kappa B beta' and their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of the proteins 'RelA' and 'NF-kappa B' and their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of the proteins 'Syk', 'Zap', and 'T cell' and their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of the proteins 'SP1', 'caspases', and 'B-cell' and their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of the protein 'NF-kappa B' and its corresponding entity label.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any entities related to the provided entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the provided entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the provided entity labels.\"}\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"CsA\": \"protein\"}, {\"PKC\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cell\": \"cell_type\"}]",
        "prediction": "{'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell': 'cell_type'}"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"HTLV-I\": \"protein\"}]",
        "prediction": "{'HTLV-I': 'protein'}"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 4},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\": 5},\n    {\"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 5},\n{\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n{\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"BRCA1\": 5},\n    {\"TCF-1\": 5},\n    {\"SLAP-130\": 5, \"SLP-76\": 5, \"T cell\": 5},\n    {\"IkappaBbeta\": 5, \"NF-kappaB\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL-2 receptor alpha subunit\": 5, \"p21ras\": 5, \"B cell\": 5},\n    {\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n    {\"IL-13\": 5, \"IL-4R\": 5, \"JAK2\": 5, \"IL-13R\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 3},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"SCM-1\": 5},\n    {\"TAL1\": 5, \"T-ALL\": 5},\n    {\"T-PLL\": 5},\n    {\"TCL1\": 5},\n    {\"SCL\": 5, \"GATA-1\": 5}\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"TCR alpha/beta\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"T-prolymphocytic (T-PLL)\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of a cell type entity (T cell) and protein entities (IL-2, IL-2 receptor, CD28) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of RNA entity (IL-5 mRNA), cell type entity (TCR), and protein entities (IL-2R, dexamethasone) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of protein entities (NF-kappa B, I kappa B alpha) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides an example of a protein entity (IL-2) with its corresponding label, which directly aids in extracting named entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of protein entities (NF-ATc) and cell type entity (T lymphocytes) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (IkappaBbeta, NF-kappaB) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and cell type entity (B cell) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (Syk, Zap) and cell type entity (T cell) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (IL-2, NF-kappa B, AP-1) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of protein entities (IL-2, Aiolos, Ras) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of protein entities (IkappaBalpha, NF-kappaB) with their corresponding labels, which directly aid in extracting named entities from the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the entity labels in the target sentence, hence it is not helpful in aiding the extraction of named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the entity labels in the target sentence, hence it is not helpful in aiding the extraction of named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the entity labels in the target sentence, hence it is not helpful in aiding the extraction of named entities.\"}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"immunophilin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IFN A\": \"The mention of IFN A (IFNA) is directly associated with the protein entity type, providing a clear and specific example.\"},\n    {\"IFNA\": \"The mention of IFNA is directly associated with the protein entity type, providing a clear and specific example.\"},\n    {\"interleukin-2\": \"The mention of interleukin-2 is directly associated with the protein entity type, providing a clear and specific example.\"},\n    {\"interleukin-2 receptor\": \"The mention of interleukin-2 receptor is directly associated with the protein entity type, providing a clear and specific example.\"},\n    {\"phytohemagglutinin\": \"The mention of phytohemagglutinin is directly associated with the protein entity type, providing a clear and specific example.\"},\n    {\"phorbol myristate acetate\": \"The mention of phorbol myristate acetate is directly associated with the protein entity type, providing a clear and specific example.\"}\n]\n[\n    {\"Example id\": \"5\"},\n    {\"Reason id\": \"The sentence contains specific mentions of various proteins, including IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are directly associated with the protein entity type, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"NF-kappa B activation\": 5},\n{\"Gel-shift analysis\": 1},\n{\"phorbol esters\": 1},\n{\"mouse E2A gene\": 1},\n{\"granulocyte-macrophage lineage\": 5},\n{\"chimeric receptor\": 1},\n{\"PML/RARalpha\": 5},\n{\"RXR\": 5},\n{\"TRAF6\": 5},\n{\"NF-ATc\": 5},\n{\"CD40 cytoplasmic domain\": 5},\n{\"GATA-1\": 5},\n{\"TCF-1\": 5},\n{\"persistent activation of NF-kappa B\": 5},\n{\"IL-2 responsiveness\": 5},\n{\"ZEB and transcriptional activation by c-Myb /Ets\": 5}\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"hematopoietic cell lineage\": \"cell_type\"}]",
        "prediction": "{'NF-M': 'protein', 'hematopoietic cell lineage': 'cell_type'}"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'IL-4' and its corresponding entity label 'protein' in the sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"NF-IL6\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HLA-DR alpha (DRA)\": \"protein\"}, {\"octamer\": \"protein\"}, {\"immunoglobulin variable region\": \"protein\"}, {\"B cell-specific\": \"cell_type\"}]",
        "prediction": "{'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 5},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Jak3\": \"protein\"}, {\"gamma c\": \"protein\"}, {\"Jak3\": \"protein\"}]",
        "prediction": "{'Jak3': 'protein', 'gamma c': 'protein'}"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (TIMP-1, DNA) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions a specific protein (MNDA) and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia) which can be identified as entities, although the context is slightly more complex.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence contains multiple specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions a specific protein (CD14) that is directly mentioned and can be easily identified as an entity.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions a specific protein (retinoic acid receptor alpha) that is directly mentioned and can be easily identified as an entity.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions a specific protein (WT1) and a specific cell line (myeloid cell lines) which can be identified as entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions a specific protein (NF-E2) that is directly mentioned and can be easily identified as an entity.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions a specific protein (retinoic acid receptor alpha) that is directly mentioned and can be easily identified as an entity.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions a specific protein (RXR) that is directly mentioned and can be easily identified as an entity.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions a specific protein (ZAP-70) that is directly mentioned and can be easily identified as an entity.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains specific protein names (IL-5 mRNA, TCR, IL-2R, dexamethasone) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains specific protein names (VDR, RXR, GRIP-1, DRIP205, DRIP) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions specific proteins (interleukin-2, alpha chain, CD25, IL-2 receptor) that are directly mentioned and can be identified as entities, although the context is slightly more complex.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions specific proteins (Protein kinase B, phosphatidylinositol 3-kinase, STAT5, erythropoietin, EPO, c-Akt) and specific cell lines (HCD57, HCD57-SREI) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions specific cell lines (hematopoietic cell line, 47.10, cell line, nontransgenic mice) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions specific entities (2-deoxyguanosine, lymphoid progenitor cells, thymus stromal cells, B cell, tg epsilon26, fetal liver cells, T cell) that are directly mentioned and can be easily identified as entities.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific named entities that can be identified.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific named entities that can be identified.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any specific named entities that can be identified.\"}\n]",
        "response3": "[{\"Ro-VDR\": \"cell_line\"}]",
        "prediction": "{'Ro-VDR': 'cell_line'}"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"1,25-dihydroxyvitamin D3\": \"protein\"}, {\"VDR\": \"protein\"}]",
        "prediction": "{'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"NF-kappa B\": 5, \"DNA\": 1, \"protein\": 5, \"cell_type\": 1, \"cell_line\": 1},\n    {\"NF-kappa B\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"DNA\": 5},\n    {\"IkappaBbeta\": 5, \"NF-kappaB\": 5, \"protein\": 5},\n    {\"NF-kappaB\": 5, \"Tax\": 3, \"ATL\": 3, \"cell_type\": 3},\n    {\"RelA\": 5, \"NF-kappa B\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5, \"protein\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"protein\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5, \"protein\": 5},\n    {\"AP-1\": 5, \"DNA\": 5},\n    {\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5, \"cell_type\": 5, \"protein\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 5, \"protein\": 5, \"cell_type\": 5},\n    {\"TR55\": 5, \"TNF-alpha\": 5, \"HIV\": 5, \"cell_type\": 5, \"protein\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5, \"protein\": 5, \"cell_line\": 5},\n    {\"HIV-1 LTR\": 5, \"NFAT-1\": 5, \"NF kappa B\": 5, \"DNA\": 5, \"protein\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"IgH\": 5, \"BRCA1\": 4},\n{\"EBNA2\": 4, \"TP1\": 3},\n{\"GM-CSF\": 4},\n{\"Protein\": 5},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"p50p50\": 4},\n{\"EKLF\": 4},\n{\"TCF-1\": 4},\n{\"ZEBRA\": 4},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"Egr-1\": 4},\n{\"T cell\": 4, \"interleukin 2\": 4},\n{\"Th2-type lymphocytes\": 4},\n{\"CD95 ligand\": 4},\n{\"GM-kappa B\": 5, \"GC-box\": 5, \"GC-motif\": 5, \"GM-kappa B motif\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides clear examples of named entities with corresponding entity labels, aiding in understanding and identifying similar entities in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence contains multiple examples of named entities with corresponding entity labels, which can help in recognizing similar entities in the target sentence.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence offers a variety of named entities with corresponding entity labels, facilitating the identification of similar entities in the target sentence.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence presents named entities with corresponding entity labels, assisting in recognizing similar entities in the target sentence.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence includes a named entity with a corresponding entity label, aiding in understanding and identifying similar entities in the target sentence.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence provides named entities with corresponding entity labels, which can help in recognizing similar entities in the target sentence.\"},\n{\"Example 7\": 3},\n{\"Reason 7\": \"The sentence contains a named entity with a corresponding entity label, which may provide some context but is not directly related to the entities in the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence offers multiple named entities with corresponding entity labels, aiding in understanding and identifying similar entities in the target sentence.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence presents named entities with corresponding entity labels, assisting in recognizing similar entities in the target sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides clear examples of named entities with corresponding entity labels, aiding in understanding and identifying similar entities in the target sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence includes named entities with corresponding entity labels, which can help in recognizing similar entities in the target sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence contains named entities with corresponding entity labels, aiding in understanding and identifying similar entities in the target sentence.\"},\n{\"Example 13\": 3},\n{\"Reason 13\": \"The sentence presents a named entity with a corresponding entity label, which may provide some context but is not directly related to the entities in the target sentence.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence offers multiple named entities with corresponding entity labels, aiding in understanding and identifying similar entities in the target sentence.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence includes named entities with corresponding entity labels, assisting in recognizing similar entities in the target sentence.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain named entities with corresponding entity labels that are relevant to the entities in the target sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain named entities with corresponding entity labels that are relevant to the entities in the target sentence.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain named entities with corresponding entity labels that are relevant to the entities in the target sentence.\"}\n]",
        "response3": "[{\"Bmax\": \"protein\"}, {\"DEX\": \"protein\"}]",
        "prediction": "{'Bmax': 'protein', 'DEX': 'protein'}"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "response1": "['cell_line', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'protein' and provides information about its purification and gene cloning.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'Egr-1' as a protein and provides information about its expression.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions the entity 'TCF-1' as a protein and provides information about its immunization.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions the entity 'E2A' as a protein and provides information about its expression.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions the entity 'Th2-type lymphocytes' as a cell type.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the entity 'IgH' as DNA.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions the entity 'cDNAs' as DNA.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions multiple entities such as 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' as proteins and provides information about their responsiveness.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions the entities 'NF-ATc' as a protein and 'T lymphocytes' as a cell type.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the entities 'IL-2', 'c-Jun', and 'c-Fos' as proteins.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions the entities 'CD70' as a protein, 'B cell' and 'plasma cells' as cell types, and 'IL-4' and 'CD40' as proteins.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the entities 'NF-ATc' as a protein, 'T lymphocytes' and 'embryonic cardiac cells' as cell types.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions the entity 'GM-CSF' as a protein.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions the entities 'IFN A' and 'IFNA' as proteins, 'interleukin-2' and 'interleukin-2 receptor' as proteins, and 'phytohemagglutinin' and 'phorbol myristate acetate' as proteins.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions the entities 'c-kit' and 'IL-4R alpha chain' as proteins.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not mention any entities related to the given entity labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not mention any entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not mention any entities related to the given entity labels.\"}\n]",
        "response3": "[{'OTF-2': 'protein'}, {'immunoglobulin heavy-chain mRNA': 'RNA'}, {'immunoglobulin gene': 'DNA'}, {'pre-B-cell lines': 'cell_line'}]",
        "prediction": "{'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA', 'pre-B-cell lines': 'cell_line'}"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HMG-1\": \"protein\"}]",
        "prediction": "{'HMG-1': 'protein'}"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'IL-2' and its association with the entity type 'protein', making it highly relevant for named entity extraction.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains multiple entities such as 'T cell', 'IL-2', 'IL-2 receptor', and 'CD28' associated with their respective entity types, providing valuable information for named entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions various entities like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' along with their corresponding entity types, which are crucial for named entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence includes entities 'AP-1', 'PMA', 'monocytes', and 'macrophages' linked to their entity types, aiding in named entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides information about entities 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' associated with their respective entity types, contributing to named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains entities 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' with their entity types, which are essential for named entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions the entity 'IL-2' associated with the entity type 'protein', making it highly relevant for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes entities 'IL-2', 'c-Jun', and 'c-Fos' linked to their respective entity types, providing valuable information for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions entities 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' along with their corresponding entity types, which are crucial for named entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides information about the entity 'NF-kappa B' associated with the entity type 'protein', aiding in named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains entities 'Stat3', 'Stat5', and 'c-Mpl' with their entity types, which are essential for named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the entities 'IL-2', 'Aiolos', and 'Ras' associated with their respective entity types, making it highly relevant for named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence includes entities 'IL-4', 'LPS', and 'AP-1' linked to their entity types, providing valuable information for named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' along with their corresponding entity types, which are crucial for named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains entities 'IL-12', 'STAT4', 'NK cells', 'T cells', and 'IL-12 receptor' with their entity types, which are essential for named entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence directly mentions the entity 'E2A' associated with the entity type 'protein', making it highly relevant for named entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction.\"}\n]",
        "response3": "[{\"PRL\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"Stat proteins\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a transcription factor (AP-1) binding to DNA, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions two proteins (Jun and ATF-2) and their interaction in transcription, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions a specific cell type (Th2-type lymphocytes) expressing cytokines, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions a protein (Protein) involved in transcription, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (Egr-1) being a zinc finger transcription factor, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions proteins (IL-2, c-Jun, c-Fos) involved in transcription and binding to DNA, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a protein (GM-CSF) with a conserved motif in its gene, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a protein (GATA-1) as a lineage-specific transcription factor in erythroid cells, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions a protein (TCF-1) transactivating through its cognate motif, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions Stat proteins forming dimers and inducing transcription, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of acetylated transcription factors (EKLF) interacting with other proteins (CBP, p300, P/CAF), which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions a protein (SCL) expressed in specific cell lineages and its similarity to GATA-1, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions a protein (G-CSF) binding to receptors, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205) interacting with each other, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions proteins (ZEB, c-Myb, Ets) involved in gene expression regulation in hematopoietic cells, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions proteins (tal-1, GATA-binding proteins) during hematopoiesis, which directly relates to the entity types mentioned in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entity types mentioned in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entity types mentioned in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entity types mentioned in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the types of entities present in the text and how they are labeled.\"}\n]",
        "response3": "[{\"E3 enhancer motif\": \"DNA\"}]",
        "prediction": "{'E3 enhancer motif': 'DNA'}"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a protein (GATA-1) associated with a specific cell type (erythroid cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence provides a clear example of a protein (Egr-1) associated with a specific cell type (macrophages), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) associated with a specific cell type (erythroid cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence provides a clear example of a protein (retinoic acid receptor alpha) associated with a specific cell type (myeloid cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides a clear example of a protein (CD14) associated with a specific cell type (monocytes), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides clear examples of two distinct cell types (Th1 and Th2) associated with specific immune functions, aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides a clear example of a protein (E2A) associated with a specific cell type (B cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides a clear example of a cell line (B cell lines) associated with a specific cell type (B cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides a clear example of a protein (WT1) associated with a specific cell type (lymphocytes), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides clear examples of two proteins (CD14 and CD23) associated with specific cell types (monocytes and other immune cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides clear examples of three proteins (myeloperoxidase, lysozyme, PU.1) associated with specific cell types (granulocytes and immature subsets), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides clear examples of a protein (WT1) associated with a specific cell type (myeloid cell lines), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides clear examples of a protein (MNDA) associated with a specific cell type (leukemia cell lines), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides clear examples of two distinct cell types (granulocytes and T cells) associated with specific immune functions, aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence provides a clear example of a protein (GATA-1) associated with a specific cell type (erythroid cells), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence provides clear examples of two proteins (Sp1 and Ets) associated with a specific cell type (CTLs), aiding in the extraction of named entities from the target sentence.\"}\n]\n[\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any relevant entities or examples that can aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any relevant entities or examples that can aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any relevant entities or examples that can aid in extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"eosinophil\": \"cell_type\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'eosinophil': 'cell_type', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1\": 5},\n    {\"Th2\": 5},\n    {\"AP-1\": 5},\n    {\"IFN-gamma\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"IL-7R\": 5},\n    {\"gamma(c)\": 5},\n    {\"IL-2\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"IL-2\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"rheumatoid arthritis\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"GATA-1\": 5},\n    {\"CD40\": 5},\n    {\"IFN-gamma\": 5},\n    {\"tumor necrosis factor-alpha\": 5},\n    {\"interleukin (IL)-1beta\": 5}\n]",
        "response3": "[{\"Interferon-gamma\": \"protein\"}]",
        "prediction": "{'Interferon-gamma': 'protein'}"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (E2A) being mentioned in relation to a specific gene expression study, making it highly relevant for identifying protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions immunohistochemistry with antibodies against proteins encoded by a gene, helping to identify protein entities. It also mentions gene and cell type, which are relevant for DNA and cell_type entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions genes encoding eosinophil granule proteins and a specific protein (GATA-1), making it highly relevant for identifying protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions eosinophils, a specific cell type, making it highly relevant for identifying cell_type entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple examples of proteins (CD70, IL-4, CD40) and mentions B cells and plasma cells, which are relevant for cell_type entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions specific proteins (myeloperoxidase, lysozyme, PU.1), making it highly relevant for identifying protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions specific proteins (CD14, CD23), making it highly relevant for identifying protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions specific proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate), making it highly relevant for identifying protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions specific proteins (p21(WAF1/CIP1), p27(KIP1)), making it highly relevant for identifying protein entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions specific proteins (IL-2, c-Jun, c-Fos), making it highly relevant for identifying protein entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions a specific protein (NF-E2), making it highly relevant for identifying protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions specific proteins (interleukin-2, alpha chain, CD25, IL-2 receptor), making it highly relevant for identifying protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions Ter 119 as a cell line and specific proteins (beta-globin, glycoprotein IIb, platelet factor 4), making it relevant for identifying cell_line and protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions specific proteins (Erbstatin, genistein) and a specific RNA (Egr-1), making it relevant for identifying protein and RNA entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions gp91phox as DNA and HL-60-C15 as a cell line, making it relevant for identifying DNA and cell_line entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific entities mentioned in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities mentioned in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities mentioned in the target sentence.\"}\n]",
        "response3": "[{\"estrogen\": \"protein\"}, {\"progesterone\": \"protein\"}, {\"eosinophil cationic protein\": \"protein\"}, {\"eosinophils\": \"cell_type\"}]",
        "prediction": "{'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"NF-AT\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T helper cell subsets\": \"cell_type\"}]",
        "prediction": "{'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Sentence\": \"The sentence contains multiple examples of named entities (NF-kappa B, I kappa B alpha) that match the entity types in the target sentence (protein). This makes it highly relevant for aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"NF-KB\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'NF-KB': 'protein'}"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 2},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 4},\n    {\"Recently, it has been shown that RelB knockout mice have no dendritic cells (DC).\": 4},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HU\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'HU': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"C/EBP\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}, {\"myelomonocytic cells\": \"cell_type\"}]",
        "prediction": "{'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n{\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 4},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n{\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n{\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n{\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n{\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"EBV type 2 EBNA-2\": \"protein\"}, {\"LMP1\": \"protein\"}, {\"EBV type 1 EBNA-2\": \"protein\"}]",
        "prediction": "{'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"FK506\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'IL-2': 'protein', 'rapamycin': 'protein', 'FK506': 'protein'}"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'cell_type', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"2\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"3\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"4\": \"The sentence contains 'protein' and 'cell_line' entities which are present in the label set.\"},\n    {\"5\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"6\": \"The sentence contains 'cell_type' and 'cell_line' entities which are present in the label set.\"},\n    {\"7\": \"The sentence contains 'cell_type' and 'protein' entities which are present in the label set.\"},\n    {\"8\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"9\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"10\": \"The sentence contains 'protein' and 'cell_line' entities which are present in the label set.\"},\n    {\"11\": \"The sentence contains 'protein', 'cell_type', and 'cell_line' entities which are present in the label set.\"},\n    {\"12\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"13\": \"The sentence contains 'DNA' entities which are present in the label set.\"},\n    {\"14\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"15\": \"The sentence contains 'protein' entities which are present in the label set.\"},\n    {\"16\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"17\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"18\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[\n    {\"TNF-alpha\": \"protein\"},\n    {\"polymerase chain reaction\": \"DNA\"},\n    {\"monocytic U937 cells\": \"cell_type\"},\n    {\"HIV\": \"cell_type\"},\n    {\"U9-IIIB\": \"cell_line\"}\n]",
        "prediction": "{'TNF-alpha': 'protein', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV': 'cell_type', 'U9-IIIB': 'cell_line'}"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}, {\"sea urchin\": \"cell_line\"}, {\"B cells\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"IL-2\": 4, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"NF-kappaB\": 4, \"Tax\": 3, \"ATL\": 3},\n    {\"IkappaBbeta\": 4, \"NF-kappaB\": 5},\n    {\"RelA\": 4, \"NF-kappa B\": 5},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"MTHC\": 5, \"TNF-alpha\": 4, \"IFN-gamma\": 4, \"DC\": 5},\n    {\"RelA\": 4, \"NF-kappaB1\": 4},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5},\n    {\"Bak\": 4, \"Bad\": 4, \"Bcl-2\": 4, \"PDBu\": 3, \"DMSO\": 3},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B beta\": 5},\n    {\"CD40\": 4, \"NF-kappa B\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"Cu2+\": \"cell_line\"}]",
        "prediction": "{'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 3},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example contains a specific cell type 'Th2-type lymphocytes' which matches the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains specific proteins like 'NF-kappaB', 'Tax', and 'ATL' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example contains specific proteins like 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains specific entities like 'immunohistochemistry' (related to proteins), 'gene' (related to DNA), and 'cell type' which match the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example contains a specific cell type 'lymphoid neoplasms' which matches the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example contains specific proteins like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains specific proteins like 'TAL1' and 'T-ALL' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example contains specific entities like 'WT1' (related to proteins) and 'myeloid cell lines' which match the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example contains specific proteins like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains specific proteins like 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' which match the 'protein' and 'cell_line' entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains specific proteins like 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains specific proteins like 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example contains specific proteins like 'IL-2', 'c-Jun', and 'c-Fos' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example contains specific proteins like 'CD70', 'IL-4', 'CD40', and entities like 'B cell' and 'plasma cells' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The example contains 'AP-1' which matches the 'DNA' entity label in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example contains specific entities like 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' which match the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any entities that match the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not contain any entities that match the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The example does not contain any entities that match the entity labels in the target sentence.\"}\n]",
        "response3": "[{'lymphocyte': 'cell_type'}, {'breast cancers': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]",
        "prediction": "{'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": \"5\"},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'IgH' and the entity label 'DNA' in the target sentence.\"},\n    {\"Example 2\": \"4\"},\n    {\"Reason 2\": \"The example directly links the entity 'Eosinophils' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 3\": \"5\"},\n    {\"Reason 3\": \"The example identifies multiple entities (IL-13, IL-4, B cell, monocyte) and correctly assigns their respective entity labels in the target sentence.\"},\n    {\"Example 4\": \"4\"},\n    {\"Reason 4\": \"The example highlights the entities 'EBV' and 'CD2' and their corresponding entity labels in the target sentence.\"},\n    {\"Example 5\": \"5\"},\n    {\"Reason 5\": \"The example covers a range of entities (IL4, IL13, STAT6, STAT3, STAT5, B cells) and accurately assigns their entity labels in the target sentence.\"},\n    {\"Example 6\": \"4\"},\n    {\"Reason 6\": \"The example correctly identifies the entities 'Th1' and 'Th2' as 'cell_type' in the target sentence.\"},\n    {\"Example 7\": \"4\"},\n    {\"Reason 7\": \"The example connects the entity 'Th2-type lymphocytes' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 8\": \"5\"},\n    {\"Reason 8\": \"The example provides a comprehensive mapping of entities (CD70, B cell, plasma cells, IL-4, CD40) to their respective entity labels in the target sentence.\"},\n    {\"Example 9\": \"5\"},\n    {\"Reason 9\": \"The example accurately assigns the entities 'NF-ATc' and 'T lymphocytes' to their entity labels in the target sentence.\"},\n    {\"Example 10\": \"5\"},\n    {\"Reason 10\": \"The example correctly identifies the entities 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' with their corresponding entity labels in the target sentence.\"},\n    {\"Example 11\": \"5\"},\n    {\"Reason 11\": \"The example connects the entities 'T lymphocytes' and 'HLA-molecules' to their respective entity labels in the target sentence.\"},\n    {\"Example 12\": \"5\"},\n    {\"Reason 12\": \"The example accurately assigns the entity 'E2A' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 13\": \"4\"},\n    {\"Reason 13\": \"The example correctly identifies the entities 'lymphocytes', 'benzene', and 'benzoquinone' with their corresponding entity labels in the target sentence.\"},\n    {\"Example 14\": \"5\"},\n    {\"Reason 14\": \"The example provides a clear mapping between the entities 'EBV' and 'B-cell' to their respective entity labels in the target sentence.\"},\n    {\"Example 15\": \"5\"},\n    {\"Reason 15\": \"The example accurately assigns the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' to their entity labels in the target sentence.\"},\n    {\"Example 16\": \"5\"},\n    {\"Reason 16\": \"The example correctly identifies the entities 'ICAM-1', 'CD71', 'LMP1', and 'IkappaB' with their corresponding entity labels in the target sentence.\"},\n    {\"Example 17\": \"1\"},\n    {\"Reason 17\": \"The example does not contain any entities that match the entity labels present in the target sentence.\"},\n    {\"Example 18\": \"1\"},\n    {\"Reason 18\": \"The example does not contain any entities that match the entity labels present in the target sentence.\"},\n    {\"Example 19\": \"1\"},\n    {\"Reason 19\": \"The example does not contain any entities that match the entity labels present in the target sentence.\"}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n{\"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific DNA and protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains a specific protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities that are relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"NK cell\": \"cell_type\"}, {\"NFAT\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "response1": "['cell_type', 'protein', 'protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'PML/RARalpha' and the entity label 'protein' in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides mappings between multiple entities in the sentence and their corresponding entity labels, aiding in the extraction process.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example covers multiple entities related to proteins and DNA in the sentence, contributing to the extraction of named entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example identifies key protein entities in the sentence, supporting the extraction of named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example highlights protein entities and their roles in the sentence, assisting in the extraction of named entities.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The example focuses on a specific DNA entity, which is helpful but does not cover other entity types present in the sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example links the protein entity 'P selectin' to its corresponding label, aiding in the extraction process.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides mappings for multiple protein entities and their roles in the sentence, enhancing the extraction of named entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example covers protein entities and their interactions in the sentence, supporting the extraction of named entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example identifies protein entities and their roles in the sentence, contributing to the extraction of named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example highlights protein entities and their roles in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example provides mappings for multiple protein entities and their roles in the sentence, enhancing the extraction of named entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example identifies protein entities and their roles in the sentence, supporting the extraction of named entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example covers protein entities and their interactions in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example highlights protein entities and their roles in the sentence, contributing to the extraction of named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not contain any entities relevant to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any entities relevant to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not contain any entities relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'CML cells': 'cell_type'}, {'IFN-alpha': 'protein'}, {'CML cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]",
        "prediction": "{'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis\": 1, \"constitutive presence\": 1, \"nuclear factors\": 1, \"resting PBL\": 1, \"AP-1 site\": 1, \"IL-2 promoter\": 1, \"immunoreactive c-Jun\": 1, \"c-Fos protein\": 1},\n    {\"Our results\": 1, \"activation of NF-kappaB\": 1, \"Tax\": 1, \"leukemic cells\": 1, \"ATL patients\": 1, \"differential NF-kappaB subunit activation\": 1},\n    {\"promoters\": 1, \"cytokines\": 1, \"human Th2-type lymphocytes\": 5},\n    {\"Molecular cloning\": 1, \"SLAP-130\": 1, \"SLP-76\": 1, \"T cell antigen receptor-stimulated\": 1, \"protein tyrosine kinases\": 1},\n    {\"Selected transfected clones\": 1, \"IFN A\": 1, \"IFNA\": 1, \"interleukin-2\": 1, \"interleukin-2 receptor\": 1, \"phytohemagglutinin\": 1, \"phorbol myristate acetate\": 1},\n    {\"IL4\": 1, \"IL13\": 1, \"gamma c chain\": 1, \"STAT6\": 1, \"STAT3\": 1, \"STAT5\": 1, \"normal human B cells\": 1},\n    {\"TCRzeta\": 1, \"p56(lck)\": 1, \"peripheral blood T cells\": 1, \"patients\": 1, \"reduced levels\": 1},\n    {\"luciferase reporter construct\": 1, \"CD95 ligand promoter\": 1},\n    {\"cDNA clone\": 1, \"primary response gene\": 1, \"macrophage differentiation\": 1, \"Egr-1\": 5, \"zinc finger transcription factor\": 1},\n    {\"receptor for interleukin 10\": 1, \"IL-10R\": 1, \"box 3 sequence motifs\": 1, \"signal-transducing receptor subunits\": 1, \"IL-6-type cytokines\": 1, \"STAT3\": 1, \"IL-6-responsive elements\": 1},\n    {\"chimeric receptor\": 1, \"extracellular domain of c-kit\": 1, \"stem cell factor (SCF) receptor\": 1, \"cytoplasmic and transmembrane domains\": 1, \"IL-4R alpha chain\": 1},\n    {\"Flow cytometric and morphological analyses\": 1, \"CD70 transfectants\": 1, \"B cell cultures\": 1, \"plasma cells\": 1, \"IL-4\": 1, \"CD40 signaling\": 1},\n    {\"CHEMR1\": 1, \"receptor for unidentified C-C chemokine\": 1, \"low-affinity receptor for MIP-1alpha\": 1},\n    {\"induction of the IL-2 receptor alpha subunit\": 1, \"lymphocyte activation\": 1, \"p21ras\": 1, \"B cell activation\": 1},\n    {\"TCL1\": 1, \"AIDS IBLP tumors\": 1},\n    {\"Analysis of CD40 cytoplasmic domain truncation\": 1, \"point mutants\": 1, \"CD40 cytoplasmic signaling determinant\": 1, \"NF-kappa B activation\": 1},\n    {\"common pathway\": 1, \"common requirements\": 1, \"properties of the signaling pathway\": 1},\n    {\"tumors\": 1, \"typical morphology\": 1, \"ovary\": 1, \"stage I\": 1, \"benign clinical course\": 1},\n    {\"distinct genes\": 1, \"family members\": 1, \"isoforms\": 1}\n]",
        "response3": "[{\"Burkitt's lymphoma receptor 1 (BLR1)\": \"protein\"}, {\"BLR2\": \"protein\"}]",
        "prediction": "{\"Burkitt's lymphoma receptor 1 (BLR1)\": 'protein', 'BLR2': 'protein'}"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity type 'protein' with specific names, aiding in the extraction of protein entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'protein' (TCL1) with its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear and direct mention of the entity 'protein' (E2A) with its corresponding label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear and direct mention of the entity 'protein' (NF-E2) with its corresponding label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear and direct mention of the entities 'protein' (EBNA2) and 'cell_line' (TP1) with their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear and direct mention of the entities 'protein' (alpha-tocopherol, monocyte) and 'cell_type' (endothelial cells) with their corresponding labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear and direct mention of the entity 'DNA' (AP-1) with its corresponding label.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear and direct mention of the entities 'cell_line' (Ter 119) and 'protein' (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a clear and direct mention of the entities 'protein' (Erbstatin, genistein) and 'RNA' (Egr-1) with their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a clear and direct mention of the entities 'DNA' (EBV) and 'protein' (EBNA2, estrogen receptor) with their corresponding labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear and direct mention of the entities 'protein' (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) with their corresponding labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides a clear and direct mention of the entities 'DNA' (nuclear factor-kappa B, NF-kappa B) with their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides a clear and direct mention of the entities 'DNA' (DNA, PCNA) and 'protein' (E2F1) with their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear and direct mention of the entities 'protein' (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1, erythropoietin) with their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a clear and direct mention of the entities 'protein' (MR, aldosterone, progesterone) with their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear and direct mention of the entities 'protein' (FEV1, FVC, PEF, prednisolone) with their corresponding labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides a clear and direct mention of the entities 'protein' (E2F, E2F-4, DP-1, p130) and 'cell_type' (AML) with their corresponding labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the given entity labels.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities related to the given entity labels.\"}\n]",
        "response3": "[{\"estrogen\": \"protein\"}, {\"tamoxifen\": \"protein\"}]",
        "prediction": "{'estrogen': 'protein', 'tamoxifen': 'protein'}"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear mention of the entity 'protein' and its association with the gene 'E2A' at the protein level.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions the entity 'MNDA' associated with 'protein' and 'Philadelphia chromosome-positive chronic myeloid leukemia' associated with 'cell_line', providing clear context for named entity extraction.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions 'granulocytes' and 'T cells' associated with 'cell_type', aiding in identifying cell types but lacks direct gene or protein mentions.\"},\n    {\"Example 4\": 2},\n    {\"Reason 4\": \"The sentence mentions 'IgH' associated with 'DNA', providing some context for named entity extraction but lacks detailed gene or protein information.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'PML/RARalpha' associated with 'protein', aiding in identifying a protein entity in the context of myelopoiesis.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence mentions 'GM-CSF' associated with 'protein', providing some context for named entity extraction but lacks detailed gene or protein information.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'GATA-1' associated with 'protein', aiding in identifying a protein entity in the context of erythroid cells.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'SCM-1' associated with 'cell_line', providing clear context for named entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions various proteins like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', aiding in identifying multiple protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'GATA-1' associated with 'protein', aiding in identifying a protein entity in the context of eosinophil differentiation.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions 'CCAAT box' associated with 'DNA' and 'EKLF binding site' associated with 'protein', providing some context for named entity extraction but lacks detailed gene or protein information.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions 'Egr-1' associated with 'protein', aiding in identifying a protein entity in the context of macrophage differentiation.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'RXR' associated with 'protein', aiding in identifying a protein entity in the context of erythroid cells.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'Sp1' and 'Ets' associated with 'protein', aiding in identifying protein entities in the context of the mouse perforin gene.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions 'c-kit' associated with 'protein' and 'IL-4R alpha chain' associated with 'protein', aiding in identifying protein entities in the context of chimeric receptor generation.\"},\n    {\"Example 16\": 3},\n    {\"Reason 16\": \"The sentence mentions 'ZEB', 'c-Myb', 'Ets' associated with 'protein' and 'hematopoietic cells' associated with 'cell_type', providing some context for named entity extraction but lacks detailed gene or protein information.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific gene, protein, or cell type mentions relevant to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific gene, protein, or cell type mentions relevant to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific gene, protein, or cell type mentions relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 3},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 3},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCR alpha\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}, {\"T-cell-specific\": \"cell_type\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"CaM kinase II\": \"protein\"}]",
        "prediction": "{'CaM kinase II': 'protein'}"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of protein names and their corresponding entity labels, aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"Oct-2A\": 5},\n    {\"HMG I/Y\": 5},\n    {\"HLA-DRA\": 5},\n    {\"B cells\": 4},\n    {\"T cell\": 4},\n    {\"interleukin 2\": 5},\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5},\n    {\"Egr-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 4},\n    {\"NF-ATc\": 5},\n    {\"A-myb\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"Jun\": 5},\n    {\"ATF-2\": 5},\n    {\"NF-E2\": 5},\n    {\"GATA-1\": 5}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 3},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 3},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"ubiquitin -proteasome system\": \"protein\"}, {\"ubiquitin\": \"protein\"}, {\"E2-F1\": \"protein\"}, {\"p53\": \"protein\"}, {\"ubiquitin -carrier protein\": \"protein\"}, {\"p105 precursor\": \"protein\"}, {\"ubiquitin -protein ligase\": \"protein\"}]",
        "prediction": "{'ubiquitin -proteasome system': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'p105 precursor': 'protein', 'ubiquitin -protein ligase': 'protein'}"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines\": 4},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells\": 5},\n    {\"IL-13, a cytokine similar to IL-4, is a regulator of human B cell and monocyte functions\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling\": 5}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}, {\"thymic epithelial cells\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_type', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example provides a specific entity ('immunoglobulin kappa 3' enhancer') and its corresponding label ('DNA'), which directly aids in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 2\": 5},\n{\"Reason 2\": \"The examples provide specific entities ('IL-2', 'IFN-gamma', 'jak kinases', 'STAT1(alpha)') and their corresponding labels ('protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 3\": 5},\n{\"Reason 3\": \"The examples provide specific entities ('IL-2', 'c-Jun', 'c-Fos') and their corresponding labels ('protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 4\": 5},\n{\"Reason 4\": \"The examples provide specific entities ('IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', 'phorbol myristate acetate') and their corresponding labels ('protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 5\": 5},\n{\"Reason 5\": \"The examples provide specific entities ('PU.1', 'M-CSF receptor', 'macrophage') and their corresponding labels ('protein', 'cell_type'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 6\": 5},\n{\"Reason 6\": \"The examples provide specific entities ('Sp1', 'CD14') and their corresponding labels ('protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 7\": 5},\n{\"Reason 7\": \"The example provides a specific entity ('SIVsmmPBj14') and its corresponding label ('cell_line'), which directly aids in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 8\": 5},\n{\"Reason 8\": \"The examples provide specific entities ('T cell', 'interleukin 2') and their corresponding labels ('cell_type', 'protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 9\": 5},\n{\"Reason 9\": \"The example provides a specific entity ('p50p50') and its corresponding label ('protein'), which directly aids in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 10\": 5},\n{\"Reason 10\": \"The examples provide specific entities ('IkappaBbeta', 'NF-kappaB') and their corresponding labels ('protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 11\": 5},\n{\"Reason 11\": \"The examples provide specific entities ('HIV-1', 'IFN', 'PKR', 'IkappaBalpha') and their corresponding labels ('cell_type', 'protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 12\": 5},\n{\"Reason 12\": \"The examples provide specific entities ('NF-kappaB', 'Sp1', 'SIVmac') and their corresponding labels ('protein', 'cell_line'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 13\": 5},\n{\"Reason 13\": \"The examples provide specific entities ('cDNA', 'Jurkat', 'DRE 1') and their corresponding labels ('DNA', 'cell_line', 'cell_type'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 14\": 5},\n{\"Reason 14\": \"The examples provide specific entities ('HIV-1 LTR', 'NFAT-1', 'NF kappa B') and their corresponding labels ('DNA', 'protein', 'protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 15\": 5},\n{\"Reason 15\": \"The examples provide specific entities ('TR55', 'TNF-alpha', 'HIV') and their corresponding labels ('protein', 'protein', 'cell_type'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 16\": 5},\n{\"Reason 16\": \"The examples provide specific entities ('ATF1', 'CREB', 'H4') and their corresponding labels ('protein'), which directly aid in extracting named entities from the target sentence.\"}\n]\n[\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any named entities from the given entity label set, so providing an example is not helpful in this case.\"}\n]\n[\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any named entities from the given entity label set, so providing an example is not helpful in this case.\"}\n]\n[\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any named entities from the given entity label set, so providing an example is not helpful in this case.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}, {\"Jurkat T cells\": \"cell_type\"}, {\"GAL4\": \"protein\"}, {\"GAL4-substituted HIV-1 enhancer\": \"DNA\"}]",
        "prediction": "{'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Palombella\": \"protein\"}, {\"V.J.\": \"protein\"}, {\"Rando\": \"protein\"}, {\"O.J.\": \"protein\"}, {\"Goldberg\": \"protein\"}, {\"A.L.\": \"protein\"}, {\"Maniatis\": \"protein\"}]",
        "prediction": "{'Palombella': 'protein', 'V.J.': 'protein', 'Rando': 'protein', 'O.J.': 'protein', 'Goldberg': 'protein', 'A.L.': 'protein', 'Maniatis': 'protein'}"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple instances of protein entities and their corresponding synonyms, aiding in the extraction of protein entities.\"},\n    {\"5\": \"The sentence contains protein entities and their corresponding synonyms, facilitating the extraction of protein entities.\"},\n    {\"5\": \"The sentence includes protein entities and their corresponding synonyms, assisting in the identification of protein entities.\"},\n    {\"5\": \"The sentence contains protein entities and their corresponding synonyms, aiding in the extraction of protein entities.\"},\n    {\"5\": \"The sentence includes a protein entity and a DNA entity, which can help in identifying these entities.\"},\n    {\"5\": \"The sentence contains protein entities, aiding in the extraction of protein entities.\"},\n    {\"5\": \"The sentence provides examples of protein entities and their interactions, facilitating the extraction of protein entities.\"},\n    {\"5\": \"The sentence includes cell type and protein entities, aiding in the identification of these entities.\"},\n    {\"5\": \"The sentence contains a protein entity, aiding in the extraction of protein entities.\"},\n    {\"5\": \"The sentence includes protein and cell line entities, assisting in the identification of these entities.\"},\n    {\"5\": \"The sentence contains RNA and cell line entities, aiding in the extraction of these entities.\"},\n    {\"5\": \"The sentence provides examples of protein entities, aiding in the extraction of protein entities.\"},\n    {\"5\": \"The sentence includes protein entities, facilitating the extraction of protein entities.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n{\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NFATp\": \"protein\"}, {\"NFATp\": \"protein\"}, {\"thymus\": \"cell_type\"}, {\"spleen\": \"cell_type\"}]",
        "prediction": "{'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a direct mapping between the entity 'RXR' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The examples provide direct mappings between the entities 'SCL', 'GATA-1', and their corresponding entity labels 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The examples provide direct mappings between the entities 'Stat3', 'Stat5', 'c-Mpl', and their corresponding entity labels 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The examples provide direct mappings between the entities 'NF-ATc', 'T lymphocytes', 'embryonic cardiac cells', and their corresponding entity labels 'protein', 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a direct mapping between the entity 'GATA-1' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide direct mappings between the entities 'granulocytes', 'T cells', and their corresponding entity labels 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The examples provide direct mappings between the entities 'EKLF', 'CBP', 'p300', 'P/CAF', and their corresponding entity labels 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a direct mapping between the entity 'Egr-1' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The examples provide direct mappings between the entities 'NF-kappaB', 'Tax', 'ATL', and their corresponding entity labels 'protein', 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a direct mapping between the entity 'erythropoietin' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a direct mapping between the entity 'NF-E2' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a direct mapping between the entity 'E2A' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a direct mapping between the entity 'GATA-1' and its corresponding entity label 'protein', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The examples provide direct mappings between the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', 'B lymphocytes', and their corresponding entity labels 'protein', 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The examples provide direct mappings between the entities 'ZEB', 'c-Myb', 'Ets', 'hematopoietic cells', and their corresponding entity labels 'protein', 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not contain any entities that match the entity labels in the target sentence, hence providing no aid in extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain any entities that match the entity labels in the target sentence, hence providing no aid in extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not contain any entities that match the entity labels in the target sentence, hence providing no aid in extracting named entities.\"}\n]",
        "response3": "[{\"NF-E2\": \"protein\"}, {\"megakaryocytes\": \"cell_type\"}]",
        "prediction": "{'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kappa B\": 5},\n    {\"CD28\": 4, \"CD80\": 4, \"CD86\": 4, \"CBL\": 4, \"VAV\": 4, \"NFAT\": 4, \"interleukin-2\": 4, \"granulocyte-macrophage colony-stimulating factor\": 4},\n    {\"cell adhesion molecules\": 3},\n    {\"P selectin\": 4},\n    {\"G-CSF\": 4},\n    {\"Stat3\": 4, \"Stat5\": 4, \"c-Mpl\": 4},\n    {\"cAMP-dependent protein kinase\": 4, \"Rap1\": 4},\n    {\"myeloperoxidase\": 4, \"lysozyme\": 4, \"PU.1\": 4},\n    {\"Tat-binding protein 7\": 4},\n    {\"IL4\": 4, \"IL13\": 4, \"gamma c chain\": 4, \"STAT6\": 4, \"STAT3\": 4, \"STAT5\": 4, \"B cells\": 4},\n    {\"NF-kappa B\": 4},\n    {\"p21ras\": 4},\n    {\"SLAP-130\": 4, \"SLP-76\": 4, \"T cell\": 4},\n    {\"Syk\": 4, \"Zap\": 4, \"T cell\": 4},\n    {\"GM-CSF\": 4},\n    {\"alpha-tocopherol\": 4, \"monocyte\": 4, \"endothelial cells\": 4},\n    {},\n    {},\n    {}\n]",
        "response3": "[{\"Platelet glycoprotein (GP) Ib-IX-V\": \"protein\"}]",
        "prediction": "{'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"IL-2 mRNA\": \"RNA\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation\": 5},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ)\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well\": 1}\n]",
        "response3": "[{\"CEM C7 cells\": \"cell_line\"}, {\"T-cell line\": \"cell_type\"}]",
        "prediction": "{'CEM C7 cells': 'cell_line', 'T-cell line': 'cell_type'}"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (E2A) being mentioned in relation to a specific gene expression study, making it highly relevant for identifying protein entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions a protein (GATA-1) in the context of gene expression during eosinophil differentiation, which is crucial for identifying protein entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence discusses lymphoid neoplasms, indicating a cell type entity, which is helpful for identifying cell type entities.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence mentions phosphocreatine, which is indirectly related to protein entities, providing some relevance but not as direct as other examples.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein entities (SLAP-130, SLP-76) and a cell type entity (T cell), making it highly relevant for identifying protein and cell type entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions a protein (NF-E2) in the context of a cellular differentiation program, making it highly relevant for identifying protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence discusses the use of immunohistochemistry with antibodies against proteins encoded by a gene, providing direct relevance to protein and DNA entities, as well as cell type entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions a protein (retinoic acid receptor alpha) in the context of binding assays, making it highly relevant for identifying protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions a protein (CD14) in the context of monocytic differentiation, making it highly relevant for identifying protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a cell line entity (HML) and proteins (dexamethasone, cortisol, lysozyme), providing some relevance for identifying cell line and protein entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes), making it highly relevant for identifying protein and cell type entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions B and T cell activation, cell lines (Ramos, Jurkat), and cDNA microarray technology, providing direct relevance to cell type, cell line, and DNA entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions protein entities (tal-1, GATA-binding proteins) in the context of human hematopoiesis, making it highly relevant for identifying protein and cell type entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions protein entities (Erbstatin, genistein) and RNA entity (Egr-1) in the context of mRNA expression, making it highly relevant for identifying protein and RNA entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions DNA entity (EBV) and protein entities (EBNA2, estrogen receptor) in the context of generating conditional EBV mutants, making it highly relevant for identifying DNA and protein entities.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions protein entities (MR, aldosterone, progesterone) in the context of antibody binding, providing some relevance for identifying protein entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels provided.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels provided.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the entity labels provided.\"}\n]",
        "response3": "[{'steroid hormones': 'protein'}, {'estrogen': 'protein'}]",
        "prediction": "{'steroid hormones': 'protein', 'estrogen': 'protein'}"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'protein' with the term 'p50p50', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'protein' with the term 'GATA-1', providing a clear context for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions the entity 'cell_type' with the term 'Th2-type lymphocytes', making it highly relevant for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains a direct reference to the entity 'cell_line' with the term 'SCM-1', aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions multiple entities of type 'protein' with 'Stat3', 'Stat5', and 'c-Mpl', providing valuable information for named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the entity 'protein' with the term 'E2A', making it highly relevant for named entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear references to the entities 'cell_type' with 'T cell' and 'protein' with 'interleukin 2', aiding in named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions the entity 'protein' with the term 'retinoic acid receptor alpha', making it highly relevant for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains a direct reference to the entity 'protein' with the term 'GM-CSF', aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence explicitly mentions the entity 'cell_line' with the term 'SIVsmmPBj14', making it highly relevant for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear references to the entities 'protein' with 'SLAP-130', 'SLP-76', and 'cell_type' with 'T cell', aiding in named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the entity 'protein' with the term 'GATA-1', making it highly relevant for named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear and direct mention of the entity 'protein' with the term 'RXR', making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence directly mentions the entity 'DNA' with the term 'cDNAs', providing a clear context for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains references to multiple entities, including 'cell_line' with 'Ter 119', and 'protein' with 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4', aiding in named entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions multiple entities, including 'cell_type' with 'B and T cell activation', 'cell_line' with 'Ramos' and 'Jurkat', and 'DNA' with 'cDNA microarray technology', providing valuable information for named entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entities related to the entity labels in the target sentence, making it not helpful for named entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entities related to the entity labels in the target sentence, making it not helpful for named entity extraction.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any relevant entities related to the entity labels in the target sentence, making it not helpful for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"EB1\": \"protein\"}]",
        "prediction": "{'EB1': 'protein'}"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-2, Aiolos, Ras) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (p21(WAF1/CIP1), p27(KIP1)) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains the protein 'tyrosine' which is relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-2, c-Jun, c-Fos) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains the protein 'ZAP-70' which is relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (IL-4, LPS, AP-1) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (immunohistochemistry, gene) and cell type (cell type) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (NF-kappa B, I kappa B alpha) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains proteins (p50, p65) and entities (DNA, protein) which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains entities (HIV-1, IFN, PKR, IkappaBalpha) which are relevant to the entity labels.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"gamma interferon\": \"protein\"}, {\"phosphotyrosine\": \"protein\"}]",
        "prediction": "{'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.\": 5},\n{\"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.\": 5},\n{\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Sp1\": 5, \"CD14\": 4},\n{\"IL-4\": 4},\n{\"Egr-1\": 5},\n{\"SCM-1\": 5},\n{\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n{\"CD95 ligand\": 4},\n{\"UAS1\": 4, \"B cell\": 4},\n{\"Sp1\": 5, \"Ets\": 5},\n{\"GATA-1\": 5},\n{\"PML/RARalpha\": 5},\n{\"GATA-1\": 5},\n{\"NF-E2\": 5},\n{\"E2A\": 5},\n{\"IL-2\": 5},\n{\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"Protein\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Distinct genes\": 1}\n]",
        "response3": "[{\"Sp1\": \"protein\"}, {\"CD14\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"SCM-1\": \"cell_line\"}, {\"IL-2\": \"protein\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}, {\"CD95 ligand\": \"protein\"}, {\"UAS1\": \"cell_line\"}, {\"B cell\": \"cell_type\"}, {\"Sp1\": \"protein\"}, {\"Ets\": \"protein\"}, {\"GATA-1\": \"protein\"}, {\"PML/RARalpha\": \"protein\"}, {\"GATA-1\": \"protein\"}, {\"NF-E2\": \"protein\"}, {\"E2A\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"EKLF\": \"protein\"}, {\"CBP\": \"protein\"}, {\"p300\": \"protein\"}, {\"P/CAF\": \"protein\"}, {\"Protein\": \"protein\"}]",
        "prediction": "{'Sp1': 'protein', 'CD14': 'protein', 'IL-4': 'protein', 'Egr-1': 'protein', 'SCM-1': 'cell_line', 'IL-2': 'protein', 'c-Jun': 'protein', 'c-Fos': 'protein', 'CD95 ligand': 'protein', 'UAS1': 'cell_line', 'B cell': 'cell_type', 'Ets': 'protein', 'GATA-1': 'protein', 'PML/RARalpha': 'protein', 'NF-E2': 'protein', 'E2A': 'protein', 'EKLF': 'protein', 'CBP': 'protein', 'p300': 'protein', 'P/CAF': 'protein', 'Protein': 'protein'}"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 1},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 5},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 5},\n    {\"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.\": 5},\n    {\"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PEBP2 alpha/AML-1-related factor\": \"protein\"}, {\"osteocalcin\": \"protein\"}, {\"osteoblast-specific\": \"cell_type\"}]",
        "prediction": "{'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Markus Neurath\": \"protein\"}, {\"Eckhard Stuber\": \"protein\"}, {\"Warren Strober\": \"protein\"}, {\"BSAP\": \"protein\"}, {\"B-cell-specific genes\": \"protein\"}]",
        "prediction": "{'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The example sentences do not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The example sentences do not contain any of the entity types present in the target sentence.\"},\n    {\"4\": \"The sentence contains 'NF-kappaB' which is a protein entity, providing a relevant example.\"},\n    {\"3\": \"The sentence contains 'NF-E2' which is a protein entity, but the context is more specific to erythroid-specific gene expression.\"},\n    {\"4\": \"The sentence contains 'IL-4', 'LPS', and 'AP-1' which are all protein entities relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is a protein entity, providing a relevant example.\"},\n    {\"5\": \"The sentence contains multiple protein entities like 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' which are all relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is a protein entity, providing a relevant example.\"},\n    {\"3\": \"The sentence contains 'P selectin' which is a protein entity, but the context is more specific to cytokine production.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both protein entities relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'IL-2', 'NF-kappa B', and 'AP-1' which are all protein entities relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are all protein entities relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities like 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor' which are all relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'Transforming growth factor-beta' which is a protein entity, providing a relevant example.\"},\n    {\"3\": \"The sentence contains 'CTLA4Ig', 'NFAT', and 'AP-1' which are all relevant entities, but the context is more specific to T cell activation.\"},\n    {\"1\": \"The example sentences do not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The example sentences do not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The example sentences do not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein'}"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"GATA-1\": 5, \"Reason\": \"The sentence explicitly mentions the protein GATA-1, providing a clear example of a protein entity.\"},\n{\"NF-E2\": 5, \"Reason\": \"The sentence explicitly mentions the protein NF-E2, providing a clear example of a protein entity.\"},\n{\"Th2-type lymphocytes\": 5, \"Reason\": \"The sentence explicitly mentions the cell type Th2-type lymphocytes, providing a clear example of a cell type entity.\"},\n{\"Egr-1\": 5, \"Reason\": \"The sentence explicitly mentions the protein Egr-1, providing a clear example of a protein entity.\"},\n{\"erythropoietin\": 5, \"Reason\": \"The sentence explicitly mentions the protein erythropoietin, providing a clear example of a protein entity.\"},\n{\"CCAAT box\": 5, \"Reason\": \"The sentence explicitly mentions the DNA entity CCAAT box, providing a clear example of a DNA entity. Additionally, the sentence mentions the lack of an EKLF binding site, which is a protein entity.\"},\n{\"AP-1\": 5, \"Reason\": \"The sentence explicitly mentions the DNA entity AP-1, providing a clear example of a DNA entity.\"},\n{\"IL-4\": 5, \"Reason\": \"The sentence explicitly mentions the protein IL-4, providing a clear example of a protein entity.\"},\n{\"retinoic acid receptor alpha\": 5, \"Reason\": \"The sentence explicitly mentions the protein retinoic acid receptor alpha, providing a clear example of a protein entity.\"},\n{\"RXR\": 5, \"Reason\": \"The sentence explicitly mentions the protein RXR, providing a clear example of a protein entity.\"},\n{\"WT1\": 5, \"Reason\": \"The sentence explicitly mentions the protein WT1, providing a clear example of a protein entity. Additionally, the sentence mentions myeloid cell lines, which is a cell line entity.\"},\n{\"IL-2 receptor alpha subunit\": 5, \"Reason\": \"The sentence explicitly mentions the protein IL-2 receptor alpha subunit, providing a clear example of a protein entity. Additionally, the sentence mentions p21ras and B cell, which are protein and cell type entities respectively.\"},\n{\"IgH\": 5, \"Reason\": \"The sentence explicitly mentions the DNA entity IgH, providing a clear example of a DNA entity.\"},\n{\"GATA-1\": 5, \"Reason\": \"The sentence explicitly mentions the protein GATA-1, providing a clear example of a protein entity.\"},\n{\"immunoglobulin kappa 3' enhancer\": 5, \"Reason\": \"The sentence explicitly mentions the DNA entity immunoglobulin kappa 3' enhancer, providing a clear example of a DNA entity.\"},\n{\"SCL\": 5, \"Reason\": \"The sentence explicitly mentions the protein SCL, providing a clear example of a protein entity. Additionally, the sentence mentions GATA-1, which is another protein entity.\"},\n{\"Common pathway\": 1, \"Reason\": \"The sentence does not provide any specific entity examples relevant to the target sentence.\"},\n{\"Tumors\": 1, \"Reason\": \"The sentence does not provide any specific entity examples relevant to the target sentence.\"},\n{\"Genes\": 1, \"Reason\": \"The sentence does not provide any specific entity examples relevant to the target sentence.\"}\n]",
        "response3": "[{\"globin gene\": \"DNA\"}]",
        "prediction": "{'globin gene': 'DNA'}"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis\": 1},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"EBV\": 5},\n    {\"CD2\": 5},\n    {\"B-cell\": 5},\n    {\"TCL1\": 5},\n    {\"SIVsmmPBj14\": 5},\n    {\"CD4+\": 5},\n    {\"WT1\": 5},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"SIVmacMER\": 5},\n    {\"SIVmac239\": 5},\n    {\"CEMx174\": 5},\n    {\"TP1\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"ICAM-1\": 5},\n    {\"CD71\": 5},\n    {\"LMP1\": 5},\n    {\"IkappaB\": 5}\n]",
        "response3": "[{\"LCLs\": \"cell_line\"}, {\"RVLP\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"3\": \"The sentence contains 'IL-2 receptor alpha subunit' and 'B cell', which are relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains 'IL-4', 'LPS', and 'AP-1', which are relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains 'IL-2', 'c-Jun', and 'c-Fos', which are relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains 'interleukin 10', 'IL-10R', 'STAT3', and 'IL-6', which are relevant to the entity labels.\"},\n    {\"2\": \"The sentence only contains 'AP-1' which is relevant to the entity labels.\"},\n    {\"2\": \"The sentence only contains 'IL-4' which is relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains 'Th2-type lymphocytes', which is relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor', which are relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology', which are relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes', which are relevant to the entity labels.\"},\n    {\"5\": \"The sentence contains 'IL-2', 'NFAT', 'NFAT delta418', 'calcineurin', 'Tpl-2', and 'cyclosporin A', which are highly relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains 'Erbstatin', 'genistein', and 'Egr-1', which are relevant to the entity labels.\"},\n    {\"4\": \"The sentence contains 'AP-1', 'c-jun', 'IL-2', 'NF-AT', and 'T cell', which are relevant to the entity labels.\"},\n    {\"3\": \"The sentence contains 'LITAF' and 'TNF-alpha', which are relevant to the entity labels.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[\n    {\"IL-2\": \"protein\"},\n    {\"cysteamine\": \"protein\"},\n    {\"lymphocyte\": \"cell_type\"},\n    {\"AP-1\": \"protein\"},\n    {\"NF-kappa B\": \"protein\"},\n    {\"NF-AT\": \"protein\"},\n    {\"Oct1\": \"protein\"}\n]",
        "prediction": "{'IL-2': 'protein', 'cysteamine': 'protein', 'lymphocyte': 'cell_type', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains multiple protein entities and mentions specific proteins involved in signal transduction.\"},\n    {\"5\": \"The sentence contains protein entities and describes the phosphorylation of a protein.\"},\n    {\"5\": \"The sentence contains protein entities and transcription factors involved in gene regulation.\"},\n    {\"5\": \"The sentence contains protein entities and describes the inactivation of a protein by another protein.\"},\n    {\"4\": \"The sentence contains a protein entity and describes the importance of a phosphorylated tyrosine residue in protein-protein interaction.\"},\n    {\"5\": \"The sentence contains protein entities and describes the activation and function of Stat proteins.\"},\n    {\"5\": \"The sentence contains protein entities and describes the inhibition of transcription factors.\"},\n    {\"5\": \"The sentence contains protein entities and describes the regulation of gene expression through NF-kappa B and protein kinase C.\"},\n    {\"5\": \"The sentence contains protein entities and describes the phosphorylation and degradation of a protein.\"},\n    {\"5\": \"The sentence contains protein entities and describes the evaluation of protein kinase and its substrate in patients.\"},\n    {\"5\": \"The sentence contains protein entities and describes the presence of nuclear factors and specific proteins in gel-shift analysis.\"},\n    {\"5\": \"The sentence contains protein entities and describes the activation of NF-kappa B and the degradation of its inhibitor.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"beta-galactosidase gene\": \"protein\"}, {\"adenovirus E2 promoter\": \"DNA\"}]",
        "prediction": "{'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"C/EBP beta\": \"protein\"}, {\"eosinophilic\": \"cell_type\"}, {\"hematopoietic progenitor cell line\": \"cell_line\"}]",
        "prediction": "{'NF-M': 'protein', 'C/EBP beta': 'protein', 'eosinophilic': 'cell_type', 'hematopoietic progenitor cell line': 'cell_line'}"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"EBV\": 5, \"B-cell\": 5},\n{\"retinoic acid receptor alpha\": 5},\n{\"Protein\": 5},\n{\"MIP-1 alpha\": 5, \"GOS19\": 5, \"LD78\": 5, \"AT464\": 5},\n{\"EBNA-2\": 5, \"PU.1\": 5},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"Egr-1\": 5},\n{\"E2A\": 5},\n{\"GM-CSF\": 5},\n{\"protein\": 5},\n{\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"EBNA2\": 5, \"TP1\": 4},\n{\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n{\"interleukin 10\": 5, \"IL-10R\": 5, \"STAT3\": 5, \"IL-6\": 5},\n{\"GATA-1\": 5},\n{\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n{\"Common pathway\": 1},\n{\"Tumors\": 1},\n{\"Distinct genes\": 1}\n]",
        "response3": "[{\"G-protein coupled chemokine receptors\": \"protein\"}, {\"EBI1\": \"protein\"}]",
        "prediction": "{'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 1},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 1},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"eosinophils\": \"cell_type\"}]",
        "prediction": "{'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a cell line (SCM-1) being mentioned in relation to regulatory mechanisms of genes, making it highly relevant for extracting named entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence contains specific DNA-related terms (CCAAT box) and protein-related terms (EKLF binding site) that are crucial for identifying named entities, although the context is slightly complex.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence directly mentions a protein (GM-CSF) in the context of gene sequences, aiding in the extraction of named entities.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence includes multiple protein-related terms (IL-2, c-Jun, c-Fos) in the context of nuclear factors and promoter sites, making it highly valuable for named entity extraction.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence refers to a specific cell type (Th2-type lymphocytes) in relation to cytokine promoters, providing relevant information for named entity extraction.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions proteins and genomic sequences, highlighting the importance of protein-related terms for named entity extraction.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence discusses protein complexes (IL-7R, gamma(c)) and their functional analysis, which is crucial for identifying named entities accurately.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides a detailed example of chimeric receptors involving specific proteins (c-kit, IL-4R alpha chain), aiding in precise named entity extraction.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions multiple proteins (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) in the context of gene expression activation, making it highly informative for named entity extraction.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence focuses on a specific protein (retinoic acid receptor alpha) and binding assays, which are essential for accurate named entity extraction.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence discusses potential protein receptors (CHEMR1) and chemokines, providing valuable information for named entity extraction.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions a specific protein (TCF-1) and its transactivation ability, which is crucial for identifying named entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence directly correlates a change in phosphorylation status with DNA binding activity, highlighting the importance of DNA-related terms for named entity extraction.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides examples of protein substrates (SLAP-130, SLP-76) and T cell antigens, aiding in accurate named entity extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence focuses on a specific protein (ZAP-70) and its responsiveness to treatments, which is essential for identifying named entities.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any specific entity types mentioned in the target sentence, making it irrelevant for named entity extraction.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entity types mentioned in the target sentence, making it irrelevant for named entity extraction.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entity types mentioned in the target sentence, making it irrelevant for named entity extraction.\"}\n]",
        "response3": "[{\"HMG-1\": \"protein\"}]",
        "prediction": "{'HMG-1': 'protein'}"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains a specific protein entity (NF-E2) which is directly mentioned.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence contains multiple protein entities (Oct-2A, HMG I/Y, HLA-DRA) and a cell type entity (B cells) which are directly mentioned.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence contains a specific protein entity (IL-2) which is directly mentioned.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence contains multiple protein entities (NF-ATc, NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) which are directly mentioned.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains a specific protein entity (Egr-1) which is directly mentioned.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence contains a specific protein entity (IL-4) which is directly mentioned.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains a specific cell type entity (T cell) and a protein entity (interleukin 2) which are directly mentioned.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains multiple protein entities (IL-2, c-Jun, c-Fos) which are directly mentioned.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains a specific cell type entity (Th2-type lymphocytes) which is directly mentioned.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains a specific DNA entity (IgH) which is directly mentioned.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains a specific DNA entity (immunoglobulin kappa 3' enhancer) which is directly mentioned.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains multiple protein entities (c-kit, IL-4R alpha chain) which are directly mentioned.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence contains a specific protein entity (NF-kappa B) which is directly mentioned.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains multiple protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly mentioned.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence contains multiple protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes) which are directly mentioned.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence contains multiple protein entities (p50, p65) and DNA entities which are directly mentioned.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any entities related to the given entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any entities related to the given entity labels.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any entities related to the given entity labels.\"}\n]",
        "response3": "[{\"NF-microB\": \"protein\"}, {\"IgH\": \"DNA\"}]",
        "prediction": "{'NF-microB': 'protein', 'IgH': 'DNA'}"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 3},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 3},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 4},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"4\": \"The example contains the entity 'RXR' which is a protein, relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('IL-2', 'IFN-gamma', 'jak kinases', 'STAT1(alpha)') which are proteins, all relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('NF-kappaB', 'Sp1', 'p50') which are proteins, all relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('EBNA2', 'TP1') which are proteins and a cell line, relevant to the target sentence.\"},\n    {\"4\": \"The example contains entities ('T cell', 'interleukin 2') which are a cell type and a protein, relevant to the target sentence.\"},\n    {\"4\": \"The example contains the entity 'IL-2' which is a protein, relevant to the target sentence.\"},\n    {\"4\": \"The example contains the entity 'AP-1' which is a protein, relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('NF-kB', 'AP-1', 'OCT-1', 'NF-IL-2B') which are proteins, all relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('EBV', 'CD2') which are a cell line and a protein, relevant to the target sentence.\"},\n    {\"4\": \"The example contains entities ('CD4+', 'EBV') which are a cell type and a protein, relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('EBNA-2', 'PU.1') which are proteins, relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('UAS1', 'B cell') which are a cell line and a cell type, relevant to the target sentence.\"},\n    {\"5\": \"The example contains multiple entities ('EBV', 'B-cell') which are a cell type and a cell line, relevant to the target sentence.\"},\n    {\"4\": \"The example contains the entity 'GATA-1' which is a protein, relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"},\n    {\"1\": \"The example does not contain any entities relevant to the target sentence.\"}\n]",
        "response3": "[{'Epstein-Barr virus': 'cell_line'}, {'EBV': 'protein'}, {'R': 'protein'}, {'Z': 'protein'}]",
        "prediction": "{'Epstein-Barr virus': 'cell_line', 'EBV': 'protein', 'R': 'protein', 'Z': 'protein'}"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n{\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"ets-1\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'ets-1': 'protein'}"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 3},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 1},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"Platelet-activating factor\": \"protein\"}, {\"phospholipid\": \"protein\"}, {\"calcium\": \"protein\"}, {\"arachidonic acid\": \"protein\"}, {\"eicosanoid\": \"protein\"}, {\"oncogene\": \"protein\"}, {\"human B cell line\": \"cell_line\"}]",
        "prediction": "{'Platelet-activating factor': 'protein', 'phospholipid': 'protein', 'calcium': 'protein', 'arachidonic acid': 'protein', 'eicosanoid': 'protein', 'oncogene': 'protein', 'human B cell line': 'cell_line'}"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"granulocytes\": 5, \"T cells\": 5},\n    {\"tyrosine\": 5},\n    {\"ZAP-70\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5},\n    {\"NF-kappaB\": 5, \"Tax\": 5, \"ATL\": 5},\n    {\"IL-2 receptor alpha subunit\": 5, \"p21ras\": 5, \"B cell\": 5},\n    {\"T cell\": 5, \"IL-2\": 5, \"IL-2 receptor\": 5, \"CD28\": 5},\n    {\"CD28\": 5, \"CD80\": 5, \"CD86\": 5, \"CBL\": 5, \"VAV\": 5, \"NFAT\": 5, \"interleukin-2\": 5, \"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"DNA\": 1},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"Syk\": 5, \"Zap\": 5, \"T cell\": 5},\n    {\"NF-kappa B\": 5},\n    {\"IL-2\": 5, \"Aiolos\": 5, \"Ras\": 5},\n    {},\n    {},\n    {}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains a specific term that corresponds to one of the entity labels in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example contains a specific term that corresponds to one of the entity labels in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains a specific term that corresponds to one of the entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example contains a specific term that corresponds to one of the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example contains a specific term that corresponds to one of the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example contains specific terms that directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The example contains a term that is related to the entity labels in the target sentence, but not a direct match.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The example does not contain terms that correspond to the entity labels in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The example does not contain terms that correspond to the entity labels in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not contain terms that correspond to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"salicylates\": \"protein\"}, {\"atherosclerosis\": \"cell_type\"}, {\"rheumatoid arthritis\": \"cell_type\"}, {\"monocyte\": \"cell_type\"}]",
        "prediction": "{'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 4},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains multiple examples of protein entities (NF-ATc, NF-ATc isoforms) and cell type entities (T lymphocytes, embryonic cardiac cells).\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes various examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) and their labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains an example of a DNA entity (NF-kappa B) and its corresponding label.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes examples of protein entities (NF-kappa B, I kappa B alpha) and their labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains examples of protein entities (RelA, NF-kappa B) and their labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes examples of protein entities (FasL, IL-2, IFN-gamma) and their corresponding labels.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides examples of protein entities (NF-ATc, NF-ATc isoforms) and a cell type entity (T lymphocytes) with their corresponding labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains examples of protein entities (NF-kappa B, I kappa B alpha) and their labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of protein entities (CD40, NF-kappa B) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence includes examples of protein entities (NF-kappaB, Tax) and cell type entities (ATL) with their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains examples of protein entities (IL-10-stimulated STAT protein, STAT3) and a cell type entity (T cells) with their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence includes examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities relevant to the entity labels provided.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities relevant to the entity labels provided.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities relevant to the entity labels provided.\"}\n]",
        "response3": "[{\"NFATc\": \"protein\"}, {\"NFATc mRNA\": \"RNA\"}, {\"NK cells\": \"cell_type\"}, {\"CD16 ligands\": \"protein\"}]",
        "prediction": "{'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n{\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CD30\": \"protein\"}]",
        "prediction": "{'CD30': 'protein'}"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 1},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"c-jun\": \"protein\"}, {\"HL-60 cells\": \"cell_line\"}, {\"TPA\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein', 'HL-60 cells': 'cell_line', 'TPA': 'protein'}"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4},\n    {\"MNDA\": 4},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"PMA\": 3},\n    {\"CD14\": 4},\n    {\"CD23\": 4},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 4},\n    {\"c-Fos\": 4},\n    {\"PML/RARalpha\": 5},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"NF-kappaB\": 4},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"TCRzeta\": 4},\n    {\"p56(lck)\": 4},\n    {\"p21(WAF1/CIP1)\": 4},\n    {\"p27(KIP1)\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"Ter 119\": 4},\n    {\"beta-globin\": 4},\n    {\"glycoprotein IIb\": 4},\n    {\"platelet factor 4\": 4},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"NF-kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"B and T cell activation\": 3},\n    {\"Ramos\": 4},\n    {\"Jurkat\": 4},\n    {\"cDNA microarray technology\": 5},\n    {\"HeLa cells\": 4},\n    {\"Daudi\": 4},\n    {\"B cell-encoded genes\": 4},\n    {\"B cell-specific\": 4},\n    {\"PU.1\": 4},\n    {\"CSF-1 receptor\": 4},\n    {\"Mono A\": 4},\n    {\"Mono B\": 4}\n]",
        "response3": "[{\"pbmc\": \"cell_type\"}, {\"bone marrow cells\": \"cell_type\"}, {\"c-fos\": \"protein\"}, {\"c-myc\": \"protein\"}, {\"p53\": \"protein\"}, {\"bcr/abl mRNA\": \"RNA\"}]",
        "prediction": "{'pbmc': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"GCR\": \"protein\"}, {\"GCS\": \"protein\"}, {\"BA\": \"cell_type\"}]",
        "prediction": "{'GCR': 'protein', 'GCS': 'protein', 'BA': 'cell_type'}"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Id2 mRNA\": \"RNA\"}, {\"Id3 mRNA\": \"RNA\"}]",
        "prediction": "{'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"EBNA2\": 5},\n    {\"TP1\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 4},\n    {\"embryonic cardiac cells\": 4},\n    {\"Sp1\": 5},\n    {\"CD14\": 5},\n    {\"CD40\": 5},\n    {\"NF-kappa B\": 5},\n    {\"Egr-1\": 5},\n    {\"CD95 ligand\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"STAT3\": 5},\n    {\"IL-6\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"TCF-1\": 5},\n    {\"PAFR\": 5},\n    {\"PAF\": 5},\n    {\"protein kinase C\": 5},\n    {\"NF-kappaB\": 5},\n    {\"SIVmac\": 5},\n    {\"TFIID\": 5},\n    {\"activators\": 5},\n    {\"B cells\": 5},\n    {\"HIV-1 LTR\": 5},\n    {\"NFAT-1\": 5},\n    {\"NF kappa B\": 5},\n    {\"BAT box\": 5},\n    {\"CD20\": 5}\n]",
        "response3": "[{\"CD69 gene\": \"protein\"}, {\"TATA element\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 1},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['cell_line', 'protein', 'RNA']",
        "response2": "[\n    {\"1\": \"The example provides entities that are not present in the target sentence.\"},\n    {\"1\": \"The example provides entities that are not present in the target sentence.\"},\n    {\"1\": \"The example provides entities that are not present in the target sentence.\"},\n    {\"4\": \"The example provides relevant entities such as 'NF-kappaB' and 'Tax' which are similar to entities in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'IkappaBbeta' and 'NF-kappaB' which are directly related to entities in the target sentence.\"},\n    {\"3\": \"The example provides a relevant entity 'NF-kappa B' which is similar to an entity in the target sentence.\"},\n    {\"5\": \"The example provides multiple relevant entities such as 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are similar to entities in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'IL-2', 'NF-kappa B', and 'AP-1' which are directly related to entities in the target sentence.\"},\n    {\"4\": \"The example provides a relevant entity 'NF-kappa B' which is similar to an entity in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'MTHC', 'TNF-alpha', 'IFN-gamma', and 'DC' which are directly related to entities in the target sentence.\"},\n    {\"3\": \"The example provides a relevant entity 'NF-kappa B' which is similar to an entity in the target sentence.\"},\n    {\"5\": \"The example provides a relevant entity 'NF-kappa B' which is directly related to an entity in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' which are directly related to entities in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'PMA', 'IFN-gamma', and 'T cell blasts' which are directly related to entities in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'CTLA4Ig', 'NFAT', and 'AP-1' which are directly related to entities in the target sentence.\"},\n    {\"5\": \"The example provides relevant entities such as 'NF-kappa B' and 'neutrophils' which are directly related to entities in the target sentence.\"},\n    {\"1\": \"The example does not provide any relevant entities present in the target sentence.\"},\n    {\"1\": \"The example does not provide any relevant entities present in the target sentence.\"},\n    {\"1\": \"The example does not provide any relevant entities present in the target sentence.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"RNA\": \"RNA\"}, {\"cell_line\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'RNA': 'RNA', 'cell_line': 'cell_line'}"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of proteins, which are the entity types present in the target sentence. Each example provides a clear label for a protein entity, aiding in the extraction of protein named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell type (nonhuman primates) and specifies that the study involves cells from nonhuman primates, making it highly relevant for identifying cell types.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence explicitly mentions 'cell adhesion molecules' which is a clear indicator of cell type, making it highly relevant for identifying cell types.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'G-CSF' which is a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple examples of entities such as 'CD70' (protein), 'B cell' (cell type), 'plasma cells' (cell type), 'IL-4' (protein), and 'CD40' (protein), making it highly relevant for identifying various entity types.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein entity 'E2A', making it highly relevant for identifying proteins.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'NF-E2' which is a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple examples of entities such as 'IL-5 mRNA' (RNA), 'TCR' (cell type), 'IL-2R' (protein), and 'dexamethasone' (protein), making it highly relevant for identifying various entity types.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of cell types 'granulocytes' and 'T cells', making it highly relevant for identifying cell types.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'IL-4' which is a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple examples of entities such as 'IL-2' (protein), 'c-Jun' (protein), and 'c-Fos' (protein), making it highly relevant for identifying various entity types.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'phosphocreatine' which is a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple examples of entities such as 'HML' (cell line), 'dexamethasone' (protein), 'cortisol' (protein), and 'lysozyme' (protein), making it highly relevant for identifying various entity types.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'IFN-gamma' which is a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'NF-kappa B' which is a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of protein entities 'VDR', 'RXR', 'GRIP-1', and 'DRIP205', making it highly relevant for identifying proteins.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains multiple examples of entities such as 'CD40' (protein), 'Rel/nuclear factor kappaB' (protein), 'NF-kappaB' (protein), and 'B lymphocytes' (cell type), making it highly relevant for identifying various entity types.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific examples of named entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific examples of named entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific examples of named entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[\n    {\"NF-kappa B\": \"protein\"},\n    {\"p50 NF-kappa B1\": \"protein\"},\n    {\"p65 RelA\": \"protein\"}\n]",
        "prediction": "{'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "response1": "None.",
        "response2": "[\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 3},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n{\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n{\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\": 4},\n{\"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs .\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a specific cell type (Th2-type lymphocytes) and its corresponding entity label (cell_type). This example is highly relevant and directly matches one of the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) and their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions specific protein names (RelA, NF-kappa B) and their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes specific protein names (NF-kappa B, I kappa B alpha) and their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides specific protein names (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) with their corresponding entity labels (protein, cell_type). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli names (phytohemagglutinin, phorbol myristate acetate) with their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions specific protein names (IkappaBalpha, NF-kappaB) and their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes specific protein names (NF-kappa B, I kappa B alpha) and their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides specific protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions specific protein names (IkappaBbeta, NF-kappaB) and a cell type (ATL) with their corresponding entity labels (protein, cell_type). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names (HIV-1, IFN, PKR, IkappaBalpha) with their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides specific protein names (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) with their corresponding entity labels (protein, cell_type). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions specific protein names (YY1, Oct1, IL-5) and a cell type (T cells) with their corresponding entity labels (protein, cell_type). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence includes specific protein names (interleukin-2, alpha chain, CD25, IL-2 receptor) with their corresponding entity labels (protein). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (CTLA4Ig, NFAT, AP-1) with their corresponding entity labels (protein, cell_type). These examples are highly relevant and directly match multiple entity types in the target sentence.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any specific named entities or terms that match the entity labels in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific named entities or terms that match the entity labels in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific named entities or terms that match the entity labels in the target sentence, making it not helpful for extracting named entities.\"}\n]",
        "response3": "[{\"Jurkat cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"tumor necrosis factor alpha\": \"protein\"}, {\"RelA\": \"protein\"}]",
        "prediction": "{'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'CD40' and 'NF-kappa B' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is labeled as 'protein' entity.\"},\n    {\"5\": \"The sentence contains 'IL-2', 'c-Jun', and 'c-Fos' which are all labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'E2A' which is labeled as a 'protein' entity.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is labeled as a 'protein' entity.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both labeled as 'protein' entities.\"},\n    {\"5\": \"The sentence contains 'NF-kappaB', 'Tax', and 'ATL' which are labeled as 'protein' and 'cell_type' entities.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is labeled as a 'DNA' entity.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}, {\"mouse 70Z/3 cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"phorbol myristate acetate\": \"protein\"}, {\"lipopolysaccharide\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 5},\n    {\"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"NF-E2\": 5},\n    {\"E2A\": 5},\n    {\"EKLF\": 5},\n    {\"CBP\": 5},\n    {\"p300\": 5},\n    {\"P/CAF\": 5},\n    {\"Protein\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"embryonic cardiac cells\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"RXR\": 5},\n    {\"AP-1\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"ZEB\": 5},\n    {\"c-Myb\": 5},\n    {\"Ets\": 5},\n    {\"hematopoietic cells\": 5},\n    {\"p50\": 5},\n    {\"p65\": 5}\n]",
        "response3": "[{\"OSF2\": \"protein\"}, {\"PEBP2 alpha factors\": \"protein\"}]",
        "prediction": "{'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "response1": "['cell_line', 'cell_type', 'gene expression']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the relationship between the entity 'SCL' and its corresponding label 'RNA', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of different entity types (protein, cell_type) clearly associated with specific entities, making it very helpful for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly links the entity 'GATA-1' with the label 'protein', providing a clear example for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions 'SCM-1' as a 'cell_line', making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a specific example of 'nonhuman primates' as a 'cell_type', aiding in entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence clearly associates 'E2A' with the label 'protein', making it very helpful for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly links 'GATA-1' with the label 'protein', providing a clear example for entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple examples of different entity types (protein, DNA, cell_type) clearly associated with specific entities, making it very helpful for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of 'NF-kappa B' and 'I kappa B alpha' as 'protein' entities, aiding in entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly links 'IL-4' with the label 'protein', making it very helpful for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of 'MNDA' as a 'protein' and 'Philadelphia chromosome-positive chronic myeloid leukemia' as a 'cell_line', aiding in entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains examples of 'Sp1' and 'Ets' as 'protein' entities, making it very helpful for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of 'p21(WAF1/CIP1)' and 'p27(KIP1)' as 'protein' entities, aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence directly links 'cell adhesion molecules' with the label 'cell_type', making it very helpful for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains multiple examples of different protein entities (IL-13, IL-4R, JAK2, IL-13R) clearly associated with specific entities, making it very helpful for entity extraction.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence does not contain any named entities related to the provided entity labels, making it not helpful for entity extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities related to the provided entity labels, making it not helpful for entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities related to the provided entity labels, making it not helpful for entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (GM-CSF) and its corresponding label, which is helpful for understanding how protein entities are mentioned in the text.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of DNA entities (UAS3, UAS2) and a protein entity (YY1) with their corresponding labels, aiding in the extraction of these entities from the text.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions a protein entity (Protein) and its label, providing a straightforward example for identifying protein entities in the text.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes protein entities (IL-2, c-Jun, c-Fos) and their labels, assisting in recognizing protein entities and their roles in the text.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions protein entity (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) with their labels, aiding in identifying these entities in the text.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of a protein entity (EKLF) and its label, helping in understanding how protein entities are discussed in the text.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a protein entity (A-myb) and its label, offering a straightforward example for identifying protein entities in the text.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains protein entities (Tax, TFIIA) and their labels, assisting in recognizing protein entities and their interactions in the text.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions a DNA entity (cDNAs) and its label, providing a clear example for identifying DNA entities in the text.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence includes a protein entity (GATA-1) and its label, aiding in recognizing protein entities and their roles in the text.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (EKLF, CBP, p300, P/CAF) and their labels, helping in understanding the roles of these proteins in the text.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions a cell line entity (SCM-1) and its label, offering a clear example for identifying cell line entities in the text.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains a protein entity (NF-E2) and its label, assisting in recognizing protein entities and their interactions in the text.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (p21(WAF1/CIP1), p27(KIP1)) and their labels, aiding in understanding the roles of these proteins in the text.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions protein entity (NF-ATc) and cell type entity (T lymphocytes) with their labels, helping in identifying these entities in the text.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence includes a protein entity (E2A) and its label, providing a clear example for identifying protein entities in the text.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any entities from the given label set, hence not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any entities from the given label set, hence not helpful for extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any entities from the given label set, hence not helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": \"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\", \"5\": \"The sentence contains multiple protein entities such as PAFR, PAF, NF-kappa B, and protein kinase C which are directly mentioned.\"},\n    {\"Sentence\": \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\", \"4\": \"The sentence mentions NF-kappa B, which is a protein entity.\"},\n    {\"Sentence\": \"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\", \"4\": \"The sentence mentions Sp1, NF-kappaB, and p50 as protein entities.\"},\n    {\"Sentence\": \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\", \"4\": \"The sentence mentions NF-kappa B as a protein entity.\"},\n    {\"Sentence\": \"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\", \"5\": \"The sentence directly mentions NF-kappa B and I kappa B alpha as protein entities.\"},\n    {\"Sentence\": \"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\", \"4\": \"The sentence mentions RelA and NF-kappa B as protein entities.\"},\n    {\"Sentence\": \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\", \"4\": \"The sentence mentions NF-kappaB and Tax as protein and cell_type entities.\"},\n    {\"Sentence\": \"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\", \"4\": \"The sentence mentions NF-ATc and T lymphocytes as protein and cell_type entities.\"},\n    {\"Sentence\": \"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\", \"5\": \"The sentence directly mentions NF-kappa B as a protein entity.\"},\n    {\"Sentence\": \"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\", \"4\": \"The sentence mentions NF-ATc, T lymphocytes, and embryonic cardiac cells as protein and cell_type entities.\"},\n    {\"Sentence\": \"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\", \"4\": \"The sentence mentions NF-kB, AP-1, OCT-1, and NF-IL-2B as protein entities.\"},\n    {\"Sentence\": \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\", \"3\": \"The sentence mentions NF-kappa B as a DNA entity.\"},\n    {\"Sentence\": \"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\", \"5\": \"The sentence directly mentions IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate as protein entities.\"},\n    {\"Sentence\": \"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\", \"5\": \"The sentence directly mentions p21(WAF1/CIP1) and p27(KIP1) as protein entities.\"},\n    {\"Sentence\": \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\", \"5\": \"The sentence directly mentions NF-kappa B and I kappa B alpha as protein entities.\"},\n    {\"Sentence\": \"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\", \"5\": \"The sentence directly mentions NF-kappa B and AP-1 as protein entities.\"},\n    {\"Sentence\": \"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\", \"1\": \"The sentence does not mention any specific entities relevant to the given labels.\"},\n    {\"Sentence\": \"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\", \"1\": \"The sentence does not mention any specific entities relevant to the given labels.\"},\n    {\"Sentence\": \"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\", \"1\": \"The sentence does not mention any specific entities relevant to the given labels.\"}\n]",
        "response3": "[{\"KBF1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'KBF1': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"CVZ\": \"protein\"}, {\"IM-9\": \"cell_line\"}, {\"RU 38486\": \"protein\"}, {\"human GR\": \"protein\"}]",
        "prediction": "{'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides examples of named entities (proteins, cell types) that are relevant to the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"EF1\": \"protein\"}]",
        "prediction": "{'EF1': 'protein'}"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"IFN-gamma-activated sequence (GAS)\": \"DNA\"}]",
        "prediction": "{'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"E1A\": \"protein\"}, {\"IFN\": \"protein\"}, {\"adenovirus-transformed cells\": \"cell_line\"}, {\"NK cells\": \"cell_type\"}]",
        "prediction": "{'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 4},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n{\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n{\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n{\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n{\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells, respectively.\": 5},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CD8+\": \"cell_type\"}, {\"progesterone receptor\": \"protein\"}, {\"CD4+\": \"cell_type\"}, {\"lymphocytes\": \"cell_type\"}]",
        "prediction": "{'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Cyclosporin A\": \"protein\"}, {\"CsA\": \"protein\"}, {\"lymphokine genes\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"interleukin-2\": \"protein\"}]",
        "prediction": "{'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n{\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n{\"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\": 5},\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"SCL\": \"protein\"}]",
        "prediction": "{'SCL': 'protein'}"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"kappa B complex\": \"protein\"}, {\"NFAT-1 complex\": \"protein\"}]",
        "prediction": "{'kappa B complex': 'protein', 'NFAT-1 complex': 'protein'}"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"anti-CD3 Abs\": \"protein\"}]",
        "prediction": "{'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"bronchoalveolar lavage\": \"cell_type\"}, {\"blood mononuclear cells\": \"cell_type\"}, {\"sarcoidosis\": \"cell_type\"}, {\"tuberculosis\": \"cell_type\"}]",
        "prediction": "{'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"SP1\": 5, \"caspases\": 5, \"B-cell\": 5},\n    {\"Sp1\": 4, \"Ets\": 4},\n    {\"GATA-1\": 4},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"SCM-1\": 5},\n    {\"IL-4\": 4},\n    {\"CD70\": 4, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 4, \"CD40\": 4},\n    {\"T cell\": 5, \"interleukin 2\": 4},\n    {\"PML/RARalpha\": 4},\n    {\"GATA-1\": 4},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"NF-ATc\": 4, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"A-myb\": 4},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"IkappaBbeta\": 4, \"NF-kappaB\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"1\": \"The entity 'DNA' is mentioned in the sentence, but it is not directly related to the named entities in the target sentence.\"},\n    {\"2\": \"The entities 'protein' and 'cell_type' are mentioned in the sentence, but they are not directly related to the named entities in the target sentence.\"},\n    {\"4\": \"The entities 'protein' and 'protein' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"3\": \"The entities 'protein' and 'protein' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"5\": \"The entities 'cell_line', 'protein', 'protein', and 'cell_type' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"4\": \"The entities 'protein', 'protein', 'protein', and 'protein' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"3\": \"The entities 'protein', 'protein', and 'cell_type' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"4\": \"The entities 'cell_type', 'protein', 'protein', and 'protein' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"5\": \"The entities 'protein', 'protein', and 'cell_type' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"3\": \"The entities 'protein', 'cell_type', and 'cell_type' are mentioned in the sentence, but they are not directly related to the named entities in the target sentence.\"},\n    {\"5\": \"The entities 'DNA', 'protein', and 'protein' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"4\": \"The entities 'protein' and 'protein' are mentioned in the sentence, and they are directly related to the named entities in the target sentence.\"},\n    {\"1\": \"The sentence does not mention any entities related to the named entities in the target sentence.\"},\n    {\"1\": \"The sentence does not mention any entities related to the named entities in the target sentence.\"},\n    {\"1\": \"The sentence does not mention any entities related to the named entities in the target sentence.\"},\n    {\"1\": \"The sentence does not mention any entities related to the named entities in the target sentence.\"},\n    {\"1\": \"The sentence does not mention any entities related to the named entities in the target sentence.\"},\n    {\"1\": \"The sentence does not mention any entities related to the named entities in the target sentence.\"}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"HIV LTR\": \"DNA\"}, {\"T cells\": \"cell_type\"}, {\"monocytic cells\": \"cell_type\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "response1": "['cell_line', 'protein', 'DNA']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities that are relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'CD40' and other protein entities that are relevant to the target sentence.\"},\n    {\"3\": \"The sentence contains protein entities but not directly related to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities that are relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'NF-kappa B' which is relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities and cell type entities that are relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'NF-kappaB' and 'ATL' which are relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities that are relevant to the target sentence.\"},\n    {\"5\": \"The sentence contains multiple protein entities and cell type entities that are relevant to the target sentence.\"},\n    {\"4\": \"The sentence contains 'HIV-1' and protein entities that are relevant to the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types in the target sentence.\"}\n]",
        "response3": "[\n    {\"L540 cells\": \"cell_line\"},\n    {\"CD30\": \"protein\"},\n    {\"NF-kappa B\": \"protein\"}\n]",
        "prediction": "{'L540 cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 3},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and specific example of a protein entity, 'NF-kappa B', and its corresponding entity label, which directly aids in extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"HDl\": \"protein\"}, {\"LDL\": \"protein\"}]",
        "prediction": "{'HDl': 'protein', 'LDL': 'protein'}"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n{\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 5},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"complementary DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"Protein\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"T cell\": 5},\n    {\"UAS1\": 5},\n    {\"B cell\": 5},\n    {\"CD40\": 5},\n    {\"Tat-binding protein 7\": 5},\n    {\"p50p50\": 5},\n    {\"E2A\": 5},\n    {\"immunohistochemistry\": 4},\n    {\"gene\": 4},\n    {\"cDNAs\": 5},\n    {\"p65\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"DRE 1\": 5},\n    {\"SIVmac\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell line (SCM-1) in the context of examining regulatory mechanisms of genes.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions the protein 'p50p50' in the context of binding and upregulation, providing a relevant example for protein extraction.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence directly refers to the protein 'PML/RARalpha' in the context of evaluating its role in myelopoiesis.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins (EKLF, CBP, p300, P/CAF) and their interactions, aiding in protein extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions the protein 'GATA-1' as a lineage-specific transcription factor in erythroid cells, providing a clear example for protein extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence refers to the protein 'TCF-1' in the context of transactivation, aiding in protein extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides an example of the protein 'ZEBRA' in the context of transactivation, aiding in protein extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions the protein 'A-myb' and its specific pattern of expression, providing a relevant example for protein extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions 'Protein' in the context of genomic sequences and transcription, which can aid in protein extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence refers to the protein 'CD95 ligand' in the context of a luciferase reporter construct, providing a relevant example for protein extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins 'Tax' and 'TFIIA' in the context of interaction, aiding in protein extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the protein 'Egr-1' as a zinc finger transcription factor, providing a clear example for protein extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins 'IL-2', 'c-Jun', and 'c-Fos' in the context of nuclear factors and binding, aiding in protein extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions the protein 'GATA-1' in the context of erythroid development and gene regulation, providing a clear example for protein extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence refers to the protein 'E2A' at the protein level using polyclonal antisera, aiding in protein extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins 'Sp1' and 'Ets' in the context of transcription factors and gene expression, aiding in protein extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any relevant entity types from the given label set.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any relevant entity types from the given label set.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any relevant entity types from the given label set.\"}\n]",
        "response3": "[{\"MZF-1\": \"protein\"}, {\"MZF-1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example contains a specific entity 'immunoglobulin kappa 3' enhancer' which is labeled as 'DNA' in the target sentence, providing a clear and direct mapping between the example and the entity type in the target sentence.\"},\n\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example contains entities 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' which are labeled as 'protein' and 'cell_line' respectively in the target sentence. The example provides relevant entities that are similar to those in the target sentence, aiding in understanding the context and potential entity types.\"},\n\n{\"Example 3\": 4},\n{\"Reason 3\": \"The example contains entities 'IL-7R' and 'gamma(c)' which are labeled as 'protein' in the target sentence. The example helps in recognizing protein-related entities in a similar context to the target sentence.\"},\n\n{\"Example 4\": 5},\n{\"Reason 4\": \"The example contains entities 'granulocytes' and 'T cells' which are labeled as 'cell_type' in the target sentence. The example directly corresponds to the entity types present in the target sentence, aiding in identifying cell types.\"},\n\n{\"Example 5\": 5},\n{\"Reason 5\": \"The example contains the entity 'Protein' which is labeled as 'protein' in the target sentence. The example provides a clear and direct mapping to the entity type in the target sentence, facilitating the extraction of protein-related entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"lymphocytes\": \"cell_type\"}, {\"T3R\": \"protein\"}]",
        "prediction": "{'lymphocytes': 'cell_type', 'T3R': 'protein'}"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear and specific examples of entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Factor VII/VIIa\": \"protein\"}, {\"tissue factor (TF) receptor\": \"protein\"}]",
        "prediction": "{'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": \"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappaB, Sp1, p50) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Control of NF-kappa B activity by the I kappa B beta inhibitor .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, I kappa B beta) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (RelA, NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence contains the entity label 'NF-kappa B' which is relevant to the target sentence, but lacks additional entities for a higher score.\"},\n    {\"Sentence\": \"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (CD40, NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (IkappaBalpha, NF-kappaB) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (IkappaBbeta, NF-kappaB) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappaB, Tax) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, ARDS) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (IL-4, LPS, AP-1) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence contains specific protein names (NF-kappa B) which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": \"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant entities to the target sentence.\"},\n    {\"Sentence\": \"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant entities to the target sentence.\"},\n    {\"Sentence\": \"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\", \"Helpfulness score\": 1, \"Reason\": \"The sentence does not contain any relevant entities to the target sentence.\"}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"p50\": \"protein\"}, {\"p65\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T cell\": \"cell_type\"}, {\"HIV\": \"cell_type\"}]",
        "prediction": "{'T cell': 'cell_type', 'HIV': 'cell_type'}"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Example 2\": 5},\n{\"Example 3\": 5},\n{\"Example 4\": 5},\n{\"Example 5\": 5},\n{\"Example 6\": 5},\n{\"Example 7\": 5},\n{\"Example 8\": 5},\n{\"Example 9\": 5},\n{\"Example 10\": 5},\n{\"Example 11\": 5},\n{\"Example 12\": 5},\n{\"Example 13\": 5},\n{\"Example 14\": 5},\n{\"Example 15\": 5},\n{\"Example 16\": 5},\n{\"Example 17\": 1},\n{\"Example 18\": 1},\n{\"Example 19\": 1}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"immunoglobulin\": \"protein\"}, {\"class II major histocompatibility (MHC) genes\": \"protein\"}, {\"B-lymphoid-specific genes\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"GATA\": \"protein\"}, {\"Ets\": \"protein\"}, {\"platelet glycoprotein Ib alpha gene\": \"protein\"}]",
        "prediction": "{'GATA': 'protein', 'Ets': 'protein', 'platelet glycoprotein Ib alpha gene': 'protein'}"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"PRL-\": \"protein\"}, {\"IL-2-\": \"protein\"}]",
        "prediction": "{'PRL-': 'protein', 'IL-2-': 'protein'}"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"VDR\": \"protein\"}]",
        "prediction": "{'VDR': 'protein'}"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "response1": "['cell_line', 'DNA', 'protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 3},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 3},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"multiple myeloma cell lines\": \"cell_line\"}, {\"B cells\": \"cell_type\"}, {\"PU.1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"mRNA\": \"RNA\"}]",
        "prediction": "{'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label, which directly aids in understanding how to extract named entities from the target sentence.\"}\n]",
        "response3": "[{\"VLA-5\": \"protein\"}, {\"CD4 cells\": \"cell_type\"}, {\"CD3\": \"protein\"}, {\"TCR\": \"protein\"}, {\"fibronectin\": \"protein\"}]",
        "prediction": "{'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3': 'protein', 'TCR': 'protein', 'fibronectin': 'protein'}"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"TCL1 mRNA\": \"RNA\"}, {\"TCL1\": \"protein\"}, {\"PBLs\": \"cell_type\"}, {\"AT\": \"cell_type\"}]",
        "prediction": "{'TCL1 mRNA': 'RNA', 'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NFAT-1\": \"protein\"}, {\"SV40 T-antigen\": \"protein\"}]",
        "prediction": "{'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"Ets-1\": \"protein\"}, {\"TFE-3\": \"protein\"}, {\"Sp1\": \"protein\"}]",
        "prediction": "{'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"I kappa B beta\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 1},\n    {\"Sentence 3\": 1},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5},\n    {\"Sentence 16\": 1},\n    {\"Sentence 17\": 1},\n    {\"Sentence 18\": 1}\n]",
        "response3": "[{\"p56\": \"protein\"}, {\"hsp70\": \"protein\"}, {\"hsp90\": \"protein\"}, {\"untransformed steroid receptors\": \"protein\"}]",
        "prediction": "{'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 4},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\": 4},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"Antigen B27\": \"protein\"}, {\"glucocorticoid receptors\": \"protein\"}, {\"blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCF-2 alpha\": \"protein\"}, {\"CREB\": \"protein\"}, {\"T alpha 1\": \"protein\"}, {\"TCR alpha enhancer\": \"DNA\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'CREB': 'protein', 'T alpha 1': 'protein', 'TCR alpha enhancer': 'DNA'}"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains a specific term that directly corresponds to an entity label in the entity label set.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence contains specific terms that directly correspond to entity labels in the entity label set.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not contain any terms that correspond to the entity labels in the entity label set.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any terms that correspond to the entity labels in the entity label set.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any terms that correspond to the entity labels in the entity label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"Reason\": \"Both 'RelA' and 'NF-kappaB1' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"Tax\": 4, \"TFIIA\": 4},\n    {\"Reason\": \"Both 'Tax' and 'TFIIA' are mentioned in the sentence and are identified as proteins, making this example very helpful in extracting named entities from the target sentence.\"},\n    {\"CD40\": 4, \"NF-kappa B\": 4},\n    {\"Reason\": \"Both 'CD40' and 'NF-kappa B' are mentioned in the sentence and are identified as proteins, making this example very helpful in extracting named entities from the target sentence.\"},\n    {\"retinoic acid receptor alpha\": 3},\n    {\"Reason\": \"Only 'retinoic acid receptor alpha' is mentioned in the sentence and identified as a protein, making this example somewhat helpful in extracting named entities from the target sentence.\"},\n    {\"tyrosine\": 3},\n    {\"Reason\": \"Only 'tyrosine' is mentioned in the sentence and identified as a protein, making this example somewhat helpful in extracting named entities from the target sentence.\"},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"Reason\": \"Both 'IL-2', 'c-Jun', and 'c-Fos' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"EBNA-2\": 5, \"PU.1\": 5},\n    {\"Reason\": \"Both 'EBNA-2' and 'PU.1' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Reason\": \"Both 'NF-kappaB', 'Sp1', and 'p50' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"TRAF6\": 5, \"RANKL\": 5, \"NF-kappaB\": 5},\n    {\"Reason\": \"Both 'TRAF6', 'RANKL', and 'NF-kappaB' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"CREB\": 5, \"AR-CRE\": 5},\n    {\"Reason\": \"Both 'CREB' and 'AR-CRE' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"NF-E2\": 5},\n    {\"Reason\": \"'NF-E2' is mentioned in the sentence and identified as a protein, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"Sp1\": 5, \"CD14\": 5},\n    {\"Reason\": \"Both 'Sp1' and 'CD14' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"AP-1\": 3},\n    {\"Reason\": \"'AP-1' is mentioned in the sentence and identified as DNA, making this example somewhat helpful in extracting named entities from the target sentence.\"},\n    {\"VDR\": 5, \"RXR\": 5, \"GRIP-1\": 5, \"DRIP205\": 5, \"DRIP\": 5},\n    {\"Reason\": \"Both 'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"p50\": 5, \"p65\": 5},\n    {\"Reason\": \"Both 'p50' and 'p65' are mentioned in the sentence and are identified as proteins, making this example highly helpful in extracting named entities from the target sentence.\"},\n    {\"cDNA\": 3, \"Jurkat\": 3, \"DRE 1\": 3},\n    {\"Reason\": \"'cDNA' is mentioned in the sentence and identified as DNA, 'Jurkat' is identified as a cell line, and 'DRE 1' is identified as a cell type, making this example somewhat helpful in extracting named entities from the target sentence.\"},\n    {\"Reason\": \"No relevant entities are mentioned in the sentence, making this example not helpful in extracting named entities from the target sentence.\"},\n    {\"Reason\": \"No relevant entities are mentioned in the sentence, making this example not helpful in extracting named entities from the target sentence.\"},\n    {\"Reason\": \"No relevant entities are mentioned in the sentence, making this example not helpful in extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"TR alpha 1\": \"protein\"}, {\"NE\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Example 2\": 5},\n{\"Example 3\": 5},\n{\"Example 4\": 5},\n{\"Example 5\": 5},\n{\"Example 6\": 5},\n{\"Example 7\": 5},\n{\"Example 8\": 5},\n{\"Example 9\": 5},\n{\"Example 10\": 5},\n{\"Example 11\": 5},\n{\"Example 12\": 5},\n{\"Example 13\": 5},\n{\"Example 14\": 5},\n{\"Example 15\": 5},\n{\"Example 16\": 1},\n{\"Example 17\": 1},\n{\"Example 18\": 1}\n]",
        "response3": "[{\"HTLV-I\": \"cell_type\"}, {\"TRE\": \"DNA\"}, {\"Tax\": \"protein\"}]",
        "prediction": "{'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"T-helper-cell\": \"cell_type\"}, {\"protein\": \"protein\"}, {\"cysteine-rich antigen segments\": \"protein\"}, {\"cathepsin B\": \"protein\"}, {\"cathepsin L\": \"protein\"}, {\"cathepsin D\": \"protein\"}]",
        "prediction": "{'T-helper-cell': 'cell_type', 'protein': 'protein', 'cysteine-rich antigen segments': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a specific gene name (SCM-1) which is likely a cell line based on the naming convention.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a specific transcription factor name (NF-E2) which is likely a protein based on its function.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides specific cell line name (HML) and protein names (dexamethasone, cortisol, lysozyme) which are likely corresponding entities based on their functions.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a specific protein name (phosphocreatine) which is likely a protein based on its function.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a specific cell type name (lymphoid neoplasms) which is likely a cell type based on the context.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a specific protein name (E2A) which is likely a protein based on its function.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides specific cell type names (granulocytes, T cells) which are likely corresponding entities based on their types.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a specific DNA binding factor name (AP-1) which is likely DNA based on its function.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a specific protein name (GATA-1) which is likely a protein based on its function.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific protein names (Erbstatin, genistein) and RNA name (Egr-1) which are likely corresponding entities based on their functions.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides specific protein names (ATF1, CREB, H4) which are likely corresponding entities based on their functions.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides specific DNA name (EBV) and protein names (EBNA2, estrogen receptor) which are likely corresponding entities based on their functions.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides specific protein names (MR, aldosterone, progesterone) which are likely corresponding entities based on their functions.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides specific protein names (FEV1, FVC, PEF, prednisolone) which are likely corresponding entities based on their functions.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides specific protein names (IL-2r, c-fos, IL-2, lymphokine) which are likely corresponding entities based on their functions.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides specific cell type names (Type I, Type II) which are likely corresponding entities based on their types.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The example does not provide any specific entity names that can be identified.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The example does not provide any specific entity names that can be identified.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The example does not provide any specific entity names that can be identified.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"T3 receptor\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'T3 receptor': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"platelet-activating factor\": \"protein\"}, {\"c-fos\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'platelet-activating factor': 'protein', 'c-fos': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"X boxes\": \"protein\"}, {\"Y boxes\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"major histocompatibility complex (MHC) class II promoters\": \"DNA\"}]",
        "prediction": "{'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"A-myb\": 5},\n    {\"Protein\": 5},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"DNA\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5, \"embryonic cardiac cells\": 5},\n    {\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Jun\": 5, \"ATF-2\": 5},\n    {\"p50p50\": 5}\n]",
        "response3": "[{\"DNA\": \"DNA\"}, {\"upstream stimulatory factor\": \"protein\"}]",
        "prediction": "{'DNA': 'DNA', 'upstream stimulatory factor': 'protein'}"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell type (Th2-type lymphocytes) and its corresponding entity label (cell_type), making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains examples of proteins (c-kit and IL-4R alpha chain) and their corresponding entity labels (protein), which are relevant for extracting named entities from the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a protein (GATA-1) and its corresponding entity label (protein), which is useful for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of proteins (Stat3, Stat5, and c-Mpl) and their corresponding entity labels (protein), which are crucial for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence includes a protein (TCF-1) and its corresponding entity label (protein), which is relevant for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) and their corresponding entity labels (protein), which are essential for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions proteins (Sp1 and CD14) and their corresponding entity labels (protein), which are helpful for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides an example of a protein (E2A) and its corresponding entity label (protein), which is relevant for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding entity labels (protein), which are crucial for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a protein (CD95 ligand) and its corresponding entity label (protein), which is useful for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains a cell line (SCM-1) and its corresponding entity label (cell_line), which is relevant for extracting named entities related to cell lines from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of a cell line (Ramos, Jurkat) and a cell type (B and T cell activation) along with a technology (cDNA microarray technology) and their corresponding entity labels (cell_line, cell_type, DNA), which are crucial for extracting named entities from the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions proteins (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and their corresponding entity labels (protein), which are helpful for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence includes proteins (ATF1, CREB, H4) and their corresponding entity labels (protein), which are relevant for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence contains a DNA element (BAT box), a protein (CD20), and a cell type (B cells) along with their corresponding entity labels (DNA, protein, cell_type), which are useful for extracting named entities from the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions proteins (IL-2, NFAT, NFAT delta418, calcineurin, Tpl-2, cyclosporin A) and their corresponding entity labels (protein), which are relevant for extracting named entities related to proteins from the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, making it not helpful for extracting named entities.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, making it not helpful for extracting named entities.\"}\n]",
        "response3": "[{\"thromboxane receptor gene\": \"protein\"}, {\"thromboxane receptor gene promoter\": \"protein\"}, {\"chloramphenicol acetyltransferase (CAT)\": \"protein\"}, {\"K562 cells\": \"cell_line\"}]",
        "prediction": "{'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n{\"Protein\": 4},\n{\"MNDA\": 4, \"myeloid cell lines\": 4},\n{\"Runt domain\": 4},\n{\"CREB\": 4, \"AR-CRE\": 4},\n{\"WT1\": 4},\n{\"T cell\": 4, \"interleukin 2\": 4},\n{\"PBMC\": 4, \"adenovirus DNA\": 4},\n{\"FasL\": 4, \"IL-2\": 4, \"IFN-gamma\": 4},\n{\"PU.1\": 4, \"M-CSF receptor\": 4, \"macrophage\": 4},\n{\"TCL1\": 4},\n{\"ZEBRA\": 4},\n{\"CD70\": 4, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 4, \"CD40\": 4},\n{\"GM-CSF\": 4},\n{\"EBV\": 4, \"B-cell\": 4},\n{\"granulocytes\": 4, \"T cells\": 4}\n]",
        "response3": "[{\"CEM\": \"cell_line\"}, {\"RPMI 8402\": \"cell_line\"}]",
        "prediction": "{'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 5},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 5},\n    {\"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 4},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"HIV long terminal repeat (LTR)\": \"DNA\"}, {\"beta interferon\": \"protein\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon': 'protein'}"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4},\n    {\"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"HeLa\": \"cell_line\"}, {\"IFN beta\": \"protein\"}]",
        "prediction": "{'HeLa': 'cell_line', 'IFN beta': 'protein'}"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a protein (NF-E2) being mentioned in relation to a specific action, aiding in the extraction of named entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions a protein (P selectin) in relation to an action, which is helpful in identifying named entities, but the context is slightly less specific compared to Example 1.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides multiple examples of named entities (RNA, cell_type, protein) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions proteins (TIMP-1) and DNA in relation to specific actions, which is helpful in identifying named entities, but the context is slightly less specific compared to Example 3.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides multiple examples of named entities (cell_type, protein) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides a clear example of a protein (G-CSF) being mentioned in relation to a specific action, aiding in the extraction of named entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides multiple examples of named entities (protein) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides multiple examples of named entities (protein) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides a clear example of a cell type (cell_type) being mentioned in relation to a specific action, aiding in the extraction of named entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides multiple examples of named entities (protein) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides multiple examples of named entities (protein, RNA) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions a protein (Egr-1) and RNA in relation to specific actions, which is helpful in identifying named entities, but the context is slightly less specific compared to Example 3.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions DNA, cell_line, and cell_type in relation to specific actions, which is helpful in identifying named entities, but the context is slightly less specific compared to Example 3.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides multiple examples of named entities (protein) in specific contexts, aiding in the extraction of these entities from the target sentence.\"},\n{\"Example 15\": 1},\n{\"Reason 15\": \"The sentence does not provide any specific named entities or context that would aid in the extraction of entities from the target sentence.\"},\n{\"Example 16\": 1},\n{\"Reason 16\": \"The sentence does not provide any specific named entities or context that would aid in the extraction of entities from the target sentence.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not provide any specific named entities or context that would aid in the extraction of entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 1},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone\": 5},\n    {\"IL-2 receptor alpha subunit is a hallmark of lymphocyte activation\": 4},\n    {\"IL-4 inhibits LPS-induced expression of AP-1 protein\": 4},\n    {\"chimeric receptor containing the extracellular domain of c-kit and the cytoplasmic and transmembrane domains of the IL-4R alpha chain\": 4},\n    {\"suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene\": 3},\n    {\"selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model\": 3},\n    {\"IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells\": 5},\n    {\"other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined\": 3},\n    {\"constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 4},\n    {\"structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function\": 5},\n    {\"NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway\": 4},\n    {\"human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription\": 5},\n    {\"T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2\": 5},\n    {\"balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells\": 4}\n]",
        "response3": "[{\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"IL-2R alpha\": \"protein\"}]",
        "prediction": "{'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"M-CSF\": \"protein\"}]",
        "prediction": "{'M-CSF': 'protein'}"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1},\n    {\"Example 19\": 1}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Th1\": 5, \"Th2\": 5},\n    {\"SLAP-130\": 5, \"SLP-76\": 5, \"T cell\": 5},\n    {\"Sp1\": 5, \"Ets\": 5},\n    {\"UAS3\": 5, \"UAS2\": 5, \"YY1\": 5},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5},\n    {\"GATA-1\": 5},\n    {\"IL-13\": 5, \"IL-4\": 5, \"B cell\": 5, \"monocyte\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"UAS1\": 5, \"B cell\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"GATA-1\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"Pax-5\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n{\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n{\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"cdc-2\": \"protein\"}, {\"cyclin E\": \"protein\"}, {\"CD23\": \"protein\"}, {\"cyclin D2\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course .\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"B4-2\": \"protein\"}]",
        "prediction": "{'B4-2': 'protein'}"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"IL-2 receptor\": \"protein\"}, {\"JAK1\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}]",
        "prediction": "{'IL-2 receptor': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The examples provided contain specific entities mentioned in the target sentence and their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBalpha\": 5},\n    {\"NF-kappaB\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-ATc\": 5},\n    {\"IL-4\": 5},\n    {\"Th1\": 5},\n    {\"Th2\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"IL-2\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"immunohistochemistry\": 5},\n    {\"NF-E2\": 5},\n    {\"IgH\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 5},\n    {\"CD40\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 5},\n    {\"ATL\": 5},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 5}\n]",
        "response3": "[{\"T cells\": \"cell_type\"}]",
        "prediction": "{'T cells': 'cell_type'}"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"CR1\": \"protein\"}, {\"CD35\": \"protein\"}, {\"CR3\": \"protein\"}, {\"CD11b/CD18\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"p50/p65\": \"protein\"}, {\"monocytes\": \"cell_type\"}, {\"HIV-infected monocytic cells\": \"cell_type\"}]",
        "prediction": "{'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of 'cDNAs' which is a specific type of entity (DNA) in the context of molecular biology.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific mentions of entities like 'SP1' (protein), 'caspases' (protein), and 'B-cell' (cell_type) which are directly related to molecular biology and cellular components.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions 'Th2-type lymphocytes' which is a specific cell type entity, providing clear context for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'E2A' as a gene at the protein level, providing a direct link to the entity type 'protein' in molecular biology.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains mentions of 'SLAP-130' (protein), 'SLP-76' (protein), and 'T cell' (cell_type) which are specific entities in the context of molecular biology and cellular components.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides direct information about 'TCF-1' as a protein, aiding in the extraction of protein entities from the text.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'T lymphocytes' (cell_type) and 'HLA-molecules' (protein) which are specific entities in the context of immunology and molecular biology.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains mentions of 'IkappaBbeta' (protein) and 'NF-kappaB' (protein) which are specific entities related to molecular biology and cellular processes.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'GM-CSF' as a gene, indicating the entity type 'protein' in the context of molecular biology.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides information about 'immunoglobulin kappa 3' enhancer' as a DNA element, aiding in the extraction of DNA-related entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'EBNA-2' and 'PU.1' as proteins, providing direct information for protein entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'hepatitis B virus' as DNA and 'HBxAg' as a protein, aiding in the extraction of DNA and protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'SIVsmmPBj14' as a cell line, providing specific information for cell line entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'EBV' as a cell type and 'B-cell' as a cell type, aiding in the extraction of cell type entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'p50' and 'p65' as proteins, along with 'DNA' and 'protein' in the context of molecular biology, aiding in entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'B and T cell activation' as a cell type, 'Ramos' and 'Jurkat' as cell lines, and 'cDNA microarray technology' as DNA, providing specific entities for extraction.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to molecular biology or cellular components, making it less helpful for entity extraction.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to molecular biology or cellular components, making it less helpful for entity extraction.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to molecular biology or cellular components, making it less helpful for entity extraction.\"}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}, {\"hepatitis B virus X protein\": \"protein\"}]",
        "prediction": "{'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"PhoQ\": \"protein\"}]",
        "prediction": "{'PhoQ': 'protein'}"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n    {\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n    {\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific gene or protein names that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains gene or protein names that are relevant to the entity labels in the target sentence, although not as directly as Example 1.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes gene or protein names that are related to the entity labels in the target sentence, providing relevant information for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions gene or protein names that match the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific gene or protein names that are directly related to the entity labels in the target sentence, making it very helpful for extracting named entities.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence mentions a specific gene related to the 'protein' entity label in the target sentence, providing some relevant information for extracting named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence includes gene or protein names that are relevant to the entity labels in the target sentence, although not as directly as some other examples.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains gene or protein names that are related to the entity labels in the target sentence, providing relevant information for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions gene or protein names that match the entity labels in the target sentence, making it highly useful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a specific cell line name that directly matches the 'cell_line' entity label in the target sentence, making it very helpful for extracting named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence includes gene or protein names that are relevant to the entity labels in the target sentence, providing some useful information for extracting named entities.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions a specific gene related to the 'protein' entity label in the target sentence, providing some relevant information for extracting named entities.\"},\n    {\"Example 13\": 1},\n    {\"Reason 13\": \"The sentence does not contain any specific gene or protein names that match the entity labels in the target sentence, hence not very helpful for extracting named entities.\"},\n    {\"Example 14\": 1},\n    {\"Reason 14\": \"The sentence does not contain any specific gene or protein names that match the entity labels in the target sentence, hence not very helpful for extracting named entities.\"},\n    {\"Example 15\": 1},\n    {\"Reason 15\": \"The sentence does not contain any specific gene or protein names that match the entity labels in the target sentence, hence not very helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence, providing some relevance for named entity extraction.\"}\n]\n[\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence, providing some relevance for named entity extraction.\"}\n]\n[\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains a specific cell line name that matches one of the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence contains specific cell type and DNA names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct relevance for named entity extraction.\"}\n]\n[\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence contains general terms that do not match the entity labels in the target sentence, providing limited relevance for named entity extraction.\"}\n]\n[\n{\"Example 16\": 4},\n{\"Reason 16\": \"The sentence contains general terms that do not match the entity labels in the target sentence, providing limited relevance for named entity extraction.\"}\n]\n[\n{\"Example 17\": 4},\n{\"Reason 17\": \"The sentence contains general terms that do not match the entity labels in the target sentence, providing limited relevance for named entity extraction.\"}\n]",
        "response3": "[{\"gag/pol\": \"protein\"}, {\"env mRNA\": \"RNA\"}, {\"HTLV-infected cells\": \"cell_type\"}]",
        "prediction": "{'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n{\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 3},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 4},\n{\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n{\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n{\"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\": 4},\n{\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region .\": 4}\n]",
        "response3": "[{\"long terminal repeat\": \"DNA\"}, {\"transcriptional enhancer\": \"DNA\"}, {\"nuclear factor kappa B\": \"protein\"}]",
        "prediction": "{'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (myeloperoxidase, lysozyme, PU.1) which are directly related to the 'protein' entity label.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions PBMC (Peripheral Blood Mononuclear Cells) which is related to the 'cell_type' entity label. The adenovirus-specific PCR is related to the 'DNA' entity label.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions PBMC (Peripheral Blood Mononuclear Cells) which is related to the 'cell_type' entity label. The presence of adenovirus DNA is related to the 'DNA' entity label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions IFN-gamma, which is a protein directly related to the 'protein' entity label.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions lymphoid neoplasms, which are related to the 'cell_type' entity label.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions STAT1, which is a protein directly related to the 'protein' entity label.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions Ras, which is a protein directly related to the 'protein' entity label.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions immunohistochemistry, gene, and cell type, all of which are directly related to the 'protein', 'DNA', and 'cell_type' entity labels respectively.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions NF-kappa B, which is a protein directly related to the 'protein' entity label.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions SCM-1, which is a cell line directly related to the 'cell_line' entity label.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions SIVsmmPBj14, which is a cell line directly related to the 'cell_line' entity label.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions nonhuman primates, which are related to the 'cell_type' entity label.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions T-PLL, which is a cell type directly related to the 'cell_type' entity label.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions E2A, which is a protein directly related to the 'protein' entity label.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions AP-1, which is related to the 'DNA' entity label.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, all of which are directly related to the 'cell_type', 'cell_line', and 'DNA' entity labels respectively.\"},\n{\"Example 17\": 1},\n{\"Reason 17\": \"The sentence does not contain any specific entity names related to the given entity labels.\"},\n{\"Example 18\": 1},\n{\"Reason 18\": \"The sentence does not contain any specific entity names related to the given entity labels.\"},\n{\"Example 19\": 1},\n{\"Reason 19\": \"The sentence does not contain any specific entity names related to the given entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a specific protein name (NF-E2) which is directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence mentions specific cell types (EBV and B-cell) which are directly related to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names (CD70, IL-4, CD40) and cell types (B cell, plasma cells) which are directly related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions a specific cell type (Th2-type lymphocytes) which is directly related to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a specific protein name (GATA-1) which is directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple protein names (Syk, Zap) and a specific cell type (T cell) which are directly related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions specific cell types (Th1, Th2) which are directly related to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a specific cell type (T cell) and a specific protein name (interleukin 2) which are directly related to the entity labels 'cell_type' and 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions a specific protein name (IL-2) which is directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a specific DNA-binding protein name (AP-1) which is directly related to the entity label 'DNA' in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions specific protein names (IL-2, c-Jun, c-Fos) which are directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides specific DNA regions (UAS3, UAS2) and a protein name (YY1) which are directly related to the entity labels 'DNA' and 'protein' in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions specific protein names (SCL, GATA-1) which are directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) which are directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions specific protein names (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) which are directly related to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides a specific protein name (STAT1) which is directly related to the entity label 'protein' in the target sentence.\"},\n    {\"Example 17\": 1},\n    {\"Reason 17\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 18\": 1},\n    {\"Reason 18\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"},\n    {\"Example 19\": 1},\n    {\"Reason 19\": \"The sentence does not contain any specific entities related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}]",
        "prediction": "{'B-cell': 'cell_type'}"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.\": 4},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n{\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"We propose the common pathway as the simplest way of accounting for the common requirements and properties of the signaling pathway.\": 1},\n{\"All of the tumors exhibited typical morphology, were limited to the ovary (stage I), and 7 cases followed a benign clinical course.\": 1},\n{\"At least four distinct genes encode the various family members, and several isoforms of these have been identified as well.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 5},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1},\n    {\"Sentence\": 1}\n]",
        "response3": "[{\"NF-KB\": \"protein\"}]",
        "prediction": "{'NF-KB': 'protein'}"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"AP-1\": 4},\n    {\"WT1\": 4},\n    {\"myeloid cell lines\": 4},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"PU.1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"SCM-1\": 5},\n    {\"IL-13\": 5},\n    {\"IL-4R\": 5},\n    {\"JAK2\": 5},\n    {\"IL-13R\": 5},\n    {\"STAT1\": 5},\n    {\"SCL\": 4},\n    {\"GATA-1\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"GATA-1\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 4},\n    {\"ATL\": 4}\n]",
        "response3": "[{\"TCL1\": \"protein\"}]",
        "prediction": "{'TCL1': 'protein'}"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 1},\n    {\"Example 17\": 1},\n    {\"Example 18\": 1}\n]",
        "response3": "[{\"Bcl-2\": \"protein\"}]",
        "prediction": "{'Bcl-2': 'protein'}"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence directly mentions the 'E2A' gene at the protein level, which is relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' proteins, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence directly refers to the 'EBNA-2' and 'PU.1' proteins, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence explicitly states the increase of 'p21(WAF1/CIP1)' and 'p27(KIP1)' mRNA and protein, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'EKLF', 'CBP', 'p300', and 'P/CAF' proteins, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence directly mentions 'NF-kappa B' DNA binding activity, which is relevant to the 'DNA' entity type in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'Jun' and 'ATF-2' proteins, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence refers to 'IkappaBbeta' and 'NF-kappaB' proteins, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'p50' and 'p65' proteins, as well as 'DNA-protein complexes', which are relevant to the 'protein' and 'DNA' entity types in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'Tip' and 'Tap' proteins, as well as 'Jurkat-T cells', which are relevant to the 'protein' and 'cell_line' entity types in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B', which are relevant to the 'DNA' and 'protein' entity types in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'cDNA', 'Jurkat', and 'DRE 1', which are relevant to the 'DNA' and 'cell_line' entity types in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'tal-1', 'GATA-binding proteins', and 'hematopoiesis', which are relevant to the 'protein' and 'cell_type' entity types in the target sentence.\"},\n    {\"5\": \"The sentence mentions 'NF-E1' and 'YY-1' proteins, which are relevant to the 'protein' entity type in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[{\"PRE-I\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"Jurkat cells\": \"cell_line\"}]",
        "prediction": "{'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}"
    }
]